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Abstract 
 
Type 1 diabetes mellitus (T1DM) is a complex metabolic condition that results in 
hyperglycemia due to insulin deficiency (Daneman, 2006).  Diabetes has a range of 
effects on almost every system in the body including the kidneys, the eyes, the 
cardiovascular system, the genito-urinary system, the gastro-intestinal system and the 
nervous system (Daneman, 2006).  The effects of this condition are widespread and 
have a significant impact both on life expectancy and the quality of life of individuals 
suffering from diabetes (Scottish Diabetes Survey Monitoring Group, 2011).  The 
impact of diabetes on oral health has been investigated over many decades, however, 
the conclusions have been varied and study design has not always been adequate 
(Mealey et al., 2006; Khader et al., 2006; Chávarray et al., 2009).  Research presented 
in this thesis is largely the result of a cross-sectional clinical study examining the oral 
cavities of non-smoking T1DM patients, funded by the Chief Scientist Office of the 
Scottish Government.  The clinical part of the study took place between January 2006 
and May 2009 in Glasgow Dental Hospital.   
 
Chapter one provides an introduction and narrative review on the subject of T1DM, 
periodontal disease, and the various other reported oral manifestations of diabetes 
mellitus.  The methods for measuring general and oral health related quality of life 
outcomes are also discussed.  Chapter one reveals some of the inadequacies of studies 
investigating the link between T1DM and oral disease to date and contextualises the 
studies presented in this thesis. 
 
Chapter two presents the main periodontal findings of a large cross-sectional study.  
112 non-diabetic subjects and 203 subjects with type 1 diabetes were examined.  203 
diabetic patients were divided into well controlled and poorly controlled groups based 
on their average blood sugar levels over the previous two years.  169 were poorly 
controlled. (PCD).  Those with T1DM, (especially those with poor glycaemic control) 
had a greater extent and severity of periodontitis than those without diabetes.  There 
was also some evidence that  never smoking T1DM patients were more likely to have 
periodontal disease than non-diabetic subjects.  The odds ratio (OR) was 1.43 [0.74 to 
2.75] (p = 0.29) for all T1DM patients and 1.58 [0.75 to 3.33] (p = 0.23) for PCD.  
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This difference remained even after the multivariable analysis took into account age, 
gender and lifestyle including: body mass index of the subject; whether they had 
smoked in the past; whether they attended a dentist; their level of education and how 
deprived the area they lived in was.  
 
Chapter three presents an analysis of the impact of age, HbA1c, and duration on the 
expression of periodontal disease in T1DM subjects.  Cross-tabulations and 
multivariable logistic regression analysis was performed on the periodontal data from 
T1DM subjects and non-diabetic subjects in order to determine the relationship 
between age, HbA1c and duration, and periodontitis.  Diabetic subjects developed 
periodontitis at a younger age than non-diabetes subjects.  This will represent a 
significant impact on life time dental service provision for subjects affected at a 
young age.  The relationship between HbA1c and severe periodontitis is not a simple 
one.  It is possible that unknown factors confound the relationship between glycaemic 
control and periodontitis.  There was no relationship between duration of diabetes and 
periodontitis when age was controlled for.  
 
Chapter four presents the results of a small study investigating biomarkers of bone 
turnover in patients with and without T1DM and in patients with and without 
periodontitis.  Patients with T1DM had higher levels of osteoprotegerin an 
osteoprotective molecule that normally leads to a reduced propensity for bone loss. 
T1DM patients were also shown to have reduced levels of biomarkers of bone 
formation (osteocalcin).  It is possible that a reduced capacity for bone repair and 
regeneration may account for the increase levels of periodontitis seen in T1DM.  
Further prospective studies would be required to confirm this hypothesis. 
 
Chapter five investigated the level of caries and oral mucosal abnormalities in T1DM.  
There was little difference in caries indicators or in oral mucosal lesions between the 
groups.  There was no difference in the bacterial microflora and in the level of 
resistance to antibiotics found in this cohort.  T1DM patients, however, did have an 
increase in the symptoms of dry mouth, an increased density of candida colonisation 
and reduced salivary flow rates. 
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Chapter six reports the data derived from the oral health questionnaire, including the 
Oral Health Impact Profile -14 (OHIP-14) and the Audit of Diabetes Dependent 
Quality of Life (ADDQOL©). Patients with T1DM, despite having increased levels of 
periodontal disease, reduced salivary flow rates and increased symptoms of 
xerostomia did not have higher OHIP scores by any measure.  The reasons for this 
apparently negligible impact of oral disease or oral health related quality of life are 
discussed.  The OHIP-14 was shown to have construct validity in this population 
although the correlations were relatively weak and the differences were small.  It is 
possible that patients with T1DM do not consider the impact of their oral health to be 
a significant problem in light of their other on-going medical issues.  This finding 
requires further in-depth investigation of the psychology behind this apparent reduced 
impact.   
 
This is the first study of its kind to examine the oral and dental health of non-smoking 
type 1 diabetic patients.   The conclusions from the clinical data support the view that 
patients with T1DM should be targeted with oral and dental health advice.  
Encouragingly the prevalence of periodontitis was lower in well controlled diabetic 
subjects suggesting that the effect of T1DM on the oral cavity can be ameliorated by 
good glycaemic control even though logistic regression analysis did not show a linear 
relationship.  It is important that health professionals work together in order to prevent 
and manage the oral complications of T1DM in the same way that there are 
preventive and screening programmes for other diabetic complications. The 
pathogenesis behind the increased prevalence and severity of periodontal disease in 
T1DM requires further study. 
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1 Introduction 
1.1 Diabetes Mellitus 
1.1.1 Introduction 
Diabetes mellitus is a heterogeneous group of metabolic conditions caused by either a lack 
of insulin, resistance to its effects, or both (Daneman, 2006).  Sufferers universally 
experience hyperglycaemia as a result of the body’s inability to maintain normal blood 
glucose levels through homeostatic mechanisms.  Diabetes has been recognised for 
millennia and was, until the development of insulin therapy, a fatal disease (Banting et al. 
1922).  Now all types of diabetes mellitus are treatable with insulin or anti-diabetic drugs 
although long term complications remain high. 
Diabetes mellitus is the fifth most common cause of death in the world and it is estimated 
that one in eight deaths (12.2%) among 20 to 79-year-olds were attributable to the 
condition in 2010 (International Diabetes Federation, 2009).  Life expectancy is reduced, 
on average, by more than 20 years in people with Type 1 diabetes and by up to 10 years in 
people with Type 2 diabetes (Diabetes U.K., 2011). 
The financial costs associated with diabetes are huge.  It is currently estimated that 10 
percent of the NHS budget in the United Kingdom is spent on diabetes and its 
complications.  This represents £9 billion a year based on the 2007/2008 budget for the 
NHS of approximately £90.7 billion.  In addition, one in ten people admitted to hospital 
have diabetes.  In 2006, 28.4 million items to treat diabetes were prescribed at a cost of 
£561.4 million (Diabetes U.K., 2011).  The impact of this chronic condition on individuals 
and society cannot be overstated.   
1.1.2 Classification 
Diabetes mellitus is classified by four distinct categories based on aetiopathogenesis 
although two main categories of diabetes make up the bulk of cases.  Type 1 diabetes 
mellitus (T1DM) (previously known as insulin dependent diabetes mellitus (IDDM)) and 
Type 2 diabetes mellitus (previously known as non-insulin dependent diabetes mellitus 
(NIDDM)) account for 99.4% of all cases in Scotland.  They are the predominant types in  
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all areas of the world (SDSMG, 2009; IDF, 2009).  Other categories include gestational 
diabetes and other specific types of diabetes.  The latter are made up of those associated 
with gene defects of pancreatic ß cell function and insulin resistance; other syndromes 
associated with diabetes; diseases of the exocrine pancreas; and endocrinopathies and 
diabetes induced by drugs, chemicals or infective agents (Table 1-1) (Expert Committee on 
the Diagnosis and Classification of Diabetes mellitus, 2003; American Diabetes 
Association, 2011).   
The above classification includes changes to reflect the aetiopathogenesis rather than the 
therapeutic implications of the groups.  It also reflects the fact that there are a range of 
presentations, as well as therapeutic treatments, all of which can change with time, 
meaning that patients should not be classified according to these overlapping criteria.  The 
terms insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus and 
their acronyms, IDDM and NIDDM, were therefore removed from the classification as a 
result of the confusion that their use generated.  The terms type 1 and type 2 diabetes 
mellitus were retained, with Arabic numerals being used (Expert Committee on the 
Diagnosis and Classification of Diabetes mellitus, 2003) and this classification will be 
adopted within this thesis. 
Type 2 diabetes mellitus includes the most prevalent form of diabetes, which results from 
insulin resistance, with or without a secretory defect.  It primarily occurs with increasing 
age and is associated with genetic and environmental risk factors.  Type 2 diabetes is 
commonly preceded by a long period of abnormal glycaemic control and is part of the 
metabolic syndrome associated with hypertension, dyslipidaemia and hyperglycaemia.  
The condition has a stronger genetic aetiology than T1DM although environmental factors 
such as diet, exercise, obesity and smoking will impact on the development of type 2 
diabetes (Stumvoll et al., 2005).   
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Table 1-1 Classification of Diabetes Mellitus (American Diabetes 
Association, 2011) 
I. Type 1 diabetes (ß-cell destruction, usually leading to absolute insulin deficiency) 
                             A. Immune mediated 
                             B. Idiopathic 
II. Type 2 diabetes (may range from predominantly insulin resistance with relative 
insulin deficiency to a predominantly secretory defect with insulin resistance) 
III. Other specific types 
      A. Genetic defects of ß-cell function 
            1. Chromosome 12, HNF-1  (MODY*3) 
            2. Chromosome 7, glucokinase (MODY2) 
            3. Chromosome 20, HNF-4  (MODY1) 
            4. Mitochondrial DNA 
            5. Others 
      B. Genetic defects in insulin action 
            1. Type A insulin resistance 
            2. Leprechaunism 
            3. Rabson-Mendenhall syndrome 
            4. Lipoatrophic diabetes 
            5. Others 
      C. Diseases of the exocrine pancreas 
            1. Pancreatitis 
            2. Trauma/pancreatectomy 
            3. Others 
      D. Endocrinopathies 
            1. Acromegaly 
            2. Cushing’s syndrome 
            3. Glucagonoma 
            4. Pheochromocytoma 
            5. Hyperthyroidism 
            6. Somatostatinoma 
            7. Aldosteronoma 
            8. Others 
      E. Drug- or chemical-induced 
      F. Infections 
      G. Uncommon forms of immune-mediated diabetes 
      H. Other genetic syndromes sometimes associated with diabetes 
IV. Gestational diabetes mellitus (GDM) 
* Maturity onset diabetes of the young 
1.1.3 Epidemiology of Type 1 Diabetes Mellitus 
Diabetes mellitus affects 284.6 million people in the world today and this figure is 
predicted to continue to rise in the coming decades.  The World Health Organisation 
(WHO) and the International Diabetes Federation (IDF) predict that by 2030 between 366 
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and 438 million individuals will be suffering from diabetes.  The burden of this major 
cause of morbidity and mortality falls on the developing world (Wild, 2004; International 
Diabetes Federation, 2009).  In 2009 there were 2.6 million diabetic patients in the United 
Kingdom.  It is estimated that this figure will rise to over 4 million by 2025 (Diabetes UK, 
2010).  World-wide, type 2 diabetes mellitus accounts for 85-95% of all diabetes and in 
Scotland type 2 diabetes mellitus accounts for 87.4% of cases (SDSMG, 2009).  The 
second largest group is T1DM which accounts for 5-15% of diabetic patients world-wide 
and 12% in Scotland.  The other forms of diabetes mellitus listed in Table 1-1 account for 
less than 2% of all diabetic subjects world wide and 0.6 % in Scotland (IDF 2009, 
SDSMG, 2009).   
The incidence of T1DM varies significantly between countries and racial groups, with 
countries such as Venezuela and China having an incidence of less than 0.1 children 
diagnosed per 100,000 per year.  However, Northern European countries have much higher 
incidence.  In Finland 40.1 children of every 100,000 are diagnosed per year (Diamond 
Project group, 2006).   
The prevalence of T1DM has been increasing world-wide over the last several decades and 
a review of the Scottish Diabetes Surveys, over the six years since implementation, 
confirms that numbers are continuing to rise in Scotland (Figure 1-1).  The absolute 
number of patients with T1DM continues to increase (22,597 in 2003; 27,367 in 2009).  
This is reflected in the rising incidence of T1DM in children over the last 30 years.  It is 
known, from a series of studies that the incidence of T1DM has been increasing by 2-3% a 
year since 1968 (Patterson et al., 1983).  T1DM is one of the most common long term 
conditions affecting children and adolescents in Scotland, which has one of the highest 
prevalence rates of T1DM in Europe.  The average annual incidence for Scotland from 
1984 to 1993 was 23.9/100,000 children. (Patterson et al., 1983; Rangasami et al., 1997).  
In the EURDIAB study of the incidence of T1DM in Europe most countries had incidence 
rates of 6-9/100 000 children. (Green et al., 1992)  
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Figure 1-1  Number of patients with type 1 diabetes registered on the 
Scottish diabetes register (2001-2009) 
1.1.4 Pathogenesis of Type 1 Diabetes Mellitus 
T1DM is normally due to autoimmune destruction of the insulin producing cells of the 
pancreas (the beta cells of the islets of Langerhans).  This results in an absolute deficiency 
in endogenous insulin production (Daneman, 2006).  Specific destruction of the beta cells 
occurs when the islets of Langerhans are infiltrated with dendritic cells, macrophages and 
CD4+ and CD8+ T lymphocytes (Atkinson et al., 2001).  As a result of the advanced stage 
of beta cell depletion, by the time symptoms appear, these cases have an acute onset and 
are prone to acute ketoacidosis.  Ketoacidosis is a condition where ketone bodies build up 
in the blood as a result of lipolysis in the absence of the insulin required for glycolysis 
(Daneman, 2006).  The majority of cases are diagnosed in the first two decades of life but a 
significant proportion of cases also present in young adults.  There is no upper age limit 
which precludes a diagnosis of type 1 diabetes (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2003).   
1.1.4.1 Clinical Presentation 
Type 1 diabetic patients normally present with the classic symptoms of polyuria, nocturia, 
enuresis, polydipsia, polyphagia, weight loss, lethargy, fatigue and abdominal pain 
(Daneman, 2006).  When blood glucose levels are allowed to increase due to excess 
carbohydrate intake, or a lack of appropriate insulin therapy, acute hyperglycaemia and 
even diabetic ketoacidosis requiring emergency medical management will occur.  Diabetic 
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ketoacidosis is a potentially fatal condition and was the cause of 39 deaths in 2009 due to 
hyperglycaemia in England and Wales (Office for National Statistics, 2009).   
The short term implications of metabolic dysregulation of blood glucose can also lead to 
acute hypoglycaemia due to lack of carbohydrate intake, excess insulin or lack of 
preparation for increased physical activity.  Acute hypoglycaemia leads to confusion, 
palpitations, sweating, tachycardia and loss of consciousness.  Without medical 
intervention this may lead to death.  Severe hypoglycaemia occurs with a frequency of 
about five to 50 episodes per 100 patient-years, dependent both on treatment approach and 
level of control achieved (Diabetes Control and Complications Trial Research Group, 
1993; Daneman, 2006).  This has implications for patient suitability for hazardous 
workplaces and even driving.  There is also evidence for cumulative neurological damage 
and other tissue damage occurring during critically low levels of blood sugar.  According 
to the Office for National Statistics 3-5 people die each year as a result of diabetic coma in 
England and Wales (Office for National Statistics, 2009).  Doctors must tread a fine line 
between the desirability of near normal blood glucose levels and the increased risk of 
severe hypoglycaemic events as reported by the Diabetes Control and Complications Trial 
(DCCT).  In this study strict blood glucose targets were met but the risk of serious 
hypoglycaemic events increased two to three fold.  Three people died due to road traffic 
accidents during the DCCT study as a result of the driver becoming hypoglycaemic 
(DCCTRG, 1993).   
Despite the seriousness of the acute complications that accompany a diagnosis of diabetes, 
the main threats to life and quality of life are the chronic complications associated with 
long term glucose and lipid dysregulation.  Complications include microvascular and 
macrovascular disease, nephropathy and retinopathy as well as increased susceptibility to 
infection and possibly oral complications.  Risk factors for the development of diabetic 
complications include the following: poor glycaemic control; early onset and long duration 
of type 1 diabetes; genetic predisposition; family history of diabetes-related complications 
or hypertension; smoking; obesity; sedentary lifestyle; hypertension; and hyperlipidaemia 
(Daneman, 2006).  While T1DM is a significant risk factor for the development of these 
complications, optimum control of blood glucose levels can reduce the risk and slow the 
progression of complications (DCCTRG, 1993). 
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T1DM includes those cases currently attributable to an autoimmune process as well as 
those with an unknown aetiology.  It does not include those forms of ß-cell destruction or 
failure for which non-autoimmune-specific causes can be assigned, for example 
pancreatitis or cystic fibrosis (Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus, 2003).  Idiopathic type 1 diabetes is a heterogenous group of conditions 
with no known aetiology.  Some of these patients have permanent insulinopenia and are 
prone to ketoacidosis, but have no evidence of autoimmunity.  The environmental or 
genetic aetiopathogenesis of this type of diabetes mellitus is not well understood.  The rate 
of beta cell destruction varies between individuals and can be rapid and complete or it can 
be a slower process whereby the patient, usually an adult, retains some residual beta cell 
function for some years.  Although only a minority of patients with type 1 diabetes fall into 
this category, of those who do, most are of African or Asian ancestry.  Individuals with this 
form of diabetes suffer from episodic ketoacidosis and exhibit varying degrees of insulin 
deficiency between episodes.  This form of diabetes is strongly inherited and is not HLA 
associated.  An absolute requirement for insulin replacement therapy in affected patients 
may come and go, although most will eventually require insulin therapy for survival 
(Imagawa et al., 2000; Pinera-Pilono et al., 2001).  
Most cases of T1DM are characterised by the presence of one or more autoantibodies to 
islet cells (ICA), insulin (IAA), glutamic acid decarboxylase (GAD65) or to the tyrosine 
phosphatases IA-2 and IA-zx2ß.  85-90% of individuals have one or more of these 
autoantibodies present at diagnosis and these are present in the blood before acute 
symptoms appear (Atkinson et al., 2001, Pihoker, et al., 2005, A.D.A., 2009).  The factor 
which initiates this cell mediated autoimmunity is not well understood although there are 
strong associations with HLA loci, strengthening the case for susceptible and resistant 
genotypes.  Models in the Non-obese Diabetic (NOD) mouse and the Biobreed diabetes 
prone rat model indicate that Human leukocyte Antigen (HLA) is necessary, but not 
sufficient, for diabetes to develop (Ounissi-Benkalha and Polychronakos, 2008).  
Eisenbarth originally proposed that all individuals had susceptibility to diabetes whether 
low or high.  This has been further explained by an understanding of the risk conferred by 
HLA genotype and a range of other less important Insulin Dependent Diabetes Mellitus 
(IDDM) susceptibility genes (Eisenbarth et al., 1986; Ounissi-Benkalha and 
Polychronakos, 2008).   
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1.1.4.2 Candidate genes influencing diabetic susceptibility 
It is clear that there is a genetic element to the development of T1DM although the 
association is much less strong than in type 2 diabetes mellitus.  Diabetes UK estimates 
that if a mother has the condition, the risk of the child developing T1DM is about 2% 
whereas if the father is diabetic then the risk to the child is estimated to be 8%.  If both 
parents suffer from T1DM then the offspring will have a 30% chance of developing the 
condition (Diabetes UK, 2010).   
For T1DM, the concordance rate for monozygotic twins from a number of studies has been 
estimated as 21-53%, with most estimates being between 30-50% (Ounissi-Benkalha and 
Polychronakos, 2008).  Candidate gene studies and genome wide analysis have revealed 
that the most important loci are in the HLA class II region on chromosome 6p21.  This 
region accounts for 50% of familial aggregation through protective and detrimental effects 
(Noble et al., 1996).  HLA class II antigens are responsible for self versus non-self 
recognition and antigen presentation to CD4+ T cells.  The DR and DQ genes have the 
greatest influence with certain combinations being of particular importance, for example 
DR4-DQ8 or DR3-DQ2 which are present in 90% of diabetic patients.  Alternatively 
DR15-DQ6 are protective haplotypes which occur in only 1 % of type 1 diabetic patients 
but in 20% of the general population (Devendra et al., 2003, 2004).  Recently a weak 
association has also been described between the ubiquitously expressed class I HLA 
antigens A and B (Nejentsev et al., 2007).  The proposed mechanism by which these 
haplotypes confer susceptibility is either by poor binding of auto antigens in the case of 
HLA class II or through endogenous antigens synthesized in response to a viral trigger in 
the case of HLA class I.  Both mechanisms may lead to compromised adaptive T cell self 
tolerance.  Use of the transgenic mouse model has confirmed that mice expressing DR3 
and DQ8 are susceptible to diabetes, shown by loss of immune tolerance to glutamic acid 
decarboxylase.  Those mice expressing DQ6 were protected from this effect thus 
confirming its protective function (Abraham et al., 2000, 2001).   
To date, candidate genes have been identified, which manifest their effects through defects 
in T cell maturation, activation and self tolerance leading to increased autoimmunity.  In 
addition, genes controlling defects in antigen presentation and response to viral triggers 
leading to alterations in self/non self recognition have been described.  It is possible that 
genetic defects in the developing immune system could account for other host mediated 
Douglas P Robertson 2011  Chapter 1-41 
tissue damage including periodontal disease (Ounissi-Benkalha and Polychronakos, 2008).  
Patients with T1DM are also prone to a range of other autoimmune conditions, and co-
morbidity is common for these diseases, including autoimmune thyroid disease, coeliac 
disease, rheumatoid arthritis and Addison’s disease (Kordonouri et al., 2005; Skovbjerg et 
al., 2005; Daneman, 2006; Liao et al., 2009)  
1.1.5 Environmental aetiology of Type 1 Diabetes Mellitus 
While genetic susceptibility has been clearly shown it is thought that susceptible 
individuals require exposure to an initiating stimulus which begins the process of beta cell 
destruction.  This would explain why genetically susceptible patients develop diabetes at 
different ages subsequent to exposure to the trigger at different times in their lives.  
Suggested environmental triggers include exposure to cow’s milk, chemicals or viral 
infections, which may initiate the autoimmune process.  Diagnosis of diabetes has been 
shown to follow seasonal variation, an observation which precludes a purely genetic basis 
for disease initiation (Moltchanova et al., 2009).  It has also been shown that some migrant 
populations assume the risk profile of their new country of residence increasing the 
likelihood of an environmental trigger (Serrano-Rios et al., 1999).  The association 
between T1DM and a viral trigger has long been hypothesised and recent evidence for a 
role of enterovirus has strengthened the case for viral involvement in susceptible patients 
(Nairn et al., 1999).  Sera from 110 children in the age range 0-15 years was obtained 
shortly after the diagnosis of T1DM, and tested for the presence of enteroviral sequences 
by the polymerase chain reaction. One hundred and eighty-two controls tested were 
matched for age, geographical location and time of year.  The authors found that a 
significantly greater number of children with diabetes had evidence of enteroviral RNA 
sequences compared with the non-diabetic subjects (27% of the patients with T1DM versus 
4.9% non-diabetic subjects, P <0.005).  Sequence analysis showed that there was 
considerable variation in the sequences detected, although all appeared to be of the 
coxsackie/echovirus type.  For a recent review of the putative viral aetiology of T1DM the 
reader is referred to Roivainen and Klingel (2010). 
1.1.6 Glycaemic control 
Glucose control is monitored on a daily basis by the individual patient using capillary 
blood samples to measure blood glucose levels.  The patient will often adjust their insulin 
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dose and sugar intake based on these “instant results”.  Longer term glucose control 
exploits the non-enzymatic glycation of haemoglobin to form glycosylated haemoglobin 
which occurs throughout the life cycle of the erythrocytes.  The percentage of haemoglobin 
which has been glycosylated when measured by High Performance Liquid 
Chromatography (HPLC), at any one time, gives an indication of the relative glucose 
control over the preceding eight to twelve week period (Rahbar et al., 1969).  Based on 
findings from the UKPDS and DCCT, patients will be asked to aim for an HbA1c below 
7% for optimum control although some authorities recommend that 7.5% be set as a target 
(Table 1-2).  It has been shown that the incidence of diabetic complications is greatly 
reduced by maintaining strict diabetic control (DCCTRG, 1993).  While there are a number 
of cut-off points used in studies reporting the effect of diabetic control on other disease 
processes, it is generally accepted that an HbA1c of 7.5% or less represents good 
glycaemic control although there are benefits from reducing this further.  Arbitrary cut off 
points and classification have been proposed and used in studies however, there is no 
HbA1c level below which complications cannot occur and no thresholds above which 
complications are certain to arise (Stratton et al., 2000). 
Table 1-2  International guidelines on target HbA1c for adults with 
Type 1 diabetes mellitus.   
Organization Target HbA1c (%) 
National Institute for 
Clinical Excellence CG15 
(2004, 2010) 
≤ 7.5% or ≤ 6.5% in those at risk of arterial 
disease 
Canadian Diabetes 
Association (2008) ≤ 7.0%, ≤ 6% if clinically safe. 
American Diabetes 
Association (2011) ≤ 7.0% 
Scottish Intercollegiate 
Guidelines Network 116 
(2010) 
≤ 7.5% 
American Academy of 
Clinical Endocrinologists 
(2011) 
≤ 6.5% 
International Diabetes 
Federation (1998) ≤ 7.5% 
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1.1.7 Mechanism of diabetic tissue damage 
Tissues in the diabetic sufferer are subject to biochemical anomalies which lead, with time, 
to damage and loss of function.  The range of tissues affected is extensive however, worst 
affected seem to be large and small blood vessels, the kidneys, eyes and nerves (DCCTRG, 
1993; Turner et al., 1996).  It is thought that the mechanism of damage is similar in most 
tissues and could be due to a combination of the following factors: increased circulating 
levels of pro-inflammatory cytokines (Signorelli et al., 2007; Navarro-González et al., 
2008) or adipokines (Hajer et al., 2008); alteration in the structure and therefore the 
antigenicity of structural proteins by the incorporation of non-enzymatically glycated 
proteins (Hudson et al., 2002; Kim et al.,2005); and the build-up of oxygen free radicals 
either through metabolic dysregulation in glucose metabolism (Zheng et al., 2009; 
Muhammad et al., 2009) or through the presence of host derived heat shock proteins 
(Hooper et al., 2003).  One of the difficulties in specifying a single pathway is that the 
mechanisms outlined above are not necessarily mutually exclusive and may in fact all play 
a part in the immunopathogenesis of tissue injury. 
1.1.7.1 Advanced Glycation End Products (AGE) 
Currently the most widely accepted mechanism of tissue damage is that of the non-
enzymatic glycation of macromolecules such as structural proteins.  When high levels of 
glucose are present in the blood this reducing sugar is able to form irreversible cross links 
with proteins through non enzymatic rearrangement with amino acids to form advanced 
glycation end products (AGEs).  Because the cross links are irreversible AGE builds up in 
the affected tissue.  This results in a loss of functionality as well as acting as a stimulus for 
pro-inflammatory cytokine release through interaction with the Receptor for Advanced 
Glycation End products (RAGE) found on the surfaces of immune and resident tissue cells 
(Kim et al., 2005).   
This mechanism has been used by researchers to monitor tissue damage in the animal 
model.  Glycation of proteins within the lens of the eye leads directly to visible alterations 
in the appearance of the lens and subsequent resultant loss of function (Cerami et al., 
1979).  This pigmentation was originally known as Maillard's browning products although 
a number of AGEs have now been identified.  These include N-(carboxymethyl) lysine 
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(CML) and pentosidine, the most studied, although others have also been identified 
(Hudson et al., 2005).   
The relationship between the glycation of macromolecules and diabetic complications was 
established during the United Kingdom Prospective Diabetes Study (UKPDS).  It was 
shown that a 1% rise in glycated haemoglobin was associated with a 37% increase in 
microvascular disease (Stratton et al., 2000).  Accumulation of AGEs in the skin has been 
shown to be associated with increased levels of diabetic complications (Sell et al., 1991; 
Beisswenger et al., 1993).   
1.1.7.2 Receptor for Advanced Glycation End Products and the inflammatory 
response 
Studies have shown that the interaction between AGEs and AGE binding receptors 
(RAGE) which bind to, remove and degrade AGE, results in activation of pro-
inflammatory pathways (Lin et al., 2009).  This chronic, low level inflammatory response 
to these altered proteins perpetuates the tissue damage through the activation of 
downstream pro-inflammatory molecules such as cytokines, chemokines and the 
arachidonic acid metabolites.  These in turn have the ability to cause tissue breakdown 
through up-regulation of molecules such as matrix metalloproteinases (MMPs) (Nah et al., 
2007) and osteolytic activators (Hein et al., 2006).  RAGE is a signalling receptor and a 
member of the immunoglobulin superfamily of receptors.  While RAGE is expressed in 
low levels in most tissues, except the lung, many studies have shown that it is up regulated 
in tissues affected by diabetic tissue damage.  These include: vascular smooth muscle 
(Schmidt et al., 1999); the glomeruli; podocytes and tubular epithelium of the kidney 
(Bierhaus et al., 1996); the endothelium in peripheral vascular disease (Ritthaler et al., 
1995); the retina (Hammes et al., 1999); and neuronal cells (Brett et al., 1993).  RAGE is 
also expressed by cell types of the immune system including macrophages and monocytes, 
a possible mechanism for interference in the immuno-inflammatory response (Brett et al., 
1993).  Studies on rat models of diabetic cardiovascular disease have shown that the 
accumulation of AGE/RAGE is proportional to the increased duration of hyperglycaemia.  
This is in agreement with human studies which clearly show the relationship between 
diabetic complications and duration of diabetes (DCCTRG, 1993; Stratton et al., 2000; 
Pambianco et al., 2006).   
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1.1.7.3 RAGE and oxidative stress 
Activation of RAGE leads to induction of an oxidative process within the affected tissue 
which could account for a continued increase in tissue damage through the direct 
production of free radicals.  Free radicals cause tissue damage as their oxidative potential 
is absorbed by the surrounding cells causing damage to DNA and promoting cell death.  
Oxidative stress and superoxide generation due to hyperglycaemia increase mitochondrial 
DNA damage and enhance the sensitivity to apoptosis (Suzuki et al., 1999).  Myocytes, 
fibroblasts, endothelial cells and podocytes are all more sensitive to apoptosis in the 
presence of hyperglycaemia-induced oxidative stress (Frustaci et al., 2000; Susztak et al., 
2006; Alikhani et al., 2007).  At the molecular level it has been shown that activation of 
RAGE leads to nuclear translocation of Nuclear Factor Kappa B (NFκB), a transcription 
factor which is implicated in inflammation within vascular tissues as well as in other parts 
of the body.  Expression of RAGE increases through a positive feedback loop initiated by 
AGE/RAGE interaction in a mechanism that is dependent on a number of key NFκB sites.  
Expression of RAGE therefore increases in tissues where there is accumulation of AGE. 
According to Hudson et al. (2005) hyperglycaemia can exert a damaging effect on the 
tissues through at least four pathways.  Hyperglycaemia leads to activation of the aldose 
reductase pathway due to an increase in the amount of glucose being metabolised through 
the polyol pathway converting glucose to sorbitol.  The production of reactive oxygen 
species, the accumulation of AGEs and activation of the protein kinase C pathway all 
contribute to possible tissue damage.  Activation of cell signalling molecules such as MAP 
Kinase and NFĸB leads to alterations in gene expression and protein function that in turn 
leads to cellular and tissue dysfunction (Hudson et al., 2005).   
Increased production of oxidants in the tissue occurs as a result of the metabolism of 
excess glucose, lipids and free fatty acids (FFAs) via a number of different pathways.  
Damaging oxidant production can occur in response to the structural changes in AGEs 
indirectly.  In addition, exposure to certain bacterial challenges can also result in increased 
superoxide production and tissue damage.  It has been concluded that, while oxidative 
stress may modify and accelerate tissue damage, it may be insufficient in itself to explain 
the level of microvascular tissue damage seen in diabetes (Hudson et al., 2005).   
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1.1.8 Conclusion 
T1DM is a common chronic inflammatory disease that affects every major system in the 
human body.  The mechanisms by which this damage occurs are being elucidated and 
investigated with a view to developing strategies to prevent, control and manage the 
complications of this disease.  The oral cavity and its associated structures cannot be 
immune from the local and systemic effects of this condition.  The aim of this thesis is to 
gain a better understanding of how T1DM affects the oral cavity and to understand the 
impact that oral health or disease has on patients with diabetes. 
1.2 Periodontal disease 
1.2.1 Introduction 
The periodontal diseases are a heterogenous group of diseases that affect the supporting 
apparatus of the teeth.  For the purposes of this thesis the term periodontal disease will 
refer to the two most common periodontal conditions, which are initiated by dental plaque, 
i.e. chronic gingivitis and chronic periodontitis.  This introductory section contains an 
overview of the anatomy of the periodontium, and of the aetiopathogenesis, classification 
and epidemiology of these conditions in order to form the basis of the work presented in 
the second, third and fourth chapters of this thesis.  
1.2.2 Anatomy 
The periodontium, which surrounds the teeth, is made up of the gingivae, cementum, 
periodontal ligament and alveolar bone.  In health, it is resistant to mechanical, 
microbiological and chemical trauma and is responsible for maintaining the attachment of 
the teeth. 
1.2.2.1 Gingivae 
The gingivae are split into the attached gingivae and the unattached gingivae.  The 
gingivae are made up of three types of epithelium and an underlying core of connective 
tissue.  The attached gingiva is covered by keratinised, stratified, squamous, epithelium.  
The gingival crevice is lined by the sulcular epithelium and the junctional epithelium.  The 
sulcular epithelium is a non-keratinised epithelium which is not attached to the tooth 
surface.  The most apical portion of the sulcular epithelium is adjacent to the junctional 
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epithelium.  The junctional epithelium is a unique structure in the body with two strati 
basale with cell maturation occurring at both surfaces.  The junctional epithelium is around 
15-20 cells thick and is attached to the tooth via hemidesmosomes.  Underlying the 
epithelium is a core of connective tissue composed of collagen fibres, fibroblasts, blood 
vessels and nerves embedded in an amorphous matrix (Lindhe et al, 2008).  In clinical 
health the gingivae contain a mild chronic inflammatory infiltrate and the inflammatory 
transudate, gingival crevicular fluid, is produced in small amounts (Page and Schroeder, 
1976).  Clinically the healthy attached gingivae appear pink and firm with stippling present 
in 30-40% of individuals (Rosenberg et al., 1967, Lindhe et al., 2008).  There is a 
physiological sulcus in health that is normally 1.5-2mm coronal to the amelocemental 
junction.  The depth of the sulcus can be increased either by coronal movement of the 
gingival margin due to oedema or hyperplasia (false pocketing) or through apical migration 
of the insertion of the periodontal ligament attachment in disease (true pocketing). Clinical 
attachment level (CAL) can be calculated using a graduated probe measuring the distance 
in millimetres from the amelocemental junction to the base of the clinical pocket.  As 
probing depths can be increased in the absence of attachment loss, clinical attachment level 
measurements are essential to indicate the cumulative attachment loss over time.  Clinical 
probing depths give an indication of current disease and treatment need.  
1.2.2.2 Cementum 
The cementum is a specialised connective tissue covering the root dentine into which the 
Sharpey's fibres of the periodontal ligament insert.  Cementum consists of two main types 
namely cellular and acellular cementum.  Acellular extrinsic fibre cementum, which is 
found in the middle and coronal aspects of the root, is an important part of the attachment 
apparatus, which links the tooth to the alveolar process proper.  Cellular mixed fibre 
stratified cementum contains cementocytes as well as both intrinsic and extrinsic fibres and 
is found around the apex of the tooth (Lindhe et al., 2008). 
1.2.2.3 The periodontal ligament 
The periodontal ligament is a soft, richly vascular and cellular connective tissue which is 
the interface between the roots and the alveolar process.  It contains specifically organised 
fibres which are arranged in a horizontal, oblique and circumferential direction.  Sharpey's 
fibres insert both into the alveolar bone and the cementum of the tooth.  The primary 
collagen type in the periodontal ligament is type 1 collagen.  The ground substance within 
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the periodontal ligament means that the ligament behaves in a viscoelastic fashion 
distributing the loading applied to the teeth (Lindhe et al., 2008).  
1.2.2.4 The alveolar bone 
The alveolar bone into which the periodontal ligament inserts is functionally and 
embryologically linked to the presence of teeth.  Patients suffering from hypodontia are 
deficient in alveolar bone in the areas where no teeth have formed, as the alveolar bone 
proper is derived from the cells of the developing dental follicle.  Functionally, after tooth 
extraction, the alveolar process associated with the tooth in question will begin to resorb.  
Alveolar bone comprises an outer cortex of cortical bone, an inner layer of compact bone 
surrounding the tooth socket and cancellous bone in between.  It is this inner layer of 
compact bone (or bundle bone) into which the fibres of the periodontal ligament insert 
(Lindhe et al., 2008).  The alveolar process follows the course of the amelocemental 
junction (Birn, 1966).  
Alveolar bone is constantly undergoing a process of remodelling due to physiological 
mesial drift and in response to alterations in loading on the supported teeth.  This process is 
carried out in health by osteoclasts, present in the Howships lacunae of the alveolar bone 
and by osteoblasts.  Osteoblasts are present on the socket walls near the periodontal 
ligament, the surface of bone trabeculae in cancellous bone and in relation to the outer and 
inner aspect of the cortical bone (Lindhe et al., 2008).  In health the process of remodelling 
is in equilibrium, also referred to as coupled.  However, if there is excessive osteoblastic or 
reduced osteoclastic activity, uncoupling of this process occurs.  This leads to increased net 
bone deposition or net loss of the cancellous bone in conditions such as osteopetrosis 
(Hamdan et al., 2006).  Similarly excessive action by osteoclasts or reduced osteoblastic 
activity will give rise to a net loss of bone and resulting loss of alveolar bone support for 
the tooth (Jeffcoat et al., 2005).  Mechanisms which impact on bone turnover will be fully 
discussed in section 1.2.5.6. 
1.2.3 Classification of periodontal diseases 
A relatively recent classification has been proposed in 1999 by the International Workshop 
on Periodontal Diseases and this has largely been accepted as the current classification 
despite a number of arguments against its application in clinical practice and basis in 
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pathogenesis (Armitage, 2000).  This classification follows many years of confusion in the 
literature as to the diagnosis and classification of cases of periodontitis which had up until 
this point made comparisons between studies extremely difficult (Borrel et al., 2005; Page 
and Eke, 2007).  The classification proposed in 1999 reduced the emphasis of the 
classification on age and was less prescriptive in definitions of levels of disease.  Previous 
classifications and indices of periodontitis measured extent and severity of loss of 
attachment as detected on clinical examination and prescribed the location and proportion 
of sites affected.  These strict classifications aided in producing phenotypically similar 
groupings but the lack of agreement resulted in significant heterogeneity in case definitions 
across research groups and thus these were abandoned in favour of the current 
classification.  This has, however, not ended the on-going controversy over the definitions 
of cases of periodontitis clinically or in the periodontal literature (Page and Eke, 2007; 
Demmer and Papapanou, 2010).   
1.2.3.1 Gingivitis 
Gingivitis is defined as gingival inflammation without any loss of attachment and may be 
purely plaque related or may be exacerbated by local or systemic factors. Gingivitis may 
be associated with a slight increase in clinical probing depth as a result of erythema and 
swelling of the gingivae resulting in false pocketing.  There is a loss of the stippling which 
can characterise healthy gingivae and an increase in the flow of gingival crevicular fluid.  
The pocket will commonly bleed on gentle probing of the sulcus.  This condition is entirely 
reversible with removal of the aetiological agent (dental plaque) with no permanent loss of 
periodontal attachment.  Chronic gingivitis can persist without the development of 
progressive periodontal destruction.  The causative relationship between dental plaque and 
gingivitis was convincingly demonstrated by Loe et al. (1965) in a study on healthy young 
adults, all of whom developed gingivitis within a 21 day period after cessation of normal 
oral hygiene practices.  When mechanical plaque control was reintroduced the swelling 
and inflammation in the gingivae reduced to baseline levels.  These studies definitively 
proved the hypothesis that gingivitis was caused by plaque and that the inflammation was 
related to the volume of plaque at the gingival margin. 
1.2.3.2 Periodontitis 
Periodontitis is defined by Flemmig as “an infectious disease resulting in inflammation 
within the supporting tissues of the teeth, progressive attachment loss and bone loss” 
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(Flemmig, 1999).  Periodontitis may present either as clinical probing depths greater than 
the depth of the physiological sulcus or as gingival recession or a combination of both 
(Novak et al., 2008).  Periodontitis can be classified as either chronic or aggressive.  
Chronic periodontitis is the most common and is generally considered to be a slowly 
progressing form of the disease.  Chronic periodontitis may be further described as mild 
moderate or severe (Armitage, 2000).  Aggressive periodontitis is a severe and widespread 
form of periodontal disease which is characterised by rapid attachment loss and bone 
destruction.  The patient will be healthy apart from the periodontitis and there is a 
propensity to familial aggregation (Armitage, 2000, Michalowicz, 2000).  Both chronic 
and aggressive periodontitis can occur in a localised form affecting a small number of teeth 
or a generalised form affecting an increased number of sites.  While age per se has been 
removed from the disease classification, aggressive periodontitis is commonly diagnosed 
in teenagers and young adults indicating the rate of disease progression.  The effects of 
chronic periodontitis increase with age and untreated this will progress slowly through life 
in a pattern of cyclical bursts of disease progression and quiescence resulting in a linear 
loss of attachment over time (Gilthorp et al., 2003).  The distinction between chronic and 
aggressive forms of disease is related to the age of onset or detection, the rate of 
progression, the pattern of destruction, the signs of inflammation and the relative amounts 
of plaque and calculus (Armitage, 2010).  The lack of specific guidelines in the definitions 
compared with previous classifications and the fact that diagnosis is dictated by the past 
history and future progression of the disease make it difficult to use the current 
classification in a cross-sectional study without knowledge of either of these factors 
(Demmer and Papapanou, 2010).  As a result of this, groups investigating periodontal 
disease have been developing criteria for diagnosis of periodontal disease taking account of 
extent, severity and age (Page and Eke 2007, Demmer and Papapanou, 2010). 
The principal headings of the International Workshop on the classification of periodontal 
diseases are shown in Table 1-3 (Armitage, 2000). 
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Table 1-3  Headings from the International Workshop, 1999 
(Armitage, 2000) 
Classification of Periodontal conditions 
 
I. Gingival Diseases 
A. Dental plaque-induced gingival diseases 
1. Gingivitis associated with dental plaque only 
a. without other local contributing factors 
b. with local contributing factors  
2. Gingival diseases modified by systemic factors 
a. associated with the endocrine system 
1) puberty-associated gingivitis 
2) menstrual cycle-associated gingivitis 
3) pregnancy-associated 
a) gingivitis 
b) pyogenic granuloma 
4) diabetes mellitus-associated gingivitis   
b. associated with blood dyscrasias 
1) leukaemia-associated gingivitis   
2) other 
3. Gingival diseases modified by medications 
4. Gingival diseases modified by malnutrition 
B. Non-plaque-induced gingival lesions 
II. Chronic Periodontitis 
A. Localized 
B. Generalized 
III. Aggressive Periodontitis 
A. Localized 
B. Generalized 
IV. Periodontitis as a Manifestation of Systemic Diseases 
A. Associated with haematological disorders 
B. Associated with genetic disorders 
C. Not otherwise specified (NOS) 
V. Necrotizing Periodontal Diseases 
A. Necrotizing ulcerative gingivitis (NUG) 
B. Necrotizing ulcerative periodontitis (NUP) 
VI. Abscesses of the Periodontium 
VII. Periodontitis Associated With Endodontic Lesions 
A. Combined periodontic-endodontic lesions 
VIII. Developmental or Acquired Deformities and Conditions 
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1.2.4 Aetiology 
The primary aetiological factor in periodontal disease is dental plaque (Socransky and 
Haffajee, 1994).  The vast majority of patients who experience an accumulation of plaque 
will develop non-destructive periodontal inflammation (gingivitis) (Loe, 1978).  Chronic 
periodontitis is a multi-factorial disease which affects a significant proportion of the 
general population to some degree or another (60%).  Severe disease is however much 
rarer, affecting only 8% of the dentate adult population in Britain (Morris, 2001) (see 
section 1.2.5 for more detail).  There are a number of suggested reasons for an increase in 
susceptibility to periodontitis. The differences between patients have been suggested to be 
due to the amount of plaque, the microbial composition of the plaque or the host response 
to the presence of dental plaque. 
1.2.4.1 Microbial aetiology of periodontitis. 
Dental plaque is a polymicrobial biofilm containing up to 500 species of bacteria up to half 
of which are yet to be cultured (Paster et al., 2001).  Dental plaque begins to form as soon 
as the teeth erupt.  After prophylaxis the teeth are initially colonised by Streptococci and 
Actinomyces species.  As the biofilm matures the type of bacteria contained within the 
plaque changes, from one composed primarily of Gram positive aerobic bacteria to one 
composed of primarily Gram negative motile rods (Bagg et al., 1999; Kolenbrander et al., 
2006).  Attempts have been made over the years to identify a specific pathogen or 
pathogens involved in the aetiology and pathogenesis of periodontitis.  While there is a 
well-documented shift in the microbial flora from health to disease it is difficult to 
determine whether this microbiological shift is the cause or an effect of the disease.  The 
species most strongly associated with the presence of disease are classified by Socransky 
and co-workers (1998) as the red complex of bacteria.  These are Tannerella forsythia (T. 
forsythia), Porphyromonas gingivalis (P. gingivalis) and Treponema denticola (T. 
denticola).   
Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans) is also strongly 
associated with certain forms of periodontal disease, specifically aggressive periodontitis 
(Berthold et al., 1986; Slots and Ting, 1999; Cortelli et al., 2005).  All of these species are 
commonly present at sites of periodontal destruction at the time of initial diagnosis and 
their elimination or persistence is associated with prognosis after treatment.  Each 
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bacterium has specific virulence factors which confer biological feasibility on their 
proposal as putative periodontal pathogens.  A further group are classified as the amber 
species and these are less strongly associated with periodontal destruction. These include 
Prevotella intermedia, Prevotella nigrescens, Peptostreptococcus micros, Fusobacterium 
nuc. vincentii, Fusobacterium nuc. nucleatum, Fusobacterium nuc. polymorphum and 
Fusobacterium periodonticum.  Eiknella nodatum, Campylobacter gracilis, Streptococcus 
constellatus and Capnocytophaga rectus (Socransky et al., 1998). 
The search therefore for a specific pathogen associated with periodontitis has led to the 
identification of a number of species which may be implicated in disease progression.  
However, not all diseased sites harbour these periodontal pathogens.  A further 
complication is that putative pathogens can be isolated from patients without periodontitis 
and from sites not associated with periodontal destruction in mouths affected by 
periodontitis.  The question that remains is why some sites exhibit loss of attachment and 
others remain resistant in spite of the presence of putative periodontal pathogens within the 
pocket.  It is also worth noting that bacterial succession is occurring throughout the disease 
process.  It may be the early coloniser, initiating the disease process, which is the most 
important factor, rather than those which subsequently colonise the altered ecological 
milieu. 
Early research focussed on the volume of plaque and calculus present at affected sites.  
Cross-sectional and longitudinal studies had shown that sites with pathologically deepened 
pockets occurred most commonly at sites affected by plaque and calculus accumulation 
(Theilade et al., 1986).  The prevailing body of clinical opinion believed that periodontal 
destruction over time was an inevitable consequence of the presence of plaque.  This 
theory was called the non-specific plaque hypothesis.  Support for this view comes from 
experimental gingivitis studies demonstrating that plaque is the causative agent in the 
development of gingivitis (Loe et al., 1965).   
At this time it was believed that gingivitis inevitably led to periodontitis with loss of 
clinical attachment and bone loss and that removal of plaque would eliminate the risk of 
progresssing to periodontitis.  However studies on the natural history of periodontal 
disease confounded this principle.  Manual labourers from tea estates in Sri Lanka were 
examined in a prospective study over a period of 18 years.  Oral hygiene was universally 
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poor with generalised plaque, calculus and gingivitis.  The importance of dental plaque in 
disease initiation and progression was demonstrated where attachment loss was evident as 
young as 16 years of age and mean attachment loss at 30 years was 3mm.  Ten millimetres 
of attachment loss was also not uncommon (Loe et al., 1986).  There were, however, three 
distinct groups who responded differently to what appeared clinically to be the same level 
of microbiological challenge.  The authors found that one group was resistant to disease 
and had no periodontitis despite poor oral hygiene and chronic gingivitis (11%), a larger 
group was moderately susceptible to disease (81%) and a third group showed severe and 
advanced bone loss compared with both other groups (8%).  The increased severity in the 
group experiencing the most severe disease and the lack of periodontitis in the gingivitis 
only group cannot be accounted for by plaque presence and volume alone.   There was no 
difference in the volume of plaque between the gingivitis only and the periodontitis groups.  
Subsequent to this study, and other reports from around the world, it is now clear that 
periodontal destruction is not an inevitable consequence of plaque accumulation (Morris et 
al., 2001; Reich, 2001; Van der Velden et al., 2006).  Other factors, such as differences in 
the microbial biofilm and the host immuno-inflammatory response, are crucial in 
determining the development of periodontal destruction.   
It is recognised that the bacteria in dental plaque are responsible for the initiation of 
periodontal disease.  This is supported by studies that confirm the association between the 
accumulation of dental plaque and periodontal disease and the absence of plaque in health 
(Loe et al., 1986).  There is also clear evidence that removal of plaque will result in clinical 
improvement and that when plaque control is poor the disease will recur (Becker et al., 
1984; Axelsson et al. 2004). 
Many in vivo and in vitro studies have confirmed the periodontopathic virulence of many 
key pathogens (Holt et al., 2005).  However, it has been clearly shown that the presence of 
dental plaque does not always lead to advanced periodontitis and that key periodontal 
pathogens can be found at sites of relative periodontal health (Wolff et al., 1993; Van der 
Velden et al., 2006).  In addition longitudinal studies have shown that a small group of 
individuals experience the majority of tooth loss (Hirschfeld and Wasserman; 1978; 
McFall, 1982).  This leads us to conclude that, in addition to the essential nature of the 
dental biofilm in initiating the inflammatory response, other host factors must also be 
involved (Kinane et al., 2006).  These factors may determine whether the inflammatory 
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response will be an efficient protective and preventive one or whether an inappropriate or 
inefficient inflammatory response leads to host induced tissue destruction. 
Investigation of the role of the innate and acquired immune response, the process of 
inflammation and the genetic susceptibility of some individuals to periodontal disease are 
the subject of ongoing and future research around the world. 
1.2.5 Pathogenesis 
The pathogenesis of periodontitis has been categorised into four stages through 
histopathological examination of the development of periodontal inflammation as a result 
of plaque accumulation.  These stages are called the initial, the early, the established and 
the advanced lesion (Page and Schroeder, 1976).  A brief description of each stage in 
lesion progression follows. 
1.2.5.1 Initial lesion 
After cessation of normal oral hygiene measures, within 2 - 4 days of plaque accumulation, 
the early inflammatory response is seen histologically.  Vasodilatation, loss of perivascular 
collagen, margination and active migration of neutrophils and monocytes into the 
periodontal tissues and junctional epithelium mediated by Intercellular adhesion molecule 
(ICAM) and Endothelial leukocyte adhesion molecule (ELAM) are observed.  The 
exudation of serum proteins from the dilated capillaries leads to an increase in GCF fluid 
flow to flush away toxins. 
1.2.5.2 Early lesion 
The early lesion was shown to be present after 7 - 14 days plaque accumulation.  This stage 
would be clinically detectable as gingivitis with more pronounced vascular changes and an 
increase in extra-vascular neutrophils. 
Histologically the inflammatory infiltrate consists of numerous lymphocytes, 
predominantly T lymphocytes, immediately below the proliferating basal cells of the 
junctional epithelium.  In order to facilitate the migration of neutrophils and lymphocytes 
destruction of the gingival connective tissue occurs.  This is through apoptosis of 
fibroblasts and a reduction in the collagen fibre network of the marginal gingivae, via host 
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and pathogen derived matrix metalloproteinases (Page and Schroeder 1976, Takahashi et 
al., 1995).   
1.2.5.3 Established lesion 
The established lesion is an extension of the histological picture seen in the early lesion.  
However, there is a shift in the cell population in the inflammatory infiltrate with large 
numbers of plasma cells being the main histological feature in older patients; in younger 
patients the infiltrate continues to be dominated by lymphocytes (Fransson et al., 1996).  
The inflammatory infiltrate extends laterally towards the oral epithelium and inflammation 
becomes more pronounced and clinically noticeable with an increase in swelling, loss of 
the knife edge margin and the development of false pocketing.  T & B lymphocytes and 
antibodies and complement are present in the inflamed marginal gingivae and gingival 
sulcus.  The junctional epithelium becomes hyperplastic and ulcerated at this stage and 
bleeding is likely to occur on gentle probing.   
1.2.5.4 Advanced lesion 
The advanced lesion is unique.  At this stage the inflammatory lesion extends into the 
periodontal ligament and alveolar bone and there is destruction of connective tissue 
attachment to the tooth (LOA).  The junctional epithelium migrates down the root surface 
to form a true periodontal pocket.  
This destruction of the periodontal ligament and the surrounding alveolar bone is thought 
to be mediated through matrix metalloproteinases and through enhanced osteolytic activity 
by osteoclasts.  While there is some evidence that highly virulent strains of bacteria can 
invade the tissues this is not normally the case (Vitkov et al., 2005).  Some direct tissue 
damage can occur through direct cytotoxicity of bacterial products such as proteinases, 
collagenases, epitheliotoxin, cytolethal distending toxin, hemolysin, hydrogen sulphide and 
ammonia (Haffajee and Socransky, 1994).  Dysregulation of host derived factors such as 
proteinases and proteinase inhibitors, matrix metalloproteinases and tissue inhibitors of 
metalloproteinases (TIMPs), pro-inflammatory cytokines such as Interleukin-1α (IL-1α), 
Interleukin-1β (IL-1β), Tumour Necrosis Factor-α (TNF-α) and others, prostaglandins and 
the products of polymorphonuclear leukocytes lead to damage to the connective tissue 
attachment (Kornman, 2008).  This is particularly the case where the immuno-
inflammatory response is unsuccessful in containing the bacterial biofilm and its products.   
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1.2.5.5 The innate immune response to periodontal microbial infection 
The developing dental biofilm consists of initially Gram-positive cocci in health, changing 
to increased numbers of motile Gram-negative anaerobes in gingivitis and periodontitis 
(Moore et al, 1994; Socransky and Hafajee, 1997).  
Gram-negative bacteria have on their cell wall endotoxin or Lipopolysacharide (LPS), a 
potent stimulator of Toll-like receptor 4 (TLR4).  The structure of the lipid A moiety and 
lipopolysaccharide (LPS) have a large bearing on the immunostimulatory capacity and 
pathogenicity of the organism.  LPS is liberated from Gram-negative bacteria and becomes 
linked to the extracellular acute phase protein LPS-binding protein before binding to 
CD14.  This leads to transfer of LPS to the extracellular domain of the TLR4 receptor and 
subsequent TLR4 signalling (Akira et al., 2006).  TLR4 deficient mice are more 
susceptible to infection with Gram-negative bacteria.  However, Gram-negative bacteria 
will also activate TLR2 through their cell membrane proteins, TLR5 if they have flagella, 
TLR9 through recognition of bacterial CpG DNA and Nucleotide-binding oligomerization 
domain-containing protein 1 and 2 (NOD 1, NOD 2) through peptidoglycan derivatives 
(Akira et al., 2006, Mogensen, 2009).   
Periodontal pathogens have been shown to stimulate TLRs in vitro.  For example P. 
gingivalis LPS and fimbriae and Bacteroides fragilis LPS are all potent TLR2 agonists 
(Hirschfield et al., 2001, Asai et al., 2001, Erridge et al., 2004).  A. actinomycetemcomitans 
and F. nucleatum LPS and whole P. gingivalis will stimulate TLR4 (Darveau et al., 2004; 
Yoshimura et al., 2002).  Most bacteria can also initiate an immune response via TLR9, 
which also detects viable bacterial DNA (Bauer et al., 2001).  It is therefore clear that the 
myriad of bacteria that are present in both health and increasing severity of periodontal 
disease will present a challenge to the innate immune response in the periodontal tissues.  
Tolerance to the healthy host microflora is achieved through the poorly understood 
differential recognition of subtle changes in LPS and other Pathogen associated molecular 
patterns (PAMPs).  These changes indicate to the host the immunogenicity and potential 
pathogenicity of the organisms present.   
 
The junctional epithelium, as described in detail in the section on the anatomy of the 
periodontium, is the front line in an uneasy peace between the host and the oral microflora.  
The junctional epithelium is well equipped to recognise invading pathogens, with studies 
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showing the presence of mRNA encoding TLR2, 3, 4, 5, 6 and 9 in gingival epithelial cells 
(Kusumoto et al., 2004).  The migrating neutrophils that are constantly recruited in small 
numbers, even where there are no signs of clinical disease, also express the full range of 
known TLRs (Mogensen, 2009).  Neutrophil defects, including defects in margination, 
adhesion, chemotaxis and inefficient cell killing, lead directly to an increased risk of 
periodontal destruction.  This occurs clearly in diseases with reduced neutrophil numbers 
and function including Leukocyte Adhesion Deficiency syndrome and Chediak Higashi 
syndrome (Meyle et al., 1994; Bailleul-Forestier et al., 2008).  Conditions resulting in a 
deficient TLR response in neutrophils could result in an increased susceptibility to 
periodontal destruction.  Tissue dendritic cells and Langerhans cells are present within the 
gingival epithelium and the underlying connective tissue.  These antigen-presenting cells 
express a wide range of TLRs including TLR1, 2, 3, 4, 5, 6, 8 and 10 (Mahanonda et al., 
2007, Mogensen, 2009).  These cells will monitor invasion of the bacteria or bacterial 
products initiating the adaptive immune response.  
Gingival and periodontal fibroblasts respond to TLR2, 4 and 9 (Hatakeyama et al., 2003). 
Cementocytes within the cellular mixed fibre stratified cementum, that may become 
involved as periodontal destruction progresses to involve and infect the root cementum, 
have also been shown to express TLR2 and 4 (Nociti et al., 2004).   
The alveolar bone is the supporting structure into which the periodontal ligament inserts 
and is the tissue that is ultimately destroyed by the inflammatory lesion of periodontitis.  
Osteoblasts and osteoclasts involved in bone turnover also express TLR1, 4, 5, 6 and 9 
(Asai 2001) and TLR1, 2, 3, 4, 5, 6, 7, 8 and 9 (Itoh et al., 2003) respectively.  It is 
therefore possible that TLR signalling within the bone can generate an inflammatory 
response to invading pathogens.  Initiation of a cascade of pro inflammatory cytokines 
within the alveolar bone will tend to lead to pathological resorption of bone through 
excessive or prolonged production of osteolytic host molecules.  These include IL-1, 
Tumour Necrosis Factor-α (TNFα) and Prostaglandin E2 (PGE2) which stimulate 
osteoblast inhibition and osteoclast activation and maturation through the Receptor 
activator of nuclear factor kappa-B ligand/Osteoprotegerin (RANKL/OPG) axis.  Studies 
have shown enhanced survival of mature osteoclasts in response to TLR4 and TLR2 
activation (Suda et al., 2002; Itoh et al., 2003).  Conflicting data showing inhibition of 
osteoclast differentiation in response to TLR stimulation means that we cannot yet define 
the role of TLRs in bone resorption and remodelling (Takami et al., 2002).   
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1.2.5.6 Bone remodelling and the RANKL/OPG axis in periodontitis 
Periodontal bone loss is the end result of periodontitis.  While the destruction of the matrix 
of the periodontal attachment is through a combination of microbial and host factors, bone 
destruction is not caused by direct osteolytic damage.  It is due to the normal biological 
mechanism involving physiological bone turnover and repair.  The alveolar bone is 
resorbed by osteoclasts creating a “safety zone”, 0.5-1mm in width, of un-infiltrated 
connective tissue (Cochran, 2008).  This encapsulation of the inflammatory infiltrate is an 
important part of the host defence mechanism in periodontitis.  Osteoclastogenesis is the 
production of bone resorbing cells which remodel the alveolar bone progressively during 
bursts of disease progression leading to decreasing bone support and subsequent tooth loss.  
Pro-inflammatory mediators such as IL-1β, PGE2, TNFα, Interleukin 6 (IL-6), Interleukin 
11 (IL-11) and Interleukin 17 (IL-17), induced by bacteria and their products through the 
NFκB pathway, result in recruitment of osteoclastic precursor cells and their differentiation 
into active osteoclast cells.  Periodontitis leads to an increase in RANKL levels relative to 
the levels of OPG resulting in an increase in the ratio of RANKL: OPG and subsequent 
periodontal bone loss (Cochran, 2008).  Activation of the osteoclast precursors is 
controlled by the RANKL/OPG axis (Cochran, 2008).   
RANKL is a member of the tumour necrosis factor ligand family (Lerner et al., 2006).  
RANKL can either be membrane bound or free in the serum.  RANKL is expressed on the 
surface of activated T and B cells as well as other cells activated by the inflammatory 
process such as periosteal osteoblasts and fibroblasts (Lerner et al., 2006).  RANKL bound 
to the membranes of these activated cells acts on preosteoclasts in the vicinity of the 
inflammatory lesion inducing maturation into active osteoclasts via receptor activator of 
nuclear factor Kappa-B (RANK).  RANK is expressed on cells such as dendritic cells, B 
and T cells, fibroblasts and osteoclastic precursors.  When RANKL activates RANK, 
RANK then activates NFκB via the tumour necrosis factor receptor associated family 
members (TRAF).  Activated osteoclasts are responsible for the controlled destruction of 
bone in natural remodelling.  They also destroy bone in inflammatory diseases affecting 
bone, as well as during orthodontic tooth movement.  The activated osteoclast undergoes 
structural changes to form a tight junction between the bone surface and basal membrane 
where it secretes lytic enzymes into a resorption pit to erode underlying bone (Boyle et al., 
2003).  RANKL also reduces osteoclast apoptosis leading to prolonged osteoclastogenic 
potential from each cell extending its life cycle and increasing the amount of bone 
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breakdown carried out.  Several pro-inflammatory cytokines for example IL-1, IL-6, IL-11, 
IL-17, TNFα, Oncostatin M (OSM) and Leukaemia Inhibitory Factor (LIF) are capable of 
inducing osteoclast activation through this pathway leading to bone resorption.  Hormones, 
which act to increase blood levels of calcium by releasing calcium from the bone, also act 
via this physiological mechanism.  The expression of RANKL on osteoblasts is reduced by 
anti-inflammatory cytokines such as IL-13, Interferon gamma (IFN-γ), and transforming 
growth factor beta 1 (TGF-β1).  These anti-inflammatory cytokines suppress the 
expression of RANKL and/or increase the expression of OPG, its decoy receptor, reducing 
osteoclastogenesis (Nakashima et al., 2000).   
Bone remodelling is a closely controlled system and the effect of RANKL is ameliorated 
by the presence of the decoy receptor osteoprotegerin.  OPG is a member of the tumour 
necrosis factor (TNF) receptor superfamily also known as osteoclastogenesis inhibitory 
factor (OCIF).  It is a basic glycoprotein comprising 401 amino acid residues arranged into 
7 structural domains and it is found as either a 60 kDa monomer or 120 kDa dimer linked 
by disulfide bonds.  By binding RANKL, OPG inhibits NF-κB a fast acting transcription 
factor which is a key regulator of innate immunity, inflammation, cell survival and 
differentiation.  Soluble OPG can reduce the amount of RANKL available for interaction 
with preosteoclasts, reducing cell-cell signalling and osteoclast activation.  OPG also 
induces apoptosis in mature and activated osteoclasts directly (Simonet et al., 1997).   
While the absolute amounts of RANKL and OPG present are affected by the presence of 
inflammation, it is the relative ratio which is more important, maintaining the balance 
between induction and inhibition of bone destruction.  Where there is an excess of OPG 
this will interact with the available RANKL reducing the osteoclastogenic potential.  
Where the amount of RANKL significantly exceeds the amount of OPG there will be an 
increased availability of RANKL thus increasing the potential for osteoclast activation 
leading to net bone loss.  Where both molecules rise or fall together i.e. there is no change 
in the ratio, there will be a negligible effect on osteoclastogenesis.  This effect has been 
shown in a number of diseases characterised by inflammatory bone loss including multiple 
myeloma, arthritis, periapical pathology and periodontitis (Dougal and Chaisson, 2006, 
Menezes et al., 2008; Maruotti et al., 2010).    
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RANKL and OPG levels can be detected in serum, GCF and saliva by enzyme linked 
immunosorbent assays (ELISAs).  Investigators have also studied tissue samples stained 
using immunohistochemistry for RANKL and OPG expression while, more recently, 
reverse transcriptase PCR measurements of mRNA levels in tissue samples have also been 
studied (Kawai et al., 2006; Cochran , 2008).   
The importance of the RANK/RANKL/OPG system on periodontal bone loss has been 
shown in a number of studies in humans.  Studies have shown that in experimentally 
induced periodontitis, levels of RANKL are relatively higher than OPG leading to an 
increase in the ratio of RANKL to OPG.  These findings have been confirmed by studies in 
humans comparing health with gingivitis and periodontitis (Nagasawa et al., 2002; Garlet 
et al., 2004, Bostanci et al., 2007a,2007b; Lu et al., 2006; Liu et al.,2003; Mogi et al., 
2004; Vernal et al., 2004; Wara-aswapati et al., 2007; Lappin et al., 2007).  The main 
source of RANKL in the periodontitis lesion is activated T and B cells (Kawai et al., 
2006). 
1.2.5.7 Animal Studies.   
Animal studies demonstrate the importance of pro-inflammatory cytokines such as IL-1 
and TNFα in the recruitment and activation of osteoclasts.  In a Macaca fascicularis 
primate model, Assuma and co-authors (1998) showed that inflammatory bone destruction 
in an experimentally induced periodontal lesion could be blocked by intrapapillary 
injection of soluble receptors to IL1 and TNFα.  Blockading the action of these 
proinflammatory cytokines resulted in an 80% reduction in the recruitment of 
inflammatory cells surrounding the alveolar bone.  Osteoclast recruitment and alveolar 
bone loss were reduced by 67% and 60% respectively. 
Having established that inflammatory cytokines are integral to active bone loss, 
investigators began investigating downstream molecules activated by these pro-
inflammatory proteins. Research has focussed on the interrelationship between the 
infective agent, the host inflammatory response and the subsequent effect on the 
underlying bone.  This branch of science has become known as osteoimmunology.   
Interleukins and other inflammatory proteins do not directly cause osteoclastogenesis by 
binding to precursor cells; rather pro-inflammatory cytokines act by influencing the 
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RANK/RANKL/OPG axis leading to osteoclast maturation and activation (Simonet et al., 
1997).   
In order to identify the source of RANKL in periodontitis lesions the congenitally athymic 
rat model has been used in a number of studies.  Han and co-workers (2006) demonstrated, 
using congenitally athymic Rowlett rats, that B cells from A. actinomycetemcomitans-
immunized animals had greater RANKL expression and induced a significantly higher 
level of osteoclast differentiation from precursors than did those specimens receiving non 
immune B cells that were not Ag specific.  Osteoprotegerin fusion protein eliminated this 
effect on the level of RANKL expression.  RANKL-expressing B cells were recovered 
from the gingival tissues of recipient rats transfected with A. actinomycetemcomitans-
binding B cells (ABB).  Rats which had received non immune B cells and those which had 
received B cells which did not bind A. actinomycetemcomitans did not demonstrate 
RANKL expression.  Those rats showing RANKL expression showed periodontal and 
alveolar bone loss (Han et al., 2006). 
The interaction between RANKL and its decoy ligand OPG regulates the initiation of 
osteoclastogenesis.  In experimentally (ligature) induced periodontitis lesions in the rat 
model Jin et al. (2007) showed that administration of intraperitoneal Human OPG-fc 
reduced alveolar bone loss and histologically suppressed osteoclast surface area at the 
alveolar crest at weeks three and six.  
The influence of the T cell in the development of periodontal bone loss has also been 
demonstrated in the mouse model.  In the non-obese diabetic mouse (NOD) model A. 
actinomycetemcomitans-reactive CD4+ T-cells in mice exhibited significantly higher 
expression of (RANKL) in experimentally induced periodontitis.  The antagonistic and 
indeed protective effect of OPG was confirmed, as there was a significant reversal of 
alveolar bone loss and reduced RANKL expression in A. actinomycetemcomitans-reactive 
CD4+ T-cells after treatment with OPG.  The authors of this study hypothesised that OPG 
may have a potential role to play in prevention or treatment of periodontitis (Mahamed et 
al., 2005).  
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1.2.6 Risk Factors  
The puzzling issue in periodontal research is the mechanism by which some people can 
maintain the established lesion for many years without progression to the advanced lesion 
while others exhibit minimal marginal bone loss and still others experience rapid and 
extensive loss of periodontal attachment.  
Periodontitis is a multi-factorial disease with many differing risk factors playing a part in 
the clinical progression of the disease.  These factors can be categorised as systemic or 
local risk factors.  Systemic risk factors are those which, in combination with local 
aetiological agents, increase the likelihood of a patient suffering from the disease, or 
increase the severity of the disease experienced for a given exposure to dental plaque.  
Large studies of populations have found that periodontal disease is affected by a number of 
risk factors including increasing age (Albander et al., 1999, 2002), smoking (Bergstrom 
and Floderus-Myrhed, 1987; Gunsolley et al.,1998, Bergstrom, 2006) genetics 
(Michalowicz et al., 1994; Michalowicz et al., 2000), race (Albander et al., 1999), gender 
(Loe and Brown 1991; Albander et al., 1999; Albander et al., 2002; Hyman and Reid 
2003), oral hygiene (Morris et al., 2001; Loe, 1986), socio-economic status (Borrell et al., 
2006, 2007), obesity (Chaffee and Weston, 2010), psychosocial stress (Dolic et al., 2005), 
osteopenia and osteoporosis (Tezal et al., 2000) and other medical conditions including 
type 2 diabetes mellitus (Taylor et al., 2008).  The putative risk factors for periodontitis are 
thoroughly reviewed by Stabholz and co-workers (2010) and Nunn et al. (2003).  The 
evidence from these associations leads us to conclude that periodontitis does not occur 
simply as a result of plaque accumulation but is also associated with host factors which 
will modulate the effect of the plaque on a given individual.   
1.2.6.1 Genetics 
As with many chronic diseases there is a genetic background to the development of 
periodontitis.  The first indication that this might be the case and indeed, some of the 
evidence enabling us to understand the pathogenesis of periodontal disease, derives from 
the studies of patients suffering from single gene defects.  It has been well established for 
many years that aggressive forms of periodontitis are often features of other syndromes 
with a genetic aetiology.  An understanding of the effects of single gene defects allows us 
to recognise the process by which these individuals have lost periodontal attachment.  
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Examples include leukocyte adhesion deficiency syndrome, a syndrome where a single 
gene defect results in the inability of the leukocytes to adhere to the endothelium and 
respond to the chemotactic signalling (Dababneh et al., 2008).  Other single gene defects in 
leukocytes, affecting their ability to respond to chemotactic stimulation or to phagocytose 
effectively, result in severe periodontal destruction.  Periodontitis is associated with the 
following genetic defects; Down syndrome, Chediak-Higashi Syndrome, Papillon-Lefèvre 
syndrome, cyclic and severe congenital neutropenia, Cohen Syndrome and the IL-1 pro-
inflammatory genotype (Modeer et al., 1990; Parkhill et al., 2000; Kinane et al., 2005; Hart 
and Atkinson 2007).  All have specific defects in their immune response which lead to 
attachment loss.  It is currently estimated that genetic differences account for at least 50% 
of all periodontitis (Michalowicz, et al., 2000).   
1.2.6.2 Smoking and Periodontitis 
The effect of smoking on the periodontium is well documented and is thoroughly reviewed 
by Warnalaksuriya et al. (2010).  There is strong evidence in support of a negative impact 
of smoking on periodontal health.  A systematic review appraised 70 cross-sectional 
studies and 14 case-control studies, all of which indicated an association between smoking 
and periodontitis (Bergström et al., 2006).  A further 21 cohort studies were also reviewed 
of which 20 indicated that smoking had a negative impact on the periodontium (Bergstrom 
et al., 2006).  Odds ratios reported in the literature range from 1.2-7.1 depending on other 
factors (Johnson et al., 2004; Do et al., 2008; Thomson et al., 2007).   
The mechanisms by which smoking has been proposed to damage the periodontium were 
thoroughly reviewed by Palmer et al.in a recent article (Palmer et al., 2005).  The proposed 
mechanisms include; alterations in the vasculature of the periodontal tissues in smokers, 
reduced neutrophil transmigration across the periodontal microvasculature, suppression of 
neutrophil chemokinesis, chemotaxis and phagocytosis.  Altered release of proteases by 
neutrophils could also be responsible for tissue damage.  Defects in cell-mediated 
immunity and humoral immunity could affect the immune response to the periodontal 
biofilm in smokers.  Cytokine and enzyme levels are also reduced in the GCF of smokers.  
In vitro studies have shown detrimental effects of nicotine and some other tobacco 
compounds on fibroblast function, including fibroblast proliferation, adhesion to root 
surfaces and cytotoxicity.  It seems likely that the bacteria associated with smoking related 
periodontitis may be different but there have been contradictory findings in this regard 
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(Palmer et al., 2005).  All current smokers, and those who had recently stopped, were 
excluded from the studies included in this thesis. 
1.2.6.3 Current model of the pathogenesis of periodontitis 
From the above discussion around the various risk factors for periodontitis it can be clearly 
seen that periodontitis is a multi-factorial disease.  Kornman (2008) describes the current 
model of periodontal pathogenesis as including two levels (Figure 1-2).  Level A includes 
the biological mechanisms involved in immuno-inflammatory responses and in bone and 
connective tissue metabolism.  In level B the products of the microbial complexes activate 
the immuno-inflammatory pathways and subsequently affect the behaviour of the bone and 
connective tissue metabolism.  Genetic and environmental factors will affect the 
expression of these interactions both in levels of metabolites that can be measured in 
samples and in clinical signs that can be observed.  The current concept is therefore a 
multilevel model, which recognises that a number of individual elements interact to confer 
periodontal risk. 
Periodontitis occurs when behavioural and environment factors, for example smoking, are 
combined with the products of microbial complexes (dental plaque).  The effectiveness of 
the host immuno-inflammatory response within the soft tissue and bone will determine 
whether the disease is contained or leads to inflammatory bone loss which can be measured 
clinically.  For example, alterations in the microbial mileu may subvert or overcome the 
host response supporting the role of specific bacteria in the pathogenesis of periodontitis 
(Socransky et al., 1998).  Alternatively hyper-inflammatory states seen in the IL-1 
genotype or IL-6(-174) could potentially result in an excessive and inappropriate response 
to a relatively innocuous microbial complex (Kornman et al., 1997; Trevilatto et al., 2003; 
Raunio et al., 2010) although many studies on the genetic susceptibility to periodontitis are 
underpowered and a recent review reported that despite speculation there is limited 
evidence for the IL-1 genotype as a risk factor for chronic periodontitis (Grigoriadou et al., 
2011). 
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Figure 1-2  Current model of the pathogenesis of periodontal disease   
(Kornman, 2008) 
1.2.7 Epidemiology of periodontal diseases 
1.2.7.1 Introduction 
Periodontal diseases are among the most common diseases affecting mankind with 
gingivitis presenting in up to 90% of individuals in some populations.  Even in populations 
with high dental awareness and good access to dental care the prevalence of gingivitis can 
be as high as 44%, although perhaps as few as 5% of sites are affected in these individuals 
(Brown et al., 1990).  Across the world there are large differences in the reported 
prevalence of periodontal disease (Papapanou, 1996).  While this may indicate a racial 
predilection it also reflects the prevalence of known risk factors for periodontal disease, the 
effects of socioeconomic factors and their relationship with oral cleanliness in different 
geographic locations.  
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1.2.7.2 Prevalence of periodontal disease 
In populations where oral hygiene is poor and access to dental care is limited or non-
existent the prevalence of periodontitis is very high.  Among the Sri Lankan tea plantation 
workers attachment loss was evident as young as 16 years of age and the mean attachment 
loss at thirty years of age was 3mm (Loe et al., 1978).  Similarly studies in Kenya found 
that where oral hygiene was poor, probing depths of ≥4mm were found at 20% of all sites 
examined (Baelum et al., 1988).  70% of all patients examined in Brazil had at least one 
site with ≥5mm CAL (Susin et al., 2004).  Holtfreter et al. (2009) reported that 51% of 
subjects had moderate or severe periodontitis in Pomerania.  In this study the Centre for 
Disease Control criteria were used meaning that all patients had at least 2 interproximal 
sites with CAL ≥ 4 mm or 2 interproximal sites with PD ≥ 5 mm (Page and Eke, 2007).  
Arguably more relevant to the findings presented in this thesis, studies in developed 
countries report a much lower prevalence of periodontitis.  Periodontal trends in Britain 
and Europe were the subject of a WHO report in 2001.  Reich states in 2001 that only 10% 
of adults between 35-44 years of age will experience advanced periodontitis (Reich, 2001).  
There are however, only a small number of countries in Europe for which there are good 
data on prevalence (Konig et al., 2010).  A study in North America reported that moderate 
disease with probing depths of up to 5mm was found in 20-30% of this age group.  
Similarly, there was an increasing prevalence with age (65-74years) (Albandar et al., 
1999).  Studies monitoring periodontal disease in populations over time have shown a 
reduction in periodontal disease in recent decades (Reich, 2001).  A study in Norway, a 
country generally believed to host a population of highly dentally motivated individuals, 
was carried out by the same investigators as the famous Sri Lankan tea worker study (Loe 
et al., 1986).  They found, in a young cohort of less than 30 years of age, that attachment 
loss was less than 1mm at 30 years and there were virtually no deep pockets.  This patient 
group had minimal plaque and calculus deposits (Loe et al., 1986).  While this is 
encouraging and suggests that the initiation of periodontitis can be prevented by good oral 
hygiene practices, reports from other northern European countries such as Sweden have 
shown higher levels of disease.  In an adult population moderate disease affected 40% of 
patients, severe disease affected only 13% and the most severely affected accounted for 
only 3% of the population.  This is consistent with the view that periodontal disease as a 
chronic condition requires a period of years of exposure to initiating factors before signs of 
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disease are measurable.  Encouragingly, the prevalence of periodontitis appeared to be 
reducing over recent decades (Hugoson et al., 1998, 2008). 
A large cross sectional study in the United States involving 15,132 adults reported that 
gingivitis was present in 44% of patients, but probing pocket depths of 4-6 mm occurred in 
only around 13% of patients (Brown et al., 1990).  These authors reported that the 
prevalence of clinical attachment loss of ≥3mm was 44% while severe disease, defined as 
probing depths ≥7mm, was only present in 0.6% of cases.  Another North American study 
reported that the prevalence of pockets ≥5mm and CAL ≥ 5mm was 8.9% and 19.9% 
respectively accross all subjects.  The levels of disease were slightly higher in non-
Hispanic blacks (18.4%, 27.9%) and Mexican Americans (14.4%, 28.34%) (Albandar et 
al., 1999).   
1.2.7.3 Periodontal disease in the United Kingdom 
Data describing the periodontal condition of the general population of the United Kingdom 
is scarce although the Adult Dental Health Survey is a useful cross sectional study of oral 
health that has been conducted on a ten yearly basis since 1968.  In addition, data derived 
from control groups in case control studies examining other risk factors can be used to 
determine the level of disease in the general population in the United Kingdom.   
Tooth extractions 
The ultimate outcome of periodontitis is tooth loss and as such a consideration of available 
data on this outcome is relevant to this overview.  Periodontitis is still a significant cause 
of tooth mortality across the world and in the United Kingdom and is one of the most 
common reasons for tooth loss in general dental practice.  Across the developed world 
periodontitis accounts for between 18% and 36% of all extractions in national cross-
sectional studies (Ainamo et al., 1984; Cahen et al., 1985; Klock and Haugejorden, 1991; 
Reich and Hiller, 1993, Ong et al., 1996; Angellilo et al., 1996; Murray et al., 1997).   
Studies in the UK population have found that dental caries and its complications are still 
the primary reason for tooth extraction with periodontitis the second most cited cause.  In 
2001, in a survey of 11,149 teeth extracted in general practice, Agerholm reported that 
45% of all extractions were due to caries and 30% were due to periodontitis (Agerholm et 
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al., 2001).  75% of all extractions due to periodontitis occurred in patients between 41 and 
70 years of age.  In both 1986 and in 1997 there were no extractions for periodontitis in 
patients below forty years of age.  Another study in 2005 in a survey of 558 extractions 
reported similar results; 29.1% were attributable to periodontitis (Richards et al., 2005).  
This finding has been confirmed in two studies over fifteen years in a Scottish population.  
In 1994 a study of extraction patterns in general dental practice in Scotland reported that of 
all the extractions carried out in general practice over a week by 139 GDPs (917 teeth) 
periodontitis  accounted for 20% of them (Chestnutt et al., 2000).  McCaul and co-workers 
(2001) ten years later in the same population confirmed that caries and its sequelae were 
the most common reason for tooth loss; 54.7% of extractions were attributable to caries 
and 16.3% to periodontitis.  Nevertheless the number of extractions attributable to 
periodontitis increased with age and accounted for a significant proportion of extractions 
particularly in the lower incisor region where this was the most common reason for 
extraction (McCaul et al., 2001).   
Clinical probing depths and clinical attachment level 
While periodontitis can lead to tooth loss, extractions are obviously not a sensitive measure 
of mild or moderate disease in a population.  Data including clinical probing depths and 
clinical attachment loss describe the prevalence of active and historic disease respectively 
in the general population.  
Robinson et al. (1996), in a survey of adult men in the UK between the ages of 18 and 65 
years, reported that clinical attachment loss (CAL) and probing depths of ≥ 4mm affected 
around a third (28.5% and 31.9% respectively) of all of the group.  Bleeding on probing 
(BOP) was almost universally present with >90% of subjects exhibiting some gingival 
bleeding.  Similarly, an examination of 100 UK military recruits showed that even in this 
young group, periodontitis was evident with CAL ≥3mm affecting up to 47% of subjects.  
The extent of CAL ≥ 3mm was uncommon (0.9%) (Griffiths et al., 2001).  This study also 
confirmed that the most severe disease affects a small proportion of the population as only 
a small number of patients had a large number of sites above the threshold for the 
diagnosis of periodontitis (Griffiths et al., 2001).  There is a paucity of data describing the 
periodontal condition of the population of the United Kingdom and Scotland outwith the 
national surveys.   
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1.2.7.4 Adult Dental Health Survey 1998 
Until recently, (March 2011) the most comprehensive data concerning the periodontal 
status of the United Kingdon was derived from the Adult Dental Health Survey 1998 
(ADHS).  The periodontal findings of this study were reported by Morris et al. (2001).  It 
represents the most comprehensive data available on the level of periodontal disease in the 
United Kingdom as there were no examinations of Scottish patients in the most recent 
survey reported in 2011 (The Health and Social Care Information Centre, 2011).  Morris 
reported that the oral hygiene of the UK population is poor with around 70% of patients 
having visible plaque and calculus present.  Even patients who had chosen to brush their 
teeth immediately prior to examination still had plaque present on one third of their teeth.  
This is indicative of the ineffectiveness of tooth brushing even when it was employed 
(Morris et al., 2001).   
The ADHS recorded clinical probing depths although a partial mouth protocol was 
adopted.  This is likely to have resulted in under-reporting of both the prevalence and 
extent of disease (Susin et al., 2005).  Mild periodontitis was common and 54% of dentate 
adults had periodontal pocketing of ≥4mm; however only 5% of patients had pockets 
deeper than 6mm.  Pocketing ≥9mm was seen in only 1% of all dentate responders.  Age or 
increased duration of exposure to risk factors clearly increases the prevalence of 
periodontitis with deep pockets (≥6mm) seen in only 1% of the 16-24 year old age group 
but in 15% of over 65 year olds.  The number of teeth involved also increased with age.  
Pocketing of 4mm affected only 5% of teeth in 16-24 year olds but up to 23% of teeth in 
those over 65 years.  Measurement of attachment loss, a better measure of total disease 
experience, showed that moderate attachment loss of up to 4mm was common (43%), but 
severe attachment loss of ≥ 6mm was only found in 8% of adults.  There were no cases of 
CAL ≥6mm in the 16-24 year old group but in those between 55 and 64 years old this 
figure rose to 17%.  30% of all subjects over 65 had one tooth with ≥ 6mm CAL.  A clear 
trend is seen with an increasing level of periodontitis with age with attachment loss of ≥ 
4mm affecting 14% of 16-24 year olds but up to 85% of those over the age of 65 years 
(Morris et al., 2001). 
Those patients suffering from severe disease account for 8% of the general population and 
have on average 2.6 teeth affected, although a further ten teeth on average were affected by 
moderate disease.  When only those suffering from pocketing ≥ 4mm were analysed, it was 
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found that there were small differences in socioeconomic factors, dental attendance and 
oral hygiene between those patients suffering from mild periodontal disease and those with 
the most severe disease.  This large study also found that the oral hygiene and periodontal 
condition of men was worse than age- matched females and that periodontitis and the 
abundance of plaque and calculus were slightly lower in patients who attended a dentist 
regularly and reported regular oral hygiene measures.   
Age, gender, previous smoking status and socioeconomic status are potential confounders 
that should be controlled for in determining the effect of T1DM on the prevalence of 
periodontal disease in the studies described in this thesis (Morris et al., 2001).  
The Adult Dental Health Survey 2009 (The Health and Social Care Information Centre, 
2011) recently reported that there has been an over all reduction in the level of moderate 
periodontal disease with 55% of dentate adults in England and Wales having no 
periodontal pocketing.  37% of adults had pockets of between 4 and 5.5mm, 7% had 
pocketing of between 6 and 8.5mm and 1% had pocketing of 9mm or more.  Overall the 
prevalence of severe disease has increased slightly since 1998 although this is likely to be 
due to increased tooth retention rather than a true increase in disease given that mild to 
moderate disease has reduced over the same period.   
1.2.7.5 Conclusion 
In conclusion, mild forms of periodontal disease, including gingivitis, are common 
conditions affecting a small number of teeth in a large number of patients.  Periodontitis 
with associated moderate loss of attachment affects up to half the population, however this 
again may be limited to a small number of teeth.  Severe attachment loss is uncommon 
despite poor oral hygiene in the population and only a small number of teeth are likely to 
be affected by the most advanced attachment loss.  The level of periodontitis in the United 
Kingdom appears to be similar to other developed countries.  There is a significant 
association between increasing age and loss of periodontal attachment.  The high 
prevalence of mild disease in the general population makes it unlikely that differences due 
to specific risk factors will be detectable.  The relative rarity of severe periodontal 
destruction, in the UK population should mean that any increase in prevalence or severity 
in high risk groups should be measureable at this level.  The extent as well as the 
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prevalence and severity of periodontitis should be reported in studies investigating 
differences in periodontal disease levels in different populations.  
1.3 Type 1 diabetes mellitus and periodontal disease 
1.3.1 Introduction 
The association between T1DM and periodontal disease has been investigated repeatedly 
over the years with the earliest reports beginning in the 1930s (Sheppard, 1936).  Early 
studies can be criticised for their lack of adequate controls and a lack of standardisation in 
their inclusion and exclusion criteria.  A detailed review of the literature will cover the 
methodological strengths and weaknesses of the studies into T1DM and periodontitis to 
date.   
1.3.2 Terminology and Nomenclature 
Diabetes mellitus, like many other complex diseases, has had its share of nomenclature 
changes over the past decades and this alone makes direct comparisons between studies 
difficult.  T1DM is variously referred to in the literature as juvenile diabetes, insulin 
dependent diabetes mellitus, insulin deficient diabetes mellitus and early onset diabetes.  
T1DM has been clearly defined in the current classification and has already been discussed 
in section 1.1.2 (ADA, 2011).  It is important to distinguish clearly between Type 1 and 
Type 2 diabetes mellitus.  Both are defined by hyperglycaemia but they are essentially two 
separate diseases with different aetiology, pathogenesis, presentation, treatment and 
complications (Daneman, 2006; Stumvoll et al., 2005).  It is the author’s view that studies 
investigating the effect of diabetes on the periodontium should not mix patients with type 1 
and type 2 diabetes together (Aspriello et al., 2010).  Unfortunately, many of the early 
studies have mixed diabetic populations making it impossible to separate the two main 
subtypes of the disease (Glavind et al., 1968; Albrecht et al., 1987; Oliver and Tervonen, 
1993; Alpagot, et al., 2001; Persson et al., 2003).  This has resulted in a large number of 
early studies being difficult to interpret in the light of unclear inclusion criteria. 
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1.3.3 Study Design 
1.3.3.1 Demographic characteristics 
The recent systematic review by Chávarry and co-workers (2009) reported that the design 
of studies investigating the periodontal condition of T1DM patients has been inadequate.  
Factors known to affect the prevalence of periodontitis should be eliminated or adequately 
controlled for by strict inclusion and exclusion criteria and where possible statistical 
analysis.  Chávarry et al. (2009) concluded that none of the studies into T1DM to date have 
adequately controlled for confounding factors.  The selection of an appropriate control 
group is central to the validity of the conclusions that can be drawn, but many studies have 
used convenience samples, limiting the applicability of the conclusions to the wider 
population (Cianciola et al., 1982; Leeper et al., 1985; Tervonen and Karjailenen, 1997; 
Sbordone et al., 1995, 1998) 
Another weakness within the literature is that many studies on diabetes and periodontitis 
have focussed on children and adolescents.  The prevalence of periodontitis in the juvenile 
population is relatively low and it is generally accepted that periodontitis normally runs a 
chronic course throughout life.  It is therefore to be expected that even adolescents with 
diabetes will exhibit little sign of periodontitis at this early stage in life and after a short 
duration of diabetes.  Increases in gingivitis which have been reported may or may not 
reflect an increase in susceptibility to periodontal destruction over time (Lalla et al., 
2006a).  Chávarry et al. (2009) called for future studies to be performed in adults with 
T1DM rather than in children and adolescents.   
It has been well documented that there is a genetic component to the pathogenesis of 
periodontitis as well as to T1DM (Michalowicz et al., 2000; Ounissi-Benkalha and 
Polychronakos, 2008).  It is therefore imperative that the control group does not include 
siblings of the diabetic patients, since they would have similar environmental and genetic 
backgrounds.  Racial differences in the prevalence of periodontitis are well documented 
with an increase in periodontitis in Afro-Caribbean, Asian and Hispanic races (Albander et 
al., 1999).  A number of studies have not reported demographic information or have 
included a number of different races in the study population (Lalla et al., 2006a). 
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1.3.3.2 Case definition   
Well defined criteria for diagnosis of disease should be employed.  Full mouth chartings of 
attachment level and clinical probing depth are the most reliable method of diagnosing 
periodontitis (Susin et al., 2005).  There is also significant heterogeneity in case definitions 
of periodontitis (Page and Eke, 2007).  Most studies only reported differences in the mean 
CPD and CAL rather than prevalence data and odds ratios for a given level of periodontitis 
(Khader et al., 2006, Chávarray et al., 2009). 
1.3.3.3 Tobacco smoking.  
Many studies have not reported the prevalence of smoking in their case and control groups 
and no study of T1DM has completely eliminated this factor.  Since smoking is the most 
important environmental risk factor for periodontitis it is essential that this information is 
gathered and allowed for in the statistical analysis.  The odds ratio for increased risk of 
periodontitis due to smoking is affected by age, duration and the cumulative number of 
cigarettes smoked over time (Warnakulasuriya et al. 2010).  Odds ratios reported in the 
literature range from 1.2-7.1 depending on other factors (Johnson et al., 2004; Do et al., 
2008; Thomson et al., 2007).  In the studies of T1DM patients which did report smoking 
data, the prevalence was high (Bridges et al., 1996; Moore et al., 1999). It was therefore 
difficult to model accurately for the effect of smoking on the periodontium in diabetic 
patients in these studies and distinguish between the two risk factors.  Haber et al. (1993) 
examined 132 T1DM patients and 88 controls measuring plaque, gingivitis, clinical 
probing depths and clinical attachment level but did not exclude smokers.  On average they 
found that T1DM smokers had higher levels of periodontitis than healthy controls.  
However the authors also noted that the smokers had experienced lower levels of 
periodontal care as, on average, it had been longer since their last prophylaxis.  This 
indicates the possibility that there were differences in the social and/or behavioural risk 
factors for periodontitis in this group.  Interestingly, there was no significant difference 
between non-smoking patients with T1DM and the healthy controls.  The odds ratio for 
former smokers was 1.8 and for current smokers this was 6.9.  The authors concluded that 
prevalence of periodontitis increased with age, past smoking experience and current 
smoking exposure.  These findings were in agreement with those of Bridges et al. (1996) 
who examined the effect of smoking and socioeconomic factors in T1DM patients.  They 
found that there was an increase in bleeding index, clinical probing depth and clinical 
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attachment level in T1DM.  However, they also reported that smoking per se was related to 
increased clinical probing depth, clinical attachment level and to missing teeth.  Many of 
the mechanisms by which smoking is related to the development and increased extent and 
severity of periodontitis are the same as those hypothesised for T1DM.  Therefore, it is 
imperative that smoking data is included and reported in studies examining the impact of 
diabetes on the periodontium.  Moore et al. (1999) reported that levels of periodontitis 
were similar to national surveys.  This study also showed that 35% of all patients with 
periodontitis were smokers.  The odds ratio for having periodontitis if subjects were 
smokers was 9.73 while the OR for T1DM was 3.36.  The three studies described above 
make it clear that in order to elucidate the role of T1DM in the development of 
periodontitis current smokers should be excluded from future studies.   
1.3.3.4 Sample size 
Sample size is of critical importance in all clinical studies both in concluding that an 
association exists or that no association is present.  Small sample sizes are a problem in a 
number of the studies reported to date.  Often studies have been under-powered to detect 
real differences in disease experience between cases and controls.  Conversely, it is also 
possible that differences reported in small samples are chance findings which would not be 
seen in a larger population (Manouchehr-pour et al., 1981, Rylander et al., 1987, Pinson et 
al., 1995, Sbordone et al., 1995, Guthmiller et al., 2001, Yucekal-Tuncer et al., 2003, Aren 
et al., 2003). 
1.3.3.5 Training and calibration 
A further weakness was the lack of calibration and training of clinical examiners.  Only 4 
out of 17 studies on T1DM included in the review by Chávarry and co-workers reported 
adequate training and calibration of examiners (Hugoson et al., 1989, Harber et al., 1993, 
Pinson et al., 1995; Guthmiller et al., 2001; Chávarry et al., 2009).  In addition, blinding of 
the examiners to the diabetic status of the subjects was only reported in 1 of the 17 studies 
(Tervonen and Karjailenen, 1997).   
1.3.3.6 Measurement of diabetes 
As diabetes is a relatively common disease affecting 4.4% of the Scottish population (SDS, 
2009) and 6.4% (3.8-10.2%) of the population worldwide, it is important that the control 
group are not unknowingly suffering from Type 2 diabetes.  A small number of studies 
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have taken blood tests for blood glucose levels, fructose levels or glycosylated 
haemoglobin from their control group, however this precaution has not been universal 
(Firatli et al., 1996, 1997, Salvi et al.,  2005).  Without this information it is not possible to 
be sure that there are no undiagnosed diabetic patients in the control group confounding the 
findings of the study.   
1.3.4 Gingivitis and Type 1 Diabetes 
Many studies have shown that there is an increase in gingivitis in diabetic patients even at 
an early age.  In a prospective experimental gingivitis study 9 subjects suffering from 
T1DM were compared with nine healthy controls.  It was found that there was an increase 
in the severity of gingivitis and a reduction in the time taken for the gingivitis to develop 
despite similar levels of plaque (Salvi et al., 2005).  This prospective in vivo experimental 
study of two small but well matched groups provides moderately good evidence that 
patients with type 1 diabetes are more susceptible to gingivitis.  Other cross-sectional 
studies have also found an increase in gingival redness and swelling in T1DM (Bernick et 
al., 1975; Ringelberg et al., 1977; Gislen et al., 1980; Faulconbridge et al., 1981; Gusberti 
et al., 1983; Harrisson and Bowen 1987; Hugoson et al., 1989; Akyuz and Oktay, 1990; De 
Pommereau et al., 1992; Seppala et al., 1993; Pinson et al., 1995; Pinducciu et al., 1996 
and Lalla et al., 2006a).  These studies have primarily used indices of gingival 
inflammation such as the Gingival Index of Loe and Silness (1963) or the Modified 
Gingival index of Lobene (1986).  As gingivitis is caused by dental plaque it is important 
that a measure of oral hygiene is included in the analysis to ascertain the cause of any 
increased gingival inflammation.  Bridges et al. (1996) reported an increased GI score in 
T1DM.  However when plaque scores were taken into account the association was no 
longer seen.   
A number of studies have shown that in diabetic patients the severity of gingivitis is related 
to glycaemic control (Kjellman et al., 1970a; Gislen et al., 1980; Gusberti et al., 1983; 
Harrisson and Bowen 1987; Seppala et al., 1994 and Firalti et al., 1996) and the occurrence 
of diabetic complications (Rylander et al., 1987).  Other investigators have found no 
increase in clinical signs of gingivitis in patients whose glycaemic control is good (Ervasti 
et al., 1985).  Clinical trials examining the effect of glycaemic control on gingivitis have 
shown that there can be a small improvement in the gingival condition, seen by a reduction 
in gingival bleeding or redness, when the glycaemic control is improved (Karjailenen and 
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Knuuttila, 1996, Sastrojiwoto et al., 1990).  While both of these studies showed a slight 
reduction in gingival bleeding, they did not result in any improvement in the underlying 
periodontal condition.  These studies support the theory that there is a relationship between 
glycaemic control and gingival inflammation but a clinically significant improvement in 
gingivitis or periodontitis has not been demonstrated (Karjailenen and Knuuttila, 1996; 
Sastrowijoto et al., 1990).  Gingivitis is found to be increased in differing hormonal states 
for example pregnancy and puberty (Armitage, 2000).  Studies investigating diabetic 
patients who are pregnant or experiencing puberty have found that they suffer from 
increased gingivitis at these times compared with non-diabetic subjects (Gusberti et al., 
1983, Guthmiller et al., 2001).  However, in one study of pregnant patients, most were 
suffering from gingivitis at the beginning of the study (Albrecht et al., 1987).  The study 
was also conducted on a mixed population of T1DM and type 2 diabetic patients.  Another 
study found an increase in gingivitis in the circumpubertal age range in T1DM in line with 
the normal adolescent population (Gusberti et al., 1983).  When age was taken into account 
the main contributing factor was average glycaemic control.   
In contrast to the above studies there have been a number of reports which have not found 
a correlation between diabetes and gingivitis (Glavind et al., 1968; Bay et al., 1974, 
Goteiner et al., 1986; Pinson et al., 1995; Sbordone et al., 1995 and 1998; Bridges et al., 
1996; Novaes et al., 1997).  These studies have either found no increase in gingivitis or 
have found that plaque control in the diabetic group is significantly poorer.  When plaque 
scores were taken into account, there was no difference in levels of gingivitis.  The studies 
reporting no differences do not seem to be significantly methodologically superior to those 
reporting an increase.  In light of the available evidence it is not possible to definitively 
conclude that the prevalence and severity of gingivitis is increased in T1DM.  Further 
studies to elucidate this relationship are required. 
1.3.5 Oral Hygiene 
As discussed in the section on the aetiology of periodontal disease, dental plaque is the 
primary aetiological factor in the development of gingivitis and periodontitis.  It is 
therefore important in all measures of periodontal disease that investigators report the level 
of plaque control in the mouth at the time of diagnosis.  Poor oral hygiene in diabetic 
patients is a possible cause of an increase in periodontal disease (Albrecht et al., 1988; 
Novaes et al., 1991; Bridges et al., 1996; Firatli et al., 1996; Lalla et al., 2006).  A possible 
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cause of increased plaque accumulation includes increased glucose content of the saliva.  
This could provide nutrients for the development of the plaque through production of 
extracellular polysaccharides such as glucans and fructans (Takahashi and Nyvad, 2008).  
It has also been suggested that lack of compliance with recommended diabetic therapy 
might in turn reflect on attitudes to maintenance of oral health (Thorstensson et al., 1989a).   
Increased plaque accumulation has not been universally reported.  A number of studies 
have found no increase in plaque deposits in T1DM (Bernick et al., 1975; Leeper et al., 
1985; Akyuz and Oktay, 1990; De Pommereau et al., 1992).  It may be that the differences 
noted in the various studies are specific to the case and control groups under investigation.  
Oral hygiene varies according to socioeconomic status, age, sex and other individual 
factors.  Factors affecting oral hygiene must be reported in cross-sectional studies in order 
to eliminate these as a confounding element in the analysis.   
1.3.6 Periodontitis and type 1 diabetes mellitus 
1.3.6.1 Cross-sectional studies 
By definition periodontitis is the progressive loss of periodontal clinical attachment which 
can either be manifested as an increase in clinical probing depths and/or recession of the 
gingivae.  Studies reporting on periodontitis should include full mouth clinical probing 
depths and attachment levels, measured from the amelocemental junction to the base of the 
probable pocket (Susin et al., 2005).  This type of assessment is time consuming for both 
the patient and the examiner and is expensive to achieve.  Therefore many studies have 
involved partial mouth measurements or have recorded only probing depths.  Studies 
reporting only clinical probing depths in T1DM have reported either no difference in 
average clinical probing depths or an increase compared with non-diabetic control subjects 
(Khader et al., 2006, Chávarry et al., 2009).  There are no studies to the knowledge of the 
author that report lower mean clinical probing depths.  Studies investigating the prevalence 
of periodontal disease in adolescents are more numerous than those investigating adult 
populations.  Many of these, while reporting increased levels of gingivitis, do not report 
any increase in probing depth or loss of attachment.   
Glavind et al. (1968) examined 102 subjects (51 diabetic patients and 51 healthy controls) 
to ascertain the relationship between periodontal status and diabetes duration, insulin 
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dosage and retinal changes.  He found no difference between the groups in oral hygiene or 
gingival inflammation.  The periodontal condition was normal up to 30 years old.  
However, in the 30-40 year age range there was an increase in mean clinical attachment 
level (diabetic patients: 4.32mm, NDS: 2.76mm).  This study also reported that 
periodontitis was related to age, duration of diabetes and retinopathy.  It contained both 
T1DM and young type 2 diabetic patients.  Cianciola and co-workers (1982) showed that 
the prevalence of periodontitis was increased in children and adults suffering from T1DM.  
The authors examined 263 patients with IDDM (T1DM) and 149 non-related controls and 
59 non-diabetic siblings.  This design could be criticised for the use of siblings who might 
share a predisposition to diabetes, or to the development of periodontitis.  However, the 
majority of control subjects were not related to the diabetic patients.  It is therefore not 
possible to quantify the effect of using siblings on the analysis.  In the sibling control 
group between 11 and 18 years of age there were no instances of periodontitis.  This would 
suggest that the differences in periodontal status between the diabetic patients and their 
siblings were due to their diabetic status.  Leeper et al. (1985) also used the siblings of 
T1DM patients as part of his group of age and sex matched controls.  The study included 
only 11 diabetic patients between 11-19 years of age.  Plaque index, clinical probing depth, 
clinical attachment loss and bleeding on probing were all measured.  The mean probing 
depth was increased in T1DM (mean 2.9mm) compared with the control group (mean 
2.3mm).  The difference between the diabetic patients and their siblings was not significant 
in this instance, adding weight to the argument against using siblings as controls however 
the small sample size means that any differences would be unlikely to be statistically 
significant in any case.  The bleeding index was increased but there were no differences in 
plaque levels indicating that there was an increased prevalence of gingival inflammation in 
the diabetic population.  The size of this study precludes drawing any conclusions from the 
data.  The researchers used the juvenile periodontal index and showed that clinical signs of 
periodontitis were not seen in patients less than 12 years of age.  However, in the 11-18 
year old group the prevalence of periodontitis was 9.8% in the T1DM group compared 
with 1.7% in controls.  There were six diabetic patients (4.2%) with severe periodontal 
destruction with radiographic signs of bone loss and attachment loss of greater than 25% 
on at least two teeth in the 11-18 year old group compared with only one patient (0.8%) in 
the control group.  As patients aged, there appeared to be an association between duration 
of diabetes and periodontitis.  Both an increase in gingivitis and an increase in radiographic 
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and clinical signs of bone loss and corresponding attachment loss of up to 39% in patients 
older than 19 years were evident.   
Galea et al. (1986) examined 82 subjects with early onset insulin-dependent diabetes 
mellitus and reported that there was evidence of increased clinical probing depths and 
clinical attachment loss in two children 11 and 13 years old respectively.  Deep probing 
depths were first found in patients aged 19 and above, while 60% of 25-29 year olds had 
established periodontitis.  While these figures are well above the reported normal 
prevalence of periodontitis in the healthy adult population, this study did not have a control 
group.  In addition it is not clear what criteria were used to define “established 
periodontitis”, and whether these definitions are comparable to those used in 
epidemiological surveys.  Periodontitis was associated with higher blood glucose 
concentration and diabetic complications (Galea et al., 1986).  Another study of 50 diabetic 
patients (53 controls) showed that there were no differences in the periodontal status 
between the diabetic patients and the controls (Tervonen and Knuuttila, 1986).  There was, 
however, an increase in the number of deep pockets and the number of bleeding sites in the 
poorly controlled diabetic patients.  In this study, the well-controlled diabetic patients had 
significantly better periodontal health than the healthy controls.  There were no differences 
detected in mean alveolar bone levels.  The main difficulty with this study is that it is not 
possible to determine from the available information the type of diabetes of the cases.  In 
addition, no smoking data were presented.  The study was also inadequately powered to 
allow comparisons between four groups.  It may be that the observed reduction in 
periodontitis in well controlled diabetic patients is representative of health attitudes and 
behaviours.  Good compliance with a diabetic care regime may be linked with a positive 
attitude to general and oral health (Syrjala et al., 1999, 2002, 2004).  
Harrisson et al.(1987) and Pinson et al.(1995) are further examples of studies which have 
reported no increase in periodontitis in a T1DM population.  Both of these studies however 
examined a paediatric and adolescent population and it may be that the children, in line 
with the findings of others, had simply not been exposed to dental plaque for long enough 
to display signs of this chronic disease  
Similarly, no increase in full mouth clinical probing depths was noted by Rylander and co-
workers (1987) in an examination of 46 T1DM patients and 41 control subjects aged 
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between 18 and 26 years.  However, when only buccal and lingual sites were examined, an 
increase in gingival redness and prevalence of attachment loss >2mm was noted.  Moore et 
al.(1999) is one of only a few studies of an adult T1DM population to have found no 
significant increase in periodontitis.  It is interesting that in this study, which included 
smoking status as a confounding factor, most of the periodontitis could be explained by 
age and smoking.  Rosenthal et al.(1988), in an uncontrolled cross-sectional descriptive 
study, found that moderate to advanced periodontitis was experienced by 5.8% of the study 
population of type 1 diabetic patients.  In addition to this higher than average prevalence of 
periodontitis in a population of 11-22 year olds, Rosenthal also reported that those patients 
who had no periodontitis had a lower mean HbA1c score than those with periodontitis.  
There was also an association between retinopathy, neuropathy and ketoacidosis and 
periodontal disease.  Similarly, Rylander et al. (1987) also reported that diabetic 
complications were associated with increases in gingival inflammation.  An association 
between HbA1c and loss of clinical attachment has also been reported by multiple authors 
(Willerhausen et al., 1991; Safkan-Seppala and Ainamo, 1992; Tervonen et al., 1993, 
1997; Patino Marin et al., 2002; Aren et al., 2003; Lalla et al., 2007).  These authors 
reported increased clinical probing depths, clinical attachment loss and radiographic bone 
loss in poorly controlled subjects but no corresponding increase in well controlled T1DM 
despite similar plaque levels.  
The average HbA1c score is linked to the development of diabetic complications.  
However, complications are not only found in poorly controlled diabetic patients nor do all 
patients with high HbA1c levels develop complications at the same rate (DCCTRG, 1993).  
Thorstensson and co-workers (1996) analysed periodontal data from 39 T1DM patients for 
associations with other systemic complications of diabetes rather than simply HbA1c.  
These workers found that periodontitis was associated with proteinuria and renal disease, 
cardiovascular disease e.g. angina and myocardial infarction, and cerebrovasculular disease 
such as stroke and transient ischaemic attacks.  This evidence may suggest that there is a 
common pathway of pathogenesis in the development of these complications. 
Hayden et al. (1989) examined 157 diabetic patients and did not find any relationship 
between periodontal indices and diabetic status.  However, this study only used index teeth 
to determine periodontal status and did not include the examination of healthy controls.  
Hugoson et al. (1989) in a study investigating the effect of the duration of diabetes on the 
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periodontium examined 82 long duration diabetic patients(mean duration 28.9 years), 77 
short duration diabetic patients (mean duration 5.2 years) and 77 controls between 20 and 
70 years of age.  The patients were all insulin-dependent but it appears from further 
reading that a number of these patients were maturity onset diabetic patients and as such 
would be classified as having type 2 diabetes mellitus.  The authors reported that long-
duration type 1 diabetic patients between 40 and 49 years of age had evidence of increased 
alveolar bone loss.  There was an increased prevalence of probing depths of 4 mm and 5 
mm in insulin-dependent diabetic patients less than 45 years of age.  There was also an 
increase in the incidence of severe disease (CPD >6mm).  This is another example of a 
study which did not report smoking status.   
Sastrowijoto et al. (1989) in a cross-sectional descriptive study showed that there was no 
relationship between periodontitis and diabetes and therefore no relationship between 
diabetic control and periodontitis.  This study however did not have a control group and 
consisted of only 22 adults (Satrowijoto et al., 1989).  A similar finding was reported by 
Akyuz and co-workers (1990) and De Pommereau (1992) who both concluded that there 
was no increase in periodontitis in T1DM children and adolescents between 5 and 18 years 
old and 12 and 18 years old respectively.  When examining adolescents, Andronikaki-
Faldami (1990) also found that there was no increase in periodontitis experience in the 15-
25 age group.  However, in the same study in a young adult population there was an 
increase in periodontitis in the 25-36 year age group.  This again emphasises the point that 
periodontitis is a chronic disease which normally takes years for clinical signs to become 
apparent.  Novaes et al. (1991) showed that the prevalence of periodontitis increased with 
age in a T1DM population and was evident at an earlier age than in healthy controls.  The 
difference in the mean probing depth between these groups was not statistically significant 
although a trend was reported.  Alveolar bone loss was found to be higher in the anterior 
region in T1DM than in healthy controls.  These mixed findings are likely to be due to lack 
of statistical power in the sample sizes.  However, it is interesting that the anterior region 
appears to be more susceptible than the posterior.  This does not follow the normal pattern 
of disease progression for chronic periodontitis where most commonly the molar teeth are 
affected in the first instance.  There was a positive correlation between periodontal 
condition and age in diabetic patients but not in healthy controls in this age group.   
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Pinducciu et al. (1996) examined 131 T1DM but only 20 healthy controls.  By using the 
Community Periodontal Index of Treatment Need (CPITN), these workers reported that 
16% of the diabetic patients had a score of 3 or 4.  This means that at least one tooth had a 
clinical probing depth >3.5mm however this does not give the reader any further 
information about the extent or severity of disease.  CPITN scores of 3 or 4 were seen in 
44% of diabetic patients over 35 years of age, compared with 12.5% of the controls.  Given 
the small size of the control group it is not surprising that the above findings lacked 
statistical significance.  The authors in turn concluded that there was little difference in 
periodontitis prevalence between this group of well controlled diabetic patients and healthy 
controls.  If this study had been adequately powered it is possible that statistically 
significant differences would have been seen; however, it is also possible that this result is 
entirely spurious due to inadequate sample size. 
Recently another study in New York reported that there was an increase in plaque index, 
gingivitis and clinical attachment loss in a large case controlled study of adolescents with 
diabetes (94% T1DM) (Lalla et al., 2006a,b).  In this study only two quadrants of the 
mouth were examined.  This is not the optimal method of examintion and it has been 
suggested that such partial mouth recordings may significantly underestimate the true 
prevalence of periodontitis (Susin et al., 2005).  This would, however, of course apply 
equally to both cases and controls in the analysis.  This study had a mixture of races 
represented although these were similarly distributed in the case and control groups.  It is 
impossible to quantify what influence racial predilection for periodontal disease will have 
had on the final analysis.  The level of disease reported in this study was very low and the 
control subjects were all patients at a paediatric dental clinic.  It is possible that selection 
bias introduced in this way would produce a control group with less periodontal disease 
than the corresponding local population.  A second paper by the same group reported that 
there was a strong association between mean HbA1c and periodontitis after controlling for 
age, gender, ethnicity, frequency of prior dental visits and dental plaque (Lalla et al., 2007) 
Since the systematic reviews by Khader et al. and Chávarry et al. there have been seven 
further studies in T1DM.  These have been primarily on children and adolescents and 
therefore do not address the concerns that were raised by these authors about the 
conclusions that can be drawn from subjects in this age group.   
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Al-Shammari et al. (2006), in a small study with only 72 T1DM subjects, showed that 
patients with one or more diabetic complications had a higher risk of periodontal disease.  
They also reported that smoking was associated with diabetic complications and severe 
CAL ≥7mm.  Luczaj-Cepowicz et al. (2006) examined a group of 50 well controlled 
diabetic adolescents, with a mean age of 14 years, and 50 matched control subjects.  There 
were no differences in the periodontal disease index between the groups.  However there 
were differences in the PI, the sulcular bleeding index and the periodontal index in the 
T1DM group.  The level of disease was very low in both groups.  Dakovic et al. (2008) 
also investigated a group of T1DM adolescents and showed that diabetes conferred an 
increased OR of 2.78 for the presence of periodontitis.  Plaque scores and gingival 
inflammation were increased and periodontitis was associated with mean HbA1c, duration 
of diabetes and bleeding/plaque ratio.  Orbak et al. (2008) also showed that children as 
young as nine years had increased gingival inflammation compared with NDS (n=50 
T1DM, 50NDS).  Silvestre et al. (2009) examined 180 subjects (T1DM 90, NDS 90) and 
showed that the T1DM subjects had higher bleeding index, deeper periodontal pockets and 
more periodontal attachment loss than NDS.  Poor glycaemic control and the presence of 
diabetic complications were associated with higher bleeding index and clinical probing 
pocket depths.  Kaur and co-workers in a study of 145 T1DM patients showed using linear 
multivariable regression that there was a significant association between T1DM and mean 
attachment loss.  Although the modelling accounted for smoking, 40.7% of T1DM were 
current smokers and a further 25.5% were previous smokers (Kaur et al.2009).  Xavier et 
al. (2009) looked at predictors of periodontitis in T1DM with no control group.  These 
authors concluded that poorly controlled T1DM patients had higher CPD and CAL than 
better controlled T1DM.  Finally a study published by Saes Busato et al. (2010) reported in 
another adolescent population that the mean Community Periodontal Index (CPI) was 
higher in well and poorly controlled T1DM subjects. However, the CPI has limited 
application in studies reporting the prevalence of periodontitis because it does not record 
clinical attachment level and does not distinguish between true and false pocketing. 
1.3.6.2 Longitudinal studies  
Seppala et al. (1993, 1994) carried out a 2 year longitudinal study in T1DM adults.  Only 
22 of the original 38 diabetic patients examined at baseline were available for assessment 
at the 24 month follow up.  There were higher levels of clinical probing depth, gingivitis 
scores, clinical attachment level, recession and radiographic signs of approximal bone loss 
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in the poorly controlled T1DM.  These findings were confirmed in a further site by site 
analysis of the same data.  The site by site analysis showed that the greatest difference was 
found when only the canines were analysed.  Overall these differences could not be 
accounted for by local plaque control as plaque levels showed no differences between the 
well and poorly controlled groups.  It is also worth noting that the mean HbA1c score of 
the well-controlled T1DM patients was poor.  This may mean that those patients who 
achieve target levels below 7.5% could be at even less risk of periodontal complications 
than this study suggests.  It may also be the case that the cut-off point in HbA1c level for 
the development of periodontal complications is higher than for other systemic 
complications.  The latter has been established by the large prospective diabetic 
complications studies (DCCTRG, 1993; Stratton et al. 2000).  The conclusions of this 
study are limited by its small size and the fact that no smoking data were presented. 
In another longitudinal study of T1DM subjects between 9 and 17 years old, Sbordone and 
co-workers (1995) examined 16 T1DM and 16 cohabiting healthy siblings.  No differences 
in periodontitis levels were detected either at baseline or at any of the three follow up time 
points.  A number of criticisms can be levelled at this study namely: the small sample size; 
the age of the subjects; and the use of cohabiting siblings as a control group.   The latter 
share the same environment and a similar genetic make-up, which may influence their 
susceptibility to diabetes and periodontitis. It is documented that periodontal pathogens can 
be transmitted within families conferring a similar microbiological profile and associated 
risk (Petit et al., 1993a,b). 
Firatli et al. (1997) examined the relationship between periodontal status and the duration 
of IDDM in 44 T1DM children and adolescents in a longitudinal study lasting five years.  
Clinical attachment loss was associated with duration of diabetes and over a five year 
period the mean CAL increased from 2.39mm to 3.51mm.  These findings are in 
agreement with those of Novaes et al. (1997) who reported that over a ten year period 
probing depths increased in diabetic patients. 
1.3.6.3 Radiographic analysis 
Rutledge et al. (1940) reported a prevalence of periodontitis of 40% in a group of T1DM 
using radiographic bone levels to determine presence or absence of disease. However no 
control patients were examined.  Sheppard et al. (1936) showed that there was a high 
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prevalence of periodontal destruction seen radiographically in a population of hospitalised 
patients with insulin-dependent diabetes mellitus.  Interestingly, and in agreement with 
later studies, he did not detect any signs of radiographic bone loss in patients less than 15 
years of age, although the numbers in this category were low.  However, in patients older 
than 20 years of age, mild alveolar bone loss was ubiquitous and moderate to severe bone 
loss was seen in 56% of subjects.  These patients were hospitalised with a variety of 
medical conditions including tuberculosis and this limits the applicability of the results to 
the ambulatory population. 
Bernick and co-workers (1975) examined 50 diabetic children less than16 years of age and 
compared their oral heath with 36 healthy controls.  They reported that there was an 
increase in radiographic bone loss in the diabetic patients while plaque levels were similar.  
The increase in radiographic signs of bone loss is remarkable given the young age of the 
sample population and the relatively short duration of diabetes experience.  These findings 
are in disagreement with another study which reported an absence of periodontitis in a 
population of 45 T1DM adolescents aged between 10 and 18 years (Barnett 1984).  These 
conflicting results may be due to differences in the definition of radiographic bone loss or 
due to real differences between the periodontal experience of the study populations, based 
on other protective or predisposing factors.  
Hugoson et al. (1989) examined 82 long duration, 77 short duration diabetic patients and 
77 healthy controls (20-70 years of age) and reported increased radiographic bone loss.  
This finding was only statistically significant in the 40-49 year age group.  This study may 
have contained a number of patients who would currently be classified as having type 2 
diabetes mellitus because they were late onset patients, who had become dependent on 
insulin.  The paper also fails to report the prevalence of smoking in the groups.   
Pinducciu et al. (1996) utilised both clinical and radiographic examination to ascertain the 
prevalence of periodontitis in T1DM by examining 131 T1DM patients and 20 healthy 
controls. The CPITN, gingival index (GI), mobility score, simplified oral hygiene index 
(OHI-S) and radiographic examinations were used.  An increase in GI, mobility and 
CPITN score were reported in T1DM.  In this study, radiographic signs of alveolar bone 
loss were not seen in the 5-15 year age group.  In the 15-25 year age group, 8.3% of T1DM 
patients showed radiographic signs of bone loss; for 4.5% of them it was severe (>30% of 
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root length).  In the 26-35 year age group, 5.2% showed signs of radiographic bone loss; 
for 3% it was severe.  In the > 35year age group, 9.1% showed signs of radiographic bone 
loss and for 5.3% it was severe.  The control group showed no signs of radiographic bone 
loss in subjects less than 35 years old.  In patients over 35 years old the prevalence was 
12%, for 2% of them it was severe.  This study examined both children and adults.  The 
size of the control group in this study was entirely inadequate.   
Another study reported that alveolar bone loss in T1DM patients was increased in subjects 
between 24-36 years of age (average age 29 years).  Thirty five T1DM and 10 healthy 
controls were examined radiographically and alveolar bone loss of >15% of root length 
was considered the cut off for an increase in bone loss (Tervonen et al., 2000).  The authors 
found no differences between the well-controlled, moderately well-controlled and the non-
diabetic subjects.  There was a non-significant increase in the radiographic signs of bone 
loss in the poorly controlled diabetic patients.  A larger study of similar design would be 
required to confirm this inference.  
Radiographic analysis as an adjunct to clinical examination in the diagnosis of 
periodontitis is a useful tool.  However, the bone loss must be significant enough to be 
measured and it is important that well recognised definitions and criteria are used.  
Radiographs may not be a good tool for measuring incipient bone loss and this may be why 
some studies utilising radiographs have not detected any differences in the youngest groups 
whose disease levels are very unlikely to be severe enough to be detected radiographically.   
1.3.6.4 Conclusion 
Despite anecdotal clinical impressions a review of the available literature does not 
unequivocally support the widely held belief that T1DM increases a patient’s risk of 
experiencing periodontal destruction.  Limitations in sampling; heterogeneity of case and 
control groups; lack of standardisation in classification both of diabetes and periodontitis; 
failure to adequately control for confounding factors; and a predilection for studies in 
adolescents with low levels of periodontitis have meant that firm conclusions cannot be 
drawn.  In the meta-analysis published by Chávarry and co-workers (2009), the authors 
concluded that there was a need for further studies in adults with T1DM controlling for 
age, sex, socioeconomic status, glycaemic control, health attitudes and behaviour and 
smoking in order to confirm this hypothesis. 
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1.3.7 Mechanisms of periodontal damage in T1DM 
In general, the mechanisms of periodontal tissue damage are similar to the mechanisms of 
microvascular and macrovascular disease in diabetic patients.  The periodontium is a 
complex highly vascularised end organ which is similar to the retina or glomerulus.  The 
current model of the pathogenesis of periodontitis involves the interaction between the 
microbial challenge, the host immuno-inflammatory response, connective tissue and bone 
metabolism, and the influence of environmental and genetic risk factors on these processes 
leading to clinical signs of disease (Kornman, 2008).  
It has been postulated that Type 1 diabetes can impact on this process at a number of levels 
outlined in Figure 1-2. 
1.3.7.1 Microbial complexes 
It has been postulated that the microbial flora of diabetic periodontitis is significantly 
different from that of chronic periodontitis.  Studies evaluating the microbial flora of 
periodontal disease are complicated by the diversity of the oral flora and dental plaque in 
health and disease (Socransky and Haffajee, 1994).  While it is reported that the oral cavity 
harbours hundreds of species of bacteria, many of these are uncultivable, limiting the 
applicability of conventional culture studies (Mandell et al., 1992; Sbordone et al., 1995, 
1998; Thorstensson et al., 1995; Takahashi et al., 2001).  Molecular techniques utilising 
species specific primers to bacterial DNA are improving and can now be used for relative 
quantification of uncultivable bacteria (Salvi et al., 2005; Lalla et al., 2006b).  This 
technique is, however, limited by the fact that unless messenger RNA (mRNA) is used, 
non-viable bacteria, which may no longer be involved in the destructive process, are also 
detected.  It is possible to only look for or report the presence of a small number of species 
of bacteria which have been shown in other studies to be associated with periodontitis.  By 
taking this approach simple answers are generated, but investigators may be asking the 
wrong questions.   
A further limitation to microbial sampling of the subgingival biofilm is that we are 
sampling the bacteria that are present in established disease states but are not able to show 
which bacteria were the initiating early colonisers.  It is possible that these early colonisers 
may be responsible for initiating the process of periodontal destruction leading to an 
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altered ecology and subsequent colonisation of the resultant periodontal pocket with 
opportunistic pathogens.  This issue could of course only be fully documented in a long 
term prospective study of a healthy cohort with plaque samples taken at every stage in the 
process over a number of months or years and analysed using molecular techniques.   
Bearing in mind the limitations described above there have been a number of studies over 
the last thirty years that have investigated alterations in the subgingival micro-flora in 
diabetic periodontitis with conflicting results. 
One of the earliest microbial studies on the dental plaque of T1DM patients was by 
Sanchez-Cordero and co-workers (1979).  They utilised conventional culture techniques 
and showed that increased amounts of staphylococci were found in the subgingival plaque 
of diabetic periodontitis patients compared with non-diabetic subjects without 
periodontitis.  No further work has been done to either reproduce or develop this finding 
due perhaps to it being well established that Gram negative anaerobes are largely 
responsible for chronic periodontitis.  Other staphylococcal infections are also more 
common in diabetic patients with staphylococcal involvement in nasal colonisation, skin 
infections and delayed wound healing (Tuazon et al., 1975; Graham, 2006).  It is possible 
that staphylococcal infection of the periodontium could lead to periodontal tissue damage 
leading to loss of attachment.  Staphylococci have not been consistently found in either 
culture or molecular investigations of diabetic periodontal disease.   
Mashimo and co-workers (1983) reported that there was an increase in Capnocytophaga 
species and anaerobic vibrios in the subgingival plaque of T1DM patients.  They reported 
that this was significantly different from the microbial flora of patients with localised 
juvenile periodontitis and chronic periodontitis.  This finding was confirmed by Ciantar 
(2005) who reported an increase in the carriage rate of Capnoctophaga species at diseased 
sites in diabetic patients.  Other authors have not been able to reproduce this finding 
(Sastriwijoto et al., 1989).   
Sandholm and co-workers, in an early microbiological study (1989), used only microscopy 
techniques and concluded that the subgingival microbial flora of juvenile diabetic patients 
was different.  However, the methods used in this study make interpretation of the data 
very difficult as no bacteria were identified by any other means.  It was also reported that 
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the diabetic patients had more periodontitis than the healthy controls.  This being the case, 
it is not possible to conclude that these differences were as a result of the diabetes when 
they could result from the different periodontal status of the subjects involved.   
Thorstensson and co-workers (1995), in a study of 28 adults with T1DM and 24 non 
diabetic subjects, reported few microbiological differences apart from an increase in P. 
gingivalis carriage which was higher in diabetic patients.  There was no increase in the 
presence of P. gingivalis in deepened pockets of diabetic subjects although this was the 
case in non-diabetic subjects.  This may indicate that P. gingivalis was more common in 
non-diseased sites in diabetic patients as well as the diseased sites.  Takahashi et al. (2001) 
reported that there was an increase in P. gingivalis carriage in 12 young people with T1DM 
and periodontitis.  Unfortunately the control group in this study was a periodontally 
healthy non diabetic control group.  No conclusions could therefore be drawn about how 
periodontal microbiology differs between patients with periodontitis with or without 
T1DM. 
There have been a number of studies that have found no differences in the microbiota of 
periodontal disease in patients with and without T1DM.  Pinduccui et al. (1996) in a study 
of 131 insulin dependent diabetic patients and 20 controls found no differences in either 
the aerobic or anaerobic flora.  Sastrowijoto and co-workers (1989) showed that there were 
no differences between the well and poorly controlled diabetic patients.  Another study 
examined the dental plaque of diabetic and non-diabetic siblings over three years and did 
not detect any differences (Sbordone et al., 1998).  
In the most comprehensive study in this area Lalla et al. (2006b) studied 50 adult type 1 
diabetic patients and 50 healthy controls that were matched for age, gender and periodontal 
status.  Using a 16s DNA checkerboard technique detecting 12 periodontal pathogens in 8 
samples per patient there were differences only in the levels of Eubacterium nodatum.  The 
IgG antibody response to these bacteria was similar in both groups.   
A review of the preceding literature indicates that there are significant deficiencies in the 
studies carried out to date.  Most studies are limited by inadequate culture techniques, poor 
matching and small sample size.  No single species or group of species has emerged as 
potential diabetes-specific periodontal pathogens.  This would lead us to conclude, on the 
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basis of the limited available evidence, that there is no significant microbial difference in 
the dental plaque of T1DM subjects compared with NDS.  Further work in adequately 
powered studies utilising advanced molecular techniques may be required in order to 
demonstrate whether an altered microbial challenge is responsible for any observed 
increase in clinical disease.   
1.3.7.2 Host response and bone and connective tissue turnover in Type 1 
diabetes mellitus 
If, as the literature suggests, there are few differences in the subgingival microbiota 
between diabetic and non-diabetic patients with periodontitis, alterations in the host 
immuno-inflammatory response to potential pathogens may play a predominant role in the 
pathogenesis of diabetes associated periodontitis.   
Salvi et al. (2005), in a 21 day gingivitis model, demonstrated that there was no difference 
in the microbiology of the developing lesion, but that diabetic patients showed an earlier 
and more pronounced inflammatory response to comparable bacterial challenge.  
The host-parasite interaction begins at the basic level of the innate immune system.  
Antimicrobial peptide levels could be altered in the GCF or saliva of T1DM patients 
leading to evasion of the innate immune system by the periodontal pathogens (Jurevic et 
al., 2003; Cabras et al., 2010).  Modification of TLRs in diabetes could mean that there are 
alterations in the initial innate response as well as communication between the innate 
immune system and the adaptive immune system resulting in a prolonged and dysregulated 
inflammatory response (Devaraj et al., 2008).  T1DM has been shown to result in 
impairment of neutrophil adherence, chemotaxis, and phagocytosis, which may facilitate 
bacterial persistence in the periodontal pocket and significantly increase periodontal 
destruction (Manouchehr-pour et al., 1981, McMullen et al., 1981, Gustke et al., 1998).  
While neutrophils are often hypofunctional in diabetes, especially where glycaemic control 
is poor, these patients may have a hyper-responsive monocyte/macrophage phenotype, 
resulting in significantly increased production of pro-inflammatory cytokines and 
mediators (Salvi et al., 1997a, 1997b).  This hyper-inflammatory response could result in 
elevated levels of pro-inflammatory cytokines in the gingival crevicular fluid.  It has been 
shown recently, in a human 21 day gingivitis study, that the presence of pro-inflammatory 
cytokines emerged earlier and at higher levels in diabetic subjects compared with controls 
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(Salvi et al., 2010).  Elevated serum levels of inflammatory mediators may be reflected in 
similarly elevated levels of these mediators in GCF.  The level of cytokines in the GCF has 
been related to the level of glycaemic control in diabetic patients.  In one study of diabetic 
subjects with periodontitis, those with HbA1c levels >8% had gingival crevice fluid levels 
of interleukin-1β almost twice as high as subjects whose haemoglobin A1C levels were 
<8% (Engbretson et al., 2004).  The net effect of these host defence alterations in diabetes 
is an increase in periodontal inflammation.  These pro-inflammatory cytokines lead to 
inflammatory destruction of the periodontal ligament and bone by matrix 
metalloproteinases in a RANKL dependent pathway leading to attachment loss, and 
alveolar bone loss (Salvi et al., 2010).  
The cause of this increase in pro-inflammatory cytokines may lie in the formation of 
advanced glycation end-product within the periodontium and their deleterious effects on 
other organ systems (Schmidt et al., 1996).  Interactions between AGEs and  RAGE lead to 
the production of pro-inflammatory cytokines as a result of receptor activation.  Increased 
inflammation may also result from increased levels of reactive oxygen species and the 
associated tissue damage caused by oxidative stress.  It is also possible that circulating 
levels of pro-inflammatory cytokines could be involved in having a local effect on the 
periodontium.  T1DM patients are in a chronic inflammatory state and serum markers of 
inflammation are increased such as IL-6, IL-1β and TNFα (Aribi et al., 2007, Sahakyan et 
al., 2010a,b).  It is hypothesised that the high levels of proinflammatory cytokines in the 
circulation could exert an effect locally in the periodontium, exaggerating, or enhancing, 
the immuno-inflammatory response to the subgingival biofilm.  This theoretical link is 
supported by the fact that periodontitis is increased in obese subjects who also exhibit low 
levels of systemic inflammation and circulating adipokines (Gupta et al., 2010, Hajri et al., 
2011).  Matrix metalloproteinases are critical components of tissue homeostasis and wound 
healing, and are produced by all of the major cell types in the periodontium (Ryan et al., 
1996).  Production of matrix metalloproteinases, such as collagenases, is increased in 
T1DM patient and is associated with the development of other diabetic complications such 
as retinopathy and renal disease (Mohammad et al., 2010; Van der Zijl et al., 2010).  
Alterations in the levels of MMPs result in changes in collagen homeostasis and wound 
healing within the periodontium.  As the evidence for a viral aetiology of both T1DM and 
periodontitis increases, it is also proposed that susceptibility to viral infection could be a 
common pathway for the development of periodontitis in T1DM (Jaidane et al., 2010; 
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Slots, 2010).  In addition, there is some evidence from the rat model that reduced capacity 
for bone repair following inoculation with periodontopathic bacteria could also be a factor 
in net periodontal bone loss in T1DM (He et al., 2004; Liu et al., 2006).  Liu et al.(2006) 
suggested diabetes enhanced net periodontal bone loss through a combination of increased 
bone resorption and reduced bone formation.  Diabetic patients have been shown to be 
prone to bone loss throughout the skeleton and bone healing is also reduced in T1DM 
(Ghandi et al., 2005). 
1.3.7.3 Host genetic variation   
Candidate gene studies, and genome wide analysis in T1DM, have revealed that the most 
important of these loci is the HLA class II region on chromosome 6p21 which accounts for 
50% of familial aggregation through protective and detrimental effects (Noble et al., 1996, 
Ounissi-Benkalha and Polychronakos, 2008).  HLA class II antigens are responsible for 
self versus non-self recognition and antigen presentation to CD4+ T cells.  The DR and DQ 
genes have the greatest influence with certain combinations being of particular importance 
either conferring susceptibility or resistance.  To date, candidate genes have been identified 
which manifest their effects through defects in T cell maturation, activation and self-
tolerance, leading to increased autoimmunity, as well as through defects in antigen 
presentation and response to viral triggers leading to alterations in self/non self recognition 
(Morran et al., 2008; Ounissi-Benkalha and Polychronakos, 2008).  Defects in the innate 
immune system through TLR2 have been reported in type 2 diabetes mellitus and TLR3 
polymorphisms have been reported in T1DM (Pirie et al., 2005).  In addition, a recent 
study has shown that the IL-6(-174) genotype is associated with periodontitis and T1DM 
(Raunio et al., 2010).   
It is possible that susceptibility to viral and bacterial infection could affect periodontal risk 
in T1DM.  Genetic defects in the developing immune system, susceptibility to viral and 
bacterial infection or an altered inflammatory response could all account for an increased 
genetic susceptibility in T1DM.   
1.3.7.4 Behaviour 
It is also possible that there is another simple explanation for the increase in periodontitis 
in poorly controlled T1DM patients.  Many studies have shown that oral hygiene is almost 
universally poorer in poorly controlled diabetic patients compared with well controlled 
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diabetic subjects and NDS.  It is possible that the increase in periodontal disease is due, at 
least in part, to poor oral hygiene and an increase in the main aetiological agent.  This may 
be due to psycho-social factors affecting motivation and interest in compliance with 
general as well as oral health advice (Thorstensson et al., 1989a; Syrjala et al., 1999 ; 
Kneckt et al., 2000,2001) or it may be due to alterations in the saliva leading to increased 
plaque accumulation (Albrecht et al., 1988; Novaes et al., 1991; Bridges et al., 1996; Firatli 
et al., 1996; Lalla et al., 2006a).  
1.3.7.5 Conclusion 
There are a number of mechanisms through which T1DM could confer an increased risk of 
periodontal destruction.  These include alterations in the psychological make-up of poorly 
controlled diabetic patients, alterations in collagen homeostasis and wound healing, 
alterations in osteoimmunology and increased tissue damage due to an hyper-inflammatory 
response to a common or subtly different subgingival biofilm.   
1.4  Dental caries 
1.4.1 Introduction 
Dental caries is one of the most common infectious diseases affecting mankind today 
(Peterson, 2003).  Dental caries can be defined as the destruction of dental hard tissues due 
to acidic and proteolytic attack.  The caries process occurs in the biofilm where acidogenic 
bacteria produce local pH reduction sufficient to cause dissolution of the hydroxyapatite 
crystals in enamel with resultant demineralisation.  The surface zone is a zone of constant 
flux where remineralisation and demineralisation are occurring constantly but it is only 
when this finely balanced equilibrium is disturbed that the lesion progresses.  If the caries 
process continues for long enough, and sufficient mineral is lost, progressive porosity and 
weakening of the tooth structure leads to cavitation.  When the lesion extends to the 
amelodentinal junction the carious lesion will begin to spread laterally, this undermines the 
enamel and further alterations in the optical properties of the tooth structure occur 
(Ekstrand et al., 2001).  Dental caries may now be detected clinically as either 
grey/pink/bluish darkening of the dentine.  The likelihood of enamel cavitation increases 
with the increasing size of the dentinal lesion (Fejerskov, 1997).  Dental caries is a 
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complex, multi-factorial disease, known to be influenced by behavioural and dietary 
factors (Marsh and Percival, 2006). 
 
Figure 1-3  Venn diagram showing the multi-factorial nature of caries 
development (Used with permission Jennifer Malcolm) 
1.4.1.1 The dental biofilm 
In order for caries to occur a susceptible tooth surface needs to be colonised by a 
pathogenic biofilm with an adequate source of fermentable carbohydrate for a prolonged 
period of time.  Caries tends to occur in sites of stagnation and is rare on self-cleansing 
smooth tooth surfaces, except in patients at high risk of caries.  The tooth may therefore be 
susceptible due to its anatomy (normal or disordered formation), iatrogenic factors such as 
restoration margins and damaged enamel surfaces or due to its local environment such as a 
reduction in quantity or quality of saliva (Dawes et al., 2008).  Caries can be classified 
according to the site at which it occurs, the tissue which it affects, whether it is primary or 
recurrent or the activity of the lesion. 
Dental plaque is a biofilm which is adherent to tooth structure and its precursor the pellicle.  
It is made up of a mixture of glycoproteins which begin to form within minutes of 
toothbrushing.  The biofilm is a microenvironment where millions of bacteria live a 
symbiotic existence.  The nature of the biofilm offers protection for the plaque bacteria 
from the non-specific immune response of the host as well as from chemicals and 
antibiotics.  The early colonisers in dental plaque include Streptococcus mitis, 
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Streptococcus salivarius and Streptococcus oralis.  These form the initial adherent layer 
which facilitates the development of the mature plaque, with its more pathogenic bacteria.  
The main bacterial species thought to be responsible for dental caries is Streptococcus 
mutans although lactobacilli are also involved in the caries process (Takahashi and Nyvad, 
2008).  Salivary Streptococcus mutans and lactobacilli counts are related to caries activity 
and indicate high caries risk (SIGN, 2000).  The characteristics of Steptococcus mutans 
that make it a potent cariogenic bacteria, are that it is aciduric, acidogenic, has the ability 
to adhere to salivary glycoproteins and produces extracellular polysaccharides (Russell, 
2009).  It is accepted that in order for caries to develop it is essential for plaque to be 
present in which are encased the cariogenic bacteria capable of rapid and prolonged acid 
production. 
1.4.1.2 Source of fermentable carbohydrate 
Dental caries occurs as a result of fluctuations in the pH of the dental plaque in response to 
the availability of fermentable carbohydrates as a substrate for the plaque bacteria.  
Frequent snacking on sugary foods, or even simply eating food with low cariogenic 
potential, frequently will increase the development of the carious lesion (Faine et al., 
1992).  Any fermentable carbohydrates can act as a food source for these bacteria.  Sucrose 
is the most potent of the extrinsic sugars, but lactose and fructose can also produce 
significant reductions in plaque pH.  The oral environment is in a constant state of flux 
with changes in local pH occurring every time food is ingested.  Epidemiological evidence 
for the association of dental caries with consumption of sugars comes from studies in 
populations with limited access to fermentable carbohydrate.  These include the Eskimo 
population and children raised under strict sugar free diets i.e. the Hope Wood House study 
in Australia.  The caries reduction seen in Europe during the second world war as a result 
of sugar rationing of the population also provided evidence (Toverud, 1949; Harris, 1963; 
Costa, 1980).  The Vipeholm and Turku studies clearly demonstrated the effect of varying 
frequency and type of sugar on the development of caries (Gustaffson et al., 1954; 
Scheinin et al., 1974).  A recent systematic review of the role of sugar in the development 
of dental caries showed that, of the 36 papers that met the authors’ inclusion criteria, only 
two showed a strong relationship between dental caries and dietary sugars, 16 showed a 
moderate relationship and 18 showed weak or non-existent relationship between the two.  
The authors concluded that the impact of widespread systemic and topical fluoride had 
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changed the fundamental relationship between dental caries and sugar (Burt and Pai, 
2001).   
1.4.2 Caries risk assessment 
Guidelines produced by the Scottish Intercollegiate Guidelines Network (SIGN) have 
identified the following factors as being implicated in the development of caries and 
should be considered in the management of an individual’s risk (SIGN, 2000).  The risk of 
new carious lesions is highest in the young, although caries can also develop at any point 
throughout life.  An individual’s risk of caries alters throughout life, as social and dietary 
habits change.  In addition, changes within the salivary glands and exposure of cementum 
and dentine, through gingival recession and periodontitis, also influence susceptibility to 
caries.  Dental caries is also reduced by removal of the dental biofilm through tooth 
brushing and the topical application of fluoride in the form of fluoride toothpaste. Caries 
prevalence is increased by infrequent toothbrushing (Treasure et al., 2001).   
As with most diseases, dental caries is most prevalent in deprived groups.  Socioeconomic 
status is a strong predictor for dental decay (Sisson, 2007).  Studies in Scotland have 
shown that patients who are in low socioeconomic groups are at increased risk (Radford et 
al., 2001).  This may be due to low education, poor parental support, poor diet, low dental 
awareness and irregular dental attendance.  Reduced access to dental services may be due 
to financial restrictions or problems with work or child-care (Hilton et el., 2007; Milsom et 
al., 2009; Goeterns et al., 2010; Boyce et al., 2010; DiMarco et al., 2010).  Patients who 
have low dental awareness and low dental motivation, due to psychological differences in 
interacting with and responding to general and oral health advice, are at increased risk of 
dental decay (Gregory et al., 2007; Syrjala et al., 2004) 
Patients who are medically compromised may be at higher risk of developing decay.  This 
may be due to xerostomic medications, lack of self-care, difficulty attending for dental 
treatment or the use of sugar containing medications.  The presence of prosthodontic or 
orthodontic appliances within the mouth will tend to increase the risk of dental caries, due 
to plaque stagnation sites, as well as alterations in the oral microflora (Sugihara et al., 
2010).   
The saliva normally has a protective effect on the oral cavity. Any reduction in salivary 
flow rate, or buffering capacity, will predispose the individual to caries development.  It is 
also clear that those patients who suffer from reduced salivary gland function, due either to 
the effect of head and neck irradiation, medication or autoimmune diseases such as 
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Sjogrens syndrome, are extremely susceptible to caries which can be rapidly destructive 
(Schwarz et al., 1999; Boutsi et al., 2000; Leung et al., 2004; Flink et al., 2007).  As well 
as its buffering capacity saliva may have a significant role in the prevention of dental 
caries through the antimicrobial effect of salivary proteins.  Specific antibacterial proteins 
and secretory immunoglobulin A (sIgA) play a role in protection of the teeth from the 
colonisation and maturation of plaque bacteria (Wallengren et al., 2004).   
1.4.3 Caries Diagnosis 
It has been difficult, in the past, to record caries at the pre-cavitational level, due to 
difficulties in standardisation and reproducibility.  For this reason caries into dentine, also 
referred to as the D3 level has been the most frequently used measure of caries in 
epidemiological studies (Pitts et al., 2004; Schulte et al., 2006; Eitner et al., 2006; Ferro et 
al., 2007).  This involves only scoring cavitated lesions and lesions that are clearly into 
dentine as shown through spreading underlying staining. While this is clearly not a 
sensitive measure of all caries experience, it is nonetheless, a standard and valid method of 
recording dental caries which has been used for decades.  New developments, such as 
quantitative light fluorescence (QLF) or fiberoptic transillumination (FOTI) are available 
but would be difficult to apply to a large scale cross-sectional study on a full mouth basis 
(Cortes et al., 2003; Ferreira Zandoná  et al., 2010).   
1.4.4 Current trends 
The prevalence of dental caries has reduced significantly over the last fifty years in the 
developed world (Reich et al., 2001).  Scotland, despite its extremely high prevalence of 
dental disease, has also benefited from a reduction in decay and tooth loss since national 
surveys began in 1972.  In 1972, the level of edentulousness was 44%, however this figure 
had dropped to 18% by the most recent survey in 1998.  There has also been a significant 
increase in the number of retained teeth from 21.6 to 23.8 in 1978 and 1998 respectively.  
Carious, or unsound teeth, reduced from 2.1 per dentate adult in 1978 to 0.9 in 1998 and 
there was also a corresponding increase in the number of sound and unfilled teeth.  New 
criteria, introduced in 1998 to include visual caries, indicated that 29% of the population 
had 18 or more sound teeth and 58% of the population had at least one or more decayed or 
unsound teeth.  Overall 24% of dentate adults had visual primary caries, 22% had primary 
cavitated caries and 8% had recurrent caries.  The mean number of missing teeth was 7.5 
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and the number of teeth that were filled, but otherwise sound, was 8.1.  The average 
number of virgin teeth was 15.7 (Nunn et al., 2001).   
The burden of oral disease is unequally distributed throughout the population with an 
increased prevalence in areas of low socioeconomic status.  Living in the north of Great 
Britain is associated with poorer dental health.  Subjects from the north of England were 
1.86 times more likely to have some untreated decay.  Those living in Scotland had almost 
two teeth less than those from southern England even after various risk factors were 
included in a multivariable analysis (Treasure et al., 2001).  Caries experience was shown 
to be associated with brushing less than once a day, lower social class, male gender and 
irregular dental attendance (Treasure et al., 2001).  The survey reports that there is almost 
50% less decay in those who attend for regular dental check-ups than those who only go to 
a dentist when they have trouble with their teeth (Nunn et al., 2001).  
1.4.5 Dental caries and Type 1 diabetes mellitus 
There have been a number of studies investigating the prevalence and incidence of dental 
caries in T1DM.  This has been a focus of interest because diabetic patients are advised to 
eat a healthy reduced sugar diet which, taken in isolation, would be expected to result in 
reduced caries experience.  This, however, has not been a universal finding, implicating 
other factors in the development of caries in this population.  Biological plausibility has 
been hypothesised to explain both the studies finding a reduced and increased caries 
prevalence.  Factors favouring an increased risk include increased glucose concentration in 
saliva and GCF, a reduced salivary flow rate resulting in reduced buffering and 
remineralisation and increased frequency of food consumption throughout the day.  Studies 
have also shown a tendency to increased plaque scores in diabetic patients compared with 
controls (Albrecht et al., 1988; Novaes et al., 1991; Bridges et al., 1996; Firatli et al., 1996; 
Lalla et al., 2006a).  An increase in the volume or nature of plaque could predispose 
patients with T1DM to the development of dental caries.   
1.4.5.1 Study quality   
While there have been several studies in this area, there are problems with the validity and 
reliability of methodology and examiner calibration, and data collected via retrospective 
examination of dental records.  It is also notable that some studies do not have a valid 
control group and there is a significant risk of selection bias.  Some studies have used a 
convenience sample of T1DM adolescents attending a diabetes summer camp. These 
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children were closely monitored and had a family history of diabetes.  It is possible that 
this group did not represent a cross section of diabetic adolescents; confounding social 
factors therefore make interpretation and application of these data difficult.  The validity of 
this kind of sampling of potentially highly motivated diabetic subjects is poor given that 
they are unlikely to be representative of the general T1DM population (Ziskin, 1944; 
Goteiner et al., 1986).   
Wegner and co-workers in 1971 examined a group of 620 T1DM patients and did not find 
any reduction in caries prevalence.  This study did not have a control group and relied on 
comparisons with national statistics.  Mattson and co-workers (1975) examined only 33 
T1DM adolescents and found a reduced number of decayed or filled surfaces (DFS), 13 in 
the diabetic patients and 20 in the controls.  However, this small study did find a delay in 
premolar eruption in T1DM patients.  This could have accounted for a reduced DFS as 
these teeth would have been exposed to the oral environment for less time than those of the 
control subjects.  Another study reported that the T1DM patients had an increased DMFT; 
however, the decayed element of this was reduced and the number of filled teeth was 
increased (Albrecht et al., 1988).  This may indicate that patients with diabetes had a 
similar level of historical decay experience.  However, they appear in this study population 
to have had access to a higher level of care than the control group. 
Akyuz and co-workers (1990) also found a reduction in caries level in a T1DM population.  
However, this paper reported an increase in caries in the poorly controlled patients.  This 
study only included 42 patients with diabetes and 20 control subjects, again limiting the 
validity of the findings.  A further study in Ireland, a country with a high prevalence of 
caries, reported that there was a reduced prevalence of caries and a higher restorative index 
in a T1DM adolescent population (Kirk et al., 1991).  This was based on comparisons 
against reported national figures and no control group was examined.  The patients with 
diabetes were also from higher socioeconomic groups which would have affected their 
initial caries risk.  Interestingly, caries was reported more frequently in the group of 
patients with diabetes who were diagnosed later in life, compared with those diagnosed 
earlier.  Taveres and co-workers (1991) reported in a study of 273 patients, 88 of whom 
had T1DM, that there was an increase in missing teeth in T1DM.  However, there was a 
reduction in coronal caries, no difference in root caries and an increase in the number of 
restored root surfaces.  It is unknown whether the restorations on the roots were placed for 
caries management or for other reasons.   
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Karjalainen et al. (1997) in a study of 80 T1DM patients reported an increase in caries in 
poorly controlled patients compared with those who were well or moderately controlled.  
This study also reported that intact dentitions were more common in the non-diabetic 
control group.  An association between the level of metabolic control and caries experience 
was confirmed in studies by Galea and co-workers (1986), Twetman et al. (1992, 2002, 
2005) as well as Syrkjala et al. (2003) and Siduikiene et al. (2006) who reported similar 
findings.  Galea and co-workers reported that caries experience varied throughout the 
mouth with an increase in the incisor region and a reduction in the molar teeth.  Caries 
prevalence was also related to metabolic control (Galea et al., 1986).   
Tenovuo and co-workers (1986) compared a T1DM population with an age and sex 
matched group of healthy controls and found that although there were a lower number of 
filled surfaces, caries increased in older T1DM patients.  Edblad and co-workers (2001) 
found that there was a significant increase in the caries experience of young adults with 
T1DM and Moore et al. (2001a) also reported an increase.   
There have however been a number of studies that have found no differences in caries 
levels in T1DM populations (Harrisson and Bowen, 1987; Bacic et al., 1989; Twetman et 
al., 1989; Swanjlung et al., 1991; Pohjamo et al., 1991; Arrieta-Blanco et al., 2003; Chuang 
Shu-Fen et al., 2005; Lalla et al., 2006a; Do Amaral et al., 2006; Patino-marin et al., 2008, 
Tagelsir et al., 2010).   
1.4.5.2 Caries risk factors in Type 1 diabetes mellitus 
Some studies have looked at a number of factors which may have an influence on the rate 
of caries.  Syrjala and co-workers (2003) examined the microbiological parameters of the 
saliva of T1DM patients.  They reported that there were no differences in Streptococcus 
mutans or lactobacillus counts between patients and controls, although there was an 
association between S. mutans counts, high HbA1c and caries.  High salivary S. mutans 
counts are associated with active caries and it is likely that the increased S. mutans counts 
were related to increased caries activity rather than the diabetes per se.  This is in 
agreement with the findings of Twetman et al. (1992) who also found that S. mutans and 
lactobacilli counts varied in response to caries rate rather than diabetic status.  Swanjlung 
and co-workers (1992) reported that S. mutans counts were increased in T1DM.  Clinically 
there was no difference in the caries experience of the diabetes patients and the control 
subjects.  In contrast, Tenovuo and co-workers (1986) reported that S. mutans counts were 
Douglas P Robertson 2011  Chapter 1-102 
slightly higher and suggested that this was a possible explanation for the higher caries 
prevalence in T1DM.   
Salivary parameters have also been examined by investigators, with most finding 
differences in flow rates and constituents (Siudikiene et al., 2006; Moreira et al., 2009; 
Saes Busato et al., 2010).  Health behaviour, oral health attitudes and practices have been 
examined in an attempt to account for possible differences (Syrjala et al., 2004). 
1.4.6 Conclusion 
While there are weaknesses in the studies to date, it seems impossible to categorise patients 
with diabetes as a homogenous group with regard to caries risk.  Caries is a multifactorial 
disease and it may be that other factors confer caries risk and account for the heterogeneity 
of these study findings.  
Studies utilising valid selection criteria and an appropriate control group are essential to 
eliminate confounding factors so that conclusions can be drawn about the effect of diabetes 
alone on the caries process.  Many previous studies have utilised convenience samples for 
case and control groups thus limiting the applicability of published findings to the general 
population.  The majority of these studies have been on children and adolescents with 
limited work on adults suffering from T1DM.  
In light of the conflicting evidence and heterogeneity in the results reported in the literature 
it is not possible to reach firm conclusions about whether T1DM alters caries experience or 
not.  It is likely that such is the multi-factorial nature of the disease that diabetes will only 
contribute to dental caries where other risk factors are present.   
1.5 Oral mucosal abnormalities in T1DM 
1.5.1 Introduction 
Patients with T1DM suffer from a number of systemic complications including 
microvascular and macrovascular disease as well as an increased susceptibility to infection 
and poor wound healing (Daneman, 2006).  They are also reported to suffer from reduced 
salivary flow rates, altered salivary constituents and higher salivary glucose concentrations 
(Banoczy et al., 1987; Cerutti et al., 1988; Borg et al., 1998; Aren et al., 2003).  As a result 
of their general susceptibility to infection, thought to be caused by a number of reported 
immunological deficiencies, as well as salivary alterations, they are potentially at risk of 
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greater disruption to the normal oral flora and increased bacterial and fungal colonisation 
in the oral cavity (Soysa et al., 2005). 
The oral flora is incredibly diverse.  Traditionally both aerobic and anaerobic culture 
methods and selective agars were used for identification of species.  More recently 
molecular testing for bacterial DNA or RNA has been used to understand better the 
presence and effect of uncultivable pathogens and also to identify and type bacteria and 
fungi phylogenetically. This was originally done using DNA checkerboard techniques but 
more recently 16S RNA or DNA has been used to identify genetic evidence of bacterial 
and fungal presence using conventional or real time PCR (Yuan et al. 2001).  Refinements 
to these techniques have meant that amplification of bacterial DNA and identification via 
international gene banks is now possible.  Novel species, hitherto unidentified, are being 
discovered with regularity. 
The oral flora is affected by local and systemic factors most obviously seen with candidal 
infections, due to either dentures, steroids, HIV-AIDS, smoking or immunosuppressive 
therapies (Abu-Elteen & Abu-Alteen, 1998; Almstahl & Wikstrom, 1999; Bergmann 1991; 
Schmidt-Westhausen et al. 1990).  Diabetes is linked to compromised immune responses in 
neutrophils (Wilson et al., 1986; Naghibi et al., 1987).  In addition, it is possible that 
changes to the mucosal immune response and altered cell adhesion, may predispose 
diabetic patients to bacterial and fungal infection (Darwazeh et al., 1997; Willis et al. 
2000a).  It has also been reported that alterations in salivary glucose levels may alter the 
microenvironment to favour the colonisation of the mouth with an opportunistic microflora 
(Darwazeh et al., 1991).  Adhesion to buccal epithelial cells by Candida species has also 
been shown to be increased in cells derived from diabetic patients (Darwazeh et al., 1990; 
Doroka-Boboskwa et al., 1996).  Reduced salivary flow rates reported in diabetic patients 
(Banoczy et al. 1987; Chavez et al., 2001; Dorko et al., 2005) may limit the eradication of 
the colonising organisms.   
1.5.2 Xerostomia 
Xerostomia is the reduction in salivary flow rate and the resultant symptoms of dryness of 
which a patient complains.  Saliva in health has lubricating, remineralising, and 
antimicrobial properties.  Reduction in salivary quality and quantity can have a devastating 
effect on the dentition and oral mucosa, resulting in rapid carious destruction, mucositis 
and fungal infections. 
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Xerostomia is caused by a large number of drugs including, but not limited to, 
antidepressants, anti-hypertensives, anti-inflammatory agents and chemotherapeutic agents 
(Scully, 2003).  A reduction in salivary flow is also seen in patients who have had previous 
radiotherapy involving the salivary glands in the field of exposure.   Sjogrens syndrome an 
autoimmune disease affecting the salivary glands is also a significant cause of oral dryness 
and this can be very difficult to alleviate (MacFarlane & Mason 1974).   
Normal salivary flow rates range from 0.3 to 0.5 ml/minute for unstimulated saliva and 
from 1 to 3ml/minute for stimulated saliva.  A patient would normally be classified as 
having reduced salivary flow rate if the unstimulated rate is below 0.1ml/min and the 
stimulated rate below1ml/min (Moore et al., 2001b). 
Patients with diabetes are reported to have generally lower salivary flow rates than non 
diabetic subjects (Ben Aryeh et al., 1988; Thorstensson et al. 1989b; Ben Aryeh et al., 
1993; Karjalainen et al., 1996; Ionescu et al., 1998; Chavez et al., 2000; Chavez et al., 
2001; Moore et al., 2001b).  However there are a number of papers which have not found 
this association (Belazi et al., 1998; Edblad et al., 2001; Harrison & Bowen, 1987; 
Swanljung et al., 1992).  The reduced salivary flow rates seen were most marked in the 
poorly controlled type 1 diabetic patients.  Theories surrounding aetiology, include specific 
autoimmune damage to the salivary glands at the onset of the initial disease (Cha et al., 
2002; Cinquini et al. 2002; Caldeira et al., 2005), autonomic neuropathy (Ben Aryeh et 
al.,1996; Lamey et al., 1986) or simply a product of dehydration due to osmotic diuresis 
(Martin, 1999). 
It is possible that T1DM is responsible for a decrease in unstimulated and stimulated 
salivary flow rates as well as a subjective feeling of dryness (Moore et al. 2001b).  This 
relationship however may be complicated by xerogenic medication, duration of diabetes, 
glycaemic control and the association with other complications of the diabetes (Conner et 
al., 1970; Tenovuo et al., 1986; Sreebny et al., 1992; Swanljung et al., 1992).  In type 2 
diabetes this is thought to be due to concomitant medication (Meurman et al., 1998).  
However, in T1DM there is evidence that this is not linked to medication, uncommonly 
prescribed in younger patients, but is rather a true complication of the disease possibly due 
to either ultrastructural changes in the salivary gland structure or neuropathic autonomic 
changes (Manfredi et al., 2004). 
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1.5.3 Oral candidosis 
Candida species are part of the normal oral flora and the most commonly identified 
pathogen is C. albicans (Manfredi et al., 2002).  There is however an increase in the 
reporting of previously rare fungi such as C. glabrata, C. dubliniensis, C. tropicalis and C. 
krusei, particularly in medically compromised patients ( Willis et al., 2000b; Cislo et al., 
2001; Bagg et al., 2003; Tekeli et al., 2004;Aguilar et al., 2005).  The oral candidal 
carriage rate is affected by salivary flow rates and systemic illness.  There are studies 
investigating the elderly (Kuc ey al.,1999), the terminally ill (Sweeney et al.,1998), HIV 
AIDS sufferers (Kerdpon et al., 2004; Pongsiriwet et al., 2004 ;Schmidt-Westhausen et al., 
1990,1991; Tsang & Samaranayake, 2000), children (Pongsiriwet et al., 2004), Sjogren’s 
syndrome sufferers (MacFarlane & Mason 1974; Radfar et al., 2003) and diabetic patients 
(Tapper-Jones et al., 1981; Aguilar, et al., 2005; Aly et al., 1991; Bai et al., 1995; Belazi et 
al., 2005; Blackwell et al.,1989; Fisher et al., 1987; Guggenheimer et al., 2000a; Kadir et 
al., 2002; Kumar et al., 2005;Lamey et al. 1988; Manfredi et al. 2002; Willis et al., 
2000a,b) and those suffering from burning mouth syndrome (Samaranayake et al., 1989).  
Oral carriage rates of C. albicans are higher in most of the above groups.  
A simplistic explanation for the increased carriage rates in diabetic patients is the increase 
in salivary glucose levels as a source of nutrients for the fungi.  However, it is also possible 
that changes to the mucosal immune response affect the ability of candida to colonise the 
oral mucosa.  It has been shown that buccal epithelial cells from diabetic patients permit 
increased adhesion of C. albicans (Darwazeh, et al., 1997; Willis et al., 2000a).  The 
mechanism of this binding is unknown but may be due to reduced salivary lysozyme 
(Pinducciu et al., 1996), production of extracellular proteinases or upregulation of 
receptors for complement such as inactivated C3b (iC3b) in high glucose concentrations 
(Manfredi et al., 2006).  Alternative theories include increased adhesion of C. albicans to 
epithelial cells when grown in high sugar media due to the development of a fibrofloccular 
layer on yeast cell surfaces.  Accumulation of glycosylation products in epithelial cells 
may increase numbers of receptors for C. albicans (Willis et al. 2000a).  In addition it has 
also been reported that high salivary glucose concentrations may lead to increased 
resistance to intracellular killing by macrophages (Willis et al., 2000a).   
Candidal carriage rates in the healthy population are reported as 2-71% with a mean value 
of 34% (MacFarlane et al., 1990).  This mean value of 34 % seems to be in agreement with 
other authors (Kadir et al., 2002b; Lamey et al., 1988a; Sedgley & Samaranayake 1994b) 
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who reported a range from 24% to 31%.  Xerostomia and other illnesses can both increase 
this carriage rate and signs of clinical infection and oral candidal carriage rates among 
some medically compromised groups can be up to 99% (Schmidt-westehausen et al., 1990; 
Wahlin et al., 1991, Sweeney et al., 1998).   
Diabetic patients were found to harbour Candida species in 77% of subjects using an oral 
rinse technique (Willis et al., 1999).  However, there is continued controversy as to 
whether this figure is accurate.  Studies investigating diabetes and oral candidal carriage 
show a carriage rate of between 23% and 77% (Barlow et al., 1969; Tapper-Jones et al., 
1981; Fisher et al., 1987; Lamey et al., 1988; Hill et al., 1989; Darwazeh et al., 1990; Aly 
et al., 1992; Dorocka-Bobkowska et al., 1996; Guggenheimer et al., 2000a; Willis et al., 
2000, Manfredi et al., 2002).  Most studies support the position that diabetic patients have 
higher carriage rates and greater density of colonization than healthy controls (Weinstein et 
al., 1959; Barlow and Chattawa, 1969; Tapper- Jones et al.,1981; Bhatt et al., 1983; 
Bartholomew et al., 1987; Fisher et al., 1987; Lamey et al., 1988; Fongsmut et al., 1998; 
Willis et al., 1999; Kumar et al.,2005).  However, some authors did not find a significant 
association (Darwazeh et al. 1991; Dorocka-Bobkowska et al.,1996; Kadir et al. 2002; 
Manfredi et al. 2002).  It may be that lack of standardisation in sampling and processing 
methods or inappropriate control groups have contributed to this variance in reporting of 
candidal carriage.  It is also possible that confounding factors such as local risk factors and 
smoking have not been adequately controlled for in the study design.  The rate of oral 
candidal carriage in tobacco smokers is higher than in non-smokers (Abu-Elteen and Abu-
Elteen, 1998; Fongsmut et al., 1998; Willis et al., 1999; Soysa et al., 2005).  Aly et al.        
(1992) found a higher carriage rate in T1DM than in type 2 diabetes, however. Darwazeh 
and co-workers (1991) found no difference as did other investigators (Dorocka-Bobkowska 
et al., 1996b).  Metabolic control of diabetes has also been suggested as a risk factor for 
increased candidal carriage, although this is controversial.  Studies by Hill and co-workers 
(1989) and Guggenheimer et al. ( 2000a) reported that the level of glycaemic control was a 
contributory factor in candidal carriage though most studies have not found a direct 
connection (Darwazeh et al., 1991; Dorocka-Bobkowska et al., 1996; Manfredi et al. 
2002).  Manfredi and co-workers (2002) found that the relationship between oral carriage 
rates of candida and diabetes was affected more by local factors for example denture 
wearing than by metabolic factors such as HbA1c or type of diabetes. 
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It is also worth noting that candidal carriage does not imply candidal infection.  Despite a 
carriage rate of 60% overall, only 3.6% of diabetic patients in one study showed clinical 
signs of infection (Manfredi et al., 2002). 
In summary it is likely that T1DM may affect candidal carriage rate however this has not 
been shown in a healthy, non-smoking population without dental prostheses.  It is possible 
that glycaemic control could impact on candidal colonisation although there is not a 
consensus in the literature about this.   
1.5.4 Staphylococcus Species 
Staphylococci are Gram positive facultative aerobic cocci and can be further subdivided 
into coagulase negative and positive subgroups.  Coagulase positive species are known to 
be responsible for a number of clinical conditions namely angular cheilitis, osteomyelitis, 
wound infection, mucositis, food poisoning, septic arthritis and septicaemia (Bagg et al. 
1995;Bergmann et al., 1989; Smith et al., 2001, 2003).  The oral cavity may serve as a 
reservoir for nosocomial infection elsewhere in the body, e.g. septic arthritis, however this 
possible source has been under recognised in the literature (Riggio et al., 2010).  
Staphylococci are commonly found in the mouths of healthy subjects (Jackson et al., 
1999).  The prevalence of S. aureus carriage increases with age, with 36% prevalence in 
the healthy elderly compared with 24% in a healthy adult population in Scotland (Jackson 
et al., 1999).  A study by Sweeney et al. (Sweeney et al., 1998b) identified S.aureus 
carriage rates of 24% in a population of terminally ill patients suffering from xerostomia. 
Another study also reported increased staphylococcal carriage rates during cytotoxic 
chemotherapy (1984).  A study in patients with leukaemia reported that most patients were 
carriers of staphylococci (Wahlin & Holm, 1988) while Jobbins et al. (1992), in examining 
the oral flora of patients with advanced malignant disease, found that 28% carried S. 
aureus in their oral cavities.  Patients suffering from hypo-salivation due to salivary gland 
disorders have been reported to carry S. aureus in 21% of cases, although, the sample size 
in this study was only 28 (Almstahl & Wikstrom 1999).  In a study of elderly hospitalised 
patients the carriage rate of S. aureus was only 4% (Wilkieson et al., 1991).  These 
findings are confirmed in a report investigating the oral health of 79 year old Swedish 
individuals who had a point prevalence of 4% (Ohman et al., 1995).  HIV status was not 
found to be a contributory factor in the carriage of oral staphylococci in a study by 
Schmidt-Westehausen who found only one isolate of staphylococci in 149 HIV positive 
patients (Schmidt-Westhausen et al., 1991).  Apart from these studies with a low 
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prevalence of staphylococcal carriage, it is clear that staphylococci are in fact, regular 
colonizers of the oral mucosa and their isolation is significantly increased by alterations to 
the patients’ systemic condition (Smith et al., 2003).  The effect that oral carriage of S. 
aureus will have in the immuno-compromised host is not known although it may serve as a 
reservoir for future nosocomial infection and cross infection. 
1.5.4.1 Staphylococcus and T1DM 
Massler (1949) first reported that increased levels of S. aureus could be found in thde 
mouths of diabetic patients reporting that 45% of 88 diabetic patients carried S. Aureus.  A 
subsequent study of dental plaque samples found that staphylococci were present in 10% 
of healthy patients and 17% of non-diabetic patients suffering from periodontitis harboured 
the bacteria.  However the highest prevalence of 60% was found in patients with diabetes 
also suffering from periodontitis.  The isolation rate of S. epidermidis, a coagulase negative 
staphylococcus, was also noted to be significantly higher in T1DM (Sanchez-Cordero et 
al., 1979).  There are no other published studies reporting the impact of diabetes on oral 
carriage of S. aureus although diabetic patients have been shown to have a higher nasal 
carriage rate and an increased susceptibility to staphylococcal infection in other body sites 
(Tuazon et al., 1975, Lipsky et al., 2010).   
1.5.4.2 Antibiotic resistance 
Methicillin resistant S. aureus (MRSA) in the oral cavity is a rare but increasing problem 
as oropharyngeal eradication is extremely difficult to achieve and this may act as a 
reservoir for nosocomial infection as well as horizontal spread of infection (Smith et al. 
2003).  There are no studies examining the relationship between diabetes and oral carriage 
of MRSA.  There are a number of studies documenting the increasing frequency of 
diabetic foot infections with MRSA (Stanaway et al., 2007; Lipsky et al., 2010; 
Eleftheriadou et al., 2010).  The nose is often cited as the source of the infection although 
the role of salivary carriage of MRSA in immuno-compromised patients is unknown 
(Smith et al., 2003).    
It can be concluded that there is a paucity of data on the oral carriage of staphylococci in 
the population generally and specifically relating to T1DM.  This is of particular concern 
regarding S. aureus as it is a common cause of wound infections and may further 
exacerbate this complication of diabetes.  The following study will aim to provide a clearer 
picture of the carriage rates of staphylococci in the oral cavity of patients with T1DM. 
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1.5.5 Coliforms 
Coliforms are facultative anaerobic Gram negative enteric rods which are found 
throughout the gastrointestinal tract and can be responsible for a number of infections e.g. 
gastroenteritis or pneumonia due to overgrowth of the commensal organisms or spread to 
distant sites. They are also found in the mouth in varying numbers, although controversy 
exists as to whether they are transient colonisers, or a permanent commensal 
(Samaranayake et al., 1984).  The prevalence of oral carriage of coliforms is affected by 
reduced salivary flow (Sweeney et al., 1998), age (Leung et al., 2003), hospitalisation 
(Campbell et al., 1983) and immunocompromised states (Jobbins et al., 1992; Tsang & 
Samaranayake, 2000).  A further study reported a significant increase in oral carriage rates 
in patients hospitalised for renal dialysis (Campbell et al., 1983).  Examination of the oral 
microflora of the staff treating these patients revealed no individuals colonised by 
coliforms.  The authors concluded that the source of the bacteria was not environmental, 
but rather represented overgrowth arising from the patients altered metabolic and 
immunological state.  Schmidt-Westehausen reported in 1991 that there was a slight 
difference in the carriage of coliforms between HIV positive patients (20 isolates from 73 
patients compared with 7 out of 58 controls) this slight difference however, was in direct 
contradiction to an earlier retrospective study carried out by the same author in 1990 which 
reported no increase in HIV positive patients (Schmidt-Westhausen et al., 1990, 1991). 
Carriage rates in the healthy population were recently reported as 1- 4% from oral rinses 
and culture techniques (Sedgely et al., 2004) but this is considerably higher (7-10%) if 
molecular techniques are employed (Sedgely et al., 2005).  The variation in the healthy 
adult population ranges from 0 to 24% with significantly higher rates in Asian countries 
such as Hong Kong, China, Malaysia and Tibet (Samaranayake et al., 1984; Sedgely and 
Samaranayake, 1994a,b; Leung et al. 2003).  Studies on the oral flora of Scottish hospital 
staff in 1984 showed a carriage rate of 5% (Samaranayake et al., 1984).  Patients with 
dentures had a higher carriage rate of 12% (Samaranayake et al., 1989).   
Coliforms have also been associated with Burning Mouth Syndrome, with a 22% carriage 
rate in patients suffering from burning mouth syndrome compared with only 12% in the 
control group (Samaranayake et al. 1989b).  Interestingly, diabetes can also give rise to the 
symptoms of Burning Mouth Syndrome (Gibson et al., 1990).   
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1.5.5.1 Predominant species of oral enterococci 
The most common species of coliform isolated from the mouth are Enterobacter and 
Klebsiella although there are a large number of other coliforms which are isolated only 
occasionally (Samaranayake et al. 1989; Schmidt-Westhausen et al.1990, 1991; Bergmann, 
1991; Ohman et al. 1995; Goldberg et al., 1997; Almstahl & Wikstrom 1999; Dennesen et 
al. 2003; Leung et al., 2003; Hagg et al., 2004).  There is evidence that an increase in 
coliform carriage is often associated with an increase in yeast carriage suggesting a 
possible symbiotic existence under the right conditions (Schmidt-Westhausen et al., 1990, 
1991; Sedgley & Samaranayake 1994). 
It is evident from the literature that coliforms form a normal part of the oral flora of a small 
number of individuals in the western world.  This colonisation begins within a short time 
after birth but the bacteria involved are often transient colonisers and are not reproducibly 
detected in longitudinal studies (Samaranayake et al., 1984, Makhoul et al., 2002). 
The prevalence of coliforms in the oral cavity of T1DM patients has not been studied 
extensively. However, Schmidt-Westhausen et al. (1990) noted that there was an increase 
in coliform carriage in patients with diabetes.  Therefore it remains a distinct possibility 
that diabetic patients are similar to other medically compromised groups mentioned above 
and are likely to have increased levels of coliforms in their oral cavities.  Whether this is 
related to a systemic weakness in their immune system or to local factors such as reduced 
salivary flow rates remains to be investigated. 
1.5.6 Techniques 
Researchers have used oral rinses, swabs, imprint sampling, ultrasonic water baths of 
dental prostheses and endodontic paper points as methods of sampling the oral flora, 
depending on the types of bacteria being investigated.  Culture has been conducted 
anaerobically and aerobically on selective media (Soysa et al., 2005).  The oral rinse 
method has been shown to be the most reliable method of quantifying the oral flora 
(Samaranayake et al., 1986).  Biochemical and metabolic markers are used to type species 
at the species and subspecies level according to standard diagnostic protocols.  The 
advances in qualitative PCR and now Real time PCR allow identification of unculturable 
species and tend to give a more complex picture of the oral flora with a generally higher 
detection rate than culture methods alone. 
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1.5.7 Soft tissue lesions 
It has been reported that there is an increased prevalence of lichen planus in patients 
suffering from diabetes mellitus.  A paper in 1966, by Grinspan et al. reported that there 
was a prevalence of oral lichen planus of 40% in patients suffering from diabetes mellitus 
(Grinspan et al., 1966).  Subsequent papers, however, have not confirmed this extremely 
high prevalence.  When studies are reported on patients who have confirmed oral lichen 
planus, the prevalence of diabetes mellitus is disproportionately high in these groups.  One 
study reported that 40% of all patients with oral lichen planus had diabetes mellitus (Sallay 
et al.1989) and a further study in Croatia reported that 20% of patients suffering from oral 
lichen planus also had diabetes mellitus (Ognjenovic et al., 1998).  This was reported to be 
more than 400 times the national prevalence of diabetes.  Apart from the early study by 
Grinspan et al. (1966), when diabetic patients are examined the prevalence of lichen planus 
is universally reported to be much lower.  Saini et al. (2010) reported that the prevalence of 
oral lichen planus was only 0.5%; Bordgelly et al. (1993) reported a prevalence of 0.55%.  
Van Dis and Parks (1995) reported that the prevalence of oral lichen planus was 4% in 
patients with diabetes but 3% in patients without diabetes mellitus.  This paper also 
reported that there was an association between patients taking non-steroidal anti-
inflammatory drugs, anti hypertensive medication and the prevalence of oral lichen planus.  
Petrou-Amerikanou et al. (1998) reported that the prevalence of oral lichen planus in 
T1DM was 5.76% however it was three times lower in non-diabetic subjects at only 
1.82%.  Other studies have not reported any association with oral lichen planus 
(Guggenheimer et al., 2000a,b).  The high prevalence of diabetes in patients suffering from 
oral lichen planus and the underlying autoimmune risk factors associated with both 
diseases mean that a connection is biologically feasible.  Cross-sectional studies to date 
have been underpowered to detect a significant difference.   
Altered taste, oral dysaesthesia and burning mouth syndrome have all been reported to be 
more prevalent in patients with diabetes.  Burning mouth has been reported to be a 
presenting symptom of undiagnosed non-insulin dependent diabetes mellitus (Gibson et al., 
1990).  A study of type 1 diabetic children reported that 11.5% of all children had a 
burning sensation within the oral cavity (Costa et al., 2004).  However, a large study in 
adults, reported that the prevalence of burning mouth syndrome was only 3.2% in patients 
with T1DM and 2.1% in patients without diabetes mellitus (Moore et al., 2007).   
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There are reports that erythema migrans or geographic tongue is increased in patients with 
T1DM (Saini et al., 2010).  Medium rhomboid glossitis, angular cheilitis, depapillation of 
the tongue, fissured tongue, irritation fibromas, traumatic ulcers and denture stomatitis are 
all reported to be more prevalent in patients suffering from T1DM (Guggenheiner et al., 
2000a,b).  It has been suggested there is an increased risk of oral cancer associated diabetes 
mellitus however this has not yet been clearly established in studies on humans (Ujpal et 
al., 2002; Ujpal et al., 2004; Dikshit et al., 2006; Saini et al., 2010).  The prevalence of oral 
cancer is extremely high in India and it may be that these differences are not seen in 
populations that are otherwise at low risk of oral cancer.   
In conclusion, there is a significant lack of information about the prevalence or increased 
risk of soft tissue lesions in patients with T1DM.  This is largely due to the fact that a 
number of studies have combined T1DM and type 2 diabetes mellitus patients in the same 
group.  In addition many studies are underpowered to detect differences in these rare 
conditions between diabetic and control subjects. 
1.6   Measuring oral and general health related quality of 
life in Type 1 diabetes mellitus 
1.6.1 Introduction 
Measuring the impact of disease on a patient’s quality of life is important, as in many 
chronic conditions, physiological measurements do not correlate with a patient’s 
experience of ill health.  If only physical or biochemical tests are used, then the impact of a 
disease process on an individual’s ability to function and the level of handicap or 
disablement, both physical and psychological, cannot be measured (Wilson & Cleary, 
1995).  In addition, it is clear, from clinical practice that individuals respond differently to 
the same disease process.  Patient centred outcomes are increasingly being reported in the 
literature in addition to the physiological or pathological end point of a specific 
pharmacological or surgical intervention.  The measurement of health related quality of life 
(HRQOL) has therefore become a focus for research in order to understand and measure 
the impact of health and disease on quality of life (Guyatt, 1989).  The search for valid 
measures of Health Related Quality of Life (HRQOL) has been extensive but no single 
method has been shown to be the gold standard in every case.  In identifying or developing 
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a tool for the measurement of health related quality of life it is important that it is valid, 
specific, sensitive, reliable, responsive and discriminative. 
1.6.2 Available tools  
Tools described for measuring HRQOL include a single question asking: “how is your 
quality of life?” This obviously has poor validity, reliability and responsiveness but may 
give useful information when measuring the health of populations, or for providing 
information for policy decisions (Torrance et al., 1986).  In the other extreme, 
psychometric measures of HRQOL may include detailed interviews by trained examiners 
asking many in depth questions.  It is more common to use sophisticated tools to measure 
HRQOL including a number of questions specific to the domain or dimension of quality of 
life that is being measured.  These can be aggregated up to the domain level as well as 
described as part of the over-all score for the instrument.  A domain is an area of 
experience or behaviour that the tool is trying to measure.  The aspect of quality of life that 
is of interest will determine the domains which the instrument will measure.   
Questionnaires can be used to assess overall health related quality of life or may be used in 
specific disease states to measure more sensitively the impact of that disease process on an 
individual's function.  In general terms, the greater the number of questions the more 
sensitive the instrument is for detecting changes or differences in HRQOL.  This is 
however limited by resources and can result in missing data if the questionnaire is too long.  
A balance must be struck between a questionnaire that is invalid because it does not ask 
enough questions and a questionnaire that becomes invalidated in practice due to the 
number of missing items recorded (Patrick & Erikson, 1993).   
1.6.3 Methods of administration   
The method used to administer the measurement of HRQOL can vary.  Face to face 
interviews are the most reliable method of making sure that the response rate is optimal 
and that there are no missing items and no misunderstandings.  Trained assessors are used 
to conduct these interviews.  The interview allows the researcher to probe deeper into other 
issues and can generate unexpected information useful for hypothesis generation using 
qualitative as well as quantitative methods.  This method is however extremely labour 
intensive and may also lead to subjects not being honest in their answers or being 
unwilling to acknowledge that they have a problem.  Use of the interview method may 
restrict the number of subjects that can be evaluated, limiting its applicability and 
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relevance to larger populations or patient groups.  The use of the interview technique may 
also lead to issues of inter assessor reproducibility and necessitates a training and 
calibration process to control for this.  In addition to this the interviewer method limits the 
format of questionnaire that can be accommodated (Patrick & Erikson, 1993).   
An alternative to the face to face interview technique is the telephone interview conducted 
by trained examiners.  This is less resource intensive and is a useful alternative to the face 
to face interview while still minimising missed items and allowing opportunity for 
clarification of any misunderstandings.  The use of self-administered questionnaires allows 
the number of subjects in the study to be larger as it is much less labour intensive.  The 
likelihood of missed items and misunderstandings are generally increased using this 
method and a reduced response rate is to be expected.  This can be offset by the use of 
validated and reliable questionnaires written in plain language.  The relatively larger 
numbers that are achieved using self-administered questionnaires may offset the 
aforementioned disadvantages.  Proxy or surrogate responders are also used in some 
conditions although the individual’s perception of the quality of life of their close relative 
may not reflect the patient’s own view.  
Methods of measuring oral and diabetes related quality of life included focus groups, 
individual interviews, telephone interviews, and self- administered questionnaires or 
supported self-administered questionnaires.  A search of the literature revealed a number of 
validated tools for measuring oral health related quality of life (OHRQOL).  Consideration 
of their relative merits included a decision about the validity, reliability, ease of use and 
acceptance in the scientific literature.  Similarly in choosing a tool to measure the diabetes 
related quality of life the same criteria were used. A combination of the self-administered 
questionnaire with a trained research assistant available for clarification and explanation 
was chosen in the study described in this thesis.  The research assistant provided the 
questionnaires and subjects were asked to fill them in on their own.  Help was available 
when required.  It was thought that this would reduce the number of missing items and 
allow clarification to avoid misunderstanding (Patrick & Erikson, 1993).   
1.6.4 Diabetes specific quality of life measures   
A search of the relevant literature revealed that a number of tools have been used to 
measure HRQOL in Diabetes.  Of these, a recent systematic review concluded that only 
three were specific to diabetes and could be said to be measuring quality of life (Speight et 
al., 2008).  The Diabetes-Specific Quality of Life Scale (DSQOLS) is a validated tool for 
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measuring the impact of diabetes on quality of life however this was only available in 
German.  Since simple translation of psychometric tests without further validation and 
testing is not possible this was not a practical option for this study.  There are two other 
diabetes specific HRQOL tools called the Diabetes Quality of Life (DQOL) and the Audit 
of Diabetes Dependent Quality of Life (ADDQL). 
1.6.4.1 Diabetes Quality of Life   
The (DQOL) was developed by Professor Jacobsen of the Joslin Diabetes Centre for use in 
the diabetes control and complications trial (DCCTRG, 1988) and has been widely used 
elsewhere.  The DQOL consists of 46 items although not all of these are diabetes specific.  
The subscales measure diabetes worry, social worry, impact and satisfaction.  The DQOL 
is responsive only to the impact of significant interventions but cannot detect subtle 
changes due for example to changes in the method of insulin delivery.  When the DQOL 
was used in the DCCT as the first diabetes specific measure of QOL no changes in QOL 
were recorded between intensified or conventional regimes.  Using the concept of 
construct validation, clinicians and researchers would theoretically expect that an 
intensification of the strict insulin regime used in the DCCT, and the associated impact and 
limitations as well as the threefold increase in severe hypoglycaemia, would be measured 
by this QOL tool.  As this does not appear to have been the case it is at least possible that 
the DQOL is not measuring adequately the domain in question (DCCTRG, 1988).  The 
DQOL is also limited by the fact that there is no provision for the patient to indicate, or 
give weighting to, one aspect of their life over another.  A patient may indicate that 
diabetes has a detrimental impact on their ability to drive a car or use machinery however 
they may not hold a licence or be required to operate machinery.  The impact of this 
limitation would be given equal weighting alongside domains that have a direct and 
material impact on the patient’s life despite the fact that it is not relevant to the individual 
concerned.   
A recent review of the literature concluded that there were concerns about the acceptability 
and the face and content validity of the DQOL despite the fact that it is widely used (El-
Achhab et al., 2008).  They also reported that the DQOL had not been subjected to 
rigorous psychometric testing such as factor analysis.  The number of questions was 
excessive for the purpose of the study reported in this thesis, due to time constraints, and 
the fact that the subjects would be experiencing a very intensive clinical examination as 
well as responding to the questionnaires.  
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1.6.4.2 Audit of diabetes dependent quality of life   
The second diabetes specific quality of life measure is the Audit of Diabetes Dependent 
Quality of Life.  The ADDQOL was developed by Bradley (1999) and contains twenty 
items.  The questionnaire is available for use at no cost with the permission of the 
copyright holder.  The ADDQOL attempts to improve on the reliability and responsiveness 
of the DQOL by addressing the issue of importance, or relevance, of each domain to the 
respondent.  Subjects are asked to rate the impact of diabetes on different aspects of their 
life but are then asked to rate how important or applicable that aspect of their life is to 
them.  As described above this is not possible with the DQOL.  The ADDQOL contains 18 
items that measure the impact of diabetes on different aspects of life.  Two further 
questions measure overall quality of life and diabetes dependent quality of life.  There are 
modifications of the ADDQOL available for the elderly, adolescents and children.   
The ADDQOL was developed using past research experience, clinical input and interviews 
with adults with diabetes making its development both patient and expert driven.  For all 
applicable domains, respondents rate the impact of diabetes on that domain and the 
importance of the domain for their QOL. The two ratings are multiplied together to provide 
a weighted impact of diabetes on each domain, which are summed and divided by the 
number of applicable domains to provide a measure of the ‘average weighted impact’ 
(AWI) of diabetes on QOL.  The recent review of diabetes specific quality of life 
concluded that the ADDQOL has been shown to be acceptable and reliable in that internal 
consistency has been shown, although it has not been subject to assessment of test-retest 
reliability (El-Achhab et al., 2008).  The validity of the ADDQOL has been demonstrated 
for face and content validity, convergent and divergent states and known and concurrent 
groups. The tool is responsive and has also been shown to be highly sensitive to subtle 
changes in diabetes therapy (El-Achhab et al., 2008). 
Criticisms include the fact that it includes hypothetical responses on the basis of what it 
would be like not to have diabetes.  A recent recommendation by the Food and Drink 
association recommends that these hypothetical questions are avoided in measures of 
patient centred outcomes (Food and Drug Agency Center for Drug Evaluation and 
Research, 2009).  It is also possible that the elderly, or those with low literacy levels would 
find the ADDQOL difficult to complete.    
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1.6.4.3 Conclusion   
In conclusion the ADDQOL is a valid, reliable, responsive and acceptable instrument for 
the measurement of diabetes specific quality of life and for these reasons it was the tool 
that was used in the study described in this thesis. 
1.6.5 Oral health related quality of life.   
Interest in Oral Health Related Quality of Life has been increasing over the last three 
decades and in dentistry, patient centred outcomes in intervention studies are beginning to 
be reported.  The medical model of disease states indicates that disease is defined by a 
pathological process that affects the biological and functional integrity of the body (WHO, 
1948).  Health is however, defined as: 
“a state of complete physical, mental, and social well-being and not merely the 
absence of disease or infirmity” (WHO, 1948).   
Disease states are observable and quantifiable however, their relationship with the presence 
or absence of health is not a linear one (Wilson and Cleary, 1995).  Conceptually the 
development of OHRQOL measures has necessitated a change in how we measure health 
and quality of life in the oral context (Slade et al., 1997).  
Oral health related quality of life (OHRQOL) has been defined as: 
“the impact of oral disorders on aspects of everyday life that are important to 
patients and persons, with those impacts, being of sufficient magnitude, whether in 
terms of severity, frequency or duration, to affect an individual’s perception of 
their life overall.” (Locker and Allen, 2007) 
It has also been defined in the following way: 
“a comfortable and functional dentition which allows individuals to continue in 
their desired social role.” (Dolan, 1993) 
This multi-factorial definition of OHRQOL gives researchers great difficulty, as we try to 
measure something that is related to disease state, but is affected by a multitude of other 
social factors that will affect the impact on a patient’s ability to function and affect their 
global quality of life.   
The ability of dentists to quantify and assess the impact of oral disease on patients’ quality 
of life has been greatly aided by the development of a number of tools that have claimed to 
be doing just this (Slade et al., 1997).  Some of the most common tools are the Oral Health 
Impact Profile questionnaires.  These were developed using Locker’s conceptual 
framework for assessing oral health (Locker, 1988).  This model used the World Health 
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Organisation’s International Classification of Impairment, Disability and Handicap 
(ICIDH) definitions of disease states (WHO, 1980).  These may lead to impairment which 
can result in functional limitation or discomfort and pain which will in turn result in 
physical, psychological or social disability which may lead to a handicap (Figure 1-4).  The 
idea that the presence of detectable dental disease could lead to symptoms which would 
lead to impairment and limitations which would in turn lead to disability and subsequent 
handicap for the subject, ultimately impacting on their quality of life, was the conceptual 
model on which the OHIP questionnaires were developed.  Different questions relate to 
seven different domains of the Impairment-Disability-Handicap construct. 
 
Figure 1-4 Conceptual model of the International Classification of 
Impairment, Disability and Handicaps (WHO, 1980) 
 
An impairment was defined by the WHO in a report (WHO, 1976) in 1976 which became 
the basis for the ICDIDH, (1980).  Impairment was described as:   
 
“any loss of or abnormality of psychological, physiological or anatomical structure 
or function” (WHO, 1980) 
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A disability was defined in the same document in the following way: 
“any restriction or lack of ability (resulting from an impairment) to perform an 
activity in the manner or within the range considered normal for a human being” 
(WHO, 1980) 
 
Disability has more recently been redefined as an umbrella term covering impairments, 
activity limitations, and participation restrictions.  Disability is a complex phenomenon 
reflecting an interaction between the features of a person’s body and features of the society 
in which he or she lives. (WHO, 2010) 
 
A handicap was defined as:  
“a disadvantage for a given individual, resulting from an impairment or a disability 
that prevents the fulfilment of a role that is considered normal (depending on age, 
sex and social and cultural factors) for that individual” (WHO, 1980) 
 
Handicap is no longer a popular term and is no longer used by the world health 
organisation.   
Tools developed for the measurement of quality of life have recently come under some 
scrutiny in the medical literature in terms of whether they are truly reflecting quality of life 
issues.  However this does not appear to have been the case in dentistry to the same extent.   
Criteria for assessing QoL tools were proposed by Guyatt and Cook (1994) (Table 1-4) 
however, it is only in the last few years that the questions about what oral health 
questionnaires are truly measuring have been addressed (Baker et al., 2006).   
Table 1-4  Criteria proposed to assess the validity of QOL measures 
(Guyatt and Cook, 1994) 
Criteria 
Do the authors show that aspects of patients’ lives they have measured are important 
to the patients? 
          If not, have previous studies demonstrated their importance? 
Do the investigators examine aspects of patients’ lives that clinical experience 
indicates patients value? 
Are there aspects of HRQL that are important to patients that have been  
omitted?                  
Were individual patients asked to directly place a value on their lives? 
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1.6.6 The Oral Health Impact Profile   
1.6.6.1 Oral health impact profile 49   
The Oral Health Impact Profile 49 (OHIP-49) is used to assess the impact of oral health on 
an individual’s quality of life and this tool was first described and validated in 1994 (Slade 
and Spencer, 1994).  The OHIP-49 was based on the ICIDH model of disease and its 
consequences (WHO, 1980). It was designed to assess the ‘social impact’ of oral disorders, 
that is, the dysfunction, discomfort, disability and handicap caused by these conditions 
(Locker, 1988).  The purpose of the measure is to: assess the priorities of care by 
documenting social impact among individuals and groups; understand oral health 
behaviours; evaluate dental treatment and provide information for planning for oral health.  
It was intended to be a measure of self-perceived oral health.  
The OHIP-49 was developed using an initial set of 535 statements obtained from open-
ended interviews with 64 dental patients recruited from a range of dental settings.  This 
initial pool was reduced to a set of 46 unique statements based on their form, content and 
ability to represent one of six domains derived from Locker’s conceptual model of oral 
health.  Three additional statements representing the concept of handicap were taken from 
an existing generic health status measure (Slade & Spencer, 1994). 
The qualitative interview based component of the development process suggests that the 
OHIP is patient-centred and therefore measures aspects of patients’ lives that are important 
to the patients.  The item reduction process was carried out by experts, designed to select 
items according to their fit with a conceptual framework rather than on the basis of their 
importance to the patients from whom they were derived.  It would be expected, although 
not necessarily proven, that the experts involved in the process would reflect the aspects of 
quality of life that clinical experience suggests are important to the patients.  The process 
by which the final 46 statements were chosen and the criteria on which others were 
discarded was not described.  Severity weights (from never through to very often) for each 
of the statements, designed to reflect their relative importance, are also included.  The 
weights for each individual domain have not been widely validated for every population 
and are therefore not always used.  These weightings were based on the judgments of 
members of community groups, dental practitioners and students in Adelaide, Australia 
(Slade and Spencer 1994).  As a result of this, the weights ascribed may not reflect the 
severity and⁄or importance of the events described by the items as perceived by all dental 
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patients, although one study did show that the weightings were similar in Ontario and 
Quebec (Jokovic et al, 1997). 
The OHIP has been shown to be a valid and reliable test.  The internal reliability ranges 
from 0.7-0.83 for six subscales but only 0.37 for handicap.  Test retest reliability was 
carried out longitudinally and Intra class Correlation Coefficients were 0.42-0.77 for six of 
the sub scales but only 0.08 for social disability.  Two further studies on patients 50+ years 
in Ontario, Canada and North Carolina showed Cronbach Correlation Coefficients of 0.8-
0.9 for all subscales and 0.96 for the overall OHIP score for all groups (Slade et al., 1996; 
Locker and Slade, 1993).    
The OHIP-49 has been shown to detect an association between scale and sub-scale scores 
and perceived need to visit a dentist (Slade and Spencer, 1994).  Further evidence of 
construct validity of the OHIP as a measure of oral health status has been provided by 
numerous investigators.  Scores distinguish between the dentate and edentulous and show 
small to moderate correlations in the hypothesised direction with a wide range of 
traditional clinical indicators and self-perceived oral conditions, such as xerostomia, tooth 
loss, caries and periodontitis (Slade et al., 1996; Locker and Slade, 1994; Hunt et al., 
1995).   
Some evidence that the events captured by the OHIP may impact on a patient’s general 
wellbeing has been provided by a study of the institutionalized elderly where there was a 
relationship between measures of oral health impacts and life satisfaction. Unlike the 
geriatric oral health assessment index (GOHAI), this association remained clearly 
significant after controlling for other predictors.  The OHIP 49 could be described as an 
expert-centred measure of subjective oral health that may be capturing events which 
impact on general well-being and quality of life.  However, the items comprising the 
measure do not necessarily, themselves, demonstrate that this is the case.  The OHIP has 
more recently been subjected to rigorous testing, utilizing structural equation modeling and 
factor analysis in order to assess the within construct and between construct validity of the 
OHIP-49 (Baker et al., 2007, 2008).  These findings indicate that there is not a simple 
direct relationship between the separate domains of Locker’s conceptual model.  The 
authors conclude that the within and between construct validity of the OHIP, in its current 
form, is questionable, and that the scale needs to undergo further testing before it can be 
assumed that it measures the concepts (and model) as originally proposed.  The authors, 
however, concede that they only used a limited number of possible structural equation 
models and that this secondary analysis was on a group of dental patients who were 
Douglas P Robertson 2011  Chapter 1-122 
dentally fit.  They are therefore unable to comment on the applicability of their findings to 
other dental groups.  Nevertheless the OHIP-49 could not be shown to truly reflect the 
model as described and further investigation and development is warranted. 
The authors state that we need to move away from simple descriptive or correlational 
research in an attempt to understand the complexity of oral health from within a patient-
centered perspective.  Practically, as the authors acknowledge, the overall OHIP score has 
been shown repeatedly to correlate with dental disease and to be related to its impact on an 
individual.  Its use as an overall measure can therefore continue to be justified.  The lack of 
direct relationships between domains and indeed the fact that multiple questions may well 
measure different domains mean that reporting of individual domains should be regarded 
as having poor validity (Baker et al., 2007, 2008).   
Despite the above conceptual limitations the OHIP-49 remains one of the most robust tools 
for assessing the impact of oral health on an individual’s life.  A systematic review 
concluded that the OHIP-49 was valid and reliable.  It has been shown to have construct 
validity and internal validity.  Test-retest reproducibility and reliability has been shown by 
multiple authors.  Epidemiological studies have shown that researchers can expect higher 
OHIP scores in patients with poorer clinical oral status, that is patients with more missing 
teeth, more retained root fragments, more untreated decay, deeper periodontal pockets and 
more periodontal recession.  OHIP scores are also higher in socially and economically 
disadvantaged groups and among those who are irregular dental attenders.  It has also been 
shown in longitudinal studies to be responsive to changes in oral status both positively 
after the provision of new dentures and negatively by further tooth loss (Slade, 1997). 
1.6.6.2 The oral health impact profile 14   
The greater the number of questions, the greater the validity of the psychometric test 
(Guyatt, 1994).  It has also been demonstrated that the longer a questionnaire the greater 
the resources in time required for its completion, the greater the likelihood of missing data 
and the less likely subjects are to complete the questionnaire correctly.  Concerns about the 
length of the questionnaire and a desire for a tool that was more amenable to chairside 
research led to the development of the short form of the OHIP-49.  Distilling the 
measurement of HRQOL into a few key questions is a goal for clinical investigators.  One 
approach is to develop a long instrument, test it, and use its performance to choose key 
questions to include in a shorter index.  Slade at al. used this approach to create the shorter 
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oral health impact profile 14 questionnaire based on the more lengthy instrument, the 
OHIP-49 (Slade et al., 1997).  
1.6.6.2.1 Derivation of the OHIP-14 
 
While accepting the desirability of a shorter questionnaire it is essential that the shortened 
form meet a number of criteria before its use can be recommended and thus the 
development of a short form of a questionnaire is not a simple task.  In deciding whether a 
short form of a questionnaire is acceptable for discriminative purposes the question is 
whether both forms of the questionnaire classify people similarly.  The extent to which 
variability in scores, in the full instrument, is predicted by scores of the short version and 
therefore how well the rating of people's quality of life by the shorter instrument 
corresponds to ratings by the longer version would indicate whether the use of the short 
form of the questionnaire would be an acceptable substitute.  
In addition, the validity and, if applicable, the responsiveness of the shorter version should 
then be tested against the full instrument. Correlations of change with independent 
measures and instrument responsiveness should be comparable.  If measurement properties 
deteriorate, the investigator needs to decide whether trading off the time required to fill in 
the questionnaire is worth the increases in sample size required for statistical power to 
detect a difference with a less responsive instrument. 
The OHIP-14 questionnaire was developed using a controlled stepwise regression 
procedure.  The authors developed a subset of 14 questions from the full 49 questions 
using stepwise regression.  Individual questions were considered sequentially for their 
contribution to total r2.  Items making the greatest contribution to total r2 were added 
sequentially, except that no more than two items from each conceptual dimension were 
permitted to enter the model.  This "controlled" regression procedure was also conducted 
until 14 items, two from each dimension, were selected.  
Subsequent comparison between the OHIP-14 and the OHIP-49 showed identification of a 
subset of 14 questions about the social impact of oral disease that accounted for 94% of 
variation in total OHIP-49 scores and which had an internal reliability coefficient (α) of 
0.88.  Summary scores, based on the OHIP-14, displayed the same pattern of variation 
among socio-demographic groups that was observed using the OHIP-49, and both the 
OHIP-14 and the OHIP-49 resulted in similar multivariate models relating oral status and 
socio-demographic variables to social impact.  Because of the controlled regression 
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technique used, the OHIP-14 contains questions that retain the original conceptual 
dimensions contained in the OHIP-49, and those questions have a good distribution of 
prevalence.  The 14 items ranged in prevalence from 33.1% (Q15) to 1.6% (Q48) while 
severity ranged from 0.97 to 0.06 (Q48) (Slade et al., 1997).  The instrument has now been 
used in a large number of situations for quantifying levels of impact on wellbeing in 
settings where only a limited number of questions can be administered. 
1.6.6.2.2 Validation 
The OHIP-14 has also been subjected to rigorous analysis examining its ability to reflect 
Locker’s conceptual model using structural equation modelling by the same authors who 
were critical of the OHIP-49.  They investigated the validity of the OHIP-14 in the general 
dental population in the United Kingdom (n=5268), a group of edentulous elders (n=133) 
and a population suffering from xerostomia (n=85).  Structural equation modeling 
indicated support for the model as applied to each of the samples.  All of the direct 
pathways hypothesized by the model were significant, in addition to several indirect 
pathways between variables.  The authors concluded that the OHIP-14 was applicable at 
individual, group, and population levels (Baker et al., 2008).  
1.6.6.2.3 Responsiveness 
Locker measured the responsiveness of the OHIP-14 to a change in oral condition.  In 
order to assess responsiveness, Locker et al. (2004), compared OHIP-14 with global 
transition judgements on dental changes as a result of the provision of dental treatment in 
an elderly population. This paper concluded that the OHIP-14 was responsive to changes 
but that the differences measured were only modest.  The authors conclude that this may be 
because the OHIP-14 was designed to be discriminative rather than responsive to changes.  
Other findings from this study supported the test-retest reliability of the OHIP-14 which 
showed excellent reproducibility with an intraclass Correlation Coefficient (ICC) of 0.84.  
Construct validity was also supported indirectly as patients who were dentally stable did 
not show any changes in their OHIP-14 score longitudinally, whereas patients who 
reported improvements in their global transition measures also showed significant 
reductions in OHIP-14 scores.  Unfortunately the minimal important difference was 5 scale 
points suggesting that studies would require to be very highly powered to detect 
statistically significant changes.   
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1.6.6.2.4 Validation in the United Kingdom 
It is important that psychometric tests are validated in a range of settings and should 
ideally have been shown to be valid and reliable in the population under investigation.  To 
date there have been three studies that have utilised the OHIP-14 in the British general 
population one of which was in a Scottish general dental practice environment.   
 
The 1998 Adult Dental Health Study used the OHIP-14 in a large study of over 5000 
patients although no robust validity or reliability testing was published.  The ADHS 1998 
utilised only one scoring method (the total number of reported problems) stating that the 
weightings had not been validated in a UK population for the individual sub-scores.  There 
were relationships described between oral health status and OHIP-14 scores and 
socioeconomic status, lending indirect support for the construct validity of the OHIP-14 in 
the British general population (Nuttall et al., 2001).  
Robinson and co-workers assessed the OHIP-14 in comparison with the Oral Impact on 
Daily Performance (OIDP) and an interview based method in 179 consecutive patients 
attending a dental hospital (Robinson et al., 2001).  These patients had a mean age of 36 
and were from a range of ethnic and socioeconomic backgrounds.  69.1% of all 
participants were experiencing pain at the time of recruitment and considered their 
condition a dental emergency.  Common diagnoses included irreversible pulpitis (26.6%), 
periapical periodontitis (13.2%) and periapical abscess (9.9%).  All but 8 of the 
participants had experienced at least one impact and using the “occasional” score, only 
twenty people reported no impacts.  Cronbachs alphas for weighted standardized OHIP 
(0.91), additive OHIP (0.92) and OIDP (0.88) were excellent.  The split half reliability, 
another measure of reliability, of both OHIP scores was 0.90 and 0.91 respectively.  The 
authors concluded that the face validity of the OIDP was relatively weak due to the 
complexity of the tool which includes a number of filter and contingency questions, the 
number of questions and the fact that in their version the questionnaire occupied eight 
pages.  In contrast the OHIP fitted on only one sheet.  The OIDP is also limited in content 
validity by virtue of the fact that, although it is based on Locker’s conceptual model of oral 
health, it measures only impacts at a functional level unlike the OHIP which records 
impacts of oral disease at multiple stages of the model.  In assessing criterion validity, 
Robinson et al. (2003), reported significant correlations between both OHIP and OIDP 
scores with global oral health scores and pain scored on a visual analogue scale.  However, 
Douglas P Robertson 2011  Chapter 1-126 
again, the correlation was stronger with OHIP than for OIDP with the global oral health 
rating.  The correlation between weighted standardized OHIP scores and the additive 
scoring was 1 (p<0.001), lending support for the use of the simpler scoring system.  The 
number of impacts in both OHIP and OIDP were weakly related to the presence of clinical 
disease.  Both methods of scoring the OHIP were significantly related to the presence of 
oral disease (p=0.004 and 0.005) however, the relationship between OIDP and oral disease 
was not significant.  Completion rates were lower for OIDP and it was also limited by its 
design, making statistical transformations unsuccessful in order to enable it to be used in 
regression modeling.  The authors concluded that the OHIP-14 (using the summary score) 
demonstrated superior validity to the OIDP when used in a dental hospital setting.  The 
OHIP-14 was shown to be related to the presence of oral disease conveying construct 
validity.  The actual scores from this study are unlikely to reflect those of the general 
population, given that many of the patients included were attending for emergency 
treatment at the time of recruitment.  In addition, given the cross-sectional nature of the 
study, authors did not assess instrument reliability and responsiveness longitudinally 
(Robinson et al., 2003). 
The use of OHIP-14 in Scottish dental patients has been recently validated as part of a 
study into the impact of impacted wisdom teeth on OHRQOL (Fernandes et al., 2006).  
278 patients were recruited from six general dental practices in Tayside, Scotland, and 
followed for a year, to assess the development of problems related to impacted wisdom 
teeth.  The OHIP-14 was completed at baseline (n=278) and at 1-year follow-up (n=169), 
and analysed using three different scoring methods: a summary score, a weighted and 
standardized score and the total number of problems reported.  Internal consistency was 
assessed using Cronbachs α which measures the correlation between questions at baseline 
and again at follow-up.  Cronbach’s α coefficients for each of the seven health domains 
ranged from 0.49 (functional limitation) to 0.74 (physical discomfort) at baseline and 0.30 
(functional limitation) to 0.75 (social disability) at 1-year follow-up.  Only the functional 
limitation domain fell below the arbitrary cut off point of acceptability of 0.5, either at 
baseline or follow-up.  Alpha coefficients for all 14 items combined were 0.88 and 0.87 for 
baseline and follow-up, respectively. Test-retest reliability was also assessed using 
intraclass correlation coefficients (ICCs).  The three methods of scoring, total OHIP-14, 
weighted and number of problems had ICCs of 0.76, 0.72, 0.77 respectively (Feranades et 
al., 2006).  
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In assessing construct validity the authors demonstrated that, in this group of Scottish 
dental patients, OHIP scores were related to occurrence of dental pain, the number of 
missing teeth, no mouthwash used, brushing less than twice a day, educational status, time 
since last dental appointment, attending only when in pain and infrequent dental 
attendance.  All of these differences were in the hypothesized direction.  Stepwise 
regression confirmed relationships between OHIP-14 scores and condition specific 
variables both at base line and follow-up.  These included presence of dental symptoms, 
number of teeth, pain scores, reason for last appointment, frequency of seeing a dentist and 
use of a mouthwash.  Although highly significant the r2 values were only 0.189-0.202.  The 
investigators did carry out periodontal screening and reported bleeding on probing but only 
as two dichotomous scores.  They reported bleeding as either limited to two sextants or 
present in more than two sextants.  They also split the CPI into two groups CPITN 1 and 2 
or 3 and 4.  Although scores were higher in the group with most bleeding and the higher 
CPITN scores, these were not significant.  It would have been interesting to see whether 
the patients scoring CPITN 4 compared with the periodontally healthy group had higher 
OHIP-14 scores, but this comparison was not carried out.  Responsiveness was measured 
using the standardized response mean (SRM).  The SRM is equal to the mean change in 
score divided by the standard deviation of individuals’ changes in scores.  An SRM of 0.2 
indicates a small effect or clinical change, 0.5 moderate, and 0.8 or greater a large effect.  
The SRMs for patients reporting symptoms within the 1-year study period were 0.55, 0.56 
and 0.37 for the summary scores method, the weighted score and the total number of 
problems respectively.  These were only significant in symptomatic patients.  The OHIP-
14 was moderately responsive to detect the alteration in oral health impact from impacted 
wisdom teeth.   
The authors summarized their assessment of the OHIP-14 by concluding that the OHIP-14 
demonstrated good levels of reliability and validity and is responsive to third molar clinical 
change when used to assess OHRQOL in general dental practice in Scotland.  They also 
concluded that of the three methods studied, the summary scores method performed, as 
well or better than the other two, and was the simplest to use.   Locker and co-workers 
(2007) also specifically addressed the issue of weighting in both the OHIP 49 and 14 and 
showed that unweighted and weighted scores discriminated between the groups enrolled in 
the study.  Previous studies had also suggested that psychometric properties are not 
improved by the use of weights (Allen and Locker, 1997, Allen et al., 2001, Robinson et 
al., 2003). 
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1.6.6.3 OHRQOL and periodontal disease.   
The majority of studies into the prevalence, progression and treatment of periodontal 
conditions involve clinical professionally measured outcomes.  While these are essential, 
increasingly researchers are interested in developing patient-centred outcomes that reflect 
the impact of periodontitis on OHRQOL.  There are a number of papers that have 
specifically investigated the impact of periodontal diseases on OHRQOL.  Needleman et 
al. (2004) reported OHRQOL measures using the OHQOL-UK© questionnaire on 205 
patients attending a private periodontal practice.  He found that the effect of oral health on 
quality of life was considerable, with many individuals experiencing negative impacts 
across a broad range of physical, social and psychological aspects of life quality.  OHQOL-
UK scores were associated with patient’s self-reported periodontal health in the past year: 
experiences of ‘‘swollen gums’’ (p=0.01), ‘‘sore gums’’ (p=0.01), ‘‘receding gums’’ 
(p=0.01), ‘‘loose teeth’’ (p=0.01), ‘‘drifting teeth’’ (p=0.01), ‘‘bad breath’’ (p=0.01) and 
‘‘toothache’’ (p=0.01).   The authors also reported that OHQOL-UK scores were correlated 
with the number of teeth affected by periodontitis (CPD>5mm).  Patients who were in a 
maintenance program had significantly lower scores than new patients.  Patients attending 
a private periodontal practice may not be representative of all patients suffering from 
periodontal destruction however, this paper was one of the first to begin to address the 
impact of periodontitis on quality of life.   
Another study assessed a number of different OHRQOL measures (OHIP, OHQUOL, 
GOHAI and a single item self report of oral health) in two different adult patient groups 
(Jones et al., 2004).  All four measures were higher in patients with higher CPITN scores 
confirming that OHRQOL was related to periodontitis and periodontal treatment need.  
The OHIP was significantly associated with CPITN score in this study and was a better 
measure than the GOHAI.   
Lawrence and co-workers showed in a birth cohort, at 32 years of age, that the OHIP-14 
was related to: DMFS ≥12; decayed surfaces >0; missing teeth; self reported oral health; 
attending only when in pain; and also to having sites with greater than or equal to 4mm of 
clinical attachment loss (Lawrence et al., 2008).  Lopez and co-authors (2007) reported in a 
group of Chilean high school students that high OHIP (Spanish) scores were associated 
with an increased odds ratio for periodontitis and acute necrotizing gingivitis 
(OR=2.0,1.6). 
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Ng and co-workers (2006) investigated the relationship between the OHIP-14 and self-
reported symptoms of periodontitis over the preceding 12 months, as well as clinical 
attachment loss.  Swollen gums, sore gums, receding gums, loose teeth, bad breath and 
toothache were all associated with higher OHIP scores.  5 out of the 7 domains of the 
OHIP-14 and the OHIP-sum were all significantly associated with high mean CAL and 
severe attachment loss.  Social disability and handicap were not associated with 
periodontitis in this Chinese population.  This differed from the study by Needleman et al. 
(2004).  The Chinese study recruited patients with low dental motivation and it is therefore 
perhaps not surprising that differences between the study populations were evident and 
reflect different social attitudes.  
Cunha-Cruz and co-workers (2007) found that periodontitis was associated with poorer 
OHRQOL.  In this study, 1497 patients filled in a short OHRQOL questionnaire and gave 
consent for data to be abstracted from their case notes.  Logistic regression models were 
used to relate both, worse perceived oral health and common oral health-related quality of 
life problems, to number of teeth with pockets deeper than 5 mm (0–2, 3–4, 5–8, 9–30 
teeth), number of teeth with pockets deeper than 8 mm (0, 1–2, 3–19 teeth) and number of 
missing teeth (0–3, 4–7, 8–11, 12–31 teeth).  The adjusted odds ratio for having poorer 
perceived oral health was 2.78 when patients had more than 9 teeth with pockets deeper 
than 5mm.  The adjusted ratio for having worse perceived oral health was 3.18 in patients 
with 3 or more teeth with probing depths >8mm.  There was also a relationship between 
the occurrence of common OHRQOL problems and the extent and severity of periodontal 
destruction as well as the number of missing teeth.  Similarly, Aslund et al. (2008) 
investigated the oral health related quality of life in 251 patients attending the department 
of periodontology and fixed prosthodontics using the German version of the OHQOL-UK 
questionnaire.  OHQOL-GE scores were significantly associated with patients' self-
reported symptoms and problems in the past year: experiences of 'tooth ache' (p < 0.05), 
'swollen gums' (p < 0.001) and 'problems with dental prosthesis' (p < 0.05).  OHRQOL-GE 
scores were also directly correlated with the BPE (r2 = -0.295, p < 0.01), the number of 
teeth present (r2 = 0.190, p < 0.01) and inversely correlated with age (r2 = 0.152, p < 0.05). 
 
Quality of life measures have also been used to report changes on QOL during and after 
periodontal procedures.  Ozcelik et al. (2007), in a randomized controlled trial, compared 
three methods of periodontal treatment using the OHIP-14 and the GOHAI as patient-
centred outcomes.  They were able to detect differences in OHQOL resulting from 
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different surgical techniques.  There was no control group for comparison at baseline, 
however, there were differences in the OHIP-14 and GOHAI scores throughout the 
immediate post-surgical period.  Another small study recruited 20 patients with moderate 
to advanced periodontitis and 16 dentally healthy patients.  Patients with periodontitis were 
treated with root surface debridement within 24 hours.  Patients filled in the OHIP-14 at 
base line and at daily intervals for 7 days.  The OHIP-14 was also administered at the final 
review between 2 and 10 months after initial treatment.  This study demonstrated that the 
median number of impacts was significantly higher among patients with periodontitis 
compared with the control group at base line, this difference continued throughout the 
study but patients receiving periodontal treatment saw the mean number of impacts 
decrease significantly over the study course.  The authors concluded that periodontitis is 
not a silent disease but is one that impacts on an individual’s quality of life.  They also 
concluded that periodontal therapy provided in a secondary care setting can result in 
improvements in a patient’s QOL (Jowett et al., 2009).  
 
In conclusion it has been shown that severe periodontitis may not be an asymptomatic 
silent disease but may in fact lead to significant oral health impacts.  These changes are 
detectable by the measures of OHRQOL available and one would therefore expect that 
groups of patients with more severe periodontitis would have higher OHIP-14 scores.    
1.6.6.4 OHRQOL and Diabetes   
There are currently three studies on OHRQOL in diabetic patients.  The first of these 
studies used the Spanish version of the OHIP-14 and examined 159 dentate patients with 
diabetes mellitus.  There was no control group and therefore no conclusions can be drawn 
about the impact of diabetes per se on OHIP scores.  Periodontitis was common in this 
group with almost 50% of all patients having periodontitis and 21.4% having advanced 
disease.  Gingival bleeding, probing depth, and clinical attachment level ≥ 4mm were 
associated with a negative impact on quality of life (p = 0.013, p < 0.001, and p = 0.012 
respectively).  Diabetic patients with mild-to-moderate and advanced periodontitis had 
worse OHIP scores than those who were periodontally healthy or had gingivitis 
(Drummond-Santana et al., 2007).  A second study examined the effects of xerostomia on 
adolescents with T1DM.  A total of 52.9% of subjects presented with xerostomia and 
40.8% with hyposalivation.  OHIP scores were significantly increased by the presence of 
xerostomia (Busato et al., 2009).   
Douglas P Robertson 2011  Chapter 1-131 
The first study to be carried out in Europe contained a mixture of T1DM and type 2 
diabetic patients who were edentulous as well as dentate (Allen et al., 2008).  Of the 101 
patients recruited only 27 had T1DM and some patients had only been diagnosed with 
diabetes for one year.  Nevertheless, this study is the only one to date that has assessed the 
impact of diabetes mellitus on OHRQOL in a European population.  Only thirty-three per 
cent of participants were aware of their increased risk for periodontitis (40% of T1DM).  
The proportion of participants who had attended a dentist within the previous year was 
only 43%, with 34% not having attended for more than 5 years.  Thirty-seven per cent of 
participants attended for dental treatment once a year, with 63% attending only when they 
had a problem.  Subjects filled in the OHIP-20 and 66% reported that they had frequent 
problems with food catching around teeth and under dentures and 43% reported that their 
diet was unsatisfactory because of their teeth.  Unfortunately, this pilot study did not 
include a control group and so no conclusions can be drawn directly about the impact of 
oral disease on non-diabetic subjects from the same area.  The authors reported that the 
OHIP-20 scores were actually lower than in a similar study carried out in the Dental 
Hospital in Cork.  This may be due to the reasons for patients attending the Dental 
Hospital.  The authors suggest that the impact and complications of diabetes mellitus may 
lessen the relative importance placed on the oral cavity by this group (Allen et al., 2008).  
While there is no direct evidence for this, it is one feasible explanation that merits further 
investigation.     
1.7 Recommendations from the FDI and IDF 
The World Dental Federation (FDI) and the International Diabetes Federation (IDF) jointly 
organized a symposium on Oral Health and Diabetes in 2007 during the FDI Annual World 
Dental Congress in Dubai, United Arab Emirates.  The presenting experts and all 
participants welcomed the initiative of the two convening organizations to emphasize the 
interrelationship between diabetes and oral health.  Experts noted the rising burden of 
diabetes worldwide and stated that there was an urgent need to inform professionals, 
people with diabetes, government policy makers as well as the general public about the 
relationship between diabetes and oral health.   
Participants and experts agreed that collaboration between dentists, physicians and policy 
makers was key to oral health promotion and the prevention of oral disease in patients with 
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diabetes.  The recommendations from this symposium to maintain oral health and 
minimize its impact on diabetes management are listed below.   
• To include prevention of oral disease and promotion of oral health as an essential 
component of diabetes management. 
• To establish periodontal disease formally as a routine complication of diabetes in 
order to increase awareness amongst health professionals, people with diabetes  and 
policy makers. 
• To initiate and support research leading to evidence-based treatment strategies to 
improve health and oral health of people with diabetes. 
• To include routine oral screening of people with diabetes. 
• To introduce screening for diabetes in the dental office among high-risk 
populations. 
• To improve knowledge about the reciprocal link between diabetes and oral health 
among all stakeholders, health professionals, people with diabetes, the public and 
policy makers. 
• To increase the focus of dental education for undergraduate and post graduate 
students on the association between diabetes and oral health. 
The participants recommended that the World Dental Federation and the International 
Diabetes Federation work more closely in future, to develop joint policy statements and 
practice guidelines, to advocate for increased awareness among all stakeholders and to 
implement tangible actions in this context (IDF, 2007).   
It is in this global context that the work contained within this thesis was carried out.  With 
an ever increasing number of patients affected by diabetes mellitus we need more 
information about how best to prevent and manage the oral complications of T1DM.  This 
can only be achieved by having reliable evidence of the prevalence, severity and extent of 
these complications.  It is hoped that the data gathered in the studies described in the 
following chapters will inform oral and general health policy for patients suffering from 
T1DM in Scotland and further afield. 
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2.1 Introduction 
The relationship between diabetes mellitus and periodontitis is one that has received 
significant attention over the last 50 years.  The association between the various types of 
diabetes mellitus and periodontitis has been the focus of two recent systematic reviews 
with meta-analysis (Khader et al., 2006; Chávarry et al., 2009).  There is now a 
considerable body of literature including large cross-sectional and prospective studies that 
demonstrates clearly that there is a link between type 2 diabetes mellitus and periodontal 
destruction (Khader et al., 2006; Chávarry et al., 2009; Taylor, 2009).  However, Chávarry 
and co-workers (2009) concluded that a causal relationship between T1DM and 
periodontitis was not established by the available literature.  
The reason that this relationship has not yet been clearly established is largely due to the 
quality of the studies that have been carried out to date.  Criticisms include: the studies 
were under powered; they did not distinguish clearly between the types of diabetes; and 
they failed to control for confounding factors such as smoking, social class and other risk 
factors.  In addition, there was a failure to confirm the status of non-diabetic controls.  
There are a number of studies reported in children and adolescents with T1DM.  However, 
these groups are unlikely to have significant periodontal disease because of their young 
age.  The authors of the systematic review called for high quality studies, in adults with 
T1DM, designed to overcome the shortcomings of the published literature (Chávarry et al., 
2009). 
Type 1 diabetes is a disease which is increasing in prevalence (International Diabetes 
Federation, 2009).  The burden on society and on individuals suffering from the disease is 
significant.  The frequency of complications has been shown to be reduced by good 
glycaemic control and management of complications has improved as patients are made 
aware of the risks and are screened appropriately (DCCTRG, 1996; Stratton et al., 2000).  
Screening for complications such as peripheral neuropathy and retinopathy often means 
that they are identified and treated at an early stage when they are more easily managed.  
Prevention and early diagnosis of diabetes associated periodontitis will only be possible if 
2 Type 1 diabetes mellitus and periodontal 
disease: A cross sectional study 
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there is evidence available to inform, and educate, diabetes physicians, general medical 
practioners, diabetes support staff and patients.  While evidence of a link is equivocal, we 
cannot move forward in developing our understanding of the disease process.  In addition, 
we cannot make progress in implementing public health measures to tackle the oral 
complications of T1DM. 
The aim of this chapter is to provide definitive evidence of the relationship, if any exists, 
between T1DM and periodontal disease.  The research questions were: 
• Is the prevalence of periodontal disease increased in non-smoking T1DM adults 
compared with healthy non diabetic control subjects (NDS)? 
• Is the prevalence of periodontal disease increased in non-smoking PCD compared 
with non-smoking well controlled diabetic subjects (WCD) and NDS?   
2.2 Materials and Methods 
2.2.1 Training and calibration 
A single blinded trained examiner recorded all the clinical examinations (DR).  Preparation 
involved clinical training in measurement of the position of the gingival margin, and 
clinical probing depth and in the use of the Modified Gingival Index (Lobene, 1986) and 
the Plaque Index (Silness and Loe, 1966).  Training was conducted by external, and 
internal, experienced clinical periodontal researchers.  This was in order to improve 
reproducibility and to provide a second trained and calibrated examiner in the event that 
the primary examiner was unable to perform the examinations.  This was never required 
during the duration of the study.  
Training included a consensus session where the standard was set between the experienced 
researchers and the examiner using clinical photographs of various levels of gingival 
inflammation and plaque accumulation.  The position of the gingival margin in relation to 
the cemento-enamel junction and periodontal probing technique were also discussed.   
Calibration included intra and inter-examiner reproducibility.  As there was to be only one 
examiner, intra-examiner reproducibility was the most important factor in training and 
calibration.  There was one calibration session prior to the commencement of the study and 
one shortly after the clinical examinations had started.   
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During the study, over 10% of all patients had at least one quadrant of their periodontal 
charting repeated in order to ensure that recordings were reproducible.  It was not practical 
for patients to return on a separate day for repeat measurements due to difficulties with 
recruitment and attendance at appointments in this population.  In order to avoid the 
examiner recalling measurements, all repeat examinations were carried out later in the 
morning after all the charting had been completed and patients had taken a break.  The 
decision about which quadrant to repeat was taken randomly by the dental research nurse.  
Reproducibility was assessed by calculating Kappa scores for all periodontal indices.  The 
percentage within 1mm or 1 point on the scale and 2mm or 2 points on the scale was also 
calculated.  The mean bias and measurement error were calculated for all indices.  Kappa 
scores were rated against the criteria proposed by Altman for the level of agreement (1991) 
(Table 2-1).  
2.2.2  Study Design 
The study protocol was approved by the Glasgow Royal Infirmary local research ethics 
committee.  The nature and purpose of the study was explained to potential recruits and 
those willing to participate signed a consent form.  
2.2.2.1 Subjects 
Patients with diabetes, 20-55 years of age, were recruited from out patient departments of 
Glasgow Royal Infirmary, the Southern General Hospital, the Victoria Infirmary and 
Stobhill Hospital in Glasgow, and the Royal Alexandra Hospital in Paisley.  All hospitals 
were in the West of Scotland and were within the Greater Glasgow and Clyde Health 
Board.  Healthy control subjects (20–55 years old) were recruited from physiotherapy 
outpatient clinics, through the buddy system and via an advertisement in a national 
newspaper.  The buddy system involves each diabetic subject asking a friend of the same 
gender and similar age to consent to joining the study as a healthy control.  Consenting 
buddies were then contacted by the dental research nurse and an appointment for the 
examination was arranged. 
2.2.2.2 Exclusion criteria 
• Subjects were excluded from taking part in the study if they had a history of 
smoking within the past five years.  It would have been preferable to have included 
only subjects with no exposure to tobacco smoking.  However, the prevalence of 
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cigarette smoking in the West of Scotland is such that it was felt that this would 
impact on recruitment and final sample size (Scottish household survey, 2009).   
• Subjects were excluded if they were pregnant at the time of recruitment.  It is well 
recognized that the hormonal changes during pregnancy have a profound impact on 
the gingival inflammatory response. 
• Patients who were immunosuppressed either due to medication or concurrent 
illness were excluded due to the possible impact of this on the periodontal tissues.   
• Any patient who was on medication with side effects shown to affect the 
periodontal tissues (other than metformin which can show taste disturbance) or 
those who had been on antibiotics or anti-inflammatory drugs within 6 weeks of the 
examination were excluded.   
• In order to minimize the possible complication of racially related genetic 
differences affecting the prevalence of periodontitis, only subjects of North 
European Caucasian origin were recruited.   
• Subjects with less than 20 teeth were excluded.  This was to ensure that patients 
had sufficient teeth on which to measure any periodontal disease present. 
•  Subjects who were unable to consent were excluded from participation. 
2.2.2.3 Descriptive data 
Data describing age, gender, social class, oral health behaviour, and body mass index were 
collected prior to the clinical examination. 
Area based social deprivation was assessed by using the Deprivation category (DEPCAT) 
and Scottish Index of Multiple Deprivation (SIMD) of each participant based on their 
home post code, available in table form from the Scottish Government (Scottish executive, 
2006).  Both DEPCAT and SIMD are area-based measures of deprivation.  DEPCAT is 
based on the Carstairs index developed for Scotland as an alternative to the Townsend 
Index of deprivation (England and Wales) (Townsend, 1988; Carstairs and Morris, 1990).   
The Carstairs index is based on four census indicators: low socioeconomic status, lack of 
car ownership, overcrowding and male unemployment (Carstairs and Morris 1990).  The 
SIMD 2006 combines 37 indicators across 7 domains, namely: current income, education, 
Douglas P Robertson 2011  Chapter 2-137 
housing, health, skills and training, employment, geographic access and crime.  These 
domains are used to give an aggregate deprivation score for a post code area.  SIMD is the 
preferred index as it uses more information to arrive at the score and in addition is 
available for smaller postcode areas.  Some DEPCAT scores are only available for the first 
number of the second part of the postcode whereas SIMD is available at the level of the 
last two digits and therefore refers to a more precise area.  DEPCAT has seven scores 
while SIMD has only five.  We recorded and reported DEPCAT as well as SIMD because 
it was the area based measure of deprivation that was used in the most recent available data 
from the Adult Dental Health Survey (Kelly et al., 1998).  Data on car ownership, 
educational level and ability to pay for dental treatment were also recorded. 
Body mass index (BMI) is defined as the individual's body weight divided by the square of 
his or her height.  The formula which produces a unit of measurement of kg/m2 was first 
described by Adolphe Quetelet in the 19th century and was validated by Keys (Keys, 
1972).  The patients’ weight and height were measured prior to the clinical examination by 
the dental research nurse.  Weight was recorded to the nearest half kilogram; height was 
recorded to the nearest centimetre.  The BMI was calculated using the freely available 
National Institute for Health (NIH) BMI calculator (www.nhlbisupport.com/bmi/). 
 
Pack years were calculated for those who had smoked in the past and are a quantification 
of past smoking experience over a period of time.  Pack years are calculated by multiplying 
the number of packs of cigarettes smoked per day by the number of years the person has 
smoked and dividing the total by 20.  Patients were identified as never smokers and former 
smokers based on their response to individual questioning by the dental research nurse. 
Never smokers were defined as those individuals who had a pack year score of less than 
0.25 during their lifetime.  
Patients were also asked about their tooth brushing frequency, use of adjunctive interdental 
cleaning aids, mouthwash use, registration with a dentist, frequency of dental attendance, 
reason for attendance, dental anxiety and dentally related symptoms.   
The glycaemic control for the T1DM patients was calculated using the average of all 
available HbA1c measurements over the last 2 years.  A two year period was chosen in 
order to give a representative picture of the patients’ glycaemic control over a prolonged 
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time period likely to affect the periodontium.  Patients were separated into well and poorly 
controlled based on an average HbA1c of ≤ 7.5% as defined by the Scottish Diabetes 
Survey (SDS, 2009).   
2.2.3 Clinical examination 
Participants responded to questions concerning their social and dental history using a 
customised oral health questionnaire. 
All clinical examinations took place in Glasgow Dental Hospital and School.  To avoid 
diurnal variation in salivary flow, examinations were mostly scheduled in the morning..  
Clinical examination normally took around 120mins.   
The clinical examination took place in the following order: 
1. The patient entered the dental clinic and was met by the dental research nurse 
who explained the nature of the examinations.  The patient was encouraged to 
ask any questions if they felt that they still had unanswered queries.   
2. The dental research nurse ensured that all of the relevant paperwork had been 
completed and that there had been no change to the patient’s medical history 
since recruitment.  The need for secrecy about the diabetic status of the subject 
was re-emphasized to the individual at this time.   
3. Saliva sampling and the oral rinse were collected first.  Details of this process 
are described fully in chapter 4. 
4. Examination of the 4 key sites one in each quadrant of the mouth (normally the 
mesiobuccal aspect of the 1st or 2nd molar tooth) was carried out.  The Modified 
Gingival Index (MGI) (Lobene, 1985) was recorded first followed by the Plaque 
Index (PI) (Silness and Loe, 1964), gingival crevicular fluid flow, clinical 
probing depth and bleeding on probing.  This is further described in chapter 3. 
5. A full mouth dichotomous plaque score was recorded at six sites around every 
tooth.  Where plaque was visible or detectable by running a probe across the 
surface it was recorded simply as present.   
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6. A full mouth dental chart was recorded as per the ADH survey 1998 (Nunn et 
al., 2001).  Recording of missing teeth, existing carious lesions, and dental 
restorations and trauma was based on clinical observation using a dental mirror 
and explorer.    
7. At this point there was a break to allow the patient to have a snack.  All patients 
had a break to ensure that the examiner remained blind to diabetic status.   
8. Full mouth periodontal chartings were recorded at six sites around every tooth 
(mesiobuccal, distobuccal, mesiolingual, distolingual, midlingual and 
midbuccal) using a manual probe (University of North Carolina PCP 15).  The 
distance between the cemento-enamel junction and the gingival margin was 
recorded to the nearest whole millimetre.  If the gingival margin was coronal to 
the cemento-enamel junction a negative value was recorded.  Gentle probing, 
approximately 25g/cm2, was performed by inserting the probe into the gingival 
crevice along the long axis of the tooth until resistance was felt.  Clinical 
probing depth (CPD) was defined as the distance between the gingival margin 
and the bottom of the probeable crevice or pocket rounded down to the nearest 
whole millimetre.  These two parameters were used to compute clinical 
attachment level (CAL).  Bleeding from the base of the pocket was recorded 30 
seconds after probing.  Third molar teeth were excluded from all recordings 
unless they were fully erupted and were replacing a missing molar tooth in the 
same quadrant.  
9. The study protocol dictated that the non-diabetic status of the control group was 
confirmed by HbA1c testing of venous blood.  Blood was taken from the 
antecubital fossa of all subjects by the dental research nurse, who was a trained 
phlebotomist, in accordance with the requirements of the local ethics committee.  
Two samples of anti-coagulated blood were collected in K2 EDTA and one in 
Sodium Heparin.  One sample of coagulated blood was collected in a plain tube 
(vacutainer TM).  The blood samples that were not required for HbA1c testing 
were separated by centrifugation (1048 xg for ten minutes), aliquotted and stored 
at -80oC.  HbA1c testing was carried out on EDTA anticoagulated blood at the 
diagnostic haematology laboratory in Glasgow Royal Infirmary. High 
Performance Liquid Chromatography (HPLC) was conducted using the 
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Menarini HA-8160 analyzer (Menarini Diagnostics Firenze, Italy) according to 
existing diagnostic protocols.  An HbA1c of <6.0% was required to confirm the 
non-diabetic status of control subjects (ADA, 2009).    
2.2.4  Data handling 
All data were handled confidentially and were stored on a password protected computer.  
Hard copies of forms were stored in a fireproof locked safe in a secure office.  Clinically 
relevant findings were recorded in the patients’ notes.  Where the patient provided the 
General Dental Practioner’s contact details, a letter was sent to the dentist informing 
him/her that the patient had participated in the study and of any disease noted.  The oral 
health questionnaire was completed on paper forms and later transcribed into a custom 
made Microsoft AccessTM database.  The caries, key sites and plaque charts were loaded 
directly into Microsoft Access forms at the chairside.  The periodontal charting was loaded 
into a custom made charting programme.  These programmes did not allow automatic or 
easy analysis and it was necessary to design Microsoft Visualbasic TM programmes to 
extract the data.  These were designed by Mr Colin Cairnie in conjunction with the author.  
Repeated testing of the programmes confirmed their reliability.  It was possible to generate 
summary data for any caries or periodontal parameters by modifying the underlying 
programme.  All data were backed up on a daily basis and stored on a DVD separately 
from the dedicated laptop.  The patient was allocated a unique identifier which was used to 
link data for future analysis. 
2.2.5 Statistical analysis 
2.2.5.1 Power calculation 
It was estimated that the level of severe periodontitis (≥ one tooth with ≥6mm CAL) in the 
general population in Glasgow, for the age group under investigation, would be around 5% 
(Morris et al., 2001).  Emrich and co-workers (1999) showed that type 2 diabetes mellitus 
conferred a three times increased risk of periodontitis in poorly controlled type 2 diabetic 
patients.  Assuming that the increase in risk would be similar we conservatively estimated 
an increase in prevalence of two and a half times. Sample size was estimated on a 
prevalence of severe periodontitis in poorly controlled diabetic subjects of two and a half 
times that in non-diabetic subjects (i.e. 12.5% and 5% respectively).  Using a simple 
matched pairs design (PCD, NDS), if the proportion of disagreements is 0.115 it was 
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estimated that a sample size of 136 pairs would have 80% power to detect a difference in 
proportions of 0.075 using a two-sided McNemar’s test at the 5% significance level 
(calculations performed using StatXact).  If the data are considered as sets of matched 
triplets, then, for a ratio of 2:1 (2 T1DM patients (1PCD, 1WCD:1 NDS) the approximate 
sample size for the control group is (3x sample size for 1:1 matching) divided by four (i.e. 
approximately ¾ of 136 = 102) (Schlesselman and Stolley, 1982).  Correspondingly the 
size of the T1DM group (including PCD and WCD) would be 2x the new size of the 
control group (i.e. 102x2 = 204).  If we therefore aim to examine 136 WCD and 136 PCD 
it will be possible to compare the matched T1DM patients with the controls looking for 
similar differences with greater than 80% power, as the actual sample size required is less 
than that for comparing only PCD with NDS.  Therefore, a recruitment target of 272 type 1 
diabetic patients and 136 non-diabetic subjects was set. 
All data analysis was undertaken using Stata (Intercooled v10.0; StataCorp LP) or PASW 
18 (PASW 18, SPSS Inc)  
2.2.5.2 Descriptive data 
Demographic and other characteristics of the study sample according to the primary 
outcome variable (severe periodontitis) and exposure/predictor variable (diabetes status) 
were described using the five number summary (median, inter-quartile range, and range) 
for skewed data and means (95% confidence intervals) for symmetrically distributed data. 
2.2.5.3 Univariable analysis 
In the univariable analysis the prevalence of periodontitis in T1DM (WCD + PCD) and 
only PCD was compared to NDS using Pearson’s Chi-squared test or Fisher’s exact test 
(when expected cell size <5).   
For the secondary outcomes that were symmetrically distributed, linear regression models 
compared T1DM vs NDS and PCD vs NDS whilst controlling for age and gender.  Where 
the secondary outcomes were skewed, the comparison was carried out using Mann-
Whitney rank sums tests to compare underlying distributions. 
2.2.5.4 Multivariable analysis 
For the multivariable analysis binary logistic regression models were used to estimate OR 
[95% CI] for severe periodontitis in T1DM versus NDS and PCD versus NDS.  
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Adjustments were made in the first instance for age and gender and then additionally for: 
SIMD, level of education, BMI (weight/height2), smoking status (never smoked, 
previously smoked) and attendance at a dentist. 
For all models, each potential confounder was included in the model separately.  Due to 
potential for collinearity between SIMD and education level, each variable was offered to 
the final model separately and then simultaneously.  A final model was then produced 
consisting of all potential confounders.  The final models were rerun restricting the 
analysis to only those subjects who had never smoked.  Due to the large number of 
comparisons, a significance level of 1% was used throughout. 
2.3 Results 
2.3.1 Recruitment 
Two hundred and ninety-six patients with diabetes and one hundred and sixty-five control 
subjects were recruited to the study.  Figure 2-1 describes the flow chart of the study 
protocol and records the number of patients assessed, enrolled, examined and finally those 
available for analysis.  In total 209 T1DM patients and 115 NDS were examined.  Three 
diabetic patients were subsequently excluded because they were later shown to have Type 
2 diabetes. Three did not have complete periodontal chartings but were included in the 
secondary analysis. Three NDS subjects were excluded: 1 was a former very heavy smoker 
(82 packyears), 1 was borderline Type 2 diabetic and 1 was excluded due to the medical 
history.  An unmatched cross sectional analysis was carried out due to the fact that there 
were insufficient patients in the WCD group to achieve statistical power.  In addition 
multivariable analysis was used to allow for correction of confounding factors.  The cross-
sectional analysis of the primary outcome for the whole diabetic group included 112 NDS 
and 203 T1DM.  In model 2 which examined the differences between PCD and the NDS, 
there were 112 NDS and 169 PCD.  The numbers examined for the secondary outcomes 
included 112 NDS and 205 T1DM patients for oral mucosal lesions and conditions and 110 
NDS and 204 T1DM patients for hard tissue.   
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Figure 2-1  Flow chart of recruitment process 
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2.3.2 Calibration 
The results of the intra-examiner calibration confirmed that there was an acceptable level 
of reproducibility by the single examining dentist.  During the first calibration exercise all 
scores were fair or moderate apart from bleeding on probing which was poor throughout 
(Table 2-2).  The initial inter examiner Kappa scores were lower although these still 
showed moderate agreement for CPD and CAL (ĸ = 0.45, 0.41) and good agreement for 
the position of the gingival margin (ĸ = 0.67) (Table 2-2).  
The calibration exercise was repeated following further training shortly after the beginning 
of the clinical examinations and the scores were improved (Table 2-2).  These data were 
considered acceptable and the clinical examinations continued.   
The results of the repeat examinations carried out by the author throughout the study 
showed very good, good or moderate agreement (Gingival margin position ĸ=0.82, CPD ĸ 
=0.64, CAL ĸ = 0.58 and BOP ĸ = 0.48).  The percentage within 1mm was greater than 
98.9% for CPD and CAL (Table 2-3).  
Table 2-1 Interpretation of Kappa scores (Altman, 1991) 
Value of K Strength of agreement  
< 0.20 Poor 
0.21 - 0.40 Fair 
0.41 - 0.60 Moderate 
0.61 - 0.80 Good 
0.81 - 1.00 Very good 
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Table 2-2 Summary of calibration exercise 
 CPD Rec CAL BOP 
Κ 0.63 0.77 0.54 0.277 
Perfect 
agreement 
69.6% 84.3% 61.3% 74.2% 
Within 1 97.5% 98.0% 94.1 N/A 
Within 2 100.0% 100.0% 99.0% N/A 
Mean bias 0.025mm 0.00mm 0.03mm 0.092 
Intra-
examiner 
calibration 
Measurement 
error 
0.62mm 0.47mm 0.78mm 0.502 
Κ 0.45 0.67 0.41 0.15 
Perfect 
agreement 
66.7% 86.9% 60.1% 62.4% 
Within 1 97.0% 98.2% 93.5% N/A 
Within 2 99.4% 100.0% 99.4% N/A 
Mean bias 0.60 mm 0.30 mm 0.89 mm 0.13 
Inter-
examiner 
calibration 
Measurement 
error 
0.67 mm 0.43 mm 0.79 mm 0.60 
CPD = Clinical probing depth                                                                                                              
CAL = Clinical attachment loss                                                                                                              
Rec = gingival margin position/recession                                                                                              
BOP = Bleeding from the base of the pocket                                                                                       
Within 1: agreement between replicates to within 1 unit on measurement scale.                                  
Within 2: agreement between replicates to within 2 units on measurement scale.                                      
Mean bias: mean of differences between replicates.                                                                          
Measurement error: standard deviation of differences between replicates 
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Table 2-3 Summary of ongoing calibration 
 CPD Rec CAL BOP 
Κ 0.64 0.82 0.58 0.48 
Perfect 
agreement % 
78.1 89.4 70.9 74.6 
Within 1 99.8 99.9 98.9 N/A 
Within 2 100 99.9 99.9 N/A 
Mean bias 0.00mm 0.00mm 0.01mm 0.0011 
Intra-examiner 
calibration 
Measurement 
error 
0.48mm 0.34mm 0.58mm 0.5 
CPD = Clinical probing depth                                                                                               
CAL=Clinical attachment loss                                                                                                              
Rec= gingival margin position/recession                                                                                              
BOP=Bleeding from the base of the pocket                                                                                       
Within 1: agreement between replicates to within 1 unit on measurement scale.                                  
Within 2: agreement between replicates to within 2 units on measurement scale.                                      
Mean bias: mean of differences between replicates.                                                                          
Measurement error: sd of differences between replicates 
 
2.3.3 Demographic data of non-participants 
Table 2-4 describes the descriptive statistics for those individuals who initially agreed to 
join the study but subsequently did not attend and those who were included in the analysis.  
Data were available for 117 non-participants and 318 participants for age, gender, diabetic 
status and socio-economic status, using both DEPCAT and SIMD.  Lifestyles variables 
including alcohol consumption, smoking status and body mass index were also included.  
There were statistically significant differences between those who participated and those 
who did not for smoking status and socio-economic status.  78.6% of non-participants were 
never smokers compared with 87.7% of participants (p = 0.02).  There were differences 
between participants and non-participants by DEPCAT but not by SIMD.  For DEPCAT 
there was no clear pattern of non-attendance by deprivation.  There were more patients in 
DEPCAT 1 and 2 (the least deprived) and 7 (the most deprived) who did not attend their 
scheduled appointment.  There were no other statistically or clinically relevant differences 
between the study participants and those who did not attend. 
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Table 2-4 Descriptive statistics for participants and non-participants 
 
Non-participants N Participants N p valuea 
N 117 
 
318 
  
Age median,  
(IQR), [range] 
39 (29, 45),  
[19-55]   117 
37.8 (27, 44), 
[20-56] 318 0.5 
 
     
Gender % (n) 
 
  117 
 
318 0.6 
Female 52 (61) 
 
55 (175) 
  
Male 48 (56) 
 
45 (143) 
  
 
     
Diabetic status % (n) 
 
  117 
 
318 0.84 
Diabetic 65 (76) 
 
64.8 (206) 
  
Non-diabetic 35 (41) 
 
35.2 (112) 
  
Socio-economic 
 
     
DEPCAT % (n)           115      318 0.001 
1   8.7 (10)         9.1 (29)   
2   22.6 (26)        10.1 (32)   
3   10.4 (12)         12.3 (39)   
4   22.6 (26)        21.7 (69)   
5   7.0 (8)        16.7 (53)   
6   6.1 (7)        13.8 (44)   
7   22.6 (26)        16.4 (52)   
SIMD % (n)         111      307 0.42a 
1   30.6 (34)        24.1 (74)   
2   16.2 (18)        12.4 (38)   
3   16.2 (18)        19.5 (60)   
4   14.4 (16)        18.9 (58)   
5   22.5 (25)        25.1 (77)   
Missing   5.1 (6)        3.5 (11)   
 
     
Lifestyle variables      
Alcohol consumption-
units/week median, 
(IQR), [range] 
  6 (1, 12), 
  [0-40]         115 
   5 (1, 10),  
   [0-40]      318 0.52
a
 
Missing % (n)   1.7 (2)     
Smoking status % (n) 
 
        117 
 
     318 0.02 
Never smoked   78.6 (92) 
 
    87.7 (279) 
  
Smoked in past   21.4 (25) 
 
    12.3 (39) 
  
 
     
Pack years for 
previous smokers 
median, (IQR), 
[range] 
  5 (1, 14.9),     
[0-28]        25 
   5 (1, 12)  
   [0-46]    39 0.85 
 
     
Body Mass Index 
median, (IQR), 
[range] 
26.6  
  (23.8, 29.3),  
  [20.7-40.8] 
      111 
  26.1  
  (23.4, 29.9),    
[18.4-49.2] 
    318 0.46a 
Missing % (n)  
 
    
 
     
a p values were calculated without missing data 
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2.3.4 Demographic data for patients with periodontitis 
Table 2-5 describes the demographic characteristics of those patients with severe 
periodontitis (SP) as defined by one site of clinical attachment loss greater than or equal to 
6mm on at least one tooth.  Patients who were diagnosed with SP had a higher median age 
of 44 compared with 35 in the non-periodontitis group (p≤ 0.0001).  Patients in the 
periodontitis group were also more likely to be male compared with the non-periodontitis 
group (p = 0.02) and had a higher BMI (p = 0.009).  Patients with SP were more likely to 
attend the dentist once a year and to use inter-dental brushes (p=0.03 and p=0.009 
respectively).  Those who were registered with a GDP and attended a dentist regularly 
were however, no less likely to suffer from severe periodontitis than those who did not.  
Patients who did not have SP were more likely to have proceeded to higher education than 
those who did (80.8% compared with 69% (p = 0.05) respectively).  They were also less 
likely to have been smokers in the past (p = 0.002). 
Table 2-5  Descriptive statistics for subjects with and without severe 
periodontitis 
 
Clinical 
attachment 
level of < 6mm 
N 
Clinical attachment 
level of ≥ 6mm on 
at least one tooth 
N p value 
N 243   72     
  
          
Demographics           
Age median, (IQR), 
[range] 
35 (27, 42),  
[20-56] 
243 44 (38, 49), 
[20-55] 
72 <0.0001 
  
          
Gender % (n)         0.02 
Female 58.4 (142) 243 43.1 (31) 72   
Male 41.6 (101)   56.9 (41)     
  
          
Most recent % 
HbA1c median, 
(IQR), [range] 
7.5 (5.3, 8.7), 
[4.3-13.7]  
235 8.0 (5.7, 9.0),  
[4.7-11.9] 
70 0.07a 
Missing % (n) 3.3 (8)   2.8 (2)     
  
          
Body Mass Index 
median, (IQR), 
[range] 
25.6 (23, 29.8),  
[18.4-49.2] 
2243 
26.7 (24.8, 31.1),  
[21-45.8] 
72 0.009 
No. units 
alchohol/week 
median, (IQR), 
[range] 
5 (1.2, 10),  
[0-40] 243 
4.5 (1, 11.8),  
[0-40] 72 0.63 
a
 p values were calculated without missing data  
Douglas P Robertson 2011  Chapter 2-149 
Table 2-5 cont. 
  
Clinical 
attachment level 
of <6mm  N 
Clinical 
attachment level of 
≥6mm on at least 
one tooth 
N 
p 
value 
N 243   72     
Socio-economic 
status 
          
DEPCAT % (n)   243   72 0.96 
1 8.6 (21)   11.1 (8)     
2 11.1 (27)   6.9 (5)     
3 11.9 (29)   12.5 (9)     
4 21.4 (52)   23.6 (17)     
5 16.5 (40)   16.7 (12)     
6 14.0 (34)   12.5 (9)     
7 16.5 (40)   16.7 (12)     
SIMD % (n)   235   70 0.98a 
1 24.7 (58)   22.9 (16)     
2 12.3 (29)   12.9 (9)     
3 18.7 (44)   21.4 (15)     
4 19.6 (46)   17.1 (12)     
5 24.7 (58)   25.7 (18)     
Missing 3.3 (8)   2.8 (2)     
Level of 
Education%(n) 
    0.05a 
Secondary school 19.2 (46)   31.0 (22)     
College/University 80.8 (193)   69.0 (49)     
Missing  1.6 (4)   1.4 (1)      
  
          
Car ownership % 
(n) 86.6 (207) 239 84.5 (60) 71 0.70
a
 
Missing  1.6 (4)   1.3 (1)     
  
          
Lifestyle variables           
  
          
Smoking status % 
(n) 
  243   72 0.002 
Never smoked  90.9 (221)   76.4 (55)     
Smoked in past  9.1 (22)   23.6 (17)     
Pack years for 
previous smokers 
median, (IQR), 
[range] 
2.3 (1, 7.6),  
[0-46] 22 
          12 (2.8, 15.4), 
          [0-41] 17 0.02 
a
 p values were calculated without missing data  
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Table 2-5 Cont. 
  
Clinical attachment 
level of <6mm  N 
Clinical attachment 
level of ≥6mm on at 
least one tooth 
N p value 
N 243   72     
Registered with 
dentist % (n) 78.7 (188) 239 84.5 (60) 71 0.32a 
Missing 1.6 (4)   1.4 (1)     
  
          
Attendance at 
dentist % (n)   239   71 0.03a 
At least once a 
year 
62.8 (150)   71.8 (51)     
Occasionally 10.0 (24)   5.6 (4)     
Only when in 
pain 
27.2 (65)   22.6 (16)     
Missing % (n) 1.6 (4)   1.4 (1)      
Oral hygiene 
habits% (n)           
Tooth brushing    239   71 0.20a 
Never or less than 
1 per day 2.5 (6)   4.2 (3)     
Once per day 15.5 (37)   25.4 (18)     
Twice per day 69.9 (167)   60.6 (43)     
More than twice 
per day 
12.1 (29)   9.9 (7)     
Missing % (n) 1.6 (4)   1.4 (1)     
Use of floss 50.2 (120) 239 43.7 (31) 71 0.35a 
Missing % (n) 1.6 (4)   1.4 (1)     
Use of interdental 
brushes 6.7 (16) 239 18.3 (13) 71 0.009
a
 
Missing % (n) 1.6 (4)   1.4 (1)     
Toothpick use 7.9 (19) 239 18.3 (13) 71 0.024a 
Missing % (n) 1.6 (4)   1.4 (1)   
 
a
 p values were calculated without missing data 
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2.3.5 Demographic data according to diabetic status 
Table 2-6 describes the demographic characteristics of the 3 groups: NDS, WCD 
(HbA1c≤7.5) and PCD (HbA1c >7.5) (SDS, 2009).  Demographic characteristics were 
analysed for differences across the 3 groups.  There were no differences in age, gender, 
duration of diabetes, socio-economic status, car ownership, alcohol consumption, smoking 
status, registration with a dentist, attendance at a dentist or oral hygiene habits.   
Differences approaching significance were noted in BMI where PCD had slightly higher 
BMI than either of the other 2 groups.  The median was 26.7 compared with 25.2 in both 
other groups (p = 0.02).  In addition, the level of education was lower in the PCD 29.1% 
having received only secondary education compared with 14.7% in the WCD group and 
11.6% in the NDS. 
Table 2-6  Descriptive statistics for non-diabetic subjects and 
diabetic patients 
 Non-
diabetic 
subjects 
N Well 
controlled 
diabetic 
patients  
N Poorly 
controlled 
diabetic 
patients  
N p 
value 
N 112  34  172   
Demographic 
characteristics 
       
Age median, 
(IQR), [Range] 
38  
(29, 44), 
[20-56] 
112 37     
(28,42),   
[22-53] 
34 38              
(27, 44),     
[20-55] 
172 0.59 
 
       
Gender % (n) 
 112  34  172 0.07 
Female 63.4 (71)  55.9 (19)  49.4 (85)   
Male 36.6 (41)  44.1 (15)  50.6 (87)   
 
       
Average % 
HbA1c median, 
(IQR), [Range] 
NA  7.2         
(6.8, 7.3), 
[5.6-7.5] 
34 8.8             
(8.3, 9.7), 
[7.6-13.9] 
172 NA 
a p values were calculated without missing data 
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Table 2-6 cont. 
 Non-
diabetic 
subjects 
N Well 
controlled 
diabetic 
patients  
N Poorly 
controlled 
diabetic 
patients  
N p value 
Most recent % 
HbA1c median, 
(IQR), [Range] 
5.2 
(4.9,5.4), 
[4.3-5.8] 
102 7.1         
(6.8, 7.4), 
[5.1-7.7] 
34 8.7             
(8.1, 9.6), 
[6.1, 13.7] 
172  
Missing % (n) 8.9 (10)  0  0   
 
       
Duration 
(years)Median, 
(IQR), [Range] NA  
21         
(10.9, 26), 
[6-39] 34 
19  
(11.6,25.8), 
[4-41] 172 0.63 
 
       
Socioeconomic 
status        
DEPCAT % (n)  112  34  172 0.3 
1 11.6 (13)  8.8 (3)  7.6 (13)   
2 9.8 (11)  8.8 (3)  10.5 (18)   
3 8.0 (9)  23.5 (8)  12.8 (22)   
4 22.3 (25)  11.8 (4)  23.3 (40)   
5 14.3 (16)  14.7 (5)  18.6 (32)   
6 19.6 (22)  8.8 (3)  11.0 (19)   
7 14.3 (16)  23.5 (8)  16.3 (28)   
SIMD % (n)  109  34  165 0.76a 
1 25.0 (28)  23.5 (8)  22.1 (38)   
2 9.8 (11)  17.6 (6)  12.2 (21)   
3 18.8 (21)  11.8 (4)  20.3 (35)   
4 22.3 (25)  14.7 (5)  16.3 (28)   
5 21.4 (24)  29.4 (10)  25.0 (43)   
Missing 2.7 (3)  2.9 (1)  4.1 (7)   
 
       
Level of Education 
% (n)  110  34  168 0.001a 
Secondary school 11.6 (13)  14.7 (5)  29.1 (50)   
College/University 86.6 (97)  85.3 (29)  68.6 (118)    
Missing 1.8 (2)  0  2.3 (4)   
 
       
Car ownership % 
(n) 82.7 (91) 110 85.3 (29) 34 88.1 (148) 168 0.45a 
Missing  1.8 (2)  0  2.3 (4)   
 
       
a p values were calculated without missing data 
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Table 2-6 Cont.  Lifestyle variables 
 Non-
diabetic 
subjects 
N Well 
controlled 
diabetic 
patients  
N Poorly 
controlled 
diabetic 
patients  
N p value 
Lifestyle variables 
       
Alcohol 
consumption-
units/week 
median, (IQR), 
[Range] 
5.3          
(1, 11),  
[0-40] 112 
4.5      
(1, 9),      
[0-27] 34 
5             
(1, 10),     
[0-40] 172 0.77 
 
       
Smoking status % 
(n)  112  34  172 0.72 
Never smoked  85.7 (96)  88.2 (30)  89 (153)   
Smoked in past  14.3 (16)  11.8 (4)  11 (19)   
Pack years for 
previous smokers 
median, (IQR), 
[Range] 
5.5 
(1.4, 12) 
[0-46] 16 
3.3 
(0.6, 7.4) [1-
8] 4 
4.8 
(1, 14) 
[0-41] 19 0.64 
Body Mass Index 
median, (IQR), 
[Range] 
25.2      
(22.6, 28.9) 
[18.4-49.2] 112 
25.2 
(22.9, 28.5), 
[19.1-36.7] 34 
26.7      
(24.3, 31.0), 
[19.6-43.2] 172 0.02 
a p values were calculated without missing data 
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Table 2-6 cont. Dental variables 
 Non-
diabetic 
subjects 
N Well 
controlled 
diabetic 
patients  
N Poorly 
controlled 
diabetic 
patients  
N p value 
N 112  34  172   
Dental 
Variables        
Registered 
with dentist 
% (n) 74.1 (83) 110 70.6 (24) 34 82.6 (142) 168 0.07a 
Missing  1.8 (2)  0  2.3 (4)   
 
       
Attendance at 
dentist % (n)  110  34  168 0.15a 
At least once 
a year 62.5 (70)  55.9 (19)  65.7 (113)   
Occasionally 6.3 (7)  8.8 (3)  10.5 (18)   
Only when in 
pain 29.4 (33)  35.3 (12)  21.5 (37)   
Missing  1.8 (2)  0  2.3 (4)   
 
       
Oral hygiene 
habits % (n)        
Tooth 
brushing  
 110  34  168 0.1a 
Never or less 
than 1 per 
day 
1.8 (2)  2.9 (1)  3.5 (6)   
Once per day 10.7 (12)  11.8 (4)  22.7 (39)   
Twice per 
day 
71.4 (80)  70.6 (24)  62.8 (108)   
More than 
twice per day 14.3 (16)  14.7 (5)  8.7 (15)   
Missing 1.8 (2)  0  2.3 (4)   
 
       
Use of floss % 
(n) 51.8 (58) 110 47.1 (16) 34 45.9 (79) 168 0.63a 
Missing  1.8 (2)  0  2.3 (4)   
Use of 
interdental 
brushes % 
(n) 
10.7 (12) 110 8.8 (3) 34 8.1 (14) 168 0.75a 
Missing 1.8 (2)  0  2.3 (4)   
Use of 
toothpicks % 
(n) 8.9 (10) 110 17.6 (6) 34 9.3 (16) 168 0.31a 
Missing 1.8 (2)  0  2.3 (4)   
a p values were calculated without missing data 
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2.3.6 Prevalence, severity and extent of periodontitis in Type 1 
diabetic subjects and poorly controlled Type 1 diabetic 
subjects 
2.3.6.1 Prevalence of Periodontitis: Clinical Attachment Loss 
Table 2-7 presents the prevalence of severe periodontitis and moderate combined with 
severe periodontitis for NDS, T1DM and the PCD.   
Figure 2-2 shows the prevalence of SP as defined by one site with CAL≥ 6mm for the 
three groups (NDS 20.5%, T1DM 24.1%, PCD 27.2, p = 0.49, 0.26).)  Clinical attachment 
level greater than or equal to 6mm at at least 4 sites, was higher in both the T1DM (10.8%) 
group and the PCD (11.8%) group compared with the NDS (5.4%).  The difference was 
not statistically significant (p = 0.14, p = 0.12) due to the small number of cases detected in 
this study (Figure 2-3).   
Figure 2-4 shows the prevalence of moderate combined with severe periodontitis was 
higher in the T1DM group (79.8%) and PCD (79.2%) compared with the NDS (61.6%) 
(p=0.001, p=0.002 respectively). 
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Table 2-7  Prevalence and severity of periodontitis in non-diabetic 
subjects compared with type 1 diabetic and poorly 
controlled patients 
  NDS All T1DM 
patients 
PCD p 
valuea 
p  
valueb 
N 112 203 169   
  
     
Missing teeth median, 
(IQR), [range] 
4 (3, 6) 
[0-17] 
4 (3, 6) 
[0-16] 
4 (3, 6) 
[0-16] 0.47 0.56 
  
     
Severe periodontitis      
Clinical attachment 
level ≥ 6mm on at least 
1 tooth % (n) (95% 
CI) 
20.5 (23) 
(13.5, 29.2) 
24.1 (49)  
(18.4, 30.6) 
27.2 (46) 
(18.1, 35.0) 0.49 0.26 
  
     
Clinical attachment 
level ≥ 6mm at at least 
4 sites % (n) (95% CI) 
5.4 (6) 
(1.9, 11.3) 
10.8 (22) 
(6.9, 15.9) 
11.8 (20) 
(7.7, 21.1) 0.14 0.12 
  
     
Clinical probing depth 
≥ 6mm on at least 1 
tooth % (n) (95% CI) 
21.4 (24) 
(14.2, 30.2) 
25.6 (52) 
(19.8, 32.2) 
27.8 (47) 
(18.9, 35.9) 0.49 0.26 
  
     
Clinical probing depth 
≥ 6mm at at least 4 
sites % (n) (95% CI) 
3.6 (4) 
(0.9, 8.9) 
10.8 (22) 
(6.9, 15.9) 
11.2 (19) 
(6.3, 19.0) 0.1 0.1 
 
     
Moderate and severe 
periodontitis Clinical 
attachment level  ≥ 
4mm on at least 1 
tooth % (n) (95% CI) 
61.6 (69) 
(51.9, 70.6) 
79.8 (162) 
(73.6, 85.1) 
79.3 (134) 
(69.8, 85.8) 
0.001 0.002 
  
          
Clinical probing depth 
≥ 4mm on at least 1 
tooth % (n) (95% CI) 
84.8 (95) 
(76.8, 90.9) 
90.1 (183) 
(85.1, 93.9) 
91.1 (154) 
(83.1, 95.0) 
0.2 0.13 
 
     
a
 NDS vs T1DM  b NDS vs PCD 
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Figure 2-2  Prevalence of severe periodontitis (1 tooth ≥ 6mm CAL) 
for NDS, T1DM and PCD 
 
 
Figure 2-3  Prevalence of severe periodontitis ( 4 sites ≥ 6mm CAL) 
between NDS, T1DM and PCD 
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Figure 2-4  Prevalence of both moderate and severe periodontitis 
combined (minimum 1 site ≥ 4 mm CAL) between NDS, 
T1DM and PCD 
2.3.6.2 Prevalence of Periodontitis: Clinical Probing Depth 
There were no significant differences in the prevalence of severe periodontitis or moderate 
combined with severe periodontitis as detected by clinical probing depths, between any of 
the 3 groups (Table 2-7).  The prevalence of severe periodontal disease as defined by 4 
sites ≥6mm CPD was three times higher in the PCD compared with the NDS (NDS 3.6%, 
T1DM 10.8%, PCD 11.2% p = 0.1, p = 0.1) (Figure 2-6).    
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Figure 2-5  Prevalence of Severe Periodontitis (4 sites ≥ 6mm CPD) 
between NDS, T1DM and PCD 
2.3.6.3 Severity and Extent of Periodontal Disease 
The extent of periodontitis was calculated using the median number of sites affected by 
severe periodontitis and moderate periodontitis combined with severe periodontitis.  There 
were no differences in the extent of severe periodontitis as defined by the number of sites 
with ≥6mm CAL due to the small number of sites affected by this level of disease (median 
number of sites [range] CAL≥ 6 NDS= 0 [0-29], T1DM = 0 [0-69], PCD = 0 [0-69], p = 
0.39, p = 0.163).  There were also no differences in the extent of severe periodontitis as 
defined by the number of sites with CPD ≥6mm (median number of sites [range] CPD ≥ 6 
NDS= 0 [0-14], T1DM = 0 [0-37], PCD = 0 [0-37], p = 0.24, p = 0.124) (Table 2-8).   
The extent of moderate combined with severe periodontal disease (median number of sites 
with clinical attachment loss ≥ 4mm) was more widespread among T1DM and PCD 
compared with NDS (median number of affected sites NDS = 1, T1DM = 3, PCD = 4 (p = 
0.0003, p = 0.0004)).  The extent of current moderate and severe periodontitis as seen in 
the number of sites affected by CPD ≥ 4mm was significantly higher for PCD and T1DM 
compared with NDS (median number of sites ≥ 4mm CPD NDS = 5, T1DM = 7, PCD = 8 
(p = 0.005, p=0.001)) (Table 2-8) (Figures 2-6 & 2-7).  
Gingivitis measured using full mouth bleeding on probing scores was significantly higher 
in the PCD group compared with T1DM and the NDS.  The median percentage bleeding 
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on probing for NDS was 36% compared with 46% for T1DM and 54% for PCD (p ≤ 
0.001).  Plaque scores were also significantly higher in both the PCD and the T1DM 
groups (NDS 63%, T1DM 73%, PCD 75% p ≤ 0.001) (Table 2-8).   
Combined measures of severity and extent and severity of periodontitis are represented by 
mean full mouth CAL and CPD (Fig 2-8 & 2-9).  Figure 2-8shows that NDS had lower 
mean full mouth clinical attachment level (1.53mm) compared with T1DM (1.85mm) and 
PCD (1.86mm) (p ≤ 0.001, p ≤ 0.001) respectively.  Figure 2-9 shows that the mean 
clinical probing depths were all significantly greater in the T1DM and PCD groups. 
2.17mm compared with 2.29mm in the T1DM and 2.31mm in the PCD group (p = 0.01, 
p≤0.005) (Table 2-8). 
2.3.7 Multivariable analysis 
The results of the multivariable analysis are shown in Table 2-9.  Odds ratios were 
calculated for comparisons between the NDS and the whole T1DM group.  The unadjusted 
odds ratio was 1.26 (0.69, 2.33).  The fully adjusted model, including BMI, attending a 
dentist, SIMD, previous smoking experience, education, age and gender gave an overall 
odds ratio of 1.19 [0.62, 2.27] (p = 0.6).  Odds ratios were also calculated comparing NDS 
with the PCD.  The unadjusted model gave an odds ratio of 1.5 [0.72, 3.11] (p = 0.28).  
The fully adjusted model including BMI, attending a dentist, SIMD, previous smoking 
experience, age and gender gave an odds ratio for the poorly controlled group of 1.43 [0.74 
to 2.75] (p = 0.29).  Restricting the analysis to those who had never smoked increased the 
fully adjusted OR [95% CI] comparing T1DM and PCD with NDS to 1.35 [0.66 to 2.8] (p 
= 0.41) and 1.58 [0.75 to 3.33] (p = 0.23) respectively. 
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Table 2-8  Extent and severity of periodontitis in non-diabetic 
subjects compared with T1DM and poorly controlled 
diabetic subjects 
  
NDS T1DM PCD  p value p value 
N 
112 203 169   
Number of sites 
clinical attachment 
level ≥ 4mm median, 
(IQR), [range] 
1(0, 6), 
[0-76] 
3(1, 11), 
[0-91] 
4(1, 11.5), 
[0-91] 0.0003 0.0004 
Number of sites 
clinical attachment 
level ≥ 6mm median, 
(IQR), [range] 
0(0, 0), 
[0-29] 
0(0, 0), 
[0-69] 
0(0, 1), 
[0-69] 0.39 0.163 
  
     
Number of sites 
clinical probing 
depth ≥ 4mm median, 
(IQR), [range] 
5(2, 10.5), 
[0-45] 
7(3, 15), 
[0-84] 
8(1, 11.5), 
[0-91] 0.005 0.001 
Number of sites 
clinical probing 
depth ≥ 6mm median 
(IQR), [range] 
0, (0, 0), 
[0-14] 
0 (0, 1), [0-
37] 
0 (0, 1), 
[0-37] 0.24 0.124 
Mean clinical 
attachment level 
(mm), (95% CI)  1.53 1.85 1.86 <0.001 <0.001 
Mean clinical 
probing depth (mm), 
(95% CI) 
2.17, 
(2.11, 2.23) 
2.29, 
(2.23, 2.35) 
2.31 
(2.24, 2.38) 0.01 <0.005 
Bleeding on probing 
(%) median, (IQR), 
[range] 
36 (26, 52),  
[4-80] 
46 (33, 61)    
[7-100] 
49 (36, 64)             
[7-100] <0.001 <0.001 
Plaque score (%) 
median, (IQR), 
[range] 
63(52, 75)            
[14-99] 
73 (63, 84)            
[7-99] 
75 (65, 85)             
[7-99] <0.001 <0.001 
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Figure 2-6  Extent of moderate periodontitis between NDS, T1DM and 
PCD (Median number of sites affected ≥4mm CAL) 
 
Figure 2-7  Extent of moderate periodontitis between NDS, T1DM and 
PCD (Median number of sites affected ≥4mm CPD) 
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Figure 2-8 Mean full mouth CAL by diabetic status 
 
Figure 2-9 Mean clinical probing depths by diabetic status 
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Table 2-9 Prevalence, unadjusted and adjusted Odds Ratios and 95% confidence intervals for severe periodontitis 
(A minimum of one tooth with CAL ≥6mm) in type 1 diabetic patients, and poorly controlled patients 
versus non-diabetic subjects 
 
 
Severe 
periodontitis % 
(n) 
Unadjusted 
OR [95% 
CI]* 
Adjusted OR 
[95% CI] with 
education** 
Adjusted OR 
[95% CI] with 
SIMD** 
Adjusted OR 
[95% CI]***  
Adjusted OR 
[95% CI]*** 
Type 1 diabetic 
Never smokers 
only  
Adjusted OR 
[95% CI]*** 
Poorly 
controlled 
Never smokers  
      (n=263) (n=234) 
Non-diabetic 
subjects 
20.5 (23/112) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)  
Type 1 diabetic 
patients 24.1 (49/203) 
1.26  
[0.69, 2.33] 
1.21 
 [0.64, 2.29] 
1.23 
 [0.65, 2.32] 
1.19 
[0.62, 2.27] 
1.35  
[0.66 to 2.8]  
p-value  0.45 0.57 0.53 0.6 0.41  
        
Non-diabetic 
subjects 20.5 (23/112) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref)  1.00 (ref) 
Poorly 
controlled 
patients 
27.2 (46/169) 
1.50  
[0.72, 3.11] 
1.61 
 [0.78, 3.34] 
1.46 
 [0.72, 2.99] 
1.43 
[0.74 to 2.75]  
1.58  
[0.75 to 3.33] 
        
p-value  0.28 0.20 0.29 0.29  0.23 
        
* Patient age and gender in unadjusted models. ** BMI (weight/height squared), attending a dentist (y/n), previous smoking experience (y/n), 
age and gender.*** Fully Adjusted for BMI, attending a dentist, SIMD, previous smoking experience, education, age and gender.  
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2.4 Discussion 
2.4.1 Calibration 
Accurate recording of periodontal indices is essential to ensure the reliability of the 
clinical data.  Training and calibration of examiners was carried out according to 
standard protocols with external training by an independent periodontal researcher as 
described in the Materials and Methods section.  The results of the training and 
calibration are presented within this thesis.  Overall we can be confident in the 
reproducibility of the clinical examiner and the reliability of the clinical data for the 
gingival margin position, CPD, CAL and BOP with all kappa scores showing 
moderate to very good agreement and with 98.9% of all CPD and CAL measurements 
being within 1mm. 
Inter-examiner agreement for BOP was initially unacceptably low (ĸ= 0.15) although 
there was perfect agreement in 62.4% of cases (Table 2-2).  The Kappa score is low, 
in part, because there are only two options, bleeding or no bleeding.  The probability 
of getting agreement by chance is therefore 50%.  High kappa scores therefore require 
that agreement is very high relative to the probability of agreement by chance, that is, 
well in excess of 50%.  Clinically the relatively low level of agreement in bleeding on 
probing could be due to the possibility that trauma caused by the first examiner may 
not cause initial bleeding but may make bleeding more likely when the gingival or 
periodontal pocket is traumatised for a second time.  In addition, variation in the 
position and force used by examiners could lead to differences in the tendency of the 
pocket to bleed.  Since, logistically, there is no other way for calibration to be carried 
out this was considered an acceptable explanation.  The kappa score for BOP for the 
single examiner showed a moderate level of agreement throughout the study (ĸ 
=0.48).   
The steps necessary to improve the intra-examiner scores further are likely to make 
the data less valid; for example only recording visible and accessible sites or similar 
strategies.  Some studies have, for example, used only buccal sites in order to improve 
reproducibility.  This can hardly be said to be representative of the clinical situation 
where periodontal destruction can occur anywhere in the mouth and is, in fact, more 
common on the lingual and palatal aspects of teeth (Kingman et al., 2002). 
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2.4.2 Comparison with the relevant literature 
The conclusion of most narrative reviews published over the last few decades has 
been that there is an association between T1DM and periodontal disease.  More recent 
systematic evaluation of the literature has called this assumption into question with 
one review in 2006 reporting that the extent of periodontal disease was similar in 
T1DM and NDS (Khader et al., 2006).  A meta-analysis by Chávarry et al. (2009) 
concluded that there was no statistical difference in the severity of periodontitis in 
type 1 diabetic patients compared with controlled subjects and called for further 
research into this area. 
The review by Chávarry and co-workers (2009) specifically criticised previous studies 
for a number of methodological inadequacies including: lack of a power calculation; 
not confirming the diabetic status of diabetic patients and controls; inadequate training 
and calibration of examiners; not reporting and adjusting for confounders such as 
smoking; inappropriate statistical analysis; the source of the control group; not 
blinding the examiners; and poor response rates.  Chávarry reported that of the 17 
papers investigating a link between T1DM the majority had significant omissions in 
their study design and reporting.   
The aim of the study reported in this thesis was to focus on the effect of T1DM on the 
oral tissues in a population of white European non-smoking subjects who were of 
similar age and from the same geographic area, thereby reducing demographic, socio-
economic and genetic variation.  This study confirmed that the prevalence, severity 
and extent of periodontal disease is increased in T1DM.  This was the first study in 
type 1 diabetic adults to confirm this association in the absence of recent or current 
smoking.   
Data synthesis and meta-analysis on the studies reporting clinical probing depths 
between T1DM compared with NDS showed that the average difference in CPD was 
0.11mm (p=0.137) (Chávarry  et al., 2009).  The magnitude of difference was similar 
in the study reported in this thesis with a mean difference of 0.12mm between NDS 
and T1DM and a mean difference of 0.17mm between NDS and PCD.  These 
differences were not significant in the meta-analysis but were highly statistically 
significant in our study (p = 0.008, p < 0.001 respectively) (Chávarry et al., 2009).  
The difference between the study presented here and the meta-analysis could be due 
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to differences in the spread of the data and heterogeneity in the studies included in the 
meta-analysis. 
Studies reporting clinical attachment loss showed a mean difference in CAL of 0.26 
(p = 0.054).  In this study the mean difference was 0.32mm for NDS compared with 
T1DM (p < 0.001) and 0.38mm for NDS compared with PCD (p <0.001).  Mean CPD 
or CAL levels give a good indicator of overall damage to the periodontium and can be 
used in populations where levels of disease are very low such as adolescent 
populations (Lalla et al., 2006, 2007).  They do not however give any information 
about the prevalence of current or historical periodontal disease at a patient level or 
indicate the need for treatment.  Many sites of 4mm CAL or CPD would lead to a 
higher mean figure than where only one or two sites are severely affected by 
periodontitis in an otherwise healthy mouth.  In addition, it is not possible to draw 
conclusions about the extent of periodontal disease between the two groups.  In the 
meta-analysis by Khader et al., (2006) it was concluded that there was an increase in 
severity but that there was no difference in extent of periodontal disease.  We have 
shown that there is an increase in the level of periodontitis in T1DM and PCD 
compared with NDS using the following parameters: prevalence of moderate 
combined with severe periodontitis, measured using CAL; severity measured by mean 
CAL and CPD; and extent measured by the median number of sites with CAL and 
CPD of ≥4mm. 
Many studies have presented their results as mean CAL or CPD (Guthmiller et al., 
2001; Alpagot et al., 2001; Aren et al., 2003; Yucekal-Tuncer et al., 2003).  A few 
studies report the extent of disease as the percentage of sites with specified levels of 
disease but this is not common.  Khader and co-workers found only three studies 
reporting this data in their systematic review (Khader et al., 2006).  Some studies have 
presented the prevalence of different levels of periodontal disease (Rylander et al., 
1986; Sandholm et al., 1989; Hugoson et al., 1989; Thorstensson et al., 1993; 1995); 
however, odds ratios are not commonly used (Haber et al.,1993).  This thesis presents 
a full picture of the prevalence, extent and severity of periodontal disease in T1DM.  
2.4.3 Recruitment   
Recruitment was much more difficult than expected and required that participation 
was sought from a number of hospitals spread throughout the city.  Extending 
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recruitment to other sites increased the time commitments for the dental research 
nurse and required the Principal Investigator and another part time research nurse to 
become involved in recruitment.  The identification of clinicians at the different sites 
able to become involved, the burden of bureaucracy and the time taken for 
amendments and extensions to the ethical approval meant that this process took 
months rather than weeks.  Other measures taken to increase recruitment were to 
increase the age limit to 55 years; using the buddy method to recruit controls and 
placing an advertisement for the study in the Metro newspaper.  
It is possible that using a number of methods of recruitment of controls increased the 
heterogeneity of the control group reducing the effect of participation bias from any 
one of the various methods employed.  As a result of the reduced rate of recruitment 
the project was extended by six months.  This has implications for the cost of running 
studies involving human recruitment.  
A pilot study was conducted prior to the start of recruitment but this only assessed the 
number of patients eligible for recruitment and not the number who would agree to 
participate.  We were recruiting in deprived areas of the West of Scotland and found 
the drop-out rate, between recruitment and participation, by DEPCAT, was different 
across the whole social spectrum.  The higher drop-out rate among more affluent 
participants could have been due to work commitments.  The slightly higher number 
of subjects who dropped out from the lowest socio-economic group fits with the 
common pattern where study participation is generally lower in more deprived groups 
(Conway et al., 2010).  There was no difference across the socio-economic spectrum 
using the preferred current measure of deprivation (SIMD) between those who 
participated and those who did not.  Therefore it is unlikely that the differences 
detected using DEPCAT would have changed the results. 
2.4.4 Sample size 
The target sample size was predetermined by a power calculation.  Unfortunately the 
target was not reached despite the efforts described in the following section.  Due to 
relatively poor glycaemic control among the diabetic patients recruited we had more 
PCD than required (see section 2.4.6).  The lack of WCD reflects the average 
metabolic control of the population from which the subjects were drawn (HbA1c 
around 8.7 for the age-group of interest; (SDS, 2009).  The fact that statistically 
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significant differences in extent and severity of periodontitis were found, without 
reaching the sample size predicted by our power calculation, indicates that a real 
difference exists.  It was disappointing not to achieve our initial target.  The results of 
the multivariable analysis indicate that there may be an increased risk of severe 
periodontitis in non-smoking type 1 diabetic patients and this is supported by other 
secondary measures of periodontal disease.  However we cannot reach firm 
conclusions about the odds ratios of severe periodontitis based on the available data.  
Given the high level of disease in both groups it is unlikely that the differences would 
have been statistically significant even if we had achieved our recruitment target.  
2.4.4.1 Control group 
A number of previous studies used inappropriate control groups such as siblings or 
patients attending a specialist paediatric dentistry department (Cianciola et al., 1982; 
Leeper et al., 1985).  We used three sources of control subjects as described in 
sections 2.2.2.1 and 2.4.3.  Some researchers have criticised using hospital based 
controls because it has been suggested that they may not be true healthy controls.  
Nonetheless the use of hospital based controls is encouraged in order to ensure that 
the factors other than the diseases under investigation are similar in both study groups.  
We recruited from the drop-in physiotherapy clinics in the same hospitals in an 
attempt to recruit patients from the same geographic and socioeconomic background.  
Subjects recruited were attending these clinics with minor physical injuries and were 
otherwise fit and well.  No patients with significant impairment issues or chronic 
arthritic conditions were recruited.  The use of the buddy system was intended to 
identify a group of controls of the same gender and similar age as the T1DM patients 
who recommended them.  Finally the use of the advertisement in the national 
newspaper was only moderately successful.  The criticism of advertising is that there 
is the potential for bias introduced by self-selection.  The Strengthening the reporting 
of observational studies in epidemiology guidelines (STROBE) suggest that controls 
with other diseases may have advantages over population-based controls for hospital-
based cases (Von Elm et al., 2007).  The guidelines state that they better reflect the 
catchment population of a hospital and have greater comparability of recall and ease 
of recruitment.  It is however also acknowledged that they can present problems if the 
exposure of interest affects the risk of developing or being hospitalized for the control 
condition(s).  To remedy this problem the authors suggest that a mixture of the best 
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defensible control populations is used (Von Elm et al., 2007).  In using different 
sources for our controls we have hopefully avoided the potential bias introduced by 
any one of the three methods used.  It could be argued that the generalizability has 
been improved by the inclusion of different types of control subject although it is not 
possible to quantify this effect.  In our experience the most successful method was the 
hospital out-patient recruitment, confirming the recommendations of the STROBE 
guidelines. 
2.4.4.2 Confirmation of non-diabetic status of control subjects 
Studies that did not confirm the non-diabetic status of the control group could have 
inadvertently recruited subjects with undiagnosed diabetes into the “healthy” control 
group.  Diabetes mellitus affects 4.4% of the population and it is estimated that there 
are another 1.1 million patients who are currently undiagnosed in the United Kingdom 
representing around 2% of the adult population (Diabetes UK, 2010).  In a study 
aiming to recruit 136 healthy adult controls it is theoretically possible that 2 or 3 
subjects could be suffering from undiagnosed type 2 diabetes.  If these few control 
subjects had severe periodontitis as a result of having undiagnosed type 2 diabetes 
then this could affect the results significantly.  We screened our control subjects using 
HbA1c as a marker and excluded one middle aged female with severe periodontitis 
because she was borderline for type 2 diabetes.   
2.4.4.3 Controlling for other confounders 
In our study we attempted to control for age, gender, race, systemic health and 
smoking by careful phenotyping, and our exclusion criteria.  The mean ages for the 
three groups were similar.  There is a near linear relationship between periodontal 
disease and age and so it is critical that there are no significant differences in age 
between T1DM and the NDS (Morris et al., 2001).  Most studies have shown that 
there is a higher prevalence of periodontal disease in men compared with women.  
There were more males in the PCD but this was adjusted for in the careful statistical 
modelling.  Patients with medical conditions or taking drugs that are known to affect 
oral and periodontal health were excluded from participation.  In the multivariable 
analysis age, gender, pack years, BMI, attendance at a dentist, deprivation and 
education were adjusted for in the analysis.  It is most interesting to note the effect of 
a multivariable analysis whereby similar prevalence rates (NDS 20.5%, T1DM 
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24.1%, PCD 27.2%) can mask differences that are only revealed by multivariable 
analysis (OR 1.58 p = 0.23).  The aim of both the inclusion/exclusion criteria and the 
multivariable analysis was to focus on the effect of diabetes on the periodontium once 
all other confounders had been accounted for.   
2.4.4.4 Comparison between periodontal data from the UK and the 
control group 
The prevalence of chronic periodontitis in the study group was significantly higher 
than was expected based on available population data (Morris et al., 2001).  While we 
did see a high prevalence of periodontal disease in our T1DM we also saw a 
correspondingly high prevalence in the NDS.  In the multi-variable model the odds 
ratio in never smoking poorly controlled diabetic adults for having 1 site with ≥6mm 
of CAL was 1.58.  Because we did not meet our recruitment target and because the 
level of disease in the control group was higher than the estimate used for the power 
calculation this was not statistically significant (p = 0.22)   
Robinson (1996), in a survey of adult men between the ages of 18 and 65 years 
including smokers reported that CAL and CPD of ≥ 4mm affected around a third 
(28.5%: 31.9%) of all of the group.  The prevalence of moderate combined with 
severe periodontitis (CAL and CPD ≥ 4mm) in the NDS in our study was 44% higher 
for CAL and more than double for CPD (41.1%, 63.4%).  The study by Robinson was 
carried out in the general population and would have included smokers.  It was 
therefore surprising to see such high levels of moderate disease in our control group.   
The high level of moderate periodontitis in the control population reflects the 
response to local aetiological factors i.e. plaque exposure where oral hygiene is 
universally poor.  The additional effect of T1DM where oral hygiene is poor is harder 
to calculate in this population.  This effect was seen in a recent study in Pomerania 
where the extent of periodontal disease was high in both groups 24.3% of sites in the 
diabetic patients had CAL ≥4mm while the control group had 19% of all sites 
affected.  No significant difference in extent of disease was found between the groups 
(Kaur et al., 2009).  
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2.4.4.5 Adult dental health Survey 1998 
In the Scottish population of the Adult Dental Health Survey (ADH) (Morris, 2001), 
the level of SP in the general population was 8% across the whole age group from 16 
years upwards.  This study population included current and former smokers.  If 
anything we would have expected the NDS would have less disease than that recorded 
in the ADH survey.  The prevalence of SP in the NDS in the current study was 20.5%.  
There are a number of reasons why this level of disease may well be representative of 
the local population.    
The ADH survey did not stipulate a minimum number of teeth for inclusion and as a 
result included both fully dentate and partially dentate in the periodontal 
examinations.  The mean number of teeth was lower in the ADH study compared with 
our control group (23.8 versus 27.2) and therefore there were fewer teeth on which to 
measure any disease present.  In addition to this the level of deprivation appears to 
have been higher in our sample compared with the ADH survey.  There was an almost 
fourfold increase in the proportion of subjects from the most deprived areas included 
in the current study (DEPCAT 6 and 7: 30.2% versus 8.0% in ADH study).  This over 
representation of DEPCATs 6 and 7 is more representative of Glasgow and Paisley 
where the study took place.  It has been shown that low socioeconomic status and low 
educational attainment are associated with poor glycaemic control as well as higher 
levels of oral disease (Mühlhauser et al., 1998; Larsson et al., 1999; Ross et al., 2001; 
Bower et al., 2007). 
The ADH study used a partial mouth recording method and this may account for part 
of the difference noted.  It has been shown that partial mouth recording while 
acceptable and indeed more practical in large population studies does lead to 
underreporting of periodontal disease levels (Susin et al., 2005; Beck et al., 2006; 
Kingman et al., 2008).  Susin (2005) showed that the level of under reporting 
increased as the CAL increased.  With CAL ≥ 6mm a number of different partial 
mouth recording methods were evaluated.  Some methods of partial mouth recording 
could underestimate the true prevalence by up to 76% (12-76%) (Table 2-10).  The 
largest effect was seen where some index teeth methods resulted in an 
underestimation when only mesial and buccal sites were examined.  The study by 
Beck (2006) showed that partial mouth recording had a marked impact on 
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underreporting of CAL ≥ 4mm and CAL ≥ 6mm (6-56% and 11.3-70.8% 
respectively).   
The ADH periodontal examination involved none of the methods described above.  It 
involved full mouth recordings at only two sites per tooth using the buccal sites in the 
upper jaw and the lingual sites in the lower jaw; a total of 56 sites were examined.  
Two methods reported by Beck examined 42 randomly selected sites and 
underestimated disease in 17.5% (CAL ≥ 4mm) and 28.2% (CAL ≥ 6mm) of cases.  It 
is reasonable to assume that an underestimation of prevalence of in the region of 20% 
took place in the ADH survey because of the partial mouth recording that took place.  
Severity as measured by mean CAL and mean CPD is not seriously affected by partial 
mouth recording techniques (Beck et al., 2006).  In another study, partial mouth 
recording resulted in an underestimation of the prevalence of periodontitis as defined 
as CAL ≥2 mm and CAL ≥3 mm by 22% and 36% respectively.  The extent of CAL 
was less affected by partial mouth recording, in that the percentage of sites with no 
sign of early attachment loss was underestimated by up to only 11%.  However, the 
percentage of sites with CAL ≥1 mm and ≥2 mm were overestimated by 11% and, 7% 
respectively (Eaton, 2001).   
Table 2-10  Underestimation of true prevalence using partial 
mouth recording techniques.  Redrawn from Susin 
(2005) 
 
Full 
mouth 
   Random 
half 
mouth 
   
CAL mm ≥ 6mm 6 Sites* MB-B MB-B-
DB 
MB-B-
DL 
6 Sites MB-B MB-B-
DB 
MB-B-
DL 
 
43.6 32.5 36.6 38.9 36.2 24.7 28.3 31.4 
% Underestimation - 34% 19% 12% 20% 76% 54% 39% 
 
The level of untreated periodontal disease in the control population may also reflect 
the system of remuneration for periodontal treatment that exists under the National 
Health Service in Scotland where many general dental practitioners do not feel that 
such treatment is adequately funded.  Subjects not registered with a dentist were no 
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more likely to have CAL of ≥6mm than those who were (24.2% (n=15/62) versus 
24.2% (n=60/248) respectively; p =1.0) (Table 2-5). 
A concern may be that there was the potential for participation bias in the NDS 
sample.  It is possible that patients who were worried about their teeth and/or had 
bleeding gums may have been more likely to have agreed to attend the Dental School 
for a thorough examination as part of a research study.  It is possible that those study 
participants who responded to the advert had concerns about their oral health.  
Although no incentives were given, participants were informed that there was the 
possibility of remedial dental treatment if disease was found during the examination.  
Given that about a quarter of all non-diabetic subjects reported that they had difficulty 
paying for dental treatment this is another feasible explanation.  However, we will 
show in chapter 6 of this thesis that the impact of dental disease (OHIP-14) was no 
worse in the NDS than in the ADH survey for the general population.   
2.4.5 Glycaemic control. 
During recruitment no account was taken of HbA1c and all willing diabetic 
participants were recruited regardless of diabetic control.  The glycaemic control of 
the study participants therefore reflects the level of control among diabetic patients in 
the respective diabetic units.  The diabetic subjects were split into WCD and PCD 
groups based on the target suggested by the Scottish Diabetes Survey of 7.5% (SDS, 
2009).  This is a conservative cut off for good glycaemic control that is also 
recommended by the current National Institute for Health and Clinical Excellence 
(NICE) guidelines (NICE CG15, 2004, 2010).  NICE states that blood glucose control 
should be optimised towards attaining DCCT-harmonised HbA1c targets for 
prevention of microvascular disease (less than 7.5%).  In those at increased risk of 
arterial disease an HbA1c of less than or equal to 6.5% is recommended (NICE, 
2004). 
The risk of serious hypoglycaemia is increased as the target HbA1c is lowered and 
this is one reason why patients rarely achieve such low levels.  There is currently 
significant debate about the target that should be set for HbA1c.  The American 
Diabetes Association (ADA) guidance suggests an HbA1c goal of <7%, while other 
diabetes organizations, such as the American Association of Clinical Endocrinologists 
(AACE) and the International Diabetes Federation (IDF) have have set their HbA1c 
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targets at <6.5% (AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. 
2007; ADA, 2011).  If we had used the cut-off of 6.5% for adequate glycaemic 
control then we would have only included seven patients in the WCD.  Diabetic 
patients with an HbA1c of 6.6% would have been classified as poorly controlled.  
This figure is not only unrealistically low but would have diluted any effect of 
increased HbA1c on the prevalence of oral complications. The evidence suggests that 
a target HbA1c of 7.5% or even slightly higher is sufficient to reduce the risk of 
microvascular complications (DCCTRG, 1993).  Little discernible benefit is derived 
in terms of diabetic microvascular disease from attempting to reduce HbA1c below 
this level.  The main advantage is gained `in the reduction of macrovascular disease as 
HbA1c is reduced toward normal levels.  However, this target has recently been 
brought into question in type 2 diabetic patients due to an increase in all causes of 
mortality in the intensive glucose control arm of a large trial (ACCORD Study Group, 
2008).  The proposed mechanism of periodontal destruction is thought to be similar to 
the pathogenesis of microvascular disease and so a target of 7.5% seems reasonable 
for pathological as well as practical reasons (SIGN, 2010).   
The majority of study patients fell into the PCD group (83%) (Table2-6).  It has been 
reported that complications are associated with high levels of deprivation in T1DM 
(Bachmann et al., 2003).  However, the Scottish Diabetes Survey (2009) showed that 
T1DM patients generally show poor metabolic control (mean HbA1c over the 
previous 15 months in patients >20 years in Greater Glasgow and Clyde was similar 
to that recorded in this diabetic group at around 8.7%).  The proportion of patients 
achieving an HbA1c of 7.5% or less in the greater Glasgow and Clyde area was only 
22.1%.  These figures are similar to the level of glycaemic control in England where 
less than 28.6% of patients met the same target (National Diabetes Audit 2008-2009). 
2.4.5.1 Glycaemic control and periodontal disease 
Clinical studies have shown that an HbA1c of 7.5% or less is required to reduce the 
incidence of microvascular diabetic complications (DCCTRG, 1996; Stratton, 2000).  
As this target is not being routinely met by T1DM patients in the West of Scotland 
then the prevalence of diabetic complications, oral and general, will be higher within 
this population.  If poor glycaemic control is independently related to periodontal 
disease then we can hypothesise that the burden of dental care will be high among 
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T1DM subjects in the West of Scotland.  A number of studies have shown that in 
diabetic patients the severity of gingivitis is related to glycaemic control (Gislen et al., 
1980; Kjellman et al., 1970a,b; Gusberti et al., 1983;Harrisson et al., 1987,  Seppala et 
al., 1993, 1994; Firalti et al., 1996).  Seppala (1993, 1994) in a longitudinal study in 
T1DM adults reported that patients with poorly controlled diabetes mellitus had 
higher clinical probing depths, gingivitis scores, clinical attachment loss, recession 
and radiographic signs of approximal bone loss than controls.  Willerhausen (1991) in 
a European study of 42 T1DM compared with 118 healthy controls reported that there 
was a significant correlation between HbA1c and loss of clinical attachment as well as 
between insulin dose and the gingival condition. 
Discussion with diabetic colleagues revealed that they were unsurprised by the 
proportion of patients failing to meet the targets set and that this is an ongoing 
problem for diabetologists.  While other organisations are recommending still lower 
target levels for HbA1c it appears that moderate and poor HbA1C levels remain high 
in the United Kingdom.  The extent and severity of periodontitis in type 1 diabetes 
reported in this study indicates that a large proportion of diabetic adults in the United 
Kingdom is at risk of developing periodontitis as a result of having poor glycaemic 
control.   
2.4.6 Smoking  
Because of the effect of smoking on periodontal health all participants were never 
smokers or had not smoked in the last five years.  The hospitals were primarily 
located in deprived areas of Glasgow.  In 2008 it was reported that in the most 
deprived groups in Scotland smoking prevalence was 45% compared with only 11% 
in the least deprived (Scottish Household Survey, 2009).  The SDS 2009 reported that 
24.6% of all T1DM in Scotland are current smokers and a further 22% are ex-
smokers.  In light of the general trend by deprivation this is likely to have been higher 
in deprived subjects with diabetes.  It is possible that this inequality could have 
affected recruitment to the study.   
We chose a cut-off of five years for former smokers.  The odds ratio for periodontitis 
starts to reduce as soon as an individual stops smoking and reduces from 3.97 to 3.15 
within 0-2 years of stopping smoking.  This continues to reduce with time and reduces 
to 1.15 eleven years after cessation of smoking (Tomar et al., 2000).  It has been 
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shown that ex-smokers have a reduced risk of periodontitis compared with smokers 
although their risk is not as low as those who have never smoked (Warnakulasuriya et 
al., 2010).  The effect of smoking on periodontitis is dose dependent and this can also 
be taken into account when analysing the data, using pack years as an estimate of 
smoking exposure over time.  We used a pack year score of less than 0.25 and not 
having smoked for five years to classify subjects as never smokers.  The five subjects 
who had between 0 and 0.25 pack years had smoked socially in their early twenties 
for a short time.  There is clear evidence that low levels of smoking over short periods 
of time have a negligible effect on the periodontium (Tomson et al., 2007). 
National statistics suggest that 75% of the population would have been eligible to 
participate.  However, the impact of our definition of non-smokers, and the 
deprivation levels in the areas in which we were recruiting, resulted in the proportion 
of the population that was eligible to be recruited being much lower (SDS, 2009).  If 
we had insisted that study participation be limited to only those who had never 
smoked then the number of potentially eligible participants would have been reduced 
even further.  There were 39 subjects in the study population who were former 
smokers (having stopped a minimum of five years previously).  Significantly higher 
proportions of the SP group were former smokers and had a higher pack year score 
(SP group 12 pack years; no SP group 2.3 pack years (p=0.02)) (Table 2-5).  This 
confirms the importance of attempting to restrict studies of the impact of diabetes on 
periodontal health to never smokers to avoid confounding.  This indicates that while 
our exclusion criteria had been designed to eliminate current smoking as a 
confounding factor past history of smoking was still a significant risk factor for 
periodontitis.  One subject that was excluded from the analysis after examination had 
a history of 82 pack years and suffered from severe generalized periodontitis.  The 
individual in question had smoked heavily for a long time although he had stopped 
more than five years before the examination.   
2.4.7 Obesity 
A potential confounder was the increased levels of obesity in the study population.  A 
recent systematic review and meta-analysis concluded that there is evidence that 
obesity is itself a risk factor for chronic periodontitis (OR 1.35) (Chaffee, 2010).  
Differences approaching significance were noted in BMI between the groups where 
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PCD had slightly higher BMI than either the whole T1DM or NDS.  The median was 
26.7 compared with 25.2 in both other groups. (p= 0.02).  Comparison with the 
information from the Scottish Diabetes Survey 2009 showed that BMI levels in our 
diabetic population were similar to levels among diabetic patients in Scotland 
generally.  The percentage of T1DM patients who were overweight or obese was 
61.5% in Scotland and 64.5% in our study group (SDS, 2009).  25.1% of all T1DM 
patients in Scotland are obese (SDS, 2009).  T1DM is not as closely related to obesity 
as type 2 diabetes mellitus.  Nonetheless it is possible that the increased levels of 
obesity may reflect general health attitudes and may in addition add to the 
inflammatory burden leading to increased risk of periodontal disease (Pischon et al., 
2007; King et al., 2009).  This was confirmed in the present study by the significantly 
higher BMI in the SP group compared with those without SP (Table 2-5). However, 
the independent impact of adipokines and the chronic inflammatory burden of this on 
the periodontium in diabetes is unknown.   
2.4.8 Oral hygiene 
One variable that was not included in the multivariable analysis was dental plaque 
score.  Although plaque is required for the initiation of gingival inflammation it has 
been shown that microbial differences account for only around 20% of variance in 
disease expression (Page et al., 1997).  Other factors may play a more important 
aetiological role in periodontitis including variations in genotype and tobacco 
smoking (Michalowicz et al., 1991; Grossi et al., 1994, 2000).  The level of interest in 
general and oral health may be low in the study population.  Oral hygiene was 
generally poor (Table 2-8) despite the fact that in the NDS 87.2% reported brushing 
twice daily or more.  52.7% claimed to be using floss and 50.9% reported that they 
used mouthwash.  Oral hygiene as described by the percentage of sites with plaque 
was significantly higher in PCD compared with NDS and WCD.  It is obvious from 
the plaque scores that the oral hygiene measures, if applied as claimed, are not being 
performed adequately.  This is consistent with the data from the ADH study where 
patients who had just brushed their teeth prior to examination still had plaque present 
at one third of all sites (Morris, 2001).  As plaque is on the causal pathway, it was not 
included as a confounding factor in the multivariable analysis.  It could be argued that 
PCD have worse periodontal disease because they have higher plaque scores.  The 
counter argument is that whether PCD have higher levels of periodontal disease 
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because of higher plaque scores, RAGE deposition in the gingivae or hyper-
responsive T cells is irrelevant.  The key question is whether they have a higher level 
of disease than NDS regardless of the aetiology.  If it is because of a hyper- 
responsive cell type then it will be necessary to identify ways of modifying this.  If, 
on the other hand, it is because of greater plaque accumulation then we need to 
understand this process and modify it accordingly.  
Plaque accumulation can relate either to an increased rate of deposition and 
maturation of the oral biofilm or a reduced frequency and efficiency of self-performed 
plaque control.  Of the poorly controlled diabetic subjects 26.5% reported that they 
brushed their teeth once per day or less while only 12.7% of the NDS and 14.7% on 
the WCD reported brushing so infrequently.  Oral hygiene habits, dental attendance 
patterns, smoking, socio-economic status, psychosocial considerations, gender, 
salivary flow rate and glucose levels in saliva can all affect the development of dental 
plaque (Kelly et al., 1998; Heitz-Mayfield et al., 2005; Marton et al., 2008).  The 
inclusion criteria for this study and the adjustment for confounding should mean that 
the groups were well matched socio-economically as well as demographically and in 
lifestyle variables.  The only significant difference was in the proportion of subjects 
who had a university/college education which was lower in the PCD.  It is to be 
expected that patients who are unable to achieve good glycaemic control are from less 
well educated and less affluent backgrounds (National Diabetes Audit, 2009).  This 
was taken into account in the statistical models.  T1DM and particularly PCD were 
shown to have significantly lower median salivary flow rates than NDS (Table 5-4  
chapter 5 (p=0.003 and 0.01 respectively)) and this together with increased glucose 
concentrations in saliva and a negative response to health care advice in the PCD 
group may have contributed to the higher plaque scores in the former group (Hanson 
et al., 1987; Paulander et al., 2004).  
2.4.9 Clinical implications for practice 
The study described above showed that severity, extent and the prevalence of 
moderate periodontitis was higher in T1DM.  These findings will serve as a spring 
board from which laboratory based studies can be funded in order to elucidate the 
aetiopathogenesis of diabetes related periodontitis in T1DM patients.  This will 
hopefully enable us to identify optimum methods of preventing and treating 
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periodontitis in these patients.  In addition this information can be used to make a case 
for an increased dental input into the management of T1DM.  We found there was a 
lack of awareness of oral complications of diabetes amongst specialist diabetes 
workers and diabetic patients.  This has been confirmed by other researchers (Kunzel 
et al., 2007; Quijano et al., 2010).  In addition study participants had often never been 
informed that their diabetic condition made them at higher risk of periodontal disease.  
Patient information, staff training and improved periodontal screening either in 
primary or secondary care are required in order to reduce the impact of this 
preventable disease which leads to significant morbidity and ultimately loss of oral 
function.  Given that we have excluded smokers from our study and still found a high 
level of disease in type 1 diabetic patients, we can only speculate that the level of 
periodontitis in the population of smoking diabetic patients (24.6%) would be much 
higher.  It has also been suggested that there is a bidirectional relationship between 
T1DM and periodontitis (Iacopino et al., 2001).  This theory proposes that the 
systemic inflammatory burden induced by the presence of periodontal inflammation 
will lead to an increase in insulin resistance in the tissues resulting in higher blood 
glucose levels and higher glycated haemoglobin levels.  It is therefore possible that 
prevention or treatment of periodontal disease could have a beneficial impact on 
diabetic management (Simpson et al., 2010; Teeuw et al., 2010).  Conversely good 
glycaemic control in conjunction with good oral hygiene could be beneficial to 
periodontal status and prevent the development of diabetes related periodontitis.  The 
impact of glycaemic control on the prevalence and severity of periodontal disease will 
be the subject of chapter 3 
2.5 Conclusions 
Type 1 diabetes is a risk factor for the development of periodontal disease.  The 
prevalence of moderate combined with severe periodontitis is increased in non-
smoking adult T1DM patients.  The severity of periodontal disease as measured by 
mean CAL and CPD levels was higher in T1DM patients compared with NDS.  The 
extent of moderate combined with severe periodontitis was also increased in PCD.  
Poor oral hygiene in PCD patients may play a part in the increased levels of 
periodontal disease.  Levels of periodontal disease were higher than expected in both 
T1DM patients and NDS due in part to full mouth periodontal charting and the large 
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number of subjects from deprived backgrounds.  Further research is required to 
establish the pathogenesis and the methods of prevention and treatment of diabetes 
associated periodontal disease.   
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3.1 Introduction 
In the previous chapter of this thesis it was shown that there is an increase in the 
prevalence, severity and extent of periodontitis in T1DM patients.  This relationship 
exists in the absence of smoking, the main environmental risk factor.  This chapter 
will investigate the relationship between age, glycaemic control and duration of 
diabetes, and the prevalence of periodontal disease.  
Micro-vascular complications have been shown to increase significantly when the 
HbA1c increases beyond 7.5%.  Risk of macro-vascular disease is increased at all 
HbA1c values above normal levels (DCCTRG, 1993).  The effect of glycaemic 
control on the periodontium in non-smoking patients with T1DM is not known.  It 
would therefore be useful to identify whether there is a similar cut-off point below 
which the risk of periodontal disease is not increased or beyond which periodontal 
disease is inevitable.   
There is some evidence that periodontitis and gingivitis are increased in PCD patients 
as compared with WCD patients.  Studies have however not been consistent in 
defining poor control.  Adequate glycaemic control is defined by some organisations 
as HbA1c ≤ 6.5% while studies into the periodontal health of T1DM patients have 
used a median HbA1c of 8%, 8.5% or even greater than 10% to 13% to define poor 
control (Seppala et al., 1993; Karjalainen et al., 1996; Tervonen and Karjalainen, 
1997; Syrjala et al., 2003; Lappin et al., 2009; Saes Busato et al., 2010).  By treating 
HbA1c as a continuous scale, as well as dividing the T1DM patients into quintiles of 
equal sized groups, the relationship between HbA1c and periodontal disease will be 
investigated.   
Rosenthal et al. (1988) reported that T1DM patients who had no periodontal disease 
had a lower mean HbA1c than those with periodontal disease.  In addition, these 
authors found an association between micro vascular diabetic complications including 
retinopathy, neuropathy and ketoacidosis, and periodontal disease.  Periodontal 
3  Type 1 diabetes and periodontitis: 
relationship between periodontitis, age, 
glycaemic control and duration  
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disease has also been associated with the diabetic complications of long term poor 
glycaemic control such as proteinuria, renal disease, cardiovascular disease e.g. 
angina and myocardial infarction, and cerebrovascular disease such as stroke and 
transient ischaemic attacks (Thorstensson et al., 1996). 
There is agreement within the published literature that there is an association between 
HbA1c and loss of clinical attachment (Willerhausen et al., 1991; Safkan-Seppala and 
Ainamo, 1992; Ternoven et al., 1997, 2000; Patino Marin et al., 2002, Aren et al., 
2003 and Lalla et al., 2007).  These studies all showed the effect of metabolic control 
on periodontal disease, reporting that clinical probing depths, clinical attachment level 
and radiographic bone loss were increased in PCD patients.  There was no 
corresponding increase in WCD patients despite similar plaque levels.  It is therefore 
believed that poor glycaemic control has a detrimental effect on periodontal health.  
However, the nature of this relationship has not been fully elucidated when 
controlling for other risk factors.  In addition, a number of studies have reported no 
relationship between glycaemic control and certain periodontal parameters 
(Sastrowijoto et al., 1989, Akyuz and Oktay, 1990, De Pommereau et al., 1992). 
There is continued controversy about the effect of diabetes on gingivitis with many 
studies reporting an increase in gingival inflammation (Kjellman et al., 1970b; Gislen 
et al., 1980; Gusberti et al., 1983; Harrisson and Bowen 1987; Seppala et al., 1992 and 
Firalti et al., 1996).  However oral hygiene has also been repeatedly shown to be 
poorer in PCD patients (Albrecht et al., 1988; Novaes et al., 1991; Bridges et al., 
1996; Firatli et al., 1996; Lalla et al., 2006a).  Where this is taken into account, some 
studies have shown that the association persists.  Others have concluded that the 
observed increase in gingivitis can be explained by oral hygiene alone (Hove et al., 
1970).  In this chapter, we will present the ratio of the percentage bleeding score for 
the whole mouth to the full mouth plaque score, known as the periodontal 
susceptibility index.  We will also examine in detail the relationship between plaque 
accumulation and gingival inflammation at index sites. 
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The research questions for this chapter are: 
• Do T1DM patients have a different age of onset of periodontal disease 
compared with NDS? 
• Does glycaemic control have an effect on periodontal disease levels 
independent of other risk factors?   
• Are T1DM subjects more susceptible to plaque related periodontal 
inflammation than NDS? 
• Does duration of diabetes have an effect on periodontal disease levels 
independent of other risk factors? 
 
3.2 Methods 
The patients were examined as described in chapter 1.  We carried out subgroup 
analysis to determine whether there was any relationship between age, HbA1c and 
duration of T1DM, and periodontal disease.  The information recorded from the index 
sites was also used to determine the relationship between the PI, MGI and CPD in 
patients with and without T1DM.   
Training included a consensus session where the standard was set between the 
external trainer, the principal investigator and the examiner using clinical photographs 
of various levels of gingival inflammation and plaque accumulation.  Calibration 
included intra and inter-examiner reproducibility.  There were two calibration sessions 
and MGI and PI charts were repeated throughout the study.  
3.2.1 Predictors of periodontal disease in type 1 diabetic 
patients  
In order to investigate the effect of age, glycaemic control and duration on periodontal 
disease prevalence, the patients were first grouped according to diabetic status (NDS; 
T1DM) then by age in 10 year increments.  Subjects were also divided into five 
quintiles based on their average HbA1c over the last two years.  Duration of diabetes 
was analyzed as a continuous variable.  Initially, the data was cross-tabulated 
according to age and Hba1c quintile, in order to assess whether there was any obvious 
relationship between these variables and periodontal disease.  Age and HbA1c 
quintile were cross tabulated with the presence of two measures of severe 
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periodontitis (CAL ≥ 6mm and CPD ≥ 6mm) and moderate plus severe periodontitis 
(CAL ≥ 4mm). 
3.2.2 Periodontal susceptibility 
The periodontal susceptibility index was calculated by dividing the number of sites 
with bleeding on probing by the number of sites harboring visible plaque.  A high 
ratio of percentage bleeding sites to the percentage of sites with plaque indicates a 
high susceptibility and a low ratio indicates resistance to inflammation (Trombelli et 
al., 2004, 2006).  The mean periodontal susceptibility index was calculated for the 
three groups WCD, PCD and NDS.  
3.2.3 Index sites 
3.2.3.1 Sampling and indices 
Examination of the 4 key sites, one in each quadrant of the mouth (normally the 
mesiobuccal aspect of the 1st or 2nd molar) was carried out.  The MGI was completed 
first, followed by the PI, then gingival crevicular fluid (GCF) was collected..  Clinical 
probing depth and bleeding on probing were recorded after GCF had been collected.  
A) Plaque Index: each site was given a score from 0 to 3, as described by 
Silness and Löe (1964): 
 - 0: no plaque. 
 - 1: plaque only detected by running a probe over the surface of the 
 tooth.  
 - 2: moderate accumulation of soft plaque that can be seen with the 
 naked eye.  
 - 3: the presence of abundant deposits of soft plaque. 
B) Modified Gingival Index: each site was given a score from 0 to 4, 
according to Lobene (1986). 
– 0: absence of inflammation.  
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– 1: mild inflammation — slight change in colour, little change in 
texture, of any portion of but not the entire papillary gingival unit. 
–
 2: mild inflammation — criteria as above but involving the entire 
papillary gingival unit. 
– 3: moderate inflammation — glazing, redness, oedema and/or 
hypertrophy of the papillary gingival unit.  
– 4: severe inflammation — marked redness, oedema and/or 
hypertrophy of the papillary gingival unit, spontaneous bleeding, 
congestion or ulceration. 
C) Probing depth, defined as the distance between the gingival margin and the 
bottom of the probeable pocket rounded down to the nearest whole millimeter.  
3.2.3.2 Summary of index sites 
Mean MGI 
The MGI for each site was summed and divided by the number of sites giving a mean 
MGI for each subject.  This average was used to indicate the amount of gingival 
inflammation present at the index sites.   
4
4321 MGIMGIMGIMGIMeanMGI +++=  
Mean PI 
The plaque index was determined as above and the mean PI for the four sites was 
calculated by summing the PI scores and dividing by the number of sites.   
4
4321 PIPIPIPIMeanPI +++=  
Mean Ratio MGI: PI 
The ratio of MGI: PI is a marker of susceptibility to inflammation.  Abundant plaque 
and a low inflammation score (in the absence of smoking) may indicate that the 
subject has a reduced inflammatory response to the irritating effect of dental plaque.  
In contrast, subjects with a low plaque score and severe gingival inflammation may 
indicate that an individual has a heightened inflammatory response to plaque.  The 
mean ratio of MGI: PI was first calculated at a site level and then the mean proportion 
across the four sites was calculated.  
4
4/43/32/21/1
:
PIMGIPIMGIPIMGIPIMGIPIGIMeanratioM +++=  
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3.2.4 Statistical analysis   
To investigate the effect of potential risk factors for severe periodontitis (1 site with 
CAL ≥ 6mm) (SP) logistic regression analysis was used to determine the relationship 
between SP and age, HbA1c and duration of diabetes.  Logistic regression analysis for 
HbA1c controlled for age, gender, SIMD, smoking status, dental attendance, 
education and BMI. Odds ratios, 95% confidence intervals and p value were 
calculated.  The spearman correlation coefficient was calculated between HbA1c and 
bleeding on probing.  The chi squared test was used to test for differences in 
proportions in the cross tabulations. Differences between the periodontal 
susceptibility index, PI, MGI, gingival crevicular flow were compared between NDS; 
WCD and PCD using ANOVA where the distributions were shown to be normally 
distributed.  The cross-tabulation, bivariate correlations and logistic regression was 
carried out using the statistical package SPSS 15 (SPSS Inc.) and the ANOVA tests 
were carried out using Minitab (Minitab 16, Minitab Inc. Philadelphia). 
3.3 Results 
3.3.1 Calibration 
The initial calibration was carried out prior to the beginning of the study and the 
results were mixed (Table 3-1).  Kappa scores showed fair agreement for the plaque 
index (ĸ = 0.34) between the two examiners but the MGI was unacceptably low at 
0.19.  The intra-examiner agreement for the primary examiner was good for MGI (ĸ = 
0.66) and fair for the PI (Κ = 0.36).  A further training exercise was carried out and 
further calibration was performed.  The intra-examiner reproducibility for the primary 
examiner was good for the MGI (ĸ = 0.61) and moderate for the PI (ĸ = 0.43).  The 
mean bias was low and the percentage within one unit was 100% for the MGI and 
98.1% for the PI.  For the inter-examiner calibration the mean bias was significantly 
lower and 94.7% of all MGI scores were within one unit on the measurement scale.  
For the PI 98.8% of all repeats were within one unit of measurement.  The inter-
examiner scores were improved with both scales showing moderate agreement, MGI 
(Κ= 0.41) and PI (Κ = 0.52).   
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The primary investigator repeated MGI and PI charts throughout the study to test for 
reproducibility.  The intra-examiner reproducibility for the primary examiner 
throughout the study was good for the MGI (ĸ = 0.77) and for the PI (ĸ = 0.64) 
according to the criteria proposed by Altman (1999).  The mean bias was low and the 
percentage within one unit was 99.1% for the MGI and 100% for the PI.  The 
reproducibility of the recording of bleeding on probing was moderate with 74.6% 
perfect agreement and a kappa score of 0.48 (Table 3-2). 
Table 3-1 Summary of 1st and 2nd calibration exercises  
 MGI  
Time 2 
 
PI  
Time 2 
MGI  
Time 1 
PI  
Time 1 
Κ 0.61 0.43 0.66 0.36 
Within 1 100.0% 98.1% 95.2% 100.0% 
Mean bias -0.02 0.03 0.01 0.08 
Intra-
examiner  
Calibration 
Measurement error 0.52 0.65 0.63 0.63 
Κ 0.66 0.53 0.45 0.54 
Within 1 98.1% 98.8% 82.1% 100.0% 
Mean bias -0.09 -0.08 -0.50 -0.07 
Intra-
examiner  
Calibration 
Measurement error 0.54 0.58 0.90 0.46 
Κ 0.41 0.52 0.19 0.34 
Within 1 94.7% 98.8% 76.2% 95.2% 
Mean bias 0.12 -0.04 0.23 0.30 
Inter-
examiner  
Calibration 
Measurement error 0.75 0.58 1.13 0.65 
Within 1: agreement between replicates to within 1 unit on measurement scale 
Mean bias: mean of differences between replicates 
Measurement error: SD of differences between replicates 
 
Table 3-2 Summary of ongoing calibration  
 
 
MGI 
 
PI 
Κ 0.77 0.64 
Perfect 
agreement 
86.4 80.7 
Within 1 99.1 100 
Within 2 100 100 
Mean bias 0.09 0.04 
Ongoing 
Intra-examiner 
calibration 
Measurement 
error 
0.39 0.43 
Within 1: agreement between replicates to within 1 unit on measurement scale 
Within 2: agreement between replicates to within 1 unit on measurement scale 
Mean bias: mean of differences between replicates 
Measurement error: SD of differences between replicates 
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3.3.2 Prevalence of severe and moderate and severe 
periodontitis by age  
Periodontitis was very common in both groups with severe periodontitis (CAL ≥6 mm 
on a minimum of one tooth) affecting 40% of the NDS >50 years of age and 64% of 
the diabetic subjects in the same age group.  The prevalence of periodontitis increased 
with age in both groups (Fig 3-1).  The relationship with age was almost linear with r2 
= 0.9602 (T1DM) and r2 = 0.9567 (NDS) respectively.  The prevalence of severe 
periodontitis in T1DM subjects under thirty years of age was 3.25 times as high in 
T1DM compared with NDS (NDS 2.8%, T1DM 9.1% ).  
Moderate combined with severe periodontitis was also consistently more common 
among T1DM compared with NDS.  In every age group the prevalence of 
periodontitis was higher among T1DM (Fig 3-2).  The differences were most marked 
in the under thirty year group and in those over fifty years of age.  CAL of ≥4mm was 
twice as common in the under thirties and the over fifties.  There was no age group in 
which there were no instances of severe periodontitis in either T1DM or NDS groups. 
Logistic regression was carried out to determine whether there was a different 
relationship between age and severe periodontitis in T1DM and NDS.  The risk of 
severe periodontitis increased more than 17 fold [CI 2.1-139.1] between the youngest 
and oldest NDS however the same odds ratio was only 7.6 [CI 3.0-19.3] in the T1DM 
group.  The level of disease was much higher in the youngest T1DM group (Table 3-
3).   
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Figure 3-1 Severe periodontitis CAL ≥ 6mm by age and prevalence  
 
Figure 3-2  Moderate combined with severe periodontitis CAL ≥ 4 
mm by age and prevalence 
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Table 3-3  Table showing the increasing relative risk of CAL ≥ 
6mm with age across three equally sized age groups  
  Percentage with 
Severe 
Periodontitis 
Severe 
Periodontitis 
(OR) 
95% 
Confidence 
intervals 
P 
value 
NDS 
Age 
group1 3.1% 1(ref)  - 
 
Age 
group 2 18.4% 7 [0.81-60.3] 0.077 
 
Age 
group 3 35.7% 17.22 [2.1-139.1] 0.008* 
T1DM 
Age 
group1 9.5% 1(Ref)  - 
 
Age 
group 2 21.2% 2.58 [0.97-6.85] 0.058 
 Age 
group 3 44.4% 7.66 [3.04-19.3] 0.000* 
* statistically significant 
3.3.3 Periodontal treatment need by age. 
The prevalence of severe periodontitis as defined by treatment need (≥ 6 mm CPD on 
a minimum of one tooth) was also examined by age.  The prevalence of CPD ≥ 6 mm 
was higher in the younger age groups but there was no difference in the older age 
groups.  Among patients less than 30 years old the prevalence was 3.8 times higher 
among the T1DM patients (10.4%) compared with NDS (2.8%) (p= 0.018).  The 
prevalence of 6mm CPD was also higher among the 30-40 year age group with NDS 
6.1% and T1DM 12.2% (p >0.05).  There were no differences between T1DM 
patients and NDS in the 40 to 50 or the over 50 year age groups (Figure 3-3).   
 
Figure 3-4 shows that the prevalence of moderate periodontal treatment need (clinical 
probing depths ≥ 4mm) was seven fold higher in patients less than 25 years old 
suffering from T1DM compared with NDS.  41.5% of all diabetic patients under 25 
had at least one tooth with CPD ≥4mm compared with only 5.9% of the NDS 
(p=0.018).  When all patients under thirty were analysed there was a 2.3 times 
increase in prevalence (NDS 16.7% T1DM 39.5%, p=0.011).  There were no 
significant differences in any other age groups. 
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Figure 3-3  Clinical probing depth ≥ 6mm on a minimum of one 
tooth by age (decade). (*p value calculated using chi 
squared test)   
 
Figure 3-4 Prevalence of moderate combined with severe 
periodontal treatment need in patients less than 25 
years and less than 30 years of age (* p value calculated 
using chi squared test) 
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3.3.4 Glycaemic control and periodontal disease  
3.3.4.1 Bleeding on probing 
Bivariable analysis showed that there is a positive correlation between average HbA1c 
and bleeding on probing (Figure 3-5).  A Spearman correlation showed that this 
relationship was statistically significant (correlation coefficient 0.31 p = 0.000).   
3.3.4.2 Periodontitis 
The influence of HbA1c on the prevalence and extent of periodontitis is less clear.  
The patients with the lowest HbA1c had the lowest prevalence of SP.  However the 
group with the highest prevalence, and the most widespread disease, was the 
moderately controlled group (Figures 3-6 and 3-7).   
 
Figure 3-5  Scatterplot of Average HbA1c against the percentage 
of sites with bleeding on probing 
Figure 3-6 shows which HbA1c quintile the patients with severe periodontitis were in.  
There was a pattern of increasing proportion of periodontal patients in the groups as 
the HbA1c increases until the last group.  Figure 3-7 shows that there was an increase 
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in the extent of periodontitis as defined by the number of sites ≥ 4mm CAL with 
increasing HbA1c although this pattern was also reversed in the most poorly 
controlled group.  Figure 3-8 shows that of those patients who were in the most poorly 
controlled group 41.5% were under twenty five and 62.6% were under 30 years of 
age.  There was an inverse relationship between age and HbA1c.  Since this was the 
age group with the lowest prevalence of periodontal disease it is not surprising that 
the prevalence of severe periodontitis was low in this group where young diabetic 
patients were over represented.  A negative relationship between HbA1c and age, and 
a positive association between periodontal disease and age, meant that in order to see 
whether the relationship between periodontitis and HbA1c required a multivariable 
logistic regression model.   
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Figure 3-6  Bar chart of the proportion of patients with severe 
periodontitis who were in each quintile of HbA1c 
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Figure 3-7 Mean number of sites ≥ 4mm by quintile of HbA1c  
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Figure 3-8  Bar chart showing the age distribution of the group 
with the highest HbA1c  
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Multivariable logistic regression analysis was used to calculate odds ratio and 95% 
confidence intervals for severe periodontitis (CAL ≥ 6mm) against the HbA1c groups 
controlling for age, gender, BMI, previous smoking status dental attendance, SIMD 
and education.  The adjusted Odds Ratio for all quintiles of HbA1c was higher than 
the lowest reference group with the fourth quintile rather than the fifth having the 
highest risk.  The adjusted Odds Ratios for quintiles 2-5 were 2.78 [CI 0.92-8.36], (p 
= 0.07), 2.68 [CI 0.87-8.20] (p = 0.085), 3.996 [CI 1.334-11.97] (p= 0.013) and 2.806 
[CI 0.901-8.739] (p=0.075) (Figure 3-9 and Table 3-4).   
 
 
Figure 3-9 Fully adjusted odds ratios (error bars 95% confidence 
intervals) for severe periodontitis by quintile of 
HbA1c.  Adjusted for age, gender, smoking status, 
BMI, attendance, education and SIMD. 
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Table 3-4 Fully adjusted odds ratio for severe periodontitis  
Quintiles 
of HbA1c 
Severe 
Periodontitis (OR) 
95% Confidence 
intervals 
P value 
1 1 (ref)  - 
2 2.775 [0.92-8.36] 0.07 
3 2.675 [0.87-8.195] 0.085 
4 3.996 [1.33-11.97] 0.013 
5 2.806 [0.90-8.74]] 0.075 
 
a  Variable(s) entered on step 1: HbA1c, age, gender, smoking status, BMI, attendance, education, 
SIMD 
 
The level of disease was much higher in the youngest T1DM group.  An interaction 
test to test whether HbA1c impacted on the relationship between SP and age showed 
that this apparent difference in the age distribution was not statistically significant       
(p = 0.692).  The relationship between HbA1c and SP was not a linear one.  
Correcting for apparent differences in age did not remove this effect and despite 
multivariable logistic regression no clear pattern emerged.   
3.3.5 Duration of diabetes and risk of SP   
The relationship between the duration of diabetes and severe periodontitis was 
investigated initially using a bivariate logistic regression analysis.  In the initial 
analysis the relationship appeared to be significant with an increase in risk of 5.1% 
with every year of duration (1.051 CI [1.014-1.09] p = 0.007).  A series of models 
were constructed where duration was adjusted for age.  This attenuated the 
relationship and there was no longer a significant association between duration and SP 
(1.003 [0.962-1.045] p = 0.891).  There was a strong correlation between age and 
duration (p = <0.00) (Fig 3-10).   
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Figure 3-10 Scatterplot of age against duration of diabetes 
3.3.6 Index sites 
When the index sites were examined, there were no differences in the number of 
bleeding sites affecting the first or second molars and the average probing depth 
across the three groups was not significantly different.  The mean MGI across the 4 
teeth was significantly higher in the PCD as compared with both the NDS (p = 0.000) 
and WCD (p = 0.001) (Figure 3-11, Tables 3-5).   
The likelihood of all 4 sites having an MGI of zero, that is to say, no visible signs of 
inflammation, were significantly higher in the NDS and WCD; 25.2% and 24.2% of 
the NDS and WCD had no visible signs of inflammation, however only 11.2% of the 
PCD had an MGI of zero (p < 0.0001).  The mean plaque index was, however, higher 
for the PCD compared with both NDS and the WCD (p=<0.001, p=0.006) (Figure 3-
12, Tables 3- 6).   
There were no differences in the probing depths of the sites (Fig 3-13, Table 3- 7) 
(NDS 2.68mm, WCD 2.51mm, PCD 2.74mm p = 0.262).   
The periodontal susceptibility index, which is the ratio of the percentage bleeding 
sites to the percentage of sites where there is visible plaque, was calculated and is 
shown in the box plot (Figure 3-14).  This showed that there was a slight increase in 
the ratio of the number of bleeding sites to the number of sites with plaque in PCD 
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compared with NDS (NDS = 0.63 [CI 0.57-0.68], PCD 0.695 [ CI 0.64-0.69] p = 
0.13).  This may mean that there is an increased susceptibility to gingival 
inflammation for a given level of plaque.  However, the difference detected was not 
statistically significant and therefore no conclusions can be drawn at the whole mouth 
level.   
In order to account for the presence of plaque at the site level the ratio of the modified 
gingival index to the plaque index was calculated.  There were no statistically 
significant differences between the three groups in the ratio of MGI to PI (Figure 3-
15, Tables 3-8).    
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Figure 3-11  Box plots comparing the distribution of the Modified 
Gingival Index in NDS, WCD and PCD subjects. 
Median, interquartile range and extremes. 
Table 3-5 Mean MGI by Diabetic status 
 N Mean Std. 
Deviation 
Min Max Std. 
Error 
95% Confidence 
Interval for Mean 
NDS v 
WCD 
NDS v 
PCD 
       Lower 
Bound 
Upper 
Bound 
P P 
NDS 110 1.56 0.804 0 3 0.0767 1.407 1.711 0.848 0.000 
WCD 34 1.48 0.877 0 3.25 0.1505 1.172 1.784   
PCD 170 1.99 0.695 0 3.5 0.0533 1.882 2.09   
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Figure 3-12  Box plots comparing the distribution of the Plaque 
Index in NDS, WCD and PCD subjects. (Median, 
interquartile range and extremes) 
 
Table 3-6  Mean Plaque Index by Diabetic status 
 N Mean Std. 
Deviation 
Min Max Std. 
Error 
95% Confidence 
Interval 
for Mean 
NDS V 
WCD 
NDS v 
PCD 
       Lower 
Bound 
Upper 
Bound 
P p 
NDS 110 1.3 0.786 0 3 0.075 1.16 1.45 0.985 0.000 
WCD 34 1.28 0.804 0 3 0.138 1 1.56   
PCD 170 1.73 0.754 0 3 0.058 1.62 1.84   
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Figure 3-13  Box plots comparing the distribution of the clinical 
probing depths in NDS, WCD and PCD subjects. 
(Median, interquartile range and extremes) 
 Table 3-7 Mean clinical probing depths (mm) comparing NDS v 
WCD and NDS v PCD 
 
N Mean 
Std. 
Deviation 
Min Max 
Std. 
Error 
95% Confidence 
Interval 
for Mean 
NDS v 
WCD 
NDS 
V 
PCD 
 
      
Lower 
Bound 
Upper 
Bound 
p P 
NDS 110 2.68 0.686 2 6 0.065 2.55 2.81 0.462 0.821 
WCD 34 2.51 0.815 0 4 0.14 2.22 2.79   
PCD 170 2.74 0.774 0 6 0.059 2.62 2.85   
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Figure 3-14  Box plots showing the distribution of the periodontal 
susceptibility index (ratio of bleeding/plaque) in NDS, 
WCD and PCD subjects 
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Figure 3-15  Box plots comparing the distribution of the ratio 
Modified Gingival Index/Plaque Index in NDS, WCD 
and PCD subjects. Median, interquartile range and 
extremes. 
 
Table 3-8 Ratio of MGI: PI by diabetic status 
 N Mean Std. 
Deviation 
Min Max Std. 
Error 
95% Confidence 
Interval 
 for Mean 
NDS V 
WCD 
NDS V 
PCD 
       Lower 
Bound 
Upper 
Bound 
P P 
NDS 110 1.28 0.512 0.542 3.25 0.049 1.179 1.37 0.898 0.95 
WCD 34 1.23 0.415 0.583 2.38 0.071 1.089 1.38   
PCD 170 1.27 0.476 0.583 3.67 0.036 1.186 1.33   
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3.4 Discussion 
3.4.1 Age 
The prevalence of SP increases linearly with age in diabetes patients as it does in 
healthy subjects.  There is no lower age limit where moderate or severe periodontal 
disease does not occur in either group, although the prevalence of periodontal disease 
seems to be much higher in younger type 1 diabetic subjects.  This is in agreement 
with studies in adolescents which showed that low levels of periodontitis are present 
even in younger age groups (Lalla et al., 2006a).   The differences in CAL between 
T1DM and NDS continue through life but the differences in CPD decrease with age.  
The differences in change in probing depth with age are interesting, as they seems to 
show that there is an accumulation of disease experience and therefore periodontal 
tissue loss over time.  However, the probing depths do not seem to get interminably 
deeper and are maintained at depths similar to those of middle-aged patients with 
chronic periodontitis.  In the ADH survey 1998 the level of CPD was always lower 
than CAL.  Between the 35-44 year age group and the 45-54 years age group there 
was only a 1% increase in the prevalence of CPD >5.5mm while there was an increase 
from 3% up to 10% in the same groups for CAL>5.5mm.  This shows that while CAL 
is cumulative CPD will not necessarily increase in the same way with increasing age 
(Morris et al., 2001).   Of real interest was the fact that the prevalence of severe 
periodontitis in T1DM subjects under thirty years of age was 3.25 times as high in 
T1DM compared with NDS age-matched controls (NDS 2.8%, PCD 9.1% p> 0.05).  
This suggests that the onset of periodontitis occurs earlier than in non-diabetic 
subjects where an increased duration of exposure to local aetiological factors such as 
plaque and inflammation is required to cause a comparable level of periodontal 
destruction.  This increase in such young adults has not been specifically reported 
before although Andronikaki-Faldami and co-authors did report an increase in 
periodontal disease in their 25-36 year age group despite not seeing any difference in 
the subjects less than 25 years of age (1990).  A number of studies in children and 
adolescents have reported increased severity of disease in young diabetic patients 
compared with age matched controls. In these studies, the prevalence of significant 
periodontal disease was very low in both groups (Lalla et al., 2006; Luczaj-Cepowicz 
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et al., 2006; Dakovic et al., 2008; Silvetre et al., 2009).  This is also similar to the 
finding of retinopathy in young diabetic patients.  Retinopathy affects diabetic 
patients at a younger age than non-diabetic patients although the disease itself is little 
different (Morello et al., 2007).  It is possible that the pathology of periodontitis is 
similar in T1DM to NDS however the natural history is accelerated in the former.   
3.4.2 Glycaemic control 
3.4.2.1 Gingival inflammation 
Bivariate analysis showed that there is a positive correlation between average HbA1c 
and bleeding on probing (correlation coefficient 0.31 p<0.000).  Poor glycaemic 
control is therefore related to an increase in periodontal inflammation as demonstrated 
by bleeding from the base of the pocket.  This analysis did not however take account 
of other confounding factors specifically including the presence of plaque.  It is not 
possible to distinguish between gingivitis and periodontitis with this index.  
3.4.2.2 Prevalence and extent of periodontitis 
The influence of HbA1c on the prevalence and extent of periodontitis is less clear.   
Although the diabetic patients with the lowest HbA1c had the lowest prevalence of 
SP, the group with the highest prevalence and the most widespread disease was the 
moderately controlled group.  It may be that differences in the age ranges across the 
five groups can account for this difference although the multivariable analysis did 
include age as a potential confounder.  The age group with the highest levels of 
periodontal disease were however, older than the worst controlled diabetic patients 
(Fig 3-8).   
There was an increase in the extent of periodontal disease as measured by the number 
of pathologically deepened pockets (≥4mm) with increasing HbA1c although this 
pattern was also reversed in the most poorly controlled group.  This is unlikely to be 
because increasing HbA1c is protective for the periodontium but rather it may reflect 
other differences between the groups.  While it was suspected that age may have been 
confounding this relationship a multivariable regression analysis model of the 
prevalence of SP against HbA1c was not modified significantly with the inclusion of 
age in the model.  It may be that with the small numbers involved the data was not 
powerful enough to detect this relationship and to account adequately for the 
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overwhelming effect of age on periodontal disease experience.   Alternatively, there 
may be other unknown factors that account for this confounding effect as well as 
differences in age with HbA1c.  The mean age of those subjects in the most poorly 
controlled group was lower than that of those in the moderately controlled groups.  
More than 60% of the group with the highest quintile of HbA1c were under thirty 
years of age and as such we would expect this group to have a correspondingly lower 
prevalence of SP.  In this circumstance the increased age and duration of exposure to 
local aetiological agents may be more important than the HbA1c alone.   
3.4.2.3 Comparison with the literature 
A number of studies have shown a relationship between periodontal disease and 
glycaemic control (Gislen et al., 1980; Kjellman et al., 1970a; Gusberti et al., 1983; 
Harrisson et al., 1987; Seppala et al., 1993, 1994; Firalti et al., 1996).  Seppala and co-
workers (1993, 1994) in a longitudinal study in T1DM adults reported that patients 
with poorly controlled diabetes mellitus had higher clinical probing depths and 
clinical attachment loss than controls.  Willerhausen and co-workers (1991) in a 
European study of 42 T1DM compared with 118 healthy controls reported that there 
was a significant correlation between HbA1c and loss of clinical attachment.    
Patients with poorer glycaemic control had more bleeding on probing and a higher 
prevalence, extent and severity of periodontal disease, although, due to confounding 
with age, this relationship was not linear although there was a positive correlation.  It 
is not possible using our data to predict a safe level of glycaemic control below which 
periodontal disease will not occur.  In the well-controlled groups, there were patients 
who suffered from periodontal disease.  For other diabetic complications, it has been 
possible to identify safe levels of glycaemic control due to the relative rarity of the 
condition in the general population (DCCTRG, 1993).  Retinopathy is rare in young 
non-diabetic patients and it was therefore possible to identify a safe level of glycaemic 
control below which this did not occur.  Due to the multi-factorial nature of 
periodontal disease and its high prevalence in our control group it is not possible to 
distinguish between periodontitis caused by local risk factors, for example poor oral 
hygiene, and that caused by diabetes alone.  Diabetic patients with good control had 
levels of periodontal disease that were less than the healthy controls.  This could 
reflect the background risk of periodontal disease in the Scottish population.  It is 
possible that if we had used a lower cut off point for HbA1c we would have been able 
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to demonstrate even more of a difference between the WCD and the PCD.  This 
would however have been impossible within our study population given the rarity of 
patients achieving HbA1c levels of <6.5% or even <7%.  
The possible mechanisms by which periodontal disease is exacerbated in diabetes 
include the deposition of advanced glycation end products (AGE) and their associated 
inflammatory effects, an altered systemic inflammatory response due to adipokines 
and circulating inflammatory cytokines, an immune deficiency or alterations in 
osteoimmunology or simply poor oral hygiene and dental compliance (Mealey et al., 
2007; King, 2008; Chavarry et al., 2009).  Most if not all of these would normally be 
worse in PCD.   
The deposition of AGE in the tissues happens at a rate dependent on the concentration 
of glucose in the serum over time.  This damage is however accumulative over time 
and so, while it is true to say that a high HbA1c will lead to an increase in 
AGE/RAGE related tissue damage, this will still take a finite amount of time to occur 
(DCCTRG, 1993; Stratton et al., 2000; Pambianco et al., 2006).  This would explain 
why the younger patients with the worst HbA1c results do not have the highest levels 
of periodontal disease due to the fact that the natural history of the disease still 
requires a time factor to cause the disease.   
Similarly, the functionality of leukocytes in terms of chemotaxis and phagocytosis has 
also been shown to be dependent on HbA1c and is therefore less of an issue in well 
controlled patients (Marhoffer et al., 1992; Gallacher et al., 1995).  There are some 
immune deficiencies in diabetic patients that have been demonstrated to be present 
regardless of glycaemic control.  These are inherent deficiencies of specific cell lines 
in T1DM regardless of external factors specifically affecting HLA type and TLR 
responsiveness (Pirie et al., 2005; Morran et al., 2008).  T regulatory cells (T reg) 
from T1DM subjects display decreased suppressive characteristics, which suggest a 
defect in T reg function in people suffering from T1DM leading to excessive tissue 
damage in the pancreas causing beta cell destruction (Brusko et al., 2005; Lindley et 
al., 2005).  The genetic and immunoregulatory factors that predisposed the patient to 
developing diabetes may be the same as the ones that predispose the patient to 
periodontal disease (Kopitar et al., 2006).  If this were to be the case then it would not 
be the diabetes per se or even glycaemic control that would be the cause of the 
periodontitis but rather they would be two separate diseases with a common genetic 
risk profile.   
Douglas P Robertson 2011                                                                                  Chapter 3-208 
Dyslipidaemia is increasingly thought to be important in the development of both 
macrovascular and microvascular disease (Tseng et al., 2019; Grauslund et al., 2010).  
This may be related to the pro-inflammatory effect of adipokines.  The majority of 
patients in this study were overweight and this is a factor that we have not 
investigated.  It is possible that the lipid profile and levels of adipokines could be an 
important factor in diabetes associated periodontitis (Karthikeyan et al., 2007; 
Fentoğlu et al., 2011).  As with cardiovascular risk, the lipid profile or circulating 
levels of adipokines are important mediators of periodontal destruction.  The 
relationship between glycaemic control and dyslipidaemia is not linear.  It is possible 
that there was no significant relationship found between HbA1c and periodontal 
disease because the latter is in fact related to the lipid profile and adipokines in the 
circulation.  However, Lim et al. (2007) recently showed that despite the fact that 
there was a trend to increased dyslipidaemia in a mixed population of type 1 and type 
2 diabetic subjects the most significant correlation was between HbA1c and the 
percentage of sites with probing depths greater than or equal to 5mm.  We have no 
available information on dyslipidaemia due to limitations on the availability of past 
laboratory data for our subjects, however it would have been interesting to investigate 
the effect of this on periodontal status.  Interetingly a recent study has shown 
statistically significant reductions in low density lipoprotein cholesterol and total 
cholesterol in response to periodontal therapy.  The role of periodontal treatment as an 
adjunct to reducing hyperlipidaemia as well as hyperglycaemia is an intriguing one 
that may merit further investigation (Kiran et al., 2005).   
3.4.2.4 Non immuno-inflammatory hypotheses 
It is possible that PCD patients have more disease simply because they do not look 
after their mouths as well as WCD patients.  Patients who are compliant with diabetic 
control measures such that they are capable of maintaining glycaemic control in the 
target range over a two-year period are patients who are generally highly motivated 
individuals (Skinner and Cameron, 2010).  This study showed some evidence that the 
PCD patients were slightly less well educated.  In addition social factors do play a 
role in the epidemiology of periodontal diseases (chapter 2 Table 2-6).  There is 
however also evidence from the psychological literature that patients react differently 
to disease states and chronic conditions.  It has been shown that patients who have 
positive health behaviour toward their diabetes also have positive oral health 
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behaviour (Kneckt et al., 1999a,b, 2000, 2001, Syrjala et al., 1999).  This may relate 
to self-efficacy and the health locus of control.  High self-esteem was also found to 
relate to good adherence with prescribed exercise regimens and adjustment of insulin 
doses.  In the dental sphere, logistic regression analysis showed an association 
between self-esteem and frequency of tooth brushing (Kneckt et al., 2001).  Put 
simply, it may be that the “type of patient” who can cope with their diabetes by 
maintaining rigid control of every aspect of their diet and lifestyle is psychologically 
the same ”type of person” who takes good care of their teeth.  There are a series of 
papers showing this phenomenon. The group which conducted this research concludes 
that the connection between these psychological factors may be one of the 
explanatory variables that make up the difference between NDS, WCD and PCD 
(Kneckt et al., 1999a,b, 2001; Syrjala et al., 1999).  The applicability of these studies 
to the Scottish diabetic population has never been shown. However, further study on 
these possible links in a Scottish population could illuminate this explanation further.   
3.4.3 Susceptibility to periodontal inflammation 
In order to account for the presence of plaque, the ratio of the percentage of bleeding 
sites to the percentage of sites with plaque was calculated (Van der Velden et al., 
1985).  The difference in the susceptibility index was not significant although it was 
slightly higher in the PCD.  There were no group differences in the MGI when the PI 
was corrected for.  The periodontal susceptibility index has been shown to be higher 
in patients with a history of severe periodontitis compared with older patients with 
copious plaque but little periodontal attachment loss (Van der Velden et al., 1985).  
There have been three studies in diabetic subjects that specifically reported the ratio of 
bleeding sites to plaque.  Paolantonio et al. (1989) reported that there was a higher 
ratio in patients with diabetes and periodontitis compared with healthy controls.  
Sastrowijoto et al.(1990) was unable to show that patients with a family history of 
diabetes and impaired glucose tolerance had any change in this ratio although the 
subjects in this study did not have any periodontal breakdown at the outset and it was 
concluded that the short duration of periods of hyperglycaemia were not sufficient to 
cause changes in the gingival condition.  Dakovic and co-workers did however show 
that adolescents with T1DM had a higher bleeding/plaque ratio (OR 1.25; 95% CI 
1.06-1.48).  It is possible that the hormonal susceptibility to gingival inflammation in 
this age group exacerbates this increase.  The same study also showed that there was a 
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weak positive relationship between the number of teeth affected by periodontal 
destruction and the bleeding/plaque ratio (regression coefficient 0.17; p = 0.021). 
As the periodontal susceptibility index is a full mouth index it is a less accurate 
reflection of what is happening on a site basis.  We have no way of knowing, from the 
susceptibility index, whether the sites that bled were also the ones where plaque was 
present, although this is likely.  The findings at the index sites indicated that there was 
an increase in gingival inflammation in T1DM.  However, this can be explained by 
the increase in plaque accumulation independent of diabetic status.   
Based on this study we can conclude that there is insufficient evidence to support the 
hypothesis that adult patients with T1DM are more susceptible to plaque induced 
inflammation than non-diabetic subjects.  This is in agreement with a number of 
studies that have found no correlation between diabetes and gingivitis (Glavind et al., 
1968; Bay et al., 1974; Goteiner et al., 1986; Pinson et al., 1995; Sbordone et al., 
1995, 1998; Bridges et al., 1996; Noaves et al., 1997).  These studies have either not 
found an increase in gingivitis at all or have found that the plaque control in the 
diabetic group is significantly poorer.  When this is taken into account there is no 
difference in gingivitis other than that resulting from the increase in plaque scores.   
A number of studies have however shown that in diabetic patients the severity of 
gingivitis is related to glycaemic control (Kjellman et al., 1970a; Gislen et al., 1980; 
Gusberti et al., 1983; Harrisson et al., 1987; Seppala et al., 1992; Firatli et al., 1996,).  
Differences in the age of the subjects may have played a part as some studies that 
found differences were in adolescents.  These hormonal effects are less relevant in an 
adult population.  However, Salvi et al. (2005, 2007, 2010) showed that the rate of 
development and severity of gingivitis is higher in diabetic patients.  There were also 
higher levels of IL-1β and MMP 9.in the T1DM patients at certain time points 
throughout the studies.  The sample size was extremely small (controls n=9, T1DM n 
= 9) but the prospective nature of this study means that it provides more reliable 
evidence than the cross-sectional data presented in this chapter.  
We cannot determine with certainty the temporal relationship between poorly 
controlled diabetes and periodontal disease or well-controlled diabetes and the 
absence of periodontal disease.  It could be argued by those unfamiliar with the 
natural history of periodontal disease, that periodontal disease is a risk factor for the 
development of diabetes rather than diabetes mellitus being a risk factor for 
periodontal disease.  This is not likely, given that periodontal disease is relatively rare 
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in youth while this is the time at which T1DM is diagnosed.  What is perhaps more 
interesting is whether having a healthy periodontium leads to good glycaemic control 
or indeed whether having a diseased periodontium leads to an increased risk of poor 
glycaemic control.  This two way or “bi-directional” relationship is one that was 
proposed by Iacopino et al. (2001) and has been the subject of two recent systematic 
reviews (Simpson et al., 2010, Teeuw et al., 2010).  We have shown that well 
controlled diabetic subjects have less periodontitis than poorly controlled subjects.  
However we cannot establish whether the good control has prevented the 
development of periodontitis or whether the poorly controlled diabetes mellitus has 
led to periodontal damage.  A prospective longitudinal study would be required to 
elucidate this relationship.  This would require periodontal healthy recently diagnosed 
T1DM subjects to be followed through life with detailed periodontal charting at 
regular intervals.    
3.4.4 Duration of diabetes  
There was no relationship between diabetes duration and periodontal disease.  While 
it may be expected that the length of time for which a subject has had diabetes would 
be an important factor in the development of periodontal disease this does not appear 
to be independent of age or glycaemic control.  Those patients who have had diabetes 
for a long time are also older.  The increasing age was more important than the 
duration of diabetes.  Glavind et al. (1968) reported that periodontitis was related to 
duration of diabetes and Leeper and co-workers also reported that periodontitis 
increased with duration (1985).  The authors did not use multi-variable analysis and 
therefore they could have been reporting the relationship with age rather than 
duration.  Firatli et al. (1997) examined the relationship between periodontal status 
and the duration of IDDM in 44 T1DM children and adolescents in a longitudinal 
study lasting five years.  Clinical attachment loss was associated with duration of 
diabetes.  Over a five year period the mean CAL increased from 2.39mm to 3.51mm.  
Silvestre et al. (2009) reported that there was an increase in gingival bleeding and 
periodontitis in patients who had had diabetes for more than ten years compared with 
those of short duration of diabetes.  This was a bivariate comparison and no age data 
was presented for either group.  It has been shown that the accumulation of AGE in 
the tissue increases with increasing duration of diabetes and exposure of diabetes and 
thus human studies clearly show the relationship between diabetic complications and 
Douglas P Robertson 2011                                                                                  Chapter 3-212 
duration of diabetes (DCCTRG, 1993; Stratton et al., 2000; Pambianco et al., 2006).  
There have been a number of studies that have concluded that duration of diabetes is 
not an independent risk factor for periodontitis (Arrietto-Blanco et al., 2003; Lalla et 
al., 2006, 2007).  It is possible that the effect of duration can be seen in adolescents 
because diabetes exposure is the main risk factor at this age.  However this effect is 
attenuated with age as increased age confers a greater risk of periodontitis than 
duration of diabetes alone.    
3.5 Conclusions  
This second results chapter has attempted to elucidate the effect of age, glycaemic 
control and duration of diabetes on the periodontal findings.  We have shown that 
periodontitis is evident in young adults although it is not necessarily particularly 
severe in this age group.  The level of disease noted in young diabetic patients would 
necessitate periodontal treatment and this has service and cost implications as well as 
implications for the patients themselves.  According to the British Society for 
Periodontology a BPE of 3 indicates a moderate periodontal need that can normally be 
managed in general practice.  A BPE of 4 is categorised as complexity 2 and may 
require specialist intervention, particularly if there is a systemic modifying factor such 
as diabetes mellitus (Dowell and Chapple, 2002).  Those patients who have diabetes 
mellitus and a BPE of 4 in one sextant represent a group of patients who may well 
require treatment in secondary care.  The cost and service implication of treating the 
periodontal disease of this group will be significant and given that this appears to be 
starting in patients as young as 25 could represent a significant lifetime cost in 
periodontal treatment and subsequent maintenance.   
Poorly controlled patients had higher full mouth plaque scores and higher mean PI 
scores at the index sites.  This accounted for most of the increase in MGI and bleeding 
scores.  This indicates that either their oral hygiene is simply inadequate or that they 
have higher plaque levels for some organic reason.  Biofilm formation may progress 
quicker in a glucose rich environment and this may lead to more rapid regrowth of 
plaque.  Reduced salivary flow rates may lead to an increased accumulation of dental 
plaque and there is also evidence that C albicans can interact with early bacterial 
colonisers and increase biofilm formation (Silverman et al., 2010).  Regardless of the 
reason for the higher plaque levels, better local measures to control plaque are 
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essential if these patients are to avoid developing periodontal disease and its sequelae.  
Patient education and oral hygiene instruction may be an effective way of reducing 
the risk of developing periodontal disease in diabetic patients in addition to improving 
glycaemic control. 
Duration of exposure to diabetes was not an independent risk factor for periodontal 
disease progression.  This is not a modifiable risk factor as the patient cannot control 
the date of their diagnosis.  Within the limits of this cross-sectional study there does 
not appear to be an inevitable progression in periodontal destruction with increasing 
duration of exposure to diabetes.   
Poor glycaemic control was also shown to be damaging to the periodontium with 
higher levels of disease in patients with poorer levels of glycaemic control.  In the 
multivariable regression analysis there did not appear to be a linear relationship 
between the prevalence of severe periodontitis and increasing HbA1c quintiles.  We 
were not able to show a threshold effect and therefore we cannot advise a certain 
target HbA1c to avoid periodontal disease.  The main difference was seen at levels of 
HbA1c above the physiological range.  This conferred at least a twofold increased risk 
of severe periodontitis.  The small number of cases in some groups and the strong 
association of periodontitis with age may have reduced the power to detect the full 
extent of the impact of HbA1c on periodontitis.  The fully adjusted model did not 
elucidate the relationship further.  Given the similarities between periodontitis and 
other microvascular complications a holistic approach to treatment should be adopted.  
Patients should be advised that poor glycaemic control is a risk factor for periodontal 
disease and should be encouraged to maintain HbA1c levels as near the 
physiologically normal range as possible.  
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4.1 Introduction 
The mechanism through which diabetes mellitus confers increased risk of 
periodontitis in T1DM is unclear, although a number of mechanisms have been 
proposed (Graves, 2006).  It is unlikely that differences in subgingival microflora are 
to blame as a number of studies both culture based and using 16s molecular 
microbiology have shown no significant differences (Sastrowijoto et al., 1989, Lalla 
et al., 2006b).  It is therefore more likely to be the host response to the common 
subgingival microflora that leads to the destruction of the periodontal ligament and 
alveolar bone.  There is some evidence that diabetes associated periodontitis may be 
due to cytokine dysregulation due to excessive TNFα expression (Salvi et al., 1997a,b, 
2010).  It is hypothesised that this hyper-inflammatory process leads to production of 
cytokines, such as IL-1 and IL-6, that influence osteoclast maturation and activation 
via a receptor activator of nuclear factor-kB ligand (RANKL) dependent pathway.  
The production of RANKL and the subsequent activation of bone destruction could 
lead to excessive alveolar bone loss.  Bone resorption and bone formation are 
processes that are ‘‘coupled’’ but can take place independently (Corral et al., 1998).  
The function of bone resorbing osteoclasts is regulated by interaction with fibroblasts 
in the ligament between the tooth and the bone (Kanzaki et al., 2002).  These 
periodontal ligament fibroblasts are involved in both stimulatory and inhibitory 
processes.  RANKL interacts with receptors on the surface of osteoclasts to stimulate 
bone resorption.  Osteoprotegerin (OPG) also produced by periodontal ligament 
fibroblasts (Kanzaki et al., 2002) blocks the activity of RANKL by binding to RANK. 
High levels of RANKL are expressed during root resorption of deciduous teeth and, 
raised levels of OPG are expressed, where no root resorption is normally taking place, 
i.e. adjacent to permanent teeth (Fukushima et al., 2003).  RANKL levels are much 
higher in periodontitis patients than in those who have never had periodontitis 
(Bostanci et al., 2007).  
The expression of OPG in periodontal tissues is decreased in both moderate 
periodontitis and advanced periodontitis, while RANKL mRNA is increased in 
4 Markers of bone turnover in Type 1 diabetes 
mellitus and periodontitis  
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periodontitis at the advanced stage (Liu et al., 2002).  Higher circulating levels of 
OPG are found in T1DM patients than in healthy individuals (Kim et al., 2005).  
Plasma OPG concentrations have been shown to be implicated in the regulation of 
vascular calcification, atherogenesis, coronary artery disease (Dhore et al., 2001; Jono 
et al., 2002) and associated with progression of coronary artery calcification in type 2 
diabetes mellitus (Anand et al., 2007). 
An increased ratio of RANKL to OPG in periodontitis may determine local bone 
resorption.  This ratio can be measured either in GCF, serum or at the mRNA level 
within tissues (Cochran, 2008).  C-terminal telopeptide of type 1 collagen (ICTP) is 
the carboxyterminal telopeptide of type 1 collagen, the only collagen type found in 
mineralized bone (Risteli & Risteli, 1993).  ICTP is released into the circulation 
during bone resorption.  Increased amounts of this product in serum or plasma 
indicates an increase in osteoclast activity which has been shown in multiple myeloma 
and osteoporosis, as well as other diseases characterised by bone resorption (Elomaa 
et al., 1992, Hassager et al., 1994, Abildgaard et al., 1997).  ICTP has also been 
shown to be related to bone resorption associated with chronic periodontitis.  Oringer 
et al. (2002) showed that ICTP and IL-1 were increased in periodontally diseased 
sites.  Sarwent also showed that levels of ICTP changed during healing after 
periodontal surgery and were increased when recombinant platelet derived growth 
factor was used as an adjunct to surgery.  Another study showed that ICTP is highly 
correlated with clinical features of periodontal disease, that levels decreased in 
response to treatment and that ICTP had been shown to possess predictive properties 
for possible future disease activity (Kinney et al., 2007).  In a study investigating the 
possibility of using saliva as a source of ICTP, ICTP was only detected in the saliva of 
patients with periodontitis (Frodge et al., 2008).  Gurlek et al. (2009) demonstrated 
that salivary ICTP levels positively correlated with the number of bleeding sites but 
also demonstrated that there was no difference in ICTP levels in smokers and non-
smokers where the levels of periodontal disease were similar.  Rheinhardt et al. (2010) 
showed that elevated baseline ICTP levels during periodontal maintenance was also 
associated with increased risk of 1- and 2-year loss of alveolar bone density.   
Osteocalcin is a major non-collagenous protein of the bone matrix that is produced by 
osteoblasts.  Serum osteocalcin levels have been used as biomarkers for bone 
formation because this protein is released into the circulation during this process 
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(Bullon et al., 2005).  A number of studies have measured osteocalcin levels in 
relation to periodontitis and in diabetic patients (Shi et al., 1996; Alexopoulou et al., 
2006; Gurlek et al., 2009) but there are no studies examining diabetic patients with 
periodontitis.  Shi et al. (1996) showed that patients with periodontitis had lower 
levels of serum osteocalcin than healthy controls.  Rheinhardt and co-workers also 
showed that the ratio of osteocalcin to ICTP was highest while bone was being laid 
down during healing of a surgically induced wound in the alveolar bone (Rheinhardt 
at al., 2005).  Higher serum levels of osteocalcin were measured in rats, with 
experimentally induced periodontitis, treated with doxycycline and alendronate 
indicating higher bone formation due to the inhibition of osteoclast activity by the 
alendronic acid (Buduneli et al., 2005).  Liu and co-workers (2009) reported that 
plasma levels of osteocalcin were higher in aggressive periodontitis than in healthy 
controls although this study did not include any data on the relative ICTP levels.   
Bone loss seen in periodontitis is associated with a perturbation in the balance of 
RANKL and OPG and may be reflected in alterations in osteocalcin and/or ICTP 
levels.  Our hypothesis is that higher levels of OPG reported for T1DM patients 
modify the level of destruction seen in those patients also suffering from periodontitis. 
The aim of this study was to measure the circulating levels of the markers of bone 
metabolism in T1DM patients with and without periodontitis.  The research question 
was: 
• Does the presence of periodontitis have an influence on the plasma 
concentrations of markers of bone metabolism in diabetic patients and 
systemically healthy individuals? 
4.2 Methods 
4.2.1 Subjects 
The ethical approval, recruitment, consent and inclusion and exclusion criteria have 
been described in chapter 2.  The age range of the subjects included in this sub group 
was 22-55 years and included both male and female Caucasians, who were generally 
healthy and had at least 20 teeth.  To be included in the periodontitis groups patients 
had to have a minimum of two sites with clinical probing depth and clinical 
Douglas P Robertson 2011                                                                                  Chapter 4-217 
attachment loss of ≥5mm.  Non-periodontitis control subjects had no sites with 
clinical attachment loss or clinical probing depths of > 4 mm. 
Full mouth six point clinical attachment level and clinical probing depth chartings 
were carried out on all subjects as described in chapter 2.  The most recent HbA1c 
available from the relevant diabetic clinic was used to categorise the T1DM subjects. 
Sixty of the patients recruited had T1DM and 38 were NDS.  10 of the NDS were 
recruited from the periodontal department of Glasgow Dental Hospital and School. 
4.2.2 Measuring RANKL, OPG, ICTP and osteocalcin   
The plasma was separated from the blood by centrifugation (1048 xg for ten minutes), 
stored in aliquots at -70oC and thawed immediately prior to assay.  The human soluble 
RANKL (hsRANKL) Enzyme Linked Immunosorbent Assay (ELISA) development 
kit (Peprotech EC, United Kingdom), the human OPG  (hOPG) ELISA development 
kit (R & D systems, United Kingdom) the UniQ ICTP Enzyme immunoassay (EIA) 
kit (Orion Dianostica, Finland) and the osteocalcin immunoassay kit (BioSource 
Europe, Belgium) were used.  ICTP assays were performed using a 1/3 dilution of 
plasma and osteocalcin assays were performed using a 1/5 dilution of plasma.  The 
kits contained all the necessary solutions for perfoming the assays and method used 
for each assay followed the manufacturers’ guidelines.  All samples were run in 
duplicate.   
4.2.2.1 ELISA solutions 
Phosphate buffered solution (PBS) - 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 
5 mM KH2PO4, pH 7.2 - 7.4, 0.2 µm filtered. 
Wash buffer - 0.05% Tween 20 in PBS, pH 7.2 - 7.4 
Reagent diluent - 0.1% Bovine serum albumin (BSA) in PBS with 1% heat 
inactivated [56oC for 30 mins] goat serum , pH 7.2 - 7.4, 0.2 µm filtered 
Streptavidin-HRP - Straptavadin conjugated to horseradish peroxidise 
Substrate solution - Tetramethylinebenzidine (TMB) (Vector Laboratories, 
Burlinhame USA). Four drops of buffer stock solution, six drops of TMB stock 
solution and 4 drops of hydrogen peroxide were sequentially added to 10ml distilled 
water.  
Stop solution - 0.12 M HCl  
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4.2.2.2 Osteoprotegerin and RANKL ELISA Protocol 
1. The capture antibody provided (biotinylated goat anti-human OPG or 
RANKL) was diluted to the working concentration of 2µg/ml in PBS without 
carrier protein. 
2. The 96-well immunolon 4 microplates (Thermolaboratories, United Kingdom) 
were immediately coated with 100 µl per well of the diluted capture antibody.  
3. The plates were sealed and incubated overnight at room temperature. 
4. Each well was aspirated and washed using a multi-chanel plate washer (Nunc 
immunowash 12 , Immunomed, Denmark) at least three times with 400µlwash 
buffer ensuring that all liquid was removed at each step. 
5. After the last wash, any remaining wash buffer was removed by inverting the 
plate and blotting it against clean paper towels. 
6. The plates were blocked by adding 300 µL of reagent diluent to each well.  
7. The plates were incubated at room temperature for a minimum of 1 hour and 
washed again as described in step 4. 
8. 100 µL of standards or samples (plasma diluted 1:5 for OPG and 1:10 for 
RANKL) in diluent, were added to each well and the wells were covered and 
incubated for 2 hours at room temperature. 
9. The aspiration/wash steps were repeated as in step 4. 
10. 100 µL of the detection antibody, diluted in reagent diluent was added to each 
well, covered with a new adhesive strip and incubated for two hours at room 
temperature. 
11. The aspiration/wash steps were repeated as in step 4. 
12. 100 µL of the working dilution of Streptavidin-HRP (streptavidin conjugated 
to horseradish-peroxidase) was added to each well.  The plates were covered 
and incubated for 20 minutes at room temperature. 
13. The aspiration/wash steps were repeated as in step 4. 
14. 100 µL of tetramethylinebenzidine (TMB) chromagen substrate solution was 
added to each well and incubated for 20 minutes at room temperature. 
15. 50 µL of stop solution was added to each well and the plates were gently 
tapped to ensure thorough mixing. 
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16. The optical density of each well was determined using a photometric 
microplate reader set to 450 nm with a reference filter at 630nm(Dynex MRX 
II, Thermal Fisher, UK).  The results were calculated from the standard curve. 
4.2.2.3 ICTP EIA protocol 
1. All the reagents, controls and patient samples were brought to room 
temperature at least 30 minutes before use. 
2. The excess strips were removed from the plate frame and returned to the 
pouch and closed tightly. 
3. 50 µL of ready to use calibrators (0µl, 1.0 µl, 2.5 µl, 5 µl, 10 µl, 25 µl, 50 µl), 
control (lyophylised in human serum reconstituted in 0.5ml of distilled water) 
and patient sample in duplicate was pipetted into the 96 well microtitre plate 
provided.  Two wells were reserved for the substrate blank. 
4. 50 µL of ICTP enzyme conjugate (ready to use peroxide labelled ICTP) was 
pipetted into all wells except the blanks. 
5. 50 µL of ICTP antiserum (ready to use rabbit antiserum) was pipetted into all 
wells except blanks. The antiserum was applied to all wells within 3 minutes.  
6. The plates were incubated on a plate shaker at 18-25°C for 2 hours. Use a 
shaking speed of 600-1000 rpm. 
7. The strips were washed 4 times with the wash solution ( 80 ml EIA wash 
concentrate diluted to 1000ml) on a plate washer. Using 300-500 µL of the 
wash solution per well.  Any remaining moisture was removed by tapping the 
strips firmly against absorbent paper.  
8. 100 µL of ICTP substrate (ready to use Tetramethylbenzidine in aqueous 
buffer) was pipetted into all wells and the plates were incubated on a plate 
shaker at 18-25 °C for 30 minutes. 
9. The enzyme reaction was stopped by adding 100 µL of stopping solution ( 
ready to use 0.5M H2SO4) into all wells. 
10. The plates were shaken for 15-30 seconds to mix the reagents. 
11. The absorbances of all wells was read at 450 nm on a photometric microplate 
reader with a reference filter at 630nm (Dynex MRX II, Thermal Fisher, UK) 
within 10minutes.  The results were calculated from the standard curve. 
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4.2.2.4 Osteocalcin ELISA protocol 
1. All the reagents, controls and patient samples were brought to room 
temperature at least 30 minutes before use.  
2. The lyophilized standards and controls were reconstituted to the volume 
specified on the vial label with distilled water and were mixed with gentle 
inversion. 
3. The wash solution was prepared by diluting 2ml of the concentrate wash 
solution in 400ml of distilled water and stirring with a magnetic stirrer.  
4. 25 µl of each calibrator, control and sample was pipetted into the 96 well 
microtitre plate precoated with anti-human osteocalcin provided. 
5. 100 µl of working anti-OST-HRP conjugate was pipetted into all the wells and 
the plates were incubated for 2 hours at room temperature on a horizontal 
shaker set at 700 plus or minus 100.. 
6. The liquid was aspirated from each well and the plates were washed three 
times by dispensing 500µL of wash solution into the well and aspirating the 
liquid. 
7. 100 µl of the chromogenic solution (ready to use TMB) was pipetted into each 
well within 15 minutes following the washing step. 
8. The microtiterplate was incubated for 30 minutes at room temperature on a 
horizontal shaker set at 700 plus or minus 100 rpm avoiding direct sunlight. 
9. 200 µl of the provided Stop solution was pipetted into each well. 
10. The absorbancies were read at 450 nm (reference filter 630 nm) within 1 hour 
using the Dynex MRX II (Thermal Fisher, UK) photometric plate reader and 
the results were calculated from the standard curve. 
The method used for each assay followed the manufacturers’ guidelines. The 
concentration of sRANKL and OPG in each of the samples was then determined by 
comparing the average sample optical density readings with the concentrations from 
the assay standard curve.  The relevant assays for these proteins are capable of 
detecting both the free and RANKL-OPG complex (Lappin et al., 2007).  The relative 
plasma concentrations of OPG and sRANKL and osteocalcin and ICTP (nanograms 
per millilitre) were calculated.   
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4.2.3 Statistical analyses of the ELISA/EIA data 
A pilot experiment, where OPG levels were measured and a two-fold difference 
obtained, was utilized in statistical power calculations.  With a power of 80% and an 
alpha = 0.0125 the minimum number of patients required for the comparisons was 68.  
Non-parametric distribution-free statistical tests were employed to analyse the data.  
The postulated null hypothesis was “no statistically significant difference” and the 
maximum number of comparisons was four.  
The relationship between the percentage of glycated haemoglobin in the blood 
(HbA1c%) and [RANKL], [OPG], [osteocalcin] and [ICTP] was determined using the 
Spearman correlation coefficient, correcting for multiple testing by applying a 
Bonferroni correction.   
4.3 Results  
4.3.1 Demographic and clinical parameters 
A full mouth six point periodontal charting was successfully carried out for 96 of the 
98 patients, recording the following: gingival recession, clinical probing depth (CPD) 
and clinical attachment level (CAL) measured from the amelocemental junction.  
Only 94 of the 98 patients had complete records of bleeding on gentle probing.  
Once the study population was divided according to the periodontal criteria, 14 had to 
be excluded from the dataset because they did not fit into either the periodontitis or 
the non-periodontitis groups (two because the clinical data was not complete and 12 
because they did not meet the criteria for either gingivitis alone or periodontitis for 
example a patient may have had 1 site with >4mm CAL and therefore could not be 
included in the healthy group).  Two non-diabetic patients who did not have full 
mouth BOP recorded were retained since full mouth records of CPD and CAL were 
available. 
The non-diabetic group consisted of 16 male and 22 female subjects and the diabetic 
group consisted of 28 male and 32 female patients.  The T1DM patients were divided 
into two groups according to the median HbA1c for the whole group.  The low 
HbA1c (<8.5%) group consisted of 12 male and 18 female patients and the high 
HbA1c (>8.5%) group of 16 male and 14 female patients.  The median ages of the 
patients in the non-diabetic and the diabetic groups (Low HbA1c% and High 
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HbA1c% groups) were very similar; non-diabetic patients 40 (range 21 – 55) years, 
diabetic patients with Low HbA1c% 34 (20 – 50) years and diabetic patients with 
High HbA1c% 40 (20 – 54) years.  Clinical data are presented in Table 4-1.  The 
number of sites and teeth with clinical probing depths and clinical attachment loss 
greater than 4mm and the number of sites bleeding on probing are indicated.  The   
NDS group appeared to have lower average levels of bleeding on probing than the 
T1DM group.  The diabetic patients with low HbA1c% appeared to have lower 
numbers of teeth and sites with CAL >4mm and CPD >4mm than the diabetic patients 
with high HbA1c, but there was no statistically significant difference in these 
parameters between the groups.  The Kruskal-Wallis test results comparing the three 
groups were as follows: CPD >4mm, p= 0.31; Number of teeth with CPD >4mm, 
p=0.26; CAL >4mm, p= 0.48 and Number of teeth with CPD >4mm, p= 0.36.  
Although, the number of teeth and sites with CPD >4mm was similar in both T1DM 
and NDS periodontitis groups there were more sites and a greater number of teeth 
with CAL >4mm in the T1DM periodontitis group.  None of these differences were 
statistically significant.  
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Table 4-1  Number of sites and teeth with clinical probing 
depths > 4mm, sites and teeth with clinical 
attachment loss > 4mm and proportion of sites 
bleeding on probing (mean ± standard deviation) 
Diabetic status (n) 
 
Number of 
sites CPD*1 
>4mm 
Number of 
teeth CPD*1 
>4mm 
 
Number of 
sites CAL*2 
>4mm 
 
Number of 
teeth CAL*2 
>4mm 
Proportion 
of sites 
BOP*3 
Non-diabetic (38)  ‡ (36) 4.13 ±5.83 2.16 ±2.49 2.82 ±5.99 1.39 ±2.57 0.34  ± 0.17 
Diabetic  (60)    3.77 ±7.6 2.14 ±3.85 2.14 ±3.85 3.22 ±5.79 0.48 ±0.18 
Periodontal status (n) Ŧ 
 
Number of 
sites CPD 
>4mm 
Number of 
teeth CPD 
>4mm 
 
Number of 
sites CAL 
>4mm 
 
Number of 
teeth CAL 
>4mm 
Proportion 
of sites  
BOP 
Non-diabetic  
control (17) 0.00 ± 0.00 0.00 ± 0.00 
 
0.00 ± 0.00 
 
 0.00 ± 0.00 0.35  ± 0.14 
Non-diabetic  
periodontitis (17)  † (15) 8.71 ± 6.09 4.47 ± 1.91 6.18 ± 7.84 3.00 ± 3.2 0.32  ± 0.21 
Diabetic (26) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.40  ± 0.16 
Diabetic  
periodontitis (24) 8.86 ± 10.02 4.87 ± 4.82 7.5 ± 7.10 4.38 ± 3.49 0.55  ± 0.16 
 
*1 CPD = Clinical Probing Depth 
*2 CAL = Clinical Attachment Loss   
*3 BOP = Bleeding on Probing  
‡ 2 patients do not have full CAL or BOP data  
† 2 of the Non-diabetic (periodontitis) patients do not have full mouth BOP data and one diabetic has this information 
missing, but full charting of CAL and CPD are available.  
Ŧ 2 non-diabetic patients and 10 diabetic patients were omitted from the periodontal status analysis as they failed to 
meet the inclusion criteria.  
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4.3.2 Plasma concentrations of RANKL, OPG, ICTP and   
osteocalcin 
The assay sensitivities and range of the standard curves are shown in table 4-2 below. 
Table 4-2  Assay Sensitivity and range of hsRANKL, 
osteoprotegerin, ICTP and osteocalcin assays 
 hsRANKL OPG ICTP Osteocalcin 
Sensitivity 7.8pg/ml 3.9pg/ml 0.5ng/ml 0.4ng/ml 
Standard curve 
range 
13.6-1000pg/ml 7.8-500pg/ml 1-50ng/ml 1-90ng/ml 
 
Diabetic patients had a higher concentration of OPG, a lower concentration of 
osteocalcin and a lower RANKL: OPG ratio than non-diabetic patients.  The Mann-
Whitney U Test indicated that both findings were statistically significantly different 
(OPG: p<0.001; osteocalcin: p = 0.047, RANKL: OPG: p<0.001).  The differences 
between the groups in RANKL and ICTP levels were not statistically significant. 
4.3.3 Influence of glycated haemoglobin on plasma RANKL, 
OPG, ICTP & osteocalcin 
Diabetic patients were divided into two groups High and Low depending on their 
most recent HbA1c.  The median HbA1c (8.60%) was taken as the cut-off point and 
the two groups were compared with each other and the non-diabetic group (Table 4-
3).  For consistency within this thesis the groups were also analysed using the cut-off 
point of ≤7.5% and both are reported here.  The results obtained for OPG, indicated a 
statistically significant difference between some of the groups according to the 
Kruskal-Wallis test (Figure 4-2).  When the three groups were compared and analysed 
post hoc with the Mann-Whitney U Test and a Bonferroni correction for multiple 
comparisons, statistically significant differences were found for the following 
comparisons: non-diabetic group and WCD (HbA1c ≤7.5%)  group (p<0.016) and the 
non-diabetic group and PCD (HbA1c >7.5%)  group (p<0.001).  PCD showed the 
lowest concentrations of osteocalcin (Figure 4-1 median= 5.19 ng/ml).  The results 
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showed a statistically significant difference between the groups according to the 
Kruskal-Wallis Test (p= 0.04).  When the three groups were analysed by the Mann-
Whitney U Test with Bonferroni correction, a statistically significant difference in 
plasma osteocalcin concentrations was observed when comparing the NDS and the 
PCD group (p = 0.016) before correction (0.06 after correction), but not between the 
WCD and PCD groups (p = 0.07) .  There were no statistically significant differences 
in RANKL or ICTP concentrations between any of the groups (Kruskal wallis            
p = 0.649, p = 0.092 respectively) (Table 4-3) (Figure 4-1). 
There was a statistically significant difference in the RANKL: OPG ratio (Table 4-2) 
between the NDS and the T1DM patient groups according to the Kruskal-Wallis test 
(p = 0.0023).  In the post hoc analysis: both PCD and WCD groups were statistically 
significantly different from the NDS (p = 0.024 & p = 0.001, respectively), but not 
from each other (p = 0.080).  
 
Table 4-3  Influence of glycated haemoglobin on plasma 
RANKL, OPG,  ICTP & osteocalcin 
        
 
Diabetic status (n) 
RANKL 
ng/ml 
OPG 
(ng/ml) 
RANKL:OPG 
(Mol:Mol) 
ICTP 
(ng/ml) 
Osteocalcin 
(ng/ml) 
 
Non-diabetic (38) 
0.83 
(0.36-1.26) 
1.11 
(0.65-1.55) 
1.45 
(0.57-2.83) 
4.78 
(3.20-6.24) 
7.18 
(4.62-14.60) 
 
Low HbA1c  
(≤ 8.5%) (30) 
0.66 
(0.17-2.37) 
2.2 
(1.51- 3.13) 
0.65 
(0.24-1.14) 
3.34 
(1.8  5.81) 
5.4 
(2.98-10.82) 
 
High HbA1c  
(> 8.5%) (30) 
0.62 
(0.22-1.8) 
1.88 
(1.31-3.11) 
0.86 
(0.24-1.44) 
3.46 
(2.49-5.85) 
5.31 
(2.79-8.19) 
 
Diabetic status (n) 
RANKL 
(ng/ml) 
OPG 
(ng/ml) 
RANKL:OPG 
(Mol:Mol) 
ICTP 
(ng/ml) 
Osteocalcin 
(ng/ml) 
 
Non-diabetic (38) 
0.83 
(0.36-1.26) 
1.11 
(0.65 -1.55) 
1.45 
(0.57-2.83) 
4.78 
(3.20-6.24) 
7.18 
(4.62-14.60) 
 
WCD  
(≤7.5%) (11) 
0.54 
(0.15-1.69) 
1.76 
(1.19–2.74) 
0.39 
(0.24-1.14) 
2.94 
(1,17–7.81) 
9.32 
(3.52–20.17) 
 
PCD  
(> 7.5%) (49) 
0.66 
(0.19-1.99) 
2.23 
(1.38-3.17) 
0.76 
(0.22-1.44) 
3.79 
(2.43-5.76) 
5.19 
(2.64–8.29) 
Indicates statistically significant differences between groups
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Figure 4-1 RANKL, OPG, Osteocalcin and ICTP by diabetic control. 
The box plot with quartiles, showing outliers circles and extreme 
values(asterisks), represents the plasma concentration of Osteoprotegerin 
(OPG), RANKL, RANKL:OPG ratio, ICTP and Osteocalcin and in 38 non-
diabetic patients and 63 patients with diabetes split into two groups based 
on their HbA1c%: 11well controlled diabetic patients% (HbA1c ≤7.5%) and 
49 poorly controlled diabetic patients (HbA1c >7.5%). ICTP, C-terminal 
telopeptide of type 1collagen; RANKL, receptor activator of nuclear factor-
kB ligand. 
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4.3.4 Influence of periodontitis on plasma RANKL, OPG, ICTP 
and osteocalcin 
There was no difference in the extent of periodontitis between the non-diabetic and 
the diabetic patients.  Fourteen patients (10 diabetic patients; 4 non-diabetic patients) 
were excluded from the rest of the study because of difficulty in placing them in either 
the periodontitis group or the non-periodontitis control group. Therefore the groups 
consisted of: T1DM non-periodontitis n = 26; T1DM with periodontitis n = 24; NDS 
non-periodontitis n = 17; and NDS with periodontitis n = 17. 
When the patients were allocated according to their disease status, T1DM with 
periodontitis had the highest plasma concentration of OPG (Table 4-4, Figure 4-2).  
The Kruskal-Wallis Test indicated that the differences were statistically significant 
(p< 0.001). The Mann-Whitney U Test with a Bonferroni correction indicated 
statistically significant differences in plasma OPG (Figure 4-2) in the following 
comparisons: non-diabetic patients and T1DM without periodontitis (p=0.009); NDS 
with periodontitis and T1DM with periodontitis (p<0.0001) and; NDS without 
periodontitis and NDS patients with periodontitis (p= 0.004).   
The highest osteocalcin levels were in the non-diabetic patients without periodontitis 
and the lowest in the non-diabetic patients with periodontitis.  The levels in the non-
diabetic patients with periodontitis were similar to those in both diabetic patient 
groups, i.e. the diabetic patients with and without periodontitis.  Post hoc tests showed 
statistically significant differences between the non-diabetic patients without 
periodontitis and the non-diabetic patients with periodontitis (p= 0.003); the NDS 
without periodontitis and T1DM without periodontitis (p= 0.009) (Table 4-4, Figure 
4-2).  There were no statistically significant differences in RANKL or ICTP 
concentrations (Table 4-4, Figures 4-2).  Statistically significant differences in the 
ratio of RANKL: OPG (Table 4-4, Figure 4-2) were observed between the following 
patient groups: the non-diabetic patients without periodontitis and the non-diabetic 
patients with periodontitis (p=0.01) and the diabetic patients with periodontitis and the 
non-diabetic patients with periodontitis (p< 0.0001).  
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Table 4-4 Comparison of median (Quartile 1–3) plasma RANKL, 
OPG, osteocalcin, ICTP levels and RANKL:OPG ratios 
in the patient groups 
Periodontal 
status (n) Ŧ
RANKL
(ng/ml)
OPG
(ng/ml)
RANKL:OPG
(Mol:Mol)
ICTP
(ng/ml)
Osteocalcin
(ng/ml)
Non-diabetic (17) 0.65
(0.31 – 1.24)
1.29
(1.06 - 1.70)
0.94
(0.43 - 1.70)
4.80
(3.02 – 6.81)
13.26
(6.7-19.9) -
Non-diabetic
Periodontitis (17) 0.953(0.69 – 1.25)
0.646
(0.60- 1.39)
2.22
(1.65 - 3.06)
5.22
(4.21 - 6.62)
5.00
(3.5-7.2)
Diabetic (26) 0.83
(0.15 – 2.34)
1.938
(1.39 – 3.13)
0.88
(0.20 - 1.98)
3.24
(2.07 – 6.07)
6.23
(4.38 – 10.54)
Diabetic 
Periodontitis (24) 0.63(0.25 -- 1.68)
2.30
(1.41 – 3.07)
0.85
(0.28 - 1.14)
3.71
(2.26 - 5.57)
5.31
(3.63 – 10.81)
 
      Indicates statistically significant differences between groups (Mann Whitney U test.p<0.05 
4.3.5 Correlations   
The plasma concentrations of RANKL did not show any statistically significant 
correlation with HbA1c%; Spearman’s correlation coefficient (rho) = -0.070 p= 
0.494.  The plasma concentration of OPG indicated a statistically significant positive 
correlation (rho= 0.391 p<0.000) with the HbA1c% in blood.  The plasma 
concentration of osteocalcin indicated a statistically significant negative correlation 
(rho= -0.226; p= 0.025) with HbA1c% and with age (rho=0.32 p=0.001).  These 
relationships remained statistically significant when the data were controlled for the 
presence of periodontitis (HbA1c% and OPG, p= 0.008 and HbA1c% and osteocalcin, 
p= 0.009) the gender (p= 0.008 and p= 0.009) or the age (p= 0.006 and p= 0.004) of 
the patients.  Osteocalcin concentrations also negatively correlated with the number of 
teeth with CAL>5mm (rho= -0.335, p= 0.001).  Plasma ICTP concentrations did not 
correlate with HbA1c% (rho= -0.141; p= 0.167), OPG levels or the number of teeth 
affected by periodontal disease, but there was a positive correlation between ICTP and 
RANKL (rho= 0.29; p= 0.004 and the RANKL:OPG ratio (rho= 0.310; p= 
0.002).Bleeding on probing correlated with the number of deep sites (rho=0.406p< 
0.001) and with the HbA1c% (rho = 0.464; p<0.001). 
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Figure 4-2  RANKL, OPG, Osteocalcin and ICTP in Type 1 
diabetes mellitus and periodontitis  
Box plot with quartiles, showing outliers (circles) and extreme values 
(asterisks), represents the plasma concentration of osteoprotegerin 
(OPG), RANKL, RANKL:OPG ratio, ICTP  and osteocalcin  in 34 patients 
without type 1 diabetes mellitus (non-diabetic) and 50patients with 
diabetes each split into two groups based on the presence of 
periodontitis.  Seventeen of the non-diabetics had periodontitis and 17 
did not and 26 diabetics had periodontitis and 24 did not. ICTP, C 
terminal telopeptide of type 1 collagen; RANKL, receptor activator of 
nuclear factor-kB ligand 
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4.4 Discussion 
There are several mechanisms that might explain the greater incidence of periodontitis 
in diabetes: a greater susceptibility to infection as a result of diminished neutrophil 
function; the formation of advanced glycation end products which increase oxidative 
stress in the tissues; and the binding of advanced glycation end products to cell 
surface receptors which stimulates the increased production of inflammatory 
cytokines and causes delayed wound healing.  These mechanisms would induce 
periodontal destruction through osteoclastogenesis.  When this study was begun it was 
thought that, based on a hyper-inflammatory model of periodontal destruction in 
T1DM, there would be higher levels of RANKL leading to increased bone destruction 
and a relative reduction in OPG the decoy receptor.  It has been shown by Salvi and 
co-workers that human GCF from type 1 diabetic patients with periodontal disease 
has higher levels of both PGE2 and IL-1 as compared with GCF from matched non-
diabetic patients (Salvi et al., 1997b).  Furthermore, monocytes isolated from 
periodontal patients with type 1 diabetes produce significantly greater amounts of 
TNF-α, IL-1ß, and PGE2 in response to lipopolysaccharide (LPS) compared with 
non-diabetic patients (Salvi et al., 1997a,b).  It was therefore hypothesised that 
dysregulation of pro-inflammatory cytokines such as IL-1, IL-6 and TNFα due to 
prolonged TNFα epression would lead to an increased propensity to inflammatory 
bone loss (Naguib et al., 2004). 
4.4.1 RANKL and Osteoprotegerin  
The results of the first studies into RANKL and OPG and their relative ratios were 
unexpected.  Activation of the transcription factor nuclear factor-kB following 
ligation of RANKL to the cell surface receptor RANK is an event that promotes 
osteoclast formation (Hofbauer et al., 2000) and also induces the production of a 
cysteine proteinase and cathepsin K, in osteoclasts.  Cathepsin K is involved in bone 
matrix solubilisation (Crotti et al., 2003).  OPG is a member of the TNF receptor 
family that is expressed by osteoblasts and other cell types, notably insulin secreting β 
cells of the pancreas (Schrader et al., 2007).  OPG inhibits osteoclast formation by 
high affinity binding to RANKL and prevents RANKL from coupling with the RANK 
receptor (Hofbauer et al., 2000).  This tends to result in reduced bone resorption.  In 
periodontitis, increased concentrations of RANKL are found in diseased tissues, and 
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the disruption to the balance between RANKL and OPG concentrations is associated 
with disease severity (Liu et al., 2003; Crotti et al., 2003; Garlet et al., 2006).  
Numerous studies have shown lower serum and salivary concentrations of OPG and 
lower expression of OPG in periodontitis and peri-implantitis patients compared with 
healthy individuals (Belibasakis et al., 2007; Bostanci et al., 2007; Lappin et al., 2007;   
Budunelli et al., 2008; Akiran et al., 2011).  The results of the present study confirmed 
that higher OPG concentrations are detected in diabetic patients, and indicated that 
there is a positive correlation between OPG and HbA1c%.  The extremely high levels 
of OPG in the serum meant that this decoy receptor would tend to protect the 
periodontium by reducing bone loss.  An examination of the literature revealed that 
high levels of OPG had already been reported in patients with type 1 diabetes in the 
context of other diseases (Kim et al., 2005).  High plasma levels of OPG are also 
linked to endothelial cell dysfunction (Secchiero et al., 2006) and the early onset of 
diabetes mellitus and have implications in the higher susceptibility of diabetic patients 
to coronary artery disease (Anand et al., 2007; Ishiyama et al., 2009) and myocardial 
infarction (Avignon et al., 2005, 2007).  Hyperglycaemia does not appear to be 
directly responsible for elevated plasma OPG in diabetic patients (Knudsen et al., 
2007).  However, our results suggest a strong relationship between HbA1c% and 
increased OPG concentrations, acting independently of other factors such as age, 
gender or periodontitis.  A question that has yet to be resolved is whether high levels 
of OPG are directly involved in the pathogenic process or are indicative of the process 
taking place.  The pathogenesis of type 1 diabetes mellitus is caused by immune 
mediated pancreatic β cell destruction.  Schrader et al. (2007) indicated that cytokine 
induced OPG production may protect pancreatic b cells from further damage.  This 
may be partially mediated through inhibition of p38 mitogen-activated protein (MAP) 
kinase phosphorylation.  The high levels of OPG that we detected were therefore not a 
novel finding in themselves although no one had reported RANKL, OPG and 
RANKL: OPG ratios in diabetic patients with and without periodontitis.  The fact that 
the group with the highest levels of OPG, an osteoprotective molecule, was found in 
the worst controlled group with the most periodontal disease was counter-intuitive.   
4.4.2 ICTP and Osteocalcin 
We decided to investigate the bone turnover in diabetic patients using two different 
molecules.  Rather than assessing this just at the level of the regulator, we examined 
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the effect of the smoking gun, ICTP, a molecule only released during bone destruction 
and of osteocalcin, a molecule that is associated with bone remodelling in general and 
new bone formation in particular.  By examining bone turnover both at the level of  
upstream activation and maturation of osteoclasts and osteoblasts, as well as the effect 
of this in real terms, we were able to see whether there was a relationship between the 
RANKL:OPG ratio and the apparent increase in periodontal bone loss in the group 
that should theoretically be protected.   
The first question to answer was whether ICTP levels were reduced by OPG as per the 
current theory.  ICTP, a specific biochemical marker of bone resorption, was 
measured (Bacovsky et al., 2002).  It was shown that there was a decrease in ICTP 
when the RANKL: OPG ratio was reduced.  This confirmed that the high levels of 
OPG are having dampening down the bone destructive process.  However, this did not 
explain the increase in periodontitis levels in this group.  Although lower levels of 
ICTP were observed in the plasma of the diabetic patients there was no statistically 
significant difference in ICTP levels between non-diabetic and diabetic patients. 
Increased levels of this bone marker have been observed in the GCF of periodontitis 
patients (Giannobile et al., 1999; Giannobile et al., 2003).  Our results would tend to 
agree with these findings, since higher median plasma concentrations of bone markers 
were observed in the groups with periodontitis, but the differences failed to reach 
statistical significance.  This failure to see a statistically significant difference may be 
due to measuring ICTP in blood rather than GCF or to the lack of sufficient statistical 
power for determining differences in this particular marker.  The lower levels of ICTP 
that were observed possibly reflect the influence of OPG at reducing bone resorption.  
If the problem was not excessive bone loss it could be a reduction in new bone 
formation or a reduced regenerative capacity.   
Serum osteocalcin is presently considered to be a valid marker of bone turnover when 
resorption and formation are coupled, and a specific marker of bone formation when 
formation and resorption are uncoupled (Giannobile et al., 2003).  It has been shown 
that osteocalcin increases during exercise as the bone remodels to cope with the 
additional strain as well as during periods of bone growth and healing after fracture 
(Ivaska et al., 2007; Banfi et al., 2010).  Although diabetes has been established as a 
risk factor for periodontitis and the osteocalcin levels correlate to periodontal status in 
non-diabetic patients (Bullon et al., 2005), the osteocalcin concentrations in diabetic 
patients and their relationship to periodontitis have not been established.  In this study 
Douglas P Robertson 2011                                                                                  Chapter 4-233 
both diabetic and periodontitis patients have lower levels of osteocalcin than non-
diabetic patients without periodontitis, suggesting lower bone formation.  Reduced 
osteocalcin levels in the presence of periodontitis have been reported before by other 
researchers (Bullon et al., 2005; Buduneli et al., 2005, 2007) and the present data 
show a statistically significant inverse relationship between the extent of periodontitis 
and the osteocalcin levels.  The data also suggest that the failure to adequately control 
diabetes leads to a reduction in plasma osteocalcin and that the elevated blood glucose 
acts independently of the presence of other factors such as, age, gender or 
periodontitis to influence the expression of osteocalcin.  Interestingly, in a prospective 
study in post-menopausal women with periodontitis, low levels of osteocalcin were 
correlated with improved outcomes of periodontal treatment (Bullon et al., 2007).  In 
addition to this it has also been shown that the cyclooxygenase-2 inhibitor, celecoxib, 
can increase osteocalcin levels in experimentally induced periodontitis and thereby 
theoretically reduce alveolar bone loss.  This finding would tend to indicate that there 
may be an uncoupling of the remodelling process and a reduction in the capacity of 
bone to regenerate during and after periods of inflammatory bone loss.  This finding 
was confirmed in a number of studies that have shown a reduced bone density and 
capacity for bone formation in T1DM (Khazai et al., 2009; Masse et al., 2010).   
4.4.3 Reduced bone regeneration 
The mechanism of action could be due to alterations in the number, structure or 
function of osteoblasts in T1DM.  A number of studies in the rat model have 
concluded that a reduced capacity for bone formation is a contributory factor in the 
development of periodontitis.  Following inoculation of bacteria, diabetes was shown 
to suppress the amount of reparative bone formation that occurs after P. gingivalis-
induced bone resorption (Graves, 2006).  In a mouse calvarial model, treatment of 
diabetic mice with a caspase-inhibitor, that blocked apoptosis, significantly improved 
the formation of new bone in diabetic mice following inoculation of P. gingivalis (Al-
Mashat et al., 2006).  The same principle has also been show in a periodontal model 
of alveolar bone loss.  Alveolar bone loss was induced by placement of ligatures in 
the rat, and a cycle of bone loss and subsequent bone formation was examined.  
Osseous repair following induction of periodontal bone resorption was significantly 
limited in diabetic mice being less than half of that of the non-diabetic mice (Liu et 
al., 2006).  Bone repair in diabetes is characterized by decreased expression of genes 
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that induce osteoblast differentiation and result in healing (Bouillon et al., 1991; 
Kawaguchi et al., 1994; He et al.,2004).  Periodontal fibroblasts derived from diabetic 
patients have altered alkaline phosphatase activity and a reduced capacity to form 
mineralised tissue (Hobbs et al., 1999).  It was also shown by Santana et al.(2003) that 
AGEs could have a detrimental effect on osseous healing in diabetic patients.  An 
increase in apoptosis of bone lining cells, the precursors of osteoblasts, has been 
suggested to be the mechanism.  Apoptosis has been implicated in the pathogenesis of 
a number of diabetic complications including neuropathy, cardiovascular disease and 
nephropathy; (Frustaci et al., 2000; Srinivasan et al., 2000; Susztak et al., 2006).  
There is evidence that diabetes suppresses osteoblastogenesis after bacterial challenge 
and the net bone loss could be due to reduced bone formation because of apoptosis of 
bone lining cells (He et al., 2004).  There is also evidence that AGE products are able 
to induce apoptosis of osteoblasts in diabetic patients via the MAP kinase and 
cytosolic apoptotic pathway (Alikhani et al., 2007a,b).  The reduced plasma 
osteocalcin concentrations in the diabetic patients in the present study could be 
explained by a reduction in the number of osteocalcin secreting osteoblasts.  
Apoptosis of matrix-producing cells may be a critical factor in the repair of soft and 
hard connective tissue and may represent an important mechanism through which 
diabetes has a negative effect on the periodontium (He et al., 2004; Liu et al., 2006; 
Graves et al., 2006).  The findings of our study add weight to the theory that diabetes 
associated periodontal destruction may not be solely a destructive process, but may 
also be related to a reduced capacity for healing subsequent to bacterially induced 
bone loss, as the process is uncoupled due to apoptosis of bone lining cells.  This the 
first study to measure these four markers of bone turnover in diabetic patients with 
periodontitis.  
4.4.4 Periodontal parameters  
In this study in order to avoid possible confounding between the periodontitis and the 
non-periodontitis groups we defined the level of disease before the analysis, i.e. a 
diagnosis of periodontitis was confirmed by a minimum of two sites with ≥5mm CAL 
and CPD.  Therefore 14 patients with only one site of ≥5mm CAL and/or CPD were 
excluded.  Statistically significant differences were not observed in RANKL 
concentrations, but in contrast, statistically significant differences in OPG and 
osteocalcin and RANKL:OPG ratios were observed.  
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The finding that the level of BOP was greater in the diabetic patients could also be 
partly explained by a dysfunction of the endothelial cells in the gingival blood vessel 
walls.  Further studies are required to confirm this.  We expected to see a significantly 
higher level of BOP in the periodontitis groups compared with those without 
periodontitis but in the non-diabetic patients this was not the case.  This may be due to 
the poor level of oral hygiene seen in the general population in the United Kingdom 
(Morris et al., 2001).  Although the number of teeth and sites with ≥5mm CPD were 
similar between the diabetic and non-diabetic periodontitis groups the diabetic 
periodontitis group had more teeth and sites affected by CAL≥5mm.  These 
differences were accounted for by a greater prevalence of gingival recession in the 
diabetic patients with periodontitis.  
4.5 Conclusion 
In conclusion, diabetic patients do not appear to be more susceptible to bone 
destruction, but may have a defect in bone formation.  The reduced osteocalcin levels 
in type 1 diabetic patients suggests that these patients have a reduction in their 
intrinsic ability to replace bone, such as has been destroyed during ‘‘acute bursts’’ of 
periodontitis.  This may make them more susceptible to progression of this disease.  
In support of this, other researchers have not indicated a significant change in bone 
density in diabetic patients but have indicated that bone formation may be lower in 
diabetic patients (Bridges et al., 2005, Oz et al., 2006).  Future studies in type 1 
diabetic patients should investigate markers of bone metabolism in combination with 
bone density measurements and pancreatic β cell destruction. 
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5.1 Introduction 
It has been suggested that diabetes has a wide range of effects on oral health beyond 
that of periodontal disease.  There are reports indicating that patients suffering from 
T1DM could be more prone to dental infections and dental caries, have higher 
carriage rates of fungal and bacterial pathogens, a higher prevalence of fungal 
infections and lower salivary flow rates (Ship, 2003).  It has also been reported that 
T1DM patients suffer from burning mouth syndrome (BMS) (Moore et al., 2007) and 
alterations in the oral mucosa due to autoimmune conditions such as lichen planus and 
other mucosal abnormalities such as leukoplakias.  Reactive fibrous growths have also 
been reported to be more common in diabetes mellitus patients (Albrecht et al., 1992, 
Petrou-Amerikanou et al., 1998; Moore et al., 2000; Ujpal et al., 2004).  It has also 
been reported that poorly controlled diabetes and smoking can lead to an increased 
risk of oral leukoplakias and other precancerous lesions. (Dikshit et al., 2006; Meisel 
et al., 2010).   
The key factors involved in these disease processes are the patients’ increased 
susceptibility to infection due to defects in the innate and adaptive immune system, a 
common autoimmune pathogenesis, poor healing capacity, ultrastructural changes due 
to AGE deposition in the mucosa and salivary glands or neuropathy affecting the 
autonomic nervous system and peripheral nerves.  
There have been a number of studies investigating the prevalence and incidence of 
dental caries in T1DM with varying results (Akjuz et al., 1990; Taveres et al., 1991; 
Karjalailen et al., 1997; Twetman et al., 2005).  Diabetic patients are advised to eat a 
reduced sugar diet which, taken in isolation, would be expected to result in a reduced 
caries risk.  This however has not been a universal finding, implicating other factors 
in the development of caries in this population.  Biological plausibility has been 
hypothesised to explain both the studies finding a reduced and increased caries 
prevalence.  Factors supporting the possibility of a reduced caries risk are mainly 
related to the dietary restrictions previously prescribed; that is a diet essentially free of 
5 Caries and oral mucosal abnormalities in 
Type 1 diabetes mellitus 
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processed sugars.  However, more recently such prescriptive and restrictive regimes 
have fallen from favour to be replaced with advice on a healthy balanced diet.  Factors 
favouring an increased caries risk include: increased glucose concentration in saliva 
and GCF, providing substrate for the plaque bacteria, a reduced salivary flow rate, 
resulting in reduced buffering and remineralisation; and increased frequency of food 
consumption throughout the day.  Studies have also shown a tendency to increased 
plaque scores in diabetic patients compared with controls, which is also a risk factor 
for the development of dental caries (Albrecht et al., 1988; Novaes et al., 1991; 
Bridges et al., 1996; Firatli et al., 1996; Lalla et al., 2006a; Kaur et al., 2009).  
 
The aim of this part of the study is to answer the following questions: 
1. Is the prevalence and extent of dental caries increased in T1DM and with 
worsening glycaemic control? 
2. Is the prevalence of oral mucosal abnormalities increased in T1DM and with 
worsening glycaemic control? 
3. Are there differences in the oral mucosal microflora between NDS and T1DM? 
5.2 Materials and methods 
5.2.1 Examination of the dental hard tissues 
Training and calibration of the single blinded examiner was carried out prior to the 
examinations by an experienced trained caries examiner from the Community Dental 
Services. 
This was a cross-sectional study of 204 adults aged 20-55 years with T1DM and 110 
NDS.  Details of recruitment and the inclusion and exclusion criteria were described 
in chapter 2.   
Caries was assessed by visual inspection of the teeth in a dental chair under a dental 
light.  A CPITN probe was used only to remove debris and confirm cavitation.  The 
teeth were examined wet and obvious caries was recorded for each surface.  The tooth 
was split into 6 sections namely mesial, occlusal, distal, buccal, lingual and root 
surfaces and a score was recorded for each.  Caries was assessed at the level of the 
dentine.  Frank cavitation was recorded as caries and un-cavitated lesions were only 
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recorded where the examiner was sure that dentine caries was present as shown by 
clear shadowing in the dentine and decalcification of the overlying enamel.  Where 
there was any doubt the principle was to score the tooth surface as non-carious.  The 
DMFT and DMFS were calculated.  Within this index; F was used for the filled teeth 
or surfaces; D denoted the number of untreated carious teeth or surfaces without 
regard to whether the lesion was in enamel or involved the root; and all teeth that 
were not present for any reason were treated as M for missing.  The care index (more 
correctly called the restorative index) was calculated by dividing the number of filled 
teeth by the total DMFT.  This gives an indication of the amount of dental care that 
the individual has received.  The total number of individuals who had more than 18 
sound and untreated teeth was also calculated as described in the ADH survey (Nunn 
et al., 2001).   
5.2.2 Examination of the oral mucosa 
Prior to the study commencing, the examiner was trained in the diagnosis of oral 
mucosal disorders by a consultant at Glasgow Dental Hospital and School.  Patients 
were asked whether they had experienced any altered taste in the last twelve months 
and if they had, whether they had experienced a metallic taste or an unpleasant taste.  
Patients were also asked whether they had experienced any pain in the preceding 
twelve months.  Where patients answered “yes” to this question and described the 
pain as burning or tingling these patients were tentatively categorised as having oral 
dysaesthesia or burning mouth syndrome.  Any mucosal abnormalities were recorded 
and where there was doubt as to the diagnosis, or where further treatment was 
required, the patient was referred to a consultant in oral medicine.   
5.2.3 Subjective assessment of xerostomia 
Patients were asked a series of questions relating to oral dryness known as the Fox’s 
xerostomia index (Fox, 1987): 
1. Does your mouth feel dry when eating a meal? 
2. Do you find it difficult to swallow dry foods? 
3. Do you sip liquids to help you swallow? 
4. Do you wake during the night with a dry mouth? 
5. Do you have too much saliva, too little or are you not aware of saliva.  
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5.2.4 Saliva collection 
Saliva was collected according to a modification of the method described by 
Navazesh (1982).  The method is described below. 
 
The patient was instructed to refrain from intake of any food or beverage (water 
exempted) one hour before the collection period.  Smoking, chewing gum and intake 
of coffee were prohibited during this hour.  
The patient was then informed that the purpose of the investigation was to measure 
the salivary flow at rest.  The patient was instructed to minimise all facial movements 
particularly movements of the mouth.   
1. To begin saliva collection the patient was asked to void the mouth of saliva by 
swallowing.   
2. The patient was asked to lean slightly forward over the tube and funnel.  This 
was demonstrated to the patient.   
3. The patient was instructed to keep his/her mouth slightly open and to allow 
saliva to drain into the funnel.  The patient was also instructed to keep his/her 
eyes open.   
4. At the end of the 5 minute collection period, the patient was asked to collect 
any remaining saliva in his/her mouth and expectorate into the funnel and test 
tube. 
5. The saliva volume was measured using micropipettes (Finnipipette, Lab 
systems). 
All samples were collected between 8:30 and 11:30 to avoid diurnal variation. 
5.2.5 Microbiological sampling 
The oral microflora was assessed using the oral rinse method (Samaranayake et al., 
1986, Smith et al., 2003).  The patient was asked to rinse their mouth for 30 seconds 
with 9ml of sterile phosphate buffered solution (PBS) pH 7.2; 0.1M.  The clinical 
pharmacy department at the Western Infirmary took responsibility for the preparation 
and quality control of the sterile oral rinse solution (Western Infirmary, NHS Greater 
Glasgow and Clyde).  
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Samples were transferred to the oral microbiology laboratory (Diagnostic services, 
Oral microbiology department, Glasgow Dental Hospital and School, NHS Greater 
Glasgow and Clyde) for immediate processing. 
5.2.6 Sample preparation and culture technique 
Samples were treated according to the laboratories standard operating procedures. 
Briefly the samples were processed in the following way. 
The oral rinses were centrifuged at 1717 xg for 10 minutes and the supernatant was 
discarded.  The pellet was reconstituted with 1ml sterile PBS and diluted to 10-2 and 
10-3.  50µL of the dilutions was spiral plated (Spiral systems inc. Cincinatti, U.S.A.) 
onto Columbia blood agar (Oxoid, Basingstoke, U.K.).  The neat reconstituted 
solution was plated onto the following selective agars: Mannitol salt agar, Sabouraud 
dextrose agar (Oxoid, Basingstoke, U.K.) and Pagano-Levin agar.  The Pagano-Levin 
was prepared in house according to the following standard operating procedure: 10g 
neutral bacteriological peptone (Unipath Ltd. Basingstoke, U.K.), 1g yeast extract 
(Unipath Ltd. Basingstoke, U.K.), 40g dextrose (BDH, Poole U.K.), 15g technical 
grade agar (Unipath Ltd. Basingstoke, U.K.) was dissolved in distilled water with 
frequent mixing and autoclaved for 15mins at 1150C.  The solution was cooled to 
500C and 10ml Triphenyltetrazoliumchloride (TTC) and 5ml of gentamycin was 
added (1ml and 0.5ml respectively/100ml).   
The plates were incubated at 37oC and read at 48 hours. 
5.2.6.1 Strain Identification and sensitivity testing: Staphylococci: 
1. Colonies that were suspected to be Staphylococci species, based on colony 
colour and morphology, were sub-cultured, purified and Gram stained.   
2. An agglutination test was performed on all staphylococcal species using the 
Staphaurex kit (Remel Europe Ltd, Kent, U.K.) and a selective chromogenic 
agar (SAID bioMe´rieux SA, Marcy l’Etoile, France).  Staphaurex and SAID 
positive strains were identified as S. aureus and antibiotic sensitivity testing 
was performed.  
3. Staphyloccus aureus strains were tested for resistance using the Clinical 
Laboratory Standards Institute (C.L.S.I.) disc diffusion method for the 
Douglas P Robertson 2011                                                                                  Chapter 5-241 
following antibiotics: clarithromycin, clindamycin, fucidin, gentamycin, 
oxacillin, mupiricin (high and low level resistance), rifampicin, tetracycline, 
trimethoprim, vancomycin and neomycin (Oxoid, Basingstoke, U.K.).  Zone 
diameters were used to determine cut off points for sensitivity using standard 
laboratory controls (CLSI M100-S19 Kirby Bauer Interpretational Zone 
Diameters (mm)).  
4. Those strains that were coagulase negative were further identified using API 
32 Staph (bioMe´rieux SA, Marcy l’Etoile, France). 
5. All results were reported as cfu/ml. 
5.2.6.2 Strain Identification and sensitivity testing: Fungi 
1. Positive fungal growth was firstly subjected to the germ tube test.  5ml of 
dilute horse serum was placed in a bijou and a small amount of one yeast 
colony was emulsified into the serum and incubated for 4 hours at 370C.  One 
drop was placed on a slide and examined microscopically for germ tube 
production at x10 and x40 objective.  Germ tube positive strains were 
tentatively identified as C albicans.  Identity was confirmed using the API 20C 
(bioMe´rieux SA, Marcy l’Etoile, France). 
2. Antifungal sensitivity testing was carried out using the C.L.S.I. disc diffusion 
method for nystatin and miconazole (Oxoid, Basingstoke, U.K.).  E tests were 
used to determine the sensitivity pattern to amphotericin, fluconazole and 
itraconazole (bioMe´rieux SA, Marcy l’Etoile, France).  A 2 MacFarland 
turbity specimen was prepared in sterile saline and the entire surface of the 
Casitone agar was swabbed evenly with the suspension.  The surface was 
allowed to dry for 10 to 15 minutes before the E-test strip was placed onto the 
surface with forceps.  The plates were incubated for 24-48 hours at 350C 
depending on the candidal species being tested.  When the growth became 
distinctly visible the MIC value at the point of the intersection between the 
zone edge and the E-test strip was reported as the minimum inhibitory 
concentration.   
3. Results were reported as either sensitive or resistant.  Strains were sensitive to 
fluconazole if the MIC was ≤8µg/ml, sensitive dependent on the dosing regime 
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(S-DD) 16-32µg/ml and resistant above 64µg/ml.  Strains were sensitive to 
itraconazole if the MIC was ≤0.125µg/ml, S-DD 0.25-0.5µg/ml and resistant 
above 1µg/ml.  Where the level of susceptibility was intermediate the 
minimum inhibitory concentrations were expressed in µg/ml.  Nystatin and 
miconazole were reported based on the diameter of a zone of clearing 
according to laboratory standards (CLSI M44-A, Kirby Bauer Interpretational 
Zone Diameters (mm)). 
5.2.6.3 Strain Identification and sensitivity testing: Coliforms 
1. Cultures that were suspected to be coliforms, based on colony morphology and 
appearance, were sub-cultured overnight, purified and Gram stained.  In 
addition an oxidase test was performed using Pyo-Test®MW990 (Medical 
Wire & Equipment Co (Bath) Ltd, Wiltshire, England).   
2. Oxidase positive gram negative rods were further identified using the API20E 
(bioMe´rieux SA, Marcy l’Etoile, France). 
3. Oxidase negative gram negative rods were further identified using the 
API20NE (bioMe´rieux SA, Marcy l’Etoile, France). 
4. Sensitivity testing was carried out for all coliforms using the CLSI disc 
diffusion method for the following antibiotics: cefuroxime, cefpodoxime, 
ciprofloxacin, ceftriaxone, gentamycin, tazosin and trimethoprim (Oxoid, 
Basingstoke, U.K.).  Zone diameters were used to determine cut points for 
sensitivity using standard laboratory controls (CLSI M100-S19 Kirby Bauer 
Interpretational Zone Diameters (mm). 
5. Stains were also tested for the presence of extended spectrum beta-lactamase 
(ESBL). 
All cultures were reported as cfu/ml using the oral rinse plate method.  All reports 
were checked and signed off by a consultant in oral microbiology.   
5.2.7 Data handling 
Please see chapter 2 for details of data handling. 
5.2.8 Statistical analysis 
The differences between the distributions of the caries outcomes, the salivary flow 
rate and the density of colonisation across the three groups were calculated using the 
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Kruskal Wallis test, followed by the Mann Whitney U test with a correction for 
multiple comparisons.  The data were not normally distributed.  Therefore the data 
were summarised using medians and interquartile ranges.  The categorical data 
including the proportion of cases: with specific oral mucosal abnormalities; 
complaining of xerostomia, carrying C albicans, Staphylococci or Coliforms; or 
having reduced salivary flow were tested using the chi squared or Fisher’s exact test 
(< 5 cases).  The significance level was set at 0.01 due to the number of comparisons.  
All statistical tests were carried out using SPSS18 (SPSS inc).   
5.3 Results  
5.3.1 Dental caries 
The calibration exercises performed prior to the study revealed that the inter-examiner 
reproducibility was very good to excellent (Table 5-1).  The kappa scores for inter-
examiner calibration for caries, restorations and missing teeth were 0.83, 1.0 and 0.91.  
The ongoing calibration throughout the study confirmed that intra-examiner 
calibration was excellent with kappa scores of 0.98, 0.98 and 1.0 for caries, 
restorations and missing teeth.   
Table 5-1 Results of calibration exercise. 
 Caries 
scale1 
 
Caries 
free/caries 
present2 
Filled3 Missing4 
Κ 0.75 0.83 1 0.91 
Perfect agreement 91.8% 93.9% 100% 99.2% 
Within 1 unit 97.4% - - - 
Mean bias 0.13 0.006 0.000 0.007 
Inter-
examiner  
Calibration 
Measurement error 0.54 0.247 0.000 0.085 
Κ 0.96 0.98 0.98 1.0 
Perfect agreement 99.7% 98.9% 99.5% 100% 
Within 1 99.8% - - - 
Intra-
examiner  
Calibration 
Mean bias 0.00 0.00 0.00 0.00 
Perfect agreement 
Within 1: agreement between replicates to within 1 unit on measurement scale 
Mean bias: mean of differences between replicates 
Measurement error: SD of differences between replicates 
1 Agreement across the scale of caries rating 0-4 
2 Agreement in dichotomous score caries free/carious surface 
3 Agreement between filled and non-filled surfaces 
4 Agreement between missing and non-missing teeth 
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The results are presented in Table 5-2 and in the following figures.  There were no 
differences in median (interquartile range) DMFT between NDS, WCD and PCD 
(NDS, 16 (16-20.5), WCD 15 (10-20), PCD, 15 (10-21) p= 0.9) (Figure 5-1).  There 
was also no difference in the DMFS scores between the three groups (NDS 54 (34.5-
73), WCD 49.5 (35-72.5), PCD 52 (33-80) p= 0.967) (Figure 5-2).  All three groups 
had the same median number of teeth missing (4 p =0.655) (Figure 5-3).  The number 
of filled teeth and filled surfaces was slightly higher in the NDS.  The median number 
of filled surfaces for the PCD group was 2.5 higher than the WCD (filled surfaces 
NDS 21(10-38), WCD 17.5 (8.5-34.5), PCD 20 (7-37).  The PCD group had the 
lowest number of filled teeth with 8 restored teeth compared with 8.5 (WCD) and 9 
(NDS) (p = 0.763, p = 0.178) (Figure 5-4).   
The number of decayed surfaces was highest in the PCD group (median, NDS 2, 
WCD 2, PCD 3 p= 0.088).  The number of decayed teeth was also slightly higher in 
PCD compared with NDS (Median NDS 1, WCD 1.5, PCD 2 (p=0.075) (Figure 5-5).  
The care index was lowest in the PCD patients and highest in the NDS (median NDS 
0.59 (0.39-0.71), WCD 0.52(0.36-0.62), PCD 0.52(0.31-0.64) p=0.03) (Figure 5-6).   
The number of patients with one or more decayed teeth was very high in all three 
groups and was slightly higher in the PCD group compared with WCD and NDS 
(NDS 68.8%, WCD 70.6%, PCD 78.8%) (Figure 5-7).  There were no statistically 
significant differences in any caries related parameters between the three patient 
groups.  The number of subjects with more than 18 sound and unfilled teeth was 
similar across the three groups (WCD 45%, WCD 47.1%, PCD 47.6% p= 0.909) 
(Figure 5-8). 
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Table 5-2 Dental caries and diabetic status. 
NDS 
(110) 
WCD 
(34) 
PCD 
(170) 
 Diabetic 
status 
Median 
(IQR) 
min-
max 
Median 
(IQR 
min-max Median 
(IQR 
min-max  P 
value 
DMFT 16 
(10-20.5) 
1-32 
15 
(10-20) 
2-23 
15 
(10-21) 
0-32 0.9 
DMFS 54 
(34.5-73) 
2-167 
49.5 
(35-72.5) 
4-151 
52 
(33-80) 
0-150 0.967 
No. of 
decayed 
teeth 
1 
(0-3) 
0-15 
1.5 
(0- 3.5) 
0-7 
2 
(1-4) 
0-14 0.075 
Missing 
teeth 
4(3-6) 0-17 4(3-6) 0-16 4(3-6) 0-16 0.655 
No. of filled 
teeth 
9 
(6-14) 
0-22 
8.5 
 (4-12) 
0-19 
8 
(4-12) 
0-21 0.178 
No. of 
decayed 
surfaces 
2 
(0-5) 
0-33 
2 
(0-7.25) 
0-21 
3 
(1-6) 
0-30 0.088 
No. of 
Filled 
surfaces 
21 
(10-38) 
0-97 
17.5 
(8.5-34.5) 
0-88 
20 
(7-37) 
0-93 0.763 
Care index 0.59 
(0.39-0.71) 
0-1 
0.52 
(0.36-0.62)  
0-1 
0.52 
(0.31-0.64) 
0-1 0.03* 
Untreated 
decay 
N,(%)  
75 
(68.8%) 
 
24  
(70.6%) 
 
131 
(78.8%) 
 0.211 
>18 virgin 
teeth N,(%) 
49  
(45%) 
 
16  
(47.1%) 
 
80 
(47.6%) 
 0.909 
Kruskal Wallis test *  Statistically significant  p<0.05 
Chi squared test ̷ 
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Figure 5-1  Box plot showing median and interquartile range of 
decayed missing and filled teeth by Diabetic status, 
WCD HbA1c≤7.5%, PCD HbA1c >7.5% 
 
Figure 5-2  Box plot showing median and interquartile range of 
decayed missing or filled surfaces by Diabetic status, 
WCD HbA1c≤7.5%, PCD HbA1c >7.5% 
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Figure 5-3  Box plot showing median and interquartile range for 
the number of missing teeth by diabetic status, WCD 
HbA1c≤7.5%, PCD HbA1c >7.5% 
 
Figure 5-4  Box plot showing median and interquartile range for 
the number of filled teeth by diabetic status, WCD 
HbA1c≤7.5%, PCD HbA1c >7.5% 
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Figure 5-5  Box plot showing median and interquartile range for 
the number of decayed teeth by diabetic status, WCD 
HbA1c≤7.5%, PCD HbA1c >7.5% 
 
Figure 5-6  Box plot showing median and interquartile range for 
the number of care index by diabetic status, WCD 
HbA1c≤7.5%, PCD HbA1c >7.5% 
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Figure 5-7  Bar chart showing the percentage of subjects in each 
group who had at least one decayed tooth by diabetic 
status, WCD HbA1c≤7.5%, PCD HbA1c >7.5% 
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Figure 5-8  Bar chart showing the percentage of patients in each 
group who had more than 18 sound and untreated 
teeth   
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5.3.2 Oral mucosal abnormalities 
All lesions are shown in Table 5-3 and in figures 5-9 and 5-10.  The lesions most 
commonly noted were frictional keratosis and lesions of the tongue including 
fissuring, glossitis and depapillation but there were no differences between the T1DM 
and NDS groups.  There were also no differences in the prevalence of oral candidal 
lesions, including median rhomboid glossitis, angular cheilitis, and denture stomatitis.  
The number of patients with oral mucosal lichen planus or lichenoid reaction was 
three times higher in the diabetic group (NDS 0.8%, T1DM 3% p= 0.168).  There 
were no other differences between the groups. 
Table 5-4 shows the median salivary flow rates, the presence of all oral mucosal 
abnormalities, the presence of all candidal lesions and the microbiological data for 
non-diabetic subjects and the diabetic groups.  Both T1DM and PCD had lower 
salivary flow levels over the 5 minute sampling period than NDS (Section 5.3.4).  
There was no difference in the overall prevalence of oral mucosal lesions across the 3 
groups when all lesions were considered (NDS 28.6%, T1DM 31.2%, PCD 28.7%).   
There were no differences in the prevalence of dry mouth, altered taste, metallic taste 
or unpleasant taste across any of the groups.  There was also no difference in the 
prevalence of altered sensation such as burning-mouth or tingling across the groups.   
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Table 5-3  Summary of all mucosal abnormalities detected in 
non-diabetic subjects and type 1 diabetes mellitus 
patients 
 
 
Soft tissue lesions Diabetic 
n=205 
 Non-Diabetic 
n=112 
Frictional keratosis 20 8 
Tongue lesions 15 8 
  fissured tongue 5 3 
  geographic tongue 3 2 
  glossitis 3 1 
  coated tongue 2 1 
  depapillation of tongue 2  
  median rhomboid glossitis  1 
Candidal lesions 7 4 
  denture stomatitis 5 1 
  angular cheilitis 1 2 
  median rhomboid glossitis  1 
  papillary hyperplasia 1  
Abscess 7 4 
Lichenoid/lichen planus 6 1 
Apthous ulcer 5 3 
Desquamative gingivitis 1 1 
Petichiae 2  
Florid gingivitis 1  
Gingival hyperplasia 1 1 
Herpes labialis 1  
Lymphadenopathy 1 2 
Mucocoele 1  
Pigmentation 1  
White/red patch 1  
Epulis  1 
Ibroma  1 
Pericoronitis  1 
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a type 1 diabetic patients vs non-diabetic subjects b poorly controlled patients vs non-diabetic subjects 
 
Table 5-4 Salivary flow rate, mucosal abnormalities and oral microflora in NDS, T1DM and PCD 
 Non-diabetic 
subjects 
N All type 1 
diabetic patients 
N Poorly controlled 
diabetic patients 
N p 
valuea 
p 
valueb 
 
N 112  205  172    
Salivary flow mls/five minute sample, 
median, (IQR), [range] 
0.8 (0.4 to 1.5) 
[0 to 4.2] 
110 0.5 (0.25 to 1.0) 
[0 to 6.5] 
202 0.5 (0.25 to 1.0) 
[0 to 6.5] 
169 0.003 0.01 
Missing % (n) 1.8 (2)  1.5 (3)  1.8 (2)    
         
Dry mouth % (n) 7.3 (8) 110 10.4 (21) 201 10.7 (18) 168 0.42 0.45 
Missing % (n) 1.8 (2)  2.0 (4)  0.6 (1)    
Altered taste 10.7(12)  8.7 (18)  8.7 (15)  0.68 0.554 
Unpleasant taste 9.0(10)  6.9(13)  7.5 (12)  0.49 0.66 
Metallic taste 10.9(12)  8.5(16)  9.4 (15)  0.54 0.68 
Burning mouth 7.1(8)  3.4 (7)  3.5 (6)  0.21 0.26 
Missing % (n) 1.8(2)  9.3 (19)  7.5 (13)    
          
All soft tissue lesions % (n) 28.6 (32) 112 31.2 (64) 205 28.7 (49) 171 0.7 0.55 
         
Candidal lesions % (n) 2.7 (3) 112 3.4 (7) 205 2.3 (4) 171 0.75 0.99 
         
Candida albicans carriage % (n) 48.5 (54) 112 59.5 (122) 205 58.5 (100) 171 0.11 0.145 
Colony forming units 
median, (IQR), [range] 
230 (60 to 725) 
[20 to 48,000] 
54 520 (160 to 1,500) 
[5 to 24,000] 
107 600 (165 to 1,500) 
[5 to 24,000] 
88 0.008 0.006 
Missing % (n) 0  9.2 (11)  10.2 (10)    
         
Staphylococcus aureus carriage % (n) 27.7 (31) 112 33.2 (68) 205 33.3 (57) 171 0.31 0.36 
Colony forming units 
median, (IQR), [range] 
640 (120 to 4,200) 
[16 to 100,000] 
31 500 (160 to 1800) 
[3 to 150,000] 
65 660 (200 to 1,975) 
[20 to 150,000] 
54 0.64 0.92 
Missing % (n) 0  4.3 (3)  7.1 (3)    
 
Douglas P Robertson 2011  Chapter 5-253 
 
 
Figure 5-9  Pie chart showing all oral mucosal lesions in patients 
with T1DM number of lesions, % of lesions 
 
Figure 5-10  Pie chart showing all oral mucosal lesions in the non 
diabetic subjects number of lesions, %of lesions 
5.3.3 Microbiological sampling 
There was no difference in the prevalence of C albicans carriage across the groups. (NDS: 
48.6%, T1DM: 59.5%, PCD: 58.5% p= 0.346, p= 0.142).  Where candidal colonisation 
was detected the growth was heavier in T1DM compared with non-diabetic patients 
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(NDS:T1DM p = 0.008, NDS:PCD p = 0.006).  There was no difference in the prevalence 
of S. aureus carriage between the groups (NDS: 27.7%, T1DM: 33.2%, WCD: 35%, PCD: 
33.3%).  There was also no difference in the density of colonisation where carriage was 
detected (Table 5-4).   
All bacteria and fungi recovered and identified are listed in Table 5-5.  There was no 
obvious difference in the species detected between the NDS, T1DM and PCD.  Between 4 
and 6% of the specimens were positive for coliforms however, there was no increase in the 
carriage of coliforms in T1DM compared with the NDS group.  Antibiotic and anti-fungal 
resistance was rare.  There was one patient who was culture positive for methicillin 
resistant S. aureus (M.R.S.A).  There were 3 clinical isolates of S. aureus that were 
reported as resistant to clarithromycin, 2 strains that were resistant to clindamycin, 8 
strains that were resistant to fucidin, 4 were resistant to oxacillin, 3 were resistant to 
tetracycline and one was resistant to neomycin.  There was no pattern of staphylococcal 
antibiotic resistance in T1DM compared with NDS.   
Anti-fungal resistance was also rare and there was only one Candida clinical isolate that 
was resistant to amphotericin, three that were resistant to fluconazole and 12 that were 
resistant to itraconazole.  Again the numbers were low and preclude comparisons between 
the groups.   
Table 5-5 All species recovered and identified, in NDS, WCD and NDS.   
Species recovered NDS (111) T1DM (205) PCD (172) 
C. albicans 48.6 (54) 59.5 (122) 58.5 (100) 
C. dubliniensis 1.8 (2) 2 (4) 2.3 (4) 
C. guillermondii 0.9 (1) 2 (4) 2.3 (4) 
C. glabrata 1.8 (2) 0.5 (1) 0 (0) 
C. tropicalis 0 (0) 0.5 (1) 0 (0) 
Saccharomyces cerevisiae 0.9 (1) 0.5 (1)  
S. aureus 28 (31) 33 (69) 33 (57) 
Coagulase negative staphylococci 9 (10) 3 (6) 4 (6) 
Coliforms 3.6(4) 3.4(7) 3.5 (5) 
Enterobacter sakazakii 
 0.5 (1) 0.58 (1) 
Enterobacter cloacae 
 1 (2)  
Chryseobacterium indologenes 
 0.5 (1) 0.58 (1) 
Citrobacter fruendii 
 0.5 (1) 0.58 (1) 
Klebsiella oxytoca 1.7(2) 0.5 (1) 0.58 (1) 
Klebsiella terrigna 
 0.5 (1) 0.58 (1) 
Serratia spp. 0.9 (1)   
Serratia liquefaciens 0.9 (1)   
Stenotrophomonas maltofilia 
 0.5 (1) 0.58 (1) 
Strepotococcus    
Streptococcus. constellatus 
 0.5 (1) 0.58 (1) 
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5.3.4 Salivary flow and the Fox’s xerostomia index 
The median salivary flow measured in millilitres per 5 minute sample was 0.8ml for the 
non-diabetic subjects (interquartile range (IQR), 0.4-1.5), and 0.5ml (IQR 0.25-1.0) for the 
T1DM and PCD groups (NDS:T1DM p = 0.003 NDS: PCD p=0.01) (Table 5-4).  When 
the groups were divided into those with normal salivary flow (>0.1ml/minute), reduced 
salivary flow (>0.1<0.2ml/minute) and very low salivary flow (>0.1ml/minute) there were 
more PCD patients in the very low salivary flow group (41%) compared with either the 
NDS or the WCD (29%, 27% p=0.043)(Figure 5-11).  There were also slightly more NDS 
with normal salivary flow than PCD (NDS: 43% vs PCD: 32% p=0.07) (Figure 5-11).   
When the T1DM patients were divided into quintiles, the number of patients reporting that 
they had problems with a dry mouth was relatively low across all five groups and there was 
no difference between the groups (NDS, 7.3% T1DM; 10.1%, Q1, 7.3%, Q2, 12.8%, Q3, 
2.4%, Q4, 13.2, Q5, 15% (p = 031)(Figure 5-12).  The number of patients reporting 
symptoms of dry mouth was twice as high in the group with the highest HbA1c compared 
with the group with the lowest HbA1c and the NDS group.  The second question related to 
those subjects having problems swallowing dry food and again, this was relatively rare 
(NDS, 10% T1DM; 13.6%, Q1, 14.6%, Q2, 7.7%, Q3, 7.3%, Q4, 10.5%, Q5, 27.5% (p = 
047) (Figure 5-13).  Again, there was a striking difference between the NDS and the better 
controlled T1DM groups.  Quintile 5 was almost three times more likely to complain of 
difficulty swallowing dry food compared with NDS.  There were slight differences 
between the groups for those who required liquids for swallowing dry foods with (NDS, 
33.6% T1DM; 40.7%, Q1, 46.3%, Q2, 25.6%, Q3, 31.7%, Q4, 42.1%, Q5, 57.5% (p = 
034) Figure 5-14).  The biggest difference was between quintile 2 and quintile 5 which had 
the highest prevalence again.   
Q1 had more symptoms of xerostomia than Q2, Q3 and Q4 for difficulty swallowing dry 
foods, requiring liquids for swallowing and for the overall Fox’s positive index.  The 
number of patients who were woken by a dry mouth was higher in the NDS group 
compared with the other 2 groups.  Specifically 19.1% of the NDS were affected, while 
only 7.3% of the Q1 and 14.1% of the T1DM group reported being woken with a dry 
mouth.  22.5% of the worst controlled T1DM group reported waking with dryness (Figure 
5-15).  The difference in those patients who felt that they had too little saliva was also 
significantly different between the best and worst-controlled diabetic subjects with 7.5% of 
the best controlled diabetic patients (Q1) reporting that they felt they had too little saliva, 
compared with 15% of the worst-controlled diabetic patients (Q5).  There were no 
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differences in the overall number of patients across the three groups who responded 
positively to any of the Fox’s Index Questions (NDS: 44.5%, T1DM:46.7%, Q1:46%, 
Q2:37%, Q3:36.6%, Q4:52.6%, Q5:60%) (Figure 5-16).  Across all of the Fox’s questions 
there was a trend towards an increase in the number of individuals reporting symptoms of 
xerostomia with increasing HbA1c.  Patients were asked whether they were aware of their 
salivary function.  There were no differences across the groups regarding those patients 
that reported that they felt they had too little saliva, (NDS: 10%, T1DM:12.6%, 
Q1:7.5%,Q2: 15.4, Q3:7.3%,Q4:13.2%, Q5:15%) (Figure 5-17).  
 
Figure 5-11  Bar chart showing the proportion of individuals who had 
normal >0.2ml/min, reduced>0.1<0.2ml/min and severely 
reduced <0.1ml/min across NDS, WCD, PCD 
Table 5-6  Self reported symptoms of xerostomia comparing non 
diabetic subjects with type 1 diabetic patients 
 NDS 
(110) 
T1DM 
(199) 
Q1  
(41) 
Q2  
(39) 
Q3  
(41) 
Q4  
(38) 
Q5  
(40) 
P 
dry mouth (%) 7.3 10.1 7.3 12.8 2.4 13.2 15 0.31 
Problem 
swallowing (%) 
10.0 13.6 14.6 7.7 7.3 10.5 27.5 0.047* 
liquid for 
swallowing (%) 
33.6 40.7 46.3 25.6 31.7 42.1 57.5 0.034* 
Woken  with dry 
mouth (%) 
19.1 14.1 7.3 20.5 12.2 7.9 22.5 0.20 
Fox's positive (%) 44.5 46.7 46.0 37.0 36.6 52.6 60.0 0.26 
too little saliva 
(%) 
10.0 12.6 7.5 15.4 7.3 13.2 15 0.26 
Chi squared test* p<0.05 
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Figure 5-12  Bar chart showing the number of patients in the T1DM, 
Quintile 1-5 by HbA1c and NDS who reported that they 
felt that they had a dry mouth 
 
Figure 5-13  Bar chart showing the number of patients in the T1DM, 
Quartile 1-5 by HbA1c and NDS who reported that they 
felt that they problems swallowing dry food 
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Figure 5-14  Bar chart showing the number of patients in the T1DM, 
Quintile 1-5 by HbA1c and NDS who reported that they 
required liquids for swallowing dry foods 
 
 
Figure 5-15  Bar chart showing the number of patients in the T1DM, 
Quintile 1-5 by HbA1c and NDS who reported that they 
felt that were woken during the night with a dry mouth 
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Figure 5-16  Bar chart showing the number of patients in the T1DM, 
Quintile 1-5 by HbA1c and NDS who answered positively 
to any one of the questions in the Fox’s xerostomia index 
 
Figure 5-17  Bar chart showing the number of patients in the T1DM, 
Quintile 1-5 by HbA1c and NDS who reported that they 
felt that they had too little saliva 
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5.4 Discussion 
5.4.1 Caries variables 
5.4.1.1 Missing teeth 
The median number of missing teeth in the present study was four in all groups.  This is 
lower than the national average as shown in the ADH survey (Nunn et al, 2001).  Surveys 
in other developed countries including Germany, Australia and the United states showed 
that the number of missing teeth was highest in the United Kingdom.  In the adult dental 
health survey the mean number of missing teeth was 7.2 while comparable data from the 
above countries were much lower.  German adults had only 2.5 missing teeth; Australians 
had 4.5 missing teeth and in the United States 5.3 in the 45-54 year old group, 2.4 in the 
35-44 year old group and only 0.6 in the 25-34 year old group (Crocombe et al., 2009).   
The lower number of missing teeth in the study reported here is a function of the inclusion 
criteria that stipulated that people should have a minimum number of 20 teeth and of 
course no edentulous patients were examined.  This feature precludes further comparisons 
with other surveys but in no way limits the validity of comparisons between the groups as 
all participants were subject to the same inclusion criteria.  In this study there were no 
differences in the number of teeth.  This is in agreement with the studies in adolescents 
where there were no differences in the number of missing teeth presumably because the 
disease was minimal and they had not the condition long enough to experience tooth loss 
as a result (Do Amaral et al., 2006; Lalla et al., 2006a; Patino-marin et al., 2008; Tagelsir 
et al., 2011).  Kaur and co-workers (2009) however reported that tooth loss was 
significantly associated with T1DM.  Al Shammari (2006) reported that the number of 
missing teeth was significantly higher in diabetic patients of long duration compared with 
those who had had the disease for less than 5 years however this study did not contain a 
healthy control group for comparison.  It is also possible that the group who had had 
diabetes longer were older.  This may account for the relationship between tooth loss and 
duration.  Moore and co-workers (1998) also found that T1DM patients did not have any 
more tooth loss than the healthy controls.  The mean number of missing teeth in this study 
was only 2.5 teeth. 
5.4.1.2 Decayed teeth   
The number of decayed teeth in all three groups was high compared with the national 
average (Nunn et al., 2000).  It is reasonable to compare with the ADH as we used the 
same level of caries as a cut off.  While the use of the D3 level accepts that there is a 
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significant amount of decay that will go unreported this is not an issue.  The absolute level 
of disease is less important than the fact that the same level was applied throughout the 
study across the groups.  About three quarters of all patients had untreated decay (NDS 
69%, WCD 71%, PCD 78%).  There was a slight difference in the number of decayed 
surfaces between the two groups although this was not significant at the 1% level.  Tagelsir 
et al. (2010) recently showed that there was no difference in the level of dental caries in 
type 1 diabetic children.  Miko et al. (2010) reported that the DMFT in T1DM adolescents 
was higher but the decayed component was lower.  Those subjects who had good oral 
hygiene and good glycaemic control were not at a higher risk of dental caries.  This may 
reflect access to dental care which may be better for this group. In our study we showed 
that there was a tendency for the care index to be lower in T1DM rather than higher.  A 
further study in T1DM adolescents showed that the level of untreated decay was higher in 
the T1DM group and that this could have been due to poorer dental attendance (Tagelsir et 
al., 2011).  Saes-Busato and co-workers (2010) reported that the DMF in adolescents with 
T1DM was higher than NDS (1.5 NDS, T1DM 3.3 p<0.05).  Patino-Marin and co-workers 
(2008) concluded that there was no difference in the level of caries between T1DM and 
NDS.   
A longitudinal study over a two year period (Siudikiene et al., 2008) reported that, in 
addition to the shared risk factor of poor oral hygiene, high levels of glucose in saliva in 
diabetic patients were associated with an increased caries increment.  Do Amaral and co-
workers (2006) reported that T1DM patients had less caries than the control group despite 
the fact that the diabetic subjects ate more frequently and had poorer oral hygiene.  In 
another study (Miralles et al., 2006) in a group of Spanish T1DM adults aged 18-50 years 
old investigators reported that the diabetic group had more caries than the control group 
despite having similar levels of oral hygiene.  Siudikiene and co-workers (2006) also 
reported that adolescents with T1DM had more caries than the control group.  There was 
also a difference between WCD patients and the PCD subjects.  Lalla et al. (2006a) also 
did not detect any differences in the level of decay in a group of American diabetic 
subjects.   
The risk of caries was investigated by Twetman and co-workers (2005). They used the 
cariogram caries risk analysis tool and reported that those patients with a high caries risk 
were 7.3 times more likely to be poorly controlled compared with those who had a low risk 
of caries.  Syrjala et al. (2004) showed that self efficacy was the best overall determinant of 
various health behaviour practices.   
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5.4.1.3 Implications of findings 
This study has showed no significant increase in dental caries in the WCD or the PCD 
groups compared with NDS.  The oral hygiene was poorer in both diabetic groups 
compared with the NDS and the PCD had the worst oral hygiene.  These differences were 
only slight and any differences may have been reduced by the high level of disease in this 
population.  The ubiquitous nature of dental caries in the adult population in the West of 
Scotland may have diluted the additive effect of diabetes mellitus.  There was no 
difference in the number of meals and snacks per day between the three groups (mean 
number of meals NDS 2.92, WCD 2.92, PCD 3.0).  Despite the fact that the PCD group 
had poorer oral hygiene, lower salivary flow and a lower level of education this did not 
appear to have a significant impact on caries experience.  A low restorative index may be 
due to low dental attendance but also may be due to dental prescribing patterns.  The 
carious lesions in question were clear unambiguous lesions that were normally cavitated.  
The frequency of dental attendance and the attitude towards health care may result in a 
reduction in the care index as there were a greater number of patients in the diabetic groups 
with a lower ratio of filled teeth to DMFT.  This indicates that there are dental needs 
among diabetic subjects that are unmet at the present time.  This is in contrast to at least 
one study that reported that the DMFT was the same between the T1DM group and the 
control group but that there were more filled teeth in the T1DM group and more decayed 
teeth in the control group.  This may reflect the availability of services or the motivation of 
patients and carers.  A recent paper demonstrated that 61.7% of all type 1 diabetic subjects 
had clinically significant apathy (Padala et al., 2008).  Clinical expressions of apathy 
include the following three characteristics: reduced goal directed behaviour, reduced goal 
directed cognition and reduced emotional concomitants of goal directed behaviours.  This 
apathy was associated with increased BMI, poor compliance with medical advice and poor 
compliance with an exercise regime.  It is possible that this apathy could also lead to low 
dental aspiration, compliance with dental goal setting and concern (Kneckt 1999a,b, 2000, 
2001; Syrjala 1999, 2002).  This could lead to apathetic diabetic subjects failing to comply 
with dental advice and failing to see the importance of dental treatment. 
5.4.2 Soft tissue abnormalities 
The examination of the oral mucosa of patients involved in this study revealed that there 
was a range of benign oral mucosal abnormalities noted in both groups.   
5.4.2.1 Frictional keratosis 
The most common of these was frictional keratosis, a normal response of the oral mucosa 
to mechanical irritation.  This condition is often found in patients who suffer from bruxism 
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and cheek biting.  It is an asymptomatic benign condition that confers no risk of malignant 
change.  In combination with other signs of Temporomandibular Joint Dysfunction (TMD) 
it can be a sign of parafunction (Scully and Shotts, 2000).  TMD can cause functional pain 
and this is often associated with psychosocial stress (Jones et al., 1997).  There are no 
studies to demonstrate a link between TMD and diabetes mellitus.  It could be 
hypothesised that the underlying stress of having a long term chronic, potentially 
debilitating condition could have contributed to an increase in TMD and frictional 
keratosis in the diabetic patients.  However, there were no differences in the prevalence of 
frictional keratosis between the groups.  
 
5.4.2.2 Abnormalities of the tongue 
Abnormalities of the tongue were the second largest group of oral mucosal abnormalities.  
These included fissuring of the tongue, glossitis, depapillation, geographic and coated 
tongue and one case of median rhomboid glossitis.  Fissuring, glossitis and depapillation 
are all associated with vitamin deficiencies including folate, vitamin B12 and iron (Field et 
al., 1995; Scully and Shotts, 2000; Thongprasom et al., 2001) although they can also be 
present in oral candidosis and xerostomia (Terai and Shimahara, 2005; Huguley, 1990).  It 
is possible that candidal carriage and/or reduced salivary flow could have resulted in an 
increase in the prevalence of these conditions in T1DM.  A large cross-sectional study on 
T1DM adults showed that median rhomboid glossitis and atrophy of the papillae of the 
tongue were more common in the T1DM group than the controls (NDS 0.4%, T1DM 7.2% 
NDS 2.2%, T1DM 8.9%) (Guggenheimer et al., 2000a, 2000b).  There was no significant 
increase in these lesions in our study (NDS 1 lesion, T1DM 0% NDS 0%, T1DM 1%).  
The study by Guggenheimer had a larger sample size which would have increased the 
statistical power for detecting differences in these rare conditions.  The prevalence of 
smoking was high in this study and this may have also affected the prevalence of oral 
mucosal abnormalities.   
5.4.2.3 Oral mucosal lesions associated with Candidal infection 
There was no difference in the prevalence of candida associated soft tissue lesions 
including denture stomatitis, angular cheilitis, median rhomboid glossitis or papillary 
hyperplasia.  This was perhaps surprising given that there was a slightly higher prevalence 
of candidal carriage in the T1DM group.  In addition, those diabetic patients that carried 
the yeast showed greater density of colonisation.  The number of candidal lesions was very 
small in all groups.  This finding is in agreement with Manfredi et al. (2002) who also 
reported that while candidal carriage was common (66%) the prevalence of candidal 
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lesions or symptoms was of the order of 3.6%.  Willis and co-workers (2000) reported that 
candida species were recovered from the mouths of 77% of diabetic subjects.  Soysa 
(2005) reported that in two comparable studies (Manfredi et al., 2002; Al-Karaawi et al., 
2002) the prevalence of candidal carriage was higher in patients with diabetes mellitus.   
5.4.2.4 Dental sepsis 
There was also no difference between the groups in the number of patients with an acute 
dental abscess at examination.  Historically, purulent oral infections were very common in 
diabetes and indeed can be the presenting feature of undiagnosed or poorly controlled 
diabetes. (Harrison et al., 1983; Ueta et al., 1993).  T1DM patients who today would be 
regarded as being poorly controlled (HbA1c>7.5%) would be unlikely to have widespread 
suppuration.  Diabetes continues however to be a risk factor for the development of 
spreading odontogenic infection of any cause a condition that can have fatal consequences 
(Huang et al., 2005).  It has been shown that subjects who suffer from diabetes have a 
higher prevalence of periapical disease radiographically (Segura-Egea et al.,2005).  
Correspondingly there are reports of improved insulin sensitivity after endodontic 
treatment in patients with diabetes (Schulze et al., 2007)  
5.4.2.5 Lichen planus 
The prevalence of lichen planus /lichenoid reaction was slightly higher in T1DM patients.  
This difference was however not statistically significant which may have been due to the 
low numbers affected.  The study was not powered to detect a difference in prevalence of 
conditions that are as rare as lichen planus.  Lichen planus only affects (0.5-1.9%) of the 
population and it is more common in women than men (Brown et al., 1993; Jaques et al., 
2003).  Lichen planus is an autoimmune disorder and as such it has been suggested that 
there may be a common pathway linking lichen planus and diabetes.  There are reports of 
higher levels of T1DM in patients with lichen planus (Nigam et al., 1987; Conte et al., 
1990; Brown et al., 1993; Denli et al., 2004; Seyhan et al., 2007).  There are also reports of 
higher levels of lichen planus in diabetes mellitus (Albrecht et al., 1992; Bagan-Sebastian, 
1992; Borghelli, 1993).  Quirino and co-workers (1995) and Guggenheimer and co-
workers (2000b) did not however find any increase in the prevalence of oral lichen planus 
in patients with diabetes.  Although in the current study there was a 3 times higher 
prevalence in the T1DM compared with the NDS group this difference may or may not 
have persisted in a larger sample with increased statistical power and further investigation 
would be required.   
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5.4.2.6 The impact of the absence of smoking on the oral mucosal findings 
There was a variety of other oral mucosal lesions reported, but mostly in only one or two 
cases.  The relative infrequency of oral mucosal lesions could be attributable to the fact 
that there were no smokers included in the study.  Tobacco use has been associated with 
premalignant lesions in the mouth including leukoplakias and erythroplakias as well as 
other reactive lesions (Warnakulasuriya et al., 2010).  A study conducted in India showed 
an increase in premalignant lesions in women with diabetes mellitus but this may have 
been due to the confounding effect of smoking (Dikshit et al., 2006).  Similarly Ujpal and 
co-workers (2004) reported in a Hungarian study that the prevalence of oral premalignant 
lesions was higher than previous studies on non-diabetic subjects.  Within the limits of this 
study it is concluded that healthy non-smoking T1DM patients do not have a higher 
prevalence of oral mucosal lesions than healthy controls.  The autoimmune, inflammatory 
and infective nature of many oral mucosal conditions makes the likelihood of a connection 
possible however this has not been born out in this study.  To detect minor differences in 
rare conditions a much greater sample size would have been required.  
5.4.3 The oral microflora in Type 1 diabetes mellitus 
5.4.3.1 Oral carriage of Yeast 
Carriage of yeasts in the oral cavity was increased slightly in the T1DM and PCD groups 
compared with the NDS although the difference was not significant.  The percentage of 
T1DM patients (59.5%) carrying C albicans was almost double the average described by 
Macfarlane et al. (1990) of 34%.  Despite the high prevalence of candidal carriage in the 
T1DM group, the prevalence was 48.5% in the NDS group meaning that the difference in 
C albicans carriage between the groups was not significant.  This is in agreement with a 
small number of studies that did not find an increase in candidal carriage in diabetes 
(Mehnert and Mehnert, 1958; Peters et al., 1966; Tapper-Jones et al., 1981; Phelan and 
Levin, 1986; Doroka-Bobkowska et al., 1996; Kadir et al., 2002; Manfredi et al., 2002).  
These studies are however in the minority.  Many studies have shown that candidal 
carriage rate is increased in T1DM patients (Barlow and Chattawa, 1969; Bhatt et al, 1983; 
Bartholomew et al., 1987; Lamey et al., 1988; Fongsmut et al., 1998; Guggenheimer et al., 
2000a).  It is possible that previous studies did not adequately allow for the confounding 
effect of smoking.  Guggenheimer (2000a) reported that Candida pseudohyphae were 
associated with cigarette smoking.  Soysa et al., (2005) also reported in a review of the 
literature that smoking causes an increase in Candida albicans carriage.  Manfredi et al. 
(2002), Budtz-Jorgensen (1990) and Guggenheimer et al. (2000a) all concluded that local 
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factors including denture wearing and tobacco smoking had a significant impact on 
carriage rates.   
There was an increased density of C. albicans colonisation in T1DM and PCD, who 
carried the yeast, compared with NDS in the current study.  This is in agreement with Odds 
et al., (1978) who also showed that candidal density was related to blood sugar levels and 
urinary glucose levels at the time of sampling.  Tapper-Jones et al. (1981), Hill et al. 
(1989) and Aly and co-workers (1992) also reported that the density of candidal 
colonization was higher in diabetic subjects particularly in those who were poorly 
controlled.   
A simplistic explanation for the increased carriage rates in diabetic patients is the increase 
in salivary glucose levels as a source of nutrients for the fungi.  Yeast grow well in high 
nutrient environment and it is thought that since salivary levels of glucose reflect the 
systemic hyperglycaemia this will encourage fungal growth.   
However, it is also possible that changes to the mucosal immune response affect the ability 
of candida to colonise the oral mucosa.  Pathogen associated molecular pattern receptors 
(PAMPs) such as TLRs are fundamental to the innate immune systems ability to recognise 
bacterial, viral and fungal pathogens and initiate both the innate and adaptive host 
response.  TLR 2 and 4 are responsible for initiating a response to yeasts through 
interaction with the fungal cell wall (Mogensen, 2009).  There are a number of studies that 
have shown that polymorphisms in TLRs are present in patients with both type 1 and type 
2 diabetes mellitus (Pirie et al., 2005; Devaraj et al., 2008).  These defects could be 
responsible for an increased susceptibility to fungal infection although this has not been 
investigated.   
The first stage of fungal colonisation is adhesion to epithelial cells and there is some 
evidence that this initial stage occurs with increased efficiency in patients with diabetes.  It 
has been shown that buccal epithelial cells (BEC) from diabetic patients permit increased 
adhesion of C. albicans (Darwazeh, MacFarlane, and Lamey;Willis et al.).  In one study 
the adhesion of C. albicans buccal epithelial cells of 50 diabetic patients was 55% higher 
than to the BEC of 50 age and sex matched non-diabetic subjects (p < 0.0001).  This was 
confirmed by later workers.  The mechanism of this binding is unknown but may be due to 
reduced salivary lysozyme (Pinducciu et al.), production of extracellular proteinases or 
upregulation of receptors to complement such as inactivated C3b (iC3b) in high glucose 
concentrations (Manfredi et al. 183-89).  An alternative theory to explain the increased 
adhesion of C. albicans to epithelial cells when grown in high sugar media due to the 
development of a fibrofloccular layer on yeast cell surfaces when grown in high sugar 
media may also explain the increased adhesion of candida albicans to the oral mucosa.  
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Accumulation of glycosylation products in epithelial cells may increase numbers of 
receptors for C. albicans (Willis et al.).  It is possible that accumulation of glycosylation 
products on buccal epithelial cells may increase the number of available receptors for 
Candida and thus increase initial adhesion.   
It is however possible that the increased colonization is related to acute hyperglycaemia 
rather than chronically elevated blood glucose levels.  In one study examining the oral 
flora of diabetic subjects admitted to hospital with acute diabetic ketoacidosis the levels of 
candidal carriage were highest in patients admitted for acute metabolic complcations.  This 
would tend to indicate that it is not directly related to long term structural changes such as 
the development of advanced glycation end products but is rather related to reversible 
changes in the oral mucosa or host response.   
Hyphae formation is a critical virulence factor that is associated with candidal adhesion 
and colonisation.  It has been shown in one study that hyphae formation occurred quicker 
in candidal species grown in sera from diabetic patients compared with controls although 
strangely a similar relationship was not seen in saliva (Kumar et al., 1980).  Strains of 
Candida albicans isolated from patients with type 1 diabetes mellitus have been shown to 
be better at forming biofilms (Rajendran et al., 2010).  This capability will greatly increase 
initial colonisation, protection from the host and subsequent resistance to treatment.   
In addition, it has also been reported that high salivary and blood glucose concentrations 
may lead to increased resistance to intracellular killing by macrophages (Willis et al., 
2000; Tsang et al., 2008).  Defects in neutrophil maturation, chemotaxis, phagocytosis and 
cell killing have all been demonstrated in patients with type 1 diabetes (Manoucher-pour et 
al., 1981; Ueta et al., 1993).  The inability of the innate and adaptive immune system to 
eliminate the fungal infections may lead to increased Candidal colonisation in T1DM.   
Changes in salivary flow level have been shown to be associated with both diabetes and 
oral candidosis.  Diabetic patients have been shown to suffer from hyposalivation and 
xerostomia more frequently than non-diabetic subjects.  Saliva produces a mechanical 
flushing and lubricating effect on the oral mucosa limiting colonization.  When this is 
reduced the prevalence of fungal infection increased.  Ben-Aryeh et al. (1993) showed that 
salivary gland dysfunction was associated with oral candidosis in type 1 diabetic patients.  
Saliva also contains a myriad of antibacterial and antifungal molecules that will be reduced 
in patients with type 1 diabetes.  Of particular relevance is secretory IgA which is 
important in preventing adhesion to the oral mucosa.  It is likely that a decrease in salivary 
flow rate consequent to diabetes may enhance candidal colonization through a number of 
mechanisms.   
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The high prevalence of C albicans carriage in the NDS group could be due to the fact that 
they were generally a relatively deprived population and may not therefore be 
representative of the general population.  It is also worth noting that the salivary flow rates 
in the NDS group were reduced compared with normal unstimulated salivary flow rates.  
The normal salivary flow rate is >0.2ml/minute however this level was only seen in 43% 
of all NDS patients.  The median salivary flow rate for NDS was only 0.8ml/5 minute 
sample.  The median salivary flow rate for the T1DM group was only 0.5ml/5 minute 
sample or 0.1ml/minute.  This reduced salivary flow rate in both groups could account for 
the high level of candidal carriage in NDS and T1DM as salivary gland hypo-function for 
any reason reduces the cleansing effects of saliva.  It is also possible that there are 
differences in the immune system that predispose T1DM patients to candidal colonisation 
(Wilson and Reeves, 1986).  We have shown elsewhere that there were differences in the 
pathogenicity of C albicans isolates from T1DM in terms of their biofilm forming capacity 
and proteinase production (Rajendran et al., 2010).  It is possible that the micro-
environment in the mouths of T1DM patients leads to changes in the expression of 
virulence factors leading to improvements in biofilm formation, adhesion and subsequent 
colonisation (Tsang et al., 2009; Rajendran et al., 2010).  The level of glucose in the saliva 
of T1DM is higher than NDS patients and this means that C albicans are constantly bathed 
in a nutrient rich broth which will increase growth (Odds et al., 1978; Darwazeh et al., 
1991).  It is also possible that there are more complex defects in the innate immune system 
including reduced antimicrobial peptide production or other differences in salivary 
composition that lead to inability of the T1DM patient to clear C albicans from the mouth.   
C albicans was the most common species recovered in accordance with all other studies 
however Willis et al. (2000) showed that there was a very high prevalence of C. 
dubliniensis in diabetic patients and HIV positive patients (58/318 of strains recovered 
(18%).  We only reported C dubliniensis in 2% of all cases.  This difference is difficult to 
explain but may represent geographic variation in candidal ecology.  It is also possible that 
there were methodological differences in the way in which the samples were processed that 
increased the sensitivity of the culture method used.   
5.4.3.2 Oral staphylococcal carriage 
S. aureus carriage was high in both groups compared to studies from different centres.  It 
has been suggested that S. aureus carriage is only a transient feature of the oral microflora 
and is not found in the same mouths on successive occasions (Smith et al., 2001).  There 
have only been two studies that have reported Staphyloccal carriage in T1DM patients.  
Massler (1949) reported that diabetic patients had oral carriage of S. aureus and Sanchez-
cordero (1979) reported that S. aureus was associated with periodontitis in T1DM.  
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Staphylococus aureus can also be associated with a painful staphylococcal mucositits 
(Smith et al., 2001).  Oral carriage of S. aureus could serve as a reservoir for nosocomial 
infection and T1DM patients have been shown to be at increased risk of staphylococcal 
skin infection (Graham et al., 2006).  Jackson et al., (1999) reported that the prevalence of 
S. aureus carriage in a healthy population in Scotland was 24% and this increased with age 
and in medically compromised patients.  The level of S. aureus carriage in T1DM was 
33% which is slightly higher than that reported from the same lab in 1999.  The healthy 
control group carried S. aureus in 28% of cases.  This was again only slightly higher than 
the figures reported by Jackson et al., (1999).  There are reports that increasing levels of 
MRSA are posing a problem in diabetic foot clinics however we only found one case of 
oral carriage of MRSA in all the patients.  This would tend to indicate that the mouth is not 
a common source of nosocomial MRSA infection although it may be a source of 
methicillin sensitive S. aureus infection.  
5.4.3.3 Oral carriage of coliforms 
The carriage of coliforms was low in all three groups (NDS:3.6%, T1DM: 3.4%, PCD 
3.5%).  These gram negative bacteria are associated with many different serious diseases 
and although there are no conditions specifically associated with oral carriage it is possible 
that the oral cavity could act as a potential reservoir of infection.  Carriage rates in the 
healthy population were recently reported as 1% to 4% from oral rinses and culture 
techniques and this figure is similar to the prevalence reported in both the T1DM and NDS 
groups (Sedgely et al., 2004).  In T1DM patients, who are at an increased risk of infections 
due to being immuno-compromised, it is potentially worrying that they have oral carriage 
of such pathogens.  There were no differences in the coliform carriage rates between NDS 
and T1DM.  
Antimicrobial resistance was reported only infrequently and there was no difference 
between NDS and T1DM groups in their resistance profiles.  Antifungal resistance was 
seen in only a small number of cases and the anti-fungal agent to which most species were 
resistant was itraconazole.  There were no differences in the resistance profiles of species 
isolated from NDS compared with T1DM.  This confirms that despite the fact that T1DM 
patients are more likely to be given antibiotics or antifungals to treat infection this has not 
had a detrimental effect on the resistance pattern of the microflora isolated from this group.  
Responsible prescribing of antibiotics and antifungal agents should however continue to be 
followed in T1DM patients as well as in the general population.   
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5.4.4 Salivary flow and xerostomia in T1DM  
The unstimulated salivary flow rate was low in T1DM and particularly PCD patients.  The 
numbers of patients with a severely reduced unstimulated salivary flow rate was highest in 
the PCD group.  We also showed that the prevalence of very reduced unstimulated salivary 
flow (<0.1ml) was as high as 29% for the NDS and 41% in the PCD.  This was 
significantly higher than that reported by Flink (2007) who measured salivary flow rates in 
adults between 20 and 70 years of age in a large study.  The prevalence of very low 
unstimulated salivary flow rate ranged from 10.9-17.8% depending on age group.  A 
number of papers have concluded that poorly controlled diabetes can lead to a reduction in 
salivary flow (Sreebny et al., 1992; Moore et al., 2001b; Siudikiene et al., 2006). This 
reduction in salivary flow can also be seen in children and adolescents although this 
finding is not universal (Siudikiene et al., 2006; Edblad et al.,2001).  It has been 
hypothesised that the reduction in salivary flow rate may be due to dehydration as the body 
excretes excess glucose through the kidneys.  Where patients are hyperglycaemic it is 
likely that patients may be slightly dehydrated as the body attempts to restore glucose 
homeostasis.  It would have been interesting to see whether the salivary flow was related to 
the concurrent blood glucose level at the time of sampling.  All patients had been 
instructed to have an early breakfast and had not had anything to eat for at least an hour 
prior to sampling so it is unlikely that they would have been hyperglycaemic when the 
saliva was collected.  There is also a diurnal pattern to salivary flow however this is 
unlikely to have been an issue as all sampling was taken at around the same time during 
the morning (Ionescu et al., 1998; Navazesh and Kumar, 2008).  Any variability in the time 
of sampling would be expected to be equally distributed across the groups.  The number of 
patients who were aware of having too little saliva was relatively low and there was no 
difference between the groups.  It has been shown that subjective assessment of reduced 
salivary flow is not an accurate measure of salivary gland hypo-function.  Use of the Fox’s 
index showed that there were very high numbers of subjects who answered positively to 
these questions.  47% of all T1DM and 45% of all NDS answered positively to at least one 
of the questions in the Fox’s index.  It is possible that the high percentage of patients 
reporting symptoms of xerostomia in the NDS group is masking the effect of diabetes on 
salivary function.  When the responses to the Fox’s questions were looked at according to 
the quintiles of HbA1c it was apparent that there were differences within the diabetic 
group.  For every question, the most poorly controlled group had the most symptoms.  
However, quintile one which consisted of a group of very well controlled subjects were 
very aware of symptoms of a dry mouth despite having a median salivary flow rate that 
was higher than the other quintiles.  An alternative explanation must be sought to explain 
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this unusual pattern.  Salivary flow rate can be reduced by stress and anxiety and it is 
possible that the group of very well controlled diabetic patients may have awareness of a 
dry mouth because of this (Hugo et al., 2008).  The data presented in this study cannot 
confirm this association and a future study with psychometric testing for personality traits, 
anxiety and depression may answer this question.  It is also the case that the best controlled 
diabetic subjects were on average slightly older than the poorest controlled subjects.  It is 
therefore possible that the long term effects of having diabetes may increase symptoms of a 
dry mouth as may the use of polypharmacy and xerostomic drugs although salivary flow 
rates were higher in WCD.  In this analysis we have not accounted for the use of 
xerostomic medication as this would be on the causal pathway.  Many patients were on 
medication that theoretically could result in reduced salivary flow mostly as a result of 
their diabetic condition.  It has been reported that the hypo-salivation seen in type 2 
diabetes mellitus is largely drug related (Meurman et al., 1998).  This does not invalidate 
the finding that type 2 diabetic patients suffer from hyposalivation and are thus at increased 
risk of oral hard and soft tissue complications as a result.  To correct for the possible 
causative agent would be to miss a real problem that exists regardless of the aetiology.  
The identification of the aetiology is secondary to the prevalence of the signs of hypo-
salivation.  The high levels of xerostomia in the control group could possibly be related to 
the use of xerostomic medication although these were not commonly reported in the 
control group that was made up of healthy individuals.  Salivary flow rates have also been 
shown to be reduced in patients who have an increased BMI (Flink, 2007).  A significant 
proportion of both the T1DM and the NDS groups had elevated BMIs and this could be a 
possible explanation for the low salivary flow.   
5.5 Conclusion 
It appears that the caries risk of T1DM adults is not significantly increased compared with 
healthy controls.  The number of restorations was also lower and the care index was 
correspondingly low in T1DM compared with NDS.  Poorly controlled diabetic patients 
had the poorest oral hygiene, the largest number of decayed surfaces and the lowest 
number of filled teeth and the lowest care index.  This may indicate that they have low 
dental interest and aspirations.  The heterogeneity of results from studies across the world 
indicates that T1DM is not associated with caries in the absence of other risk factors.  
Local and systemic risk factors including the presence of dental plaque and the frequency 
of intake of processed sugars are more important than T1DM as an independent factor. 
Dietary advice to T1DM patients should be targeted to avoiding frequent processed sugars 
and maintaining a healthy diet.  In addition advice on effective oral hygiene measures is 
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essential as this advice is clearly not being followed in either group.  Consideration should 
be given to motivational methods encouraging T1DM patients to manage both their oral 
and systemic health (Rosenbek et al., 2011).  
Within the limits of this study it is concluded that healthy non-smoking T1DM patients do 
not have a higher prevalence of oral mucosal lesions than healthy controls.  The only lesion 
that was slightly increased in T1DM was the prevalence of lichen planus.  To detect minor 
differences in a rare condition such as this would require a much greater sample size. 
T1DM patients had only a slight increase in candidal carriage rates but a significant 
increase in the density of colonisation where it occurred.  We have also shown that 
differences in the pathogenicity in a small number of strains isolated from T1DM may 
account in part for this increase (Rajendran et al., 2010).  The literature to date has often 
mixed up T1DM and type 2 Diabetes and has also failed to account for smoking and 
denture wearing.  In our non-smoking population, the majority of whom had 20 teeth, there 
was no difference in prevalence between the T1DM group and NDS despite poor 
glycaemic control.  There were no differences in the carriage rates of S. aureus or 
coliforms.  There was also no difference in the antibacterial or anti-fungal resistance 
pattern between NDS and T1DM.   
The unstimulated salivary flow rate across the groups was low and the prevalence of self-
reported symptoms of xerostomia were very high in all groups.  T1DM and PCD subjects 
were shown to have reduced unstimulated salivary flow rates.  This information on its own 
would lead us to conclude that these patients are at higher risk of dental caries, mucositis 
and candidal carriage.  The mechanism by which the salivary flow rate is reduced is 
unknown.  Further studies would be required to elucidate the connection between T1DM 
and reduced salivary flow.  Possibilities include ultrastructural changes to the salivary 
glands themselves, the role of osmotic diuresis in causing dehydration and consequent 
reduced salivary flow or autonomic neuropathy.  The impact of progressive neuropathy on 
the sympathetic and parasympathetic control of the salivary glands might also be another 
mechanism for hyposalivation in T1DM patients.   
Douglas P Robertson, 2011   Chapter 6-273 
6 Oral and General Health Related Quality of life  
 in Type 1 Diabetic patients 
6.1 Introduction 
T1DM has been shown in the preceding chapters to be associated with an increased 
prevalence of periodontal disease and xerostomia.  The clinical data has shown that poorly 
controlled diabetic patients produce less saliva and have higher mean periodontal probing 
depths and clinical attachment level as well as an increased prevalence of moderate and 
severe periodontitis.  There was also an increase in the total load of C. albicans with higher 
mean cfu/ml in those diabetic subjects that carried the fungus and a trend to an increase in 
dental caries.  The impact that these clinical findings have on oral function and oral and 
general health related quality of life has not been examined in this group.  It is not known 
whether the presence of diabetes alone is sufficient to significantly impact on the patient’s 
perception of Oral Health Related Quality Of Life (OHRQOL).  The aim of this chapter is 
to examine the relationship, if any, between type 1 diabetes and general and OHRQOL and 
to measure its impact. 
The research questions are: 
• Do patients with T1DM report a greater impact of oral diseases on OHRQOL? 
• Does poor glycaemic control result in a greater impact of OHRQOL?  
• Do measures of diabetes related quality of life correlate with OHRQOL measures? 
6.2 Materials and Methods 
Recruitment method and inclusion and exclusion criteria have been described in chapter 2.  
All patients were asked to complete two questionnaires during the visit for the clinical 
examination.  The clinical research nurse was available to assist with completion of the 
questionnaires if required.  A generic oral health questionnaire was also used to record 
demographic information as well as information about the subjects’ medical and dental 
history. 
6.2.1 OHIP-14 Questionnaire 
The subjects were given all necessary information about the study and provided informed 
consent to participation. All subjects were asked by the clinical research nurse to complete 
the Oral Health Impact Profile (OHIP-14) questionnaire during the clinical examination 
visit.  This instrument consists of 14 questions organized into 7 dimensions: functional 
limitation (2 questions), physical pain (2 questions), psychological discomfort (2 
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questions), physical disability (2 questions), psychological disability (2 questions), social 
disability (2 questions), and handicap (2 questions).  Each question had 5 response 
categories from “never” to “very often.”  The questions referred to the subject’s experience 
in the previous 12 months.  The questions included in the OHIP-14 are listed in table 6-1 
including their domains.  
6.2.2 ADDQOL 
At the same visit the T1DM subjects were asked to complete the Audit of Diabetes 
Dependent Quality of Life Questionnaire (ADDQOL).  The ADDQOL questionnaire 
consists of two overview questions including, a global quality of life question, and a 
question about the impact of diabetes on their quality of life, followed by 18 questions 
about the impact of diabetes on specific aspects of their lives.  Subjects were asked to 
complete the ADDQOL at the same visit.  The ADDQOL questions are listed in table 6-2 
Answers ranged from very much better/increased to very much worse/decreased.  The 
maximum negative score was -3 and the maximum positive score was 3.  For each separate 
question, subjects were asked to rate the importance of each domain to them.  Importance 
was scored in the following way: very important (3), important (2), somewhat important 
(1), not at all important (0).  The individual domain score was multiplied by the relative 
importance giving a maximum negative impact of -9 and a maximum positive impact of 9.  
Question 1 records the individual’s general quality of life. Question 2 records the patients’ 
perception of the impact that diabetes specifically has had on their quality of life.  The 
average weighted impact (AWI) of the diabetes on the patient’s quality of life was 
calculated by adding up the scores for the individual domains and dividing by the number 
of valid domains.  The maximum tolerable number of missing or non-applicable items was 
6 maintaining an alpha >0.8 as calculated by Bradley et al. (1999).  The ADDQOL was 
summarised using the two overview items and the AWI.  Further exploratory analyses 
were also performed on the impact of the individual domains on the global, diabetes 
specific, and OHRQOL measures. 
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Table 6-1 OHIP-14 Questions and domains (Slade et al., 1997) 
Domain Question: In the Last 12 months… 
Functional Limitation Have you had trouble pronouncing any words because of 
problems with your teeth, mouth or dentures? 
Have you felt that your sense of taste has worsened 
because of problems with your teeth, mouth or dentures? 
 
Physical pain 
 
Have you had painful aching in your mouth? 
Have you found it uncomfortable to eat any foods because 
of problems with your teeth, mouth or dentures? 
 
Psychological 
discomfort  
 
Have you been self-conscious because of your teeth, mouth 
or dentures? 
Have you felt tense because of problems with your teeth, 
mouth or dentures? 
 
Physical disability  
 
Has your diet been unsatisfactory because of problems with 
your teeth, mouth or dentures? 
Have you had to interrupt meals because of problems with 
your teeth, mouth or dentures? 
 
Psychological 
disability 
 
Have you found it difficult to relax because of problems 
with your teeth, mouth or dentures? 
Have you been a bit embarrassed because of problems with 
your teeth, mouth or dentures? 
 
Social disability  
 
Have you been a bit irritable with other people because of 
problems with your teeth, mouth or dentures? 
Have you had difficulty doing your usual jobs because of 
problems with your teeth, mouth or dentures? 
 
Handicap  
 
Have you felt that life in general was less satisfying 
because of problems with your teeth, mouth or dentures? 
Have you been totally unable to function because of 
problems with your teeth, mouth or dentures? 
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Table 6-2 ADDQOL questionnaire (Bradley, 1999) 
ADDQOL  
1. In general, my present quality of life is: 
2. If I did not have diabetes, my quality of life would be: 
3. If I did not have diabetes, my working life and work-related opportunities would 
be: 
4. If I did not have diabetes, my family life would be: 
5. If I did not have diabetes, my friendships and social  life would be: 
6. If I did not have diabetes, my sex life would be: 
7. If I did not have diabetes, my physical appearance would be: 
8. If I did not have diabetes, the things I could do physically would be: 
9. If I did not have diabetes, my holidays or leisure activities would be: 
10. If I did not have diabetes, ease of travelling (local or long distance) would be: 
11. If I did not have diabetes, my finances would be: 
12. If I did not have diabetes, my confidence in my ability to do things would be: 
13. If I did not have diabetes, my motivation to achieve things would be: 
14. If I did not have diabetes, the way society at large reacts to me would be: 
15. If I did not have diabetes, my worries about the future would be: 
16. If I did not have diabetes, my need to depend on others for things I would like to 
do for myself would be: 
17. If I did not have diabetes, my living conditions would be: 
18. If I did not have diabetes, my freedom to eat as I wish would be: 
19. If I did not have diabetes, my enjoyment of food would be: 
20. If I did not have diabetes, my freedom to drink as I wish (e.g. sweetened hot and 
cold drinks, fruit juice, alcohol) would be: 
 
6.2.3 Data management 
The three questionnaires were filled in on paper and were later transcribed into a custom-
made electronic form in Microsoft AccessTM.  A unique identifier was used to link all 
questionnaire data to the clinical parameters.  Full clinical dental examinations were 
carried out on all subjects as described in chapter 2 and stored electronically as described. 
6.2.4 Statistical analysis 
The OHIP-14 data was analysed using a number of different algorithms.  The scores for the 
different domains (0-4) can simply be summed to give a score ranging from 0-56 (OHIP 
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Sum).  In this method 0=Never, 1= Hardly ever, 2= occasionally, 3= Fairly often and 
4=Very often.  The simple count method counts the number of impacts above a certain 
threshold.  In this study we used three levels; firstly, any impact in the last 12 months 
(OHIP count) secondly, any impact that occurred occasionally (OHIP count >1) - and the 
most frequent impacts of fairly often or very often (OHIP >2).  The individual questions 
were also computed into a dichotomous record of an impact in each of the seven domains.  
The summaries of both OHIP-14 and ADDQOL were subsequently linked to the generic 
oral health questionnaire and the clinical data and loaded into PASW18 (SPSS inc.) for 
analysis.   
OHIP sum and the three OHIP count scores and individual domains were calculated and 
tested for differences according to the demographic data and clinical disease.  The 
demographic data included the following; age, gender, difficulty paying for dental 
treatment, dental anxiety, dental attendance, SIMD, alcohol consumption, frequency of 
tooth cleaning, access to own transport and educational status.  The OHIP scores were also 
compared between patients in whom dental disease was reported including pain, dry 
mouth, altered taste, periodontal disease, plaque levels, bleeding on probing and dental 
caries.  Where the disease was recorded as a dichotomous variable the Mann Whitney U 
test was used to calculate differences in the distributions between the OHIP scores for 
individuals with and without the disease or complaint.  Where the dental disease was 
expressed as a continuous variable the Spearman rank correlation statistic was calculated.   
Spearman Rank correlations were calculated between OHIP scores and the severity of 
pain, percentage bleeding on probing, percentage of sites with plaque, mean clinical 
probing depths, mean clinical attachment loss, number of sites with CPD and CAL >3mm, 
5mm and 7mm, DMFT, DMFS the number of missing teeth, number of filled surfaces and 
the number of decayed surfaces.  
The distribution of OHIP-14 scores (sum, count and individual domains) were compared 
between NDS and T1DM, NDS and WCD and NDS and PCD.  Because the data were not 
normally distributed the Mann Whitney U test was used to compare between two groups 
and the Kruskal-Wallis test was used to test for differences in the distributions between 
NDS:WCD:PCD.   
The distribution of OHIP scores was also compared across the five quintiles of HbA1c 
using the Kruskal-Wallis test.  OHIP scores were also tested for correlations with the 
average HbA1c using the Spearman Rank correlation  
Data was extracted from the ADHS 1998 (Nuttal et al., 2001) and the number of impacts in 
this national dataset was compared with the data derived from the NDS and T1DM groups.  
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Differences in the frequency of oral health impacts between the three groups were 
calculated using the Chi squared test.   
The ADDQOL scores were correlated with the demographic information in a similar way 
to the OHIP-14 scores using the Spearman Rank correlation.  QOL, Diabetes related QOL 
and AWI were all correlated against the OHIP14 scores and the clinical variables. Further 
exploratory analyses were also performed on the impact of the individual domains on the 
global, diabetes specific and oral health related quality of life measures.   
6.3 Results 
The descriptive data for the three groups (NDS, WCD, PCD) were re-analysed based on 
those who had OHIP and ADDQOL data.  OHIP scores were calculated for 110 NDS, 27 
WCD and 157 PCD.  There were no changes from the descriptive data reported in chapter 
2 (Table 2-6).   
In order to establish the construct validity of the OHIP-14 in this patient group the OHIP 
scores were examined for relationships between the summary measures and the 
demographic and clinical findings across all groups.  The relationships between OHIP 
scores and these variables are shown in Table 6-3 and 6-4.   
The median OHIP-14 scores were higher in individuals who were dentally anxious, 
brushed infrequently, who had difficulty paying for dental treatment and who did not have 
access to transport.  Median OHIP-14 scores were also increased by the presence of certain 
oral diseases.  Patients had higher OHIP-14 scores if they had any of the following; less 
than 18 sound teeth, more than 5 carious surfaces, symptoms of dry mouth, pain in the 
previous year and either metallic or unpleasant taste (Table 6-3).  Strangely there was only 
a weak association with the presence of dental sepsis with an increase in the median 
number of frequent impacts in patients with clinically obvious sepsis (p=0.039).  The 
severity of pain experienced, as measured on a scale of one to ten, was strongly correlated 
with OHIP sum, OHIP count, and OHIP count >2 (0.275-0.576, p=0.000).   
When periodontal variables were examined there were only two statistically significant 
correlations.  OHIP sum and OHIP count >1 were weakly correlated with bleeding on 
probing (Spearman rho= 0.15 p=0.01, 0.16 p=0.006) and plaque scores were correlated 
with OHIP sum and OHIP count >1 (Spearman rho= 0.15 p=0.01, 0.18 p=0.002).  There 
were no other statistically significant correlations with the periodontal parameters although 
when the scores were compared between patients with and without severe periodontitis, as 
defined by the presence of CAL ≥5mm, the median OHIP count was higher in those 
patients with severe periodontitis.  This difference was not however statistically significant 
(p = 0.26).   
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The caries related variables were positively correlated with the OHIP scores.  OHIP sum, 
OHIP count, OHIP count >1 and OHIP count >2 were significantly correlated with DMFS 
(Spearman rho= 0.23 p<0.001, 0.222 p<0.001,0.252 p<0.001, 0.216 p<0.001),  DMFT 
(Spearman rho= 0.24 p<0.001, 0.231 p<0.001,0.248 p<0.001, 0.223 p<0.001), the number 
of missing teeth (0.164 p=0.005, 0.152 p=0.009, 0.188 p<0.001, 0.141 p=0.016) and the 
number of filled surfaces (0.176 p=0.003, 0.169 p=0.004, 0.189 p=0.001, 0.224 p<0.001).  
OHIP-14 scores were significantly higher in patients who had answered positively to any 
of the xerostomia questions as shown in Table 6-3.  In addition, there were differences in 
the distribution of OHIP sum, OHIP count, and OHIP count >2 in patients who reported 
having metallic or unpleasant taste.   
OHIP-14 scores were not significantly affected by age, gender, SIMD, dental attendance, 
alcohol intake, education or saliva level. 
 
 
Table 6-3 Relationship between OHIP outcomes and dental variables 
 
OHIP SUM OHIP count 
OHIP 
count>2 Direction 
Infrequent tooth 
cleaning 0.018* 0.017* 0.007** ↑ 
Difficulty paying for 
dental treatment 0.000** 0.000** 0.000** ↑ 
Dental anxiety 0.000** 0.000** 0.069 ↑ 
Access to own transport 0.002** 0.001** 0.36 ↑ 
Pain in the last year 0.000** 0.000** 0.000** ↑ 
Dental sepsis 0.267 0.066 0.039 ↑ 
<18 sound teeth 0.006** 0.005** 0.009** ↑ 
>5 decayed surfaces 0.022* 0.024* 0.87 ↑ 
Dry mouth 0.029* 0.015* 0.007** ↑ 
Fox’s positive 0.002** 0.002** 0.011* ↑ 
Problems swallowing 0.001** 0.001** 0.008** ↑ 
Needs liquids for 
swallowing 0.000** 0.000** 0.047* ↑ 
Woken with a dry mouth 0.002** 0.002** 0.009** ↑ 
Unpleasant taste 0.000** 0.000** 0.000** ↑ 
Metallic taste 0.000** 0.000** 0.000** ↑ 
• p<0.05, ** p<0.01  Mann Whitney U test.  The OHIP scores were statistically 
significantly higher for those subjects in the above categories.  
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Table 6-4 Correlations between OHIP outcomes and dental variables 
 Spearman's 
rho 
OHIP 
SUM 
OHIP 
count  
OHIP 
count 
>1 
OHIP 
count 
>2 
DMFT Corr Coeff 
.240** .231** .248** .223** 
 Sig. (2-tailed) 0.000 0.000 0.000 0.000 
 N 290 290 290 290 
DMFS Corr Coeff .234** .222** .252** .216** 
 Sig. (2-tailed) 0.000 0.000 0.000 0.000 
 N 290 290 290 290 
Number of decayed 
teeth 
Corr Coeff 0.105 0.109 0.096 -0.043 
 Sig. (2-tailed) 0.073 0.063 0.101 0.464 
 N 290 290 290 290 
Number of missing teeth Corr Coeff .164** .152** .188** .141* 
 Sig. (2-tailed) 0.005 0.009 0.001 0.016 
 N 290 290 290 290 
Number of filled teeth Corr Coeff .151** .143* .165** .220** 
 Sig. (2-tailed) 0.01 0.015 0.005 0 
 N 290 290 290 290 
 Number of decayed 
teeth 
Corr Coeff 0.113 0.11 0.112 -0.022 
 Sig. (2-tailed) 0.055 0.062 0.056 0.704 
 N 290 290 290 290 
Number of filled surfaces Corr Coeff .176** .169** .189** .224** 
 Sig. (2-tailed) 0.003 0.004 0.001 0.000 
` N `290 290 `290 290 
Bleeding Corr Coeff .150* .136* .160** 0.034 
 Sig. (2-tailed) 0.01 0.02 0.006 0.567 
 N 294 294 294 292 
Plaque Corr Coeff .151** .136* .180** 0.061 
 Sig. (2-tailed) 0.01 0.02 0.002 0.299 
 N 293 293 293 291 
Severity of dental pain Corr Coeff .573** .576** .455** .275** 
 
Sig.  
(2-tailed) 
0.000 0.000 0.000 0.000 
 N 296 296 292 294 
*p<0.05, **p<0.01 Spearman Rank Correlation.  
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There was no relationship between summary OHIP measures and diabetic status (Table 6-
5).  OHIP sum and OHIP count scores were in fact slightly lower in the well-controlled 
diabetic group than in the control group (Figures 6-1 - 6-4).  
Table 6-5  Median OHIP score by diabetic status.  WCD 
HbA1c≤7.5%, PCD HbA1c>7.5% 
Group 
(n) 
NDS  
(108) 
T1DM 
(184) 
WCD 
 (27) 
PCD 
(157) 
P 
value 
OHIP Sum  
Median(IQR) 
2  
(1-7) 
2  
(0-7) 
2  
(0-7) 
2  
(0-7) 
0.348 
OHIP Count  
Median(IQR) 
2  
(1-4) 
1.5  
(0-4) 
1  
(0-4) 
2  
(0-4) 
0.282 
OHIP Count>1 
Median(IQR) 
1  
(0-2) 
0  
(0-2) 
0  
(0-2) 
0  
(0-2) 
0.693 
OHIP Count>2 
Median(IQR) 
0  
(0-0) 
0  
(0-0) 
0  
(0-0) 
0  
(0-0) 
0.111 
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Figure 6-1   Box plot showing median and interquartile range of OHIP 
sum by diabetic status  
 
Figure 6-2  Box plot showing median and interquartile range of OHIP 
count by diabetic status 
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Figure 6-3  Box plot showing median and interquartile range of OHIP 
Sum by diabetic status (NDS, WCD HbA1c ≤7.5%, PCD 
HbA1c >7.5%) 
` 
Figure 6-4  Box plot showing median and inter-quartile range of OHIP 
count by diabetic status (NDS, WCD HbA1c ≤7.5%, PCD 
HbA1c >7.5%) 
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Table 6-6  Frequency of OHIP-14 scored cross-tabulated against and 
diabetic status 
 Non Diabetic 
Subjects 
N=108 
Well controlled 
diabetes  
N=27 
Poorly 
controlled 
diabetes N=157 
 
P value 
OHIP Sum 
(%) 
    
0 21.8 48.1 30.2 nsd 
1 18.2 0 13.8  
2 8.2 7.4 10.1  
3 8.2 7.4 9.4  
4 2.7 7.4 3.8  
5 7.3 0 1.3  
>5 33.6 29.6 31.4  
OHIP count 
(%) 
    
0 21.8 48.1 30.2 nsd 
1 23.6 3.7 18.9  
2 15.5 18.5 11.9  
3 2.7 0.0 8.8  
>3 36.4 29.6 30.2  
OHIP count >1 
(%) 
    
0 48.2 51.9 55.3 nsd 
1 20.0 11.1 14.5  
2 10.0 18.5 8.8  
3 8.2 0 5.7  
>3 13.6 18.5 15.7  
OHIP >2 (%)     
0 80.9 81.5 89.2 nsd 
1 8.2 11.1 7.0  
2 6.4 3.7 0.6  
3 0.9 0 2.5  
>3 3.6 0.0 0.6  
Chi squared test - no significant differences 
 
Because the OHIP data was skewed towards zero we also cross-tabulated OHIPSum scores 
for 0, 1, 2, 3, 4, 5 and >5.  There were no differences in the proportion of NDS, WCD or 
PCD in any category (Table 6-6).  The same analysis was performed for OHIP count, 
OHIP count >1 and OHIP count >2.  This did not show any other differences between 
NDS, WCD or PCD in the proportion of subjects in any level of oral health impact (Table 
6-6). 
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Prevalence of OHIP impact by 
Domain
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Figure 6-5  Bar chart showing the frequency of oral health impacts 
by domain comparing T1DM with NDS and with data 
extracted from the Adult Dental Health (ADH) survey 
representing the United Kingdom population (Nuttal et al., 
2001) 
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Table 6-7  Frequency of oral health impacts by domain comparing 
T1DM with NDS and with data extracted from the Adult 
Dental Health survey representing the United Kingdom 
population (Nuttal et al., 2001) 
Proportion experiencing 
problem at threshold of 
occasional and abovea (%) 
NDS 
(n=110) 
T1DM 
(n=184) 
ADH 
1998 
(n=6204) 
P value 
NDS vs 
ADH 
P value 
ADH vs 
T1DM 
Physical pain (%) 37.5 35.8 40.0 0.485 0.01* 
Psychological Discomfort (%) 28.2 23.7 27.0 0.829 0.356 
Psychological disability (%) 25.0 20.4 18.0 0.063 0.403 
Functional limitation (%) 8.2 6.9 10.0 0.631 0.213 
Physical Disability (%) 6.3 8.6 9.0 0.402 1.0 
Social Disability (%) 10.7 6.5 8.0 0.296 0.433 
Handicap (%) 10.7 7.5 8.0 0.476 1.0 
a Domain proportion represents those who report an impact for at least one of the questions representing the domain 
 
Both the NDS and the T1DM patients were also compared with the data extracted from the 
ADH survey (1998) (Nuttal et al., 2001).  37.5% of all NDS experienced dental pain at 
least occasionally in the previous year while the same frequency of discomfort affected 
35.8% and 40% of T1DM and ADH respondents respectively NDS v ADH (p = 0.485; 
ADH v T1DM p = 0.01).  ADH respondents therefore reported more frequent physical 
pain than T1DM subjects.   
Subgroup analysis separating the diabetic subjects into five groups by average HbA1c did 
not reveal any significant trends relating either OHIP sum or count scores to the level of 
glycaemic control (Figure 6-6). 
Figure 6-7 represents the OHIP domains by the three groups NDS, WCD and PCD.  There 
was a lower prevalence of physical disability in the WCDs compared with the (NDS 19%, 
WCD 11%, PCD 22%) however this was not statistically significant.  Similarly, there was 
a slightly lower prevalence of psychological discomfort among the WCDs compared with 
the other groups (NDS 43%, WCD 26%, PCD 35%) again this was not statistically 
significant. WCD had a slightly higher prevalence of handicap (NDS 16%, WCD 24%, 
PCD 18%).  There were no significant differences in any of the OHIP domains. 
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a.
b 
Figure 6-6  Box plots comparing the distribution of  (a) OHIP Sum 
and  (b) OHIP count median and inter-quartile range 
between NDS and 5 quintiles of HbA1c 
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Figure 6-7  Bar charts comparing the proportion of NDS, WCD 
(HbA1c ≤ 7.5%) and PCD (HbA1c > 7.5) who experienced 
at least one impact in each of the seven domains.  No 
significant differences in chi squared test   
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Figure 6-8  Bar chart showing the mean negative impact on different 
life domains represented in the ADDQOL   
The ADDQOL items are arranged in order of increasing negative impact in figure 6-8. 
They range from the relatively rare items with minimal impact including living conditions 
and finances (-0.4/-9, -0.41/-9) through to those aspects of life where diabetes has a 
significant impact.  The higher scoring life aspects were the impact on diabetes of their 
worries and their freedom (-3.4/-9, -3.51/-9). 
The ADDQOL scores were correlated with the demographic data, the OHIP scores, and the 
clinical outcomes.   
Table 6-8  Table of bivariate correlation between OHIP outcomes 
and summary measures of ADDQOL (Spearman 
correlation) 
    OHIP SUM OHIP count OHIP count  
>1 
OHIP count 
>2 
QoL Corr Coeff -0.13 -0.139 -0.069 0.032 
  Sig. (2-tailed) 0.089 0.07 0.37 0.674 
  N 172 172 172 172 
AWI Corr Coeff -.307** -.298** -.309** -.179* 
  Sig. (2-tailed)        0.000 0.000 0.000 0.024 
  N 158 158 158 159 
Diabetes 
effect 
Corr Coeff -.160* -.164* -0.138 -0.091 
  Sig. (2-tailed) 0.035 0.031 0.071 0.233 
  N 173 173 173 173 
**. Correlation is significant at the 0.01 level (2-tailed). 
*.   Correlation is significant at the 0.05 level (2-tailed). 
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There were no correlations between QoL and any of the OHIP outcomes.  There were 
highly significant correlations between the average weighted impact of diabetes and OHIP 
sum, OHIP count and OHIP coun t>1(0.307 p<0.000, 0.298 p<0.000, 0.309 p<0.000).  
OHIP sum and OHIP count were correlated with the negative impact of diabetes (-0.160 
p=0.035, 0-.164 p=0.031) however these did not reach significance at the 1% level (Table 
6-8). 
Table 6-9 shows the correlations between the ADDQOL summary items and the individual 
domains of the OHIP questionnaire.  There were strong correlations between the AWI of 
diabetes and functional limitation (-0.219 p=0.006), physical pain (-0.245 p = 0.002), 
psychological discomfort (-0.215 p=0.007), psychological disability (-0.308 p<0.000), 
physical disability (-0.218 p=0-006) and handicap (-0.245 p=0.001). 
There were statistically significant correlations between OHIP sum and OHIP count and 
leisure (-0.26 p=0.001, -0.276 p<0.000), finances (-0.304 p<0.000, -0.308 p<0.000) and 
worries (0.29 p<0.000, 0.28 p<0.000).  OHIP >1 was also correlated with finances, 
enjoyment of food, freedom and dependency on others. 
 
Table 6-9  Table showing bivariate correlation coefficients for OHIP 
domains and summary measures of ADDQOL (Spearman 
correlation) 
  
 
Functional 
limitation 
Physical 
pain 
Psych 
discomfort 
Psych 
disability Handicap 
Social 
disability 
Physical 
Disability 
QoL  Corr 
Coeff 
-0.059 -0.095 -0.076 -0.126 0.022 -0.07 -0.045 
 Sig.  
(2-tailed) 
0.439 0.217 0.324 0.09 0.769 0.352 0.555 
  N 172 172 172 181 181 181 172 
 AWI Corr 
Coeff 
-.219** -.245** -.215** -.308** -.245** -0.144 -.218** 
 Sig.  
(2-tailed) 
0.006 0.002 0.007 0.000 0.001 0.063 0.006 
  N 158 158 158 167 167 167 158 
Diabetes 
effect 
Corr 
Coeff 
-0.122 -.151* -0.087 -.166* -0.133 -0.047 -.162* 
 Sig.  
(2-tailed) 
0.109 0.048 0.254 0.025 0.072 0.527 0.034 
  N 173 173 173 182 182 182 173 
** Correlation is significant at the 0.01 level (2-tailed). 
*   Correlation is significant at the 0.05 level (2-tailed). 
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Table 6-10 shows the correlations between the individual items on the ADDQOL and the 
OHIP domains.  There were statistically significant correlations between “Functional 
Limitation” and the impact of diabetes on family life (-0.209 p=0.007), physical 
appearance (-0.209 p=0.006), motivation (-0.248 p=0.001), enjoyment of food (-0.205 
p=0.009) and finances (-0.205 p=0.009).  The experience of dental pain was also highly 
significantly correlated with a negative impact on leisure (-0.278,p < 0.001), worries         
(-0.202 p = 0.009) and finance (-0.262 p = 0.001).  Psychological discomfort was 
correlated with a negative impact on the social life (-0.215 p < 0.001) worries and a 
negative impact on finance (-0.249 p < 0.001).  Psychological disability was correlated 
with a negative impact on leisure (-0.215 p = 0.004), worries (-0.312 p < 0.001) and 
finance (-328 p < 0.001).  Physical disability correlated with worries (-0.283 p < 0.001).  
Oral handicap correlated with a negative impact on leisure (-0.218 p = 0.003), worries (-
0.236 p = 0.002), and finance (-0.255 p = 0.001).   
None of the ADDQOL summary scores correlated with age, gender, average HbA1c, 
duration, BMI, pack years, alcohol consumption or difficulty paying for dental treatment.  
SIMD was correlated with the average weighted impact (-0.183 p=0.019) and global 
quality of life (-0.186 p=0.013).  Access to the patient’s own transport was also correlated 
with global quality of life (0.237 p=0.001) (Table 6-11) 
There were also strong correlations between age and impact on sexual and family life (-
0.29 p<0.000, -0.262 p<0.000).  Gender was also correlated with impact on sex life (-0.219 
p=0.004).  Duration of diabetes was correlated with negative impacts on freedom to eat and 
drink (-0.218 p=0.004, -0.218 p=0.004).  BMI was strongly correlated with negative 
impact of diabetes on physical appearance (-0.257 p<0.000).  The number of pack years 
was correlated with the impact of diabetes on subjects motivation (-0.275 p<0.000).  SIMD 
was correlated with negative impacts on freedom and a negative impact on the ability to be 
involved in different activities (-0.217 p=0.005, -0.203 p=0.007).  There were no 
correlations between any other demographic variables and any other ADDQOL items 
(Table 6-11). 
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Table 6-10  Exploratory analysis of correlations between the OHIP 
domains and the individual ADDQOL items   
 ADDQOL Items Functional 
limitation 
Pain Psychol. 
discomfort 
Psychol. 
disability 
Social 
disability 
Physical 
disability 
Handicap 
life opportunities -0.086 -0.114 -0.065 -0.135 0.115 -0.018 -0.069 
Corr Coeff 
Sig. (2-tailed) 0.263 0.138 0.398 0.071 0.124 0.817 0.354 
family impact -.209** -0.124 -0.065 -0.127 0.002 -0.09 -0.092 
Corr Coeff 
Sig. (2-tailed) 0.007 0.111 0.407 0.095 0.98 0.248 0.228 
social life -0.056 -0.062 0.001 -0.024 0.016 -0.003 0.025 
Corr Coeff 
Sig. (2-tailed) 0.531 0.487 0.987 0.789 0.856 0.974 0.778 
Sex -0.121 -0.044 -0.098 -0.134 -0.046 -0.125 -0.122 
Corr Coeff 
Sig. (2-tailed) 0.124 0.576 0.216 0.082 0.549 0.113 0.114 
Physical -.209** -.151* -0.129 -.178* -0.088 -0.131 -.171* 
Corr Coeff 
Sig. (2-tailed) 0.006 0.049 0.093 0.017 0.239 0.089 0.022 
Activities -0.143 -0.1 -0.117 -.173* -0.065 -.157* -0.142 
Corr Coeff 
Sig. (2-tailed) 0.061 0.192 0.127 0.02 0.389 0.04 0.057 
Leisure -.179* -.278** -0.092 -.215** -0.071 -.168* -.218** 
Corr Coeff 
Sig. (2-tailed) 0.019 <0.001 0.231 0.004 0.344 0.028 0.003 
Travel -0.051 -0.131 -0.078 -.169* -0.05 -0.087 -0.126 
Corr Coeff 
Sig. (2-tailed) 0.512 0.089 0.31 0.023 0.504 0.26 0.092 
Ability -0.052 -0.138 -0.109 -.182* -0.062 -0.094 -0.12 
Corr Coeff 
Sig. (2-tailed) 0.502 0.074 0.159 0.014 0.412 0.225 0.109 
Motivation -.248** -0.127 0.023 -0.099 -0.044 -0.137 -0.14 
Corr Coeff 
Sig. (2-tailed) 0.001 0.099 0.768 0.188 0.556 0.075 0.062 
Social -.157* -0.076 -.215** -.185* -0.004 -0.022 -.156* 
Corr Coeff 
Sig. (2-tailed) 0.046 0.332 0.006 0.015 0.961 0.782 0.042 
Worries -0.054 -.202** -.331** -.312** -.187* -.283** -.236** 
Corr Coeff 
Sig. (2-tailed) 0.483 0.009 <0.001 <0.001 0.013 <0.001 0.002 
Dependence -0.078 -0.07 -.174* -0.142 0.027 -0.131 -0.083 
Corr Coeff 
Sig. (2-tailed) 0.328 0.384 0.029 0.068 0.724 0.101 0.284 
living conditions 0.005 -0.105 -.193* -.151* -0.069 -.196* -.184* 
Corr Coeff 
Sig. (2-tailed) 0.947 0.186 0.014 0.049 0.372 0.013 0.017 
Freedom -.160* -.172* -0.113 -.173* -0.107 -0.144 -0.08 
Corr Coeff 
Sig. (2-tailed) 0.042 0.028 0.151 0.024 0.162 0.068 0.299 
enjoy food -.205** -0.132 -0.073 -0.149 -.193* -0.151 -.157* 
Corr Coeff 
Sig. (2-tailed) 0.009 0.094 0.354 0.052 0.011 0.056 0.04 
freedom drink -0.106 -0.012 -0.114 -.212** -.165* -0.149 -.165* 
Corr Coeff 
Sig. (2-tailed) 0.18 0.884 0.149 0.005 0.031 0.059 0.032 
Finance -.205** -.262** -.249** -.328** -.151* -.191* -.255** 
Corr Coeff 
Sig. (2-tailed) 0.009 0.001 0.001 <0.001 0.049 0.015 0.001 
**. Correlation is significant at the 0.01 level (2-tailed). *.   Correlation is significant at the 0.05 level (2-tailed). 
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Table 6-11  Table of bivariate correlations between the ADDQOL 
summary measures and demographic data. 
  Spearman's rho AWI QoL Diabetes effect 
Age Correlation 
Coefficient -0.111 0.056 -0.071 
 Sig. (2-tailed) 0.15 0.447 0.338 
 N 170 184 185 
Gender Correlation 
Coefficient 0.001 -0.008 0.09 
 Sig. (2-tailed) 0.994 0.912 0.221 
 N 170 184 185 
Average 
HbA1c 
Correlation 
Coefficient -0.084 -0.138 0.023 
 Sig. (2-tailed) 0.277 0.062 0.755 
 N 170 184 185 
Duration Correlation 
Coefficient 0.083 0.088 0.033 
 Sig. (2-tailed) 0.283 0.236 0.651 
 N 170 184 185 
BMI Correlation 
Coefficient -0.104 -0.091 -0.106 
 Sig. (2-tailed) 0.175 0.217 0.152 
 N 170 184 185 
Pack Years Correlation 
Coefficient -0.112 -0.003 -0.103 
 Sig. (2-tailed) 0.145 0.965 0.164 
 N 170 184 185 
** Correlation is significant at the 0.01 level (2-tailed). 
*   Correlation is significant at the 0.05 level (2-tailed). 
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Table 6-11 cont. 
 
Spearman's 
rho AWI QoL Diabetes effect 
Alcohol 
Consumption 
Correlation 
Coefficient 0.076 0.096 0.007 
 Sig. (2-tailed) 0.326 0.195 0.93 
 N 170 184 185 
SIMD Correlation Coefficient -.183* -.186* -0.13 
 Sig. (2-tailed) 0.019 0.013 0.083 
 N 164 178 179 
Difficulty paying 
for treatment 
Correlation 
Coefficient -0.149 -0.131 -0.015 
 Sig. (2-tailed) 0.054 0.078 0.844 
 N 168 182 183 
Educational 
status 
Correlation 
Coefficient .175* 0.117 0.103 
 Sig. (2-tailed) 0.023 0.116 0.165 
 N 168 182 183 
Availability of 
transport. 
Correlation 
Coefficient 0.076 .237** 0.006 
 Sig. (2-tailed) 0.326 0.001 0.931 
  N 168 182 183 
** Correlation is significant at the 0.01 level (2-tailed). 
*   Correlation is significant at the 0.05 level (2-tailed). 
 
. 
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Table 6-12 Table of summary ADDQOL measures and oral disease 
  QoL AWI Diabetes effect 
  
Corr 
Coeff 
Sig.  
(2-tailed) N 
Corr 
Coeff 
Sig.  
(2-tailed) N 
Corr 
Coeff 
Sig.  
(2-tailed) N 
Number 
missing teeth -0.012 0.868 184 -0.118 0.127 170 
-
0.095 0.196 185 
Number of 
decayed teeth 0.106 
0.155 182 -0.056 0.468 168 -0.031 0.676 183 
Number of 
decayed 
surfaces 
-0.118 0.114 182 0.044 0.575 168 0.082 0.269 183 
Decay>1 -0.091 0.222 182 0.085 0.275 168 0.039 0.6 183 
Decay>3 -0.126 0.089 182 0.015 0.847 168 0.05 0.506 183 
Decay>5 -0.127 0.087 182 0.011 0.885 168 0.055 0.462 183 
Bleeding -.177* 0.017 181 -0.046 0.558 167 0.062 0.403 182 
Attach >3mm 0.03 0.685 181 -0.078 0.314 167 
-
0.128 0.084 182 
Attach >5mm -0.123 0.098 181 -0.017 0.829 167 
-
0.068 0.36 182 
Sepsis -0.017 0.819 183 -0.069 0.375 169 
-
0.049 0.513 184 
Pain year -0.09 0.225 182 -.307** 0.000 168 
-
.196** 0.008 183 
Pain scale -0.07 0.351 182 -.270** 0.000 168 -.179* 0.015 183 
Altered 
metallic -0.087 0.253 173 -.188* 0.018 159 
-
0.071 0.351 174 
Altered taste -0.137 0.071 174 -.221** 0.005 160 
-
0.147 0.052 175 
FOX’S yes/no -.157* 0.034 182 -.195* 0.011 168 -0.14 0.058 183 
** Correlation is significant at the 0.01 level (2-tailed). 
*Correlation is significant at the 0.05 level (2-tailed). 
 
The ADDQOL summary items were correlated with signs and symptoms of dental disease.  
The results of these correlations are summarised in Tables 6-12.  The average weighted 
impact was highly significantly correlated with pain in the last year, severity of pain and 
altered taste (-0.307 p<0.000, -0.270 p<0.000, -0.221 p=0.005).  The effect of diabetes on 
quality of life was weakly correlated with pain experience (-0.196 P=0.08).   
The number of missing teeth was weakly correlated with the impact of diabetes on 
motivation (-0.192 p=0.009).  There were no other statistically significant correlations 
between ADDQOL items and dental caries.  Bleeding on probing was correlated with the 
impact of diabetes on finances (-0.233 p=0.002) and the number of sites with attachment 
loss of ≥3mm was also correlated with those patients who felt that diabetes had a negative 
impact on their family lives (-0.251 p=0.001).  Three of the individual items (finance -
0.274 p<0.000, freedom -0.256 p=0.001, and leisure -0.292 p<0.000) were significantly 
correlated with pain in the last year.  There were also significant correlations between pain 
scale and finance (-0.251 p=0.001), leisure (-0.312 p<0.000), worries (-0.204 p=0.006), 
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ability (-0.192 p=0.01) and motivation (-0.215 p=0.004).  Altered taste was correlated with 
impact on family life (-0.261 p=0.001) and finance (-0.218 p=0.005) as well as dependence 
(-0.211 p=0.008), physical appearance (-0.272 p<0.000 and motivation (-0.267 p<0.000).  
The Fox’s xerostomia index was also correlated with impact on family (-0.195 p=0.01) and 
leisure (-0.241 p=0.001).   
The Global quality of life measure was positively correlated at the 5% level with SIMD 
(p=0.013) as well as bleeding on probing (p=0.017), the Fox’s index (p=0.034) and 
frequency of tooth cleaning (p = 0.028).  The score for the impact of diabetes on QOL 
correlated with mean clinical attachment level (p=0.012), furcation involvement (p=0.028) 
and mobility (p = 0.036).  The average weighted impact was correlated with SIMD 
(p=0.019), education (p = 0.023), the percentage plaque score (p=0.01), and the Fox’s 
index (p=0.011).   
6.4 Discussion 
The OHIP scores were not increased in the T1DM groups despite the fact that they had 
generally higher levels of periodontal disease, reduced salivary flow rate, increased density 
of candidal colonisation and slightly higher levels of caries.  The lack of difference in 
OHIP scores could be accounted for in a number of possible ways.  One possibility is that 
OHRQOL is worse in T1DM but that the NDS were not representative of the general 
population with regard to OHRQOL.  Secondly, it could be that OHIP is not a sensitive 
enough instrument to detect differences in OHRQOL caused by periodontal disease, caries 
and xerostomia.  Thirdly, it is possible that T1DM patients experience no difference in 
impact on quality of life as a result of higher levels of oral disease.   
6.4.1 Poor control selection 
With regard to the first possibility, the control group for some reason could have had 
particularly poor oral health or disproportionately poorer OHRQOL.  In order to 
investigate this possibility, the results of the ADH survey OHIP data were compared with 
both the control group and the diabetic group.  This showed that the pattern of impacts was 
similar and the overall differences in scores were not statistically significant.  Therefore 
poor control selection cannot be the explanation for the lack of differences.   
6.4.2 Poor tool 
The second hypothesis is a feasible explanation.  In the preliminary analysis, it was shown 
that OHIP summary measures correlated significantly with oral symptoms of disease, pain, 
dry mouth, some but not all measures of caries. However, there was little relationship 
between OHIP and periodontal parameters.  Many of the studies validating the OHIP and 
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OHIP-14 have used correlations between oral disease and OHIP summary measures.  
These correlations can be highly statistically significant despite only being <0.1 if there is 
enough data.  Although the p values were extremely low, the correlations were quite weak.  
Aslund reported that there was a strong correlation between B.P.E .and OHRQOL however 
in fact the correlation was only 0.295.  This means that there is a significant part of this 
apparent relationship that cannot be explained by the B.P.E. score.  In most studies it is 
acknowledged that the correlations are low to moderate (Robinson et al., 2003).  Even the 
correlation with dental pain was only moderate at 0.43-0.49 in this study.  It is therefore to 
be expected that less obvious dental disease would have less of an impact and therefore the 
correlations would be correspondingly poorer.   
It is possible that the OHIP-14 is not a sensitive enough measure of the signs of oral 
disease such as mild to moderate periodontitis and dental caries detected during a detailed 
clinical examination.  In the study reported by Drummond-Santana and co-workers (2007) 
they conclude that OHIP scores are increased in patients with periodontitis.  21.4% of these 
patients had advanced periodontal disease which was likely to be impacting on their oral 
health.  Cunha-Cruz showed a similar increase in oral health impact due to periodontal 
disease however again this study was extremely large and the levels of periodontal disease 
were severe (Cunha-Cruz et al., 2007).  Nine teeth with CPD > 5mm or three teeth with 
CPD ≥8mm were statistically significantly associated with the oral health impact.  Busato 
and co-workers (2009) showed that OHRQOL was associated with xerostomia and 
hyposalivation.  This association was also confirmed in this study but did not lead to higher 
overall OHIP scores for patients with T1DM. 
6.4.2.1 Other explanatory variables   
It may also be that there are other factors that determine an individual’s response to the 
OHIP questions for example social, or psychological factors as well as dental factors that 
may have an overriding impact over the presence of moderate asymptomatic periodontal 
disease.  It has been shown in this population that there is a statistically significant 
difference in OHIP outcomes with dental disease although this was not as great as might 
have been expected.  All tests were in the expected direction but the differences were 
minimal and not statistically significant.  This is perhaps due to the fact that the OHIP is 
designed to measure the impact of disease on an individual’s OHRQOL, therefore diseases 
that do not cause significant problems will have less of an impact.  While correlations with 
pain, missing teeth or caries confirm the validity of the tool as these change in the presence 
of oral disease, this does not mean that this is all that is being measured.  Caries will only 
impact on an individual’s quality of life if it gives them halitosis, pulpitis or a periapical 
abscess.  Similarly, periodontal disease will only impact on an individual’s OHRQOL if or 
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when they develop obvious bleeding, halitosis, mobility, pain or when it leads to tooth loss.   
Both pain and missing teeth, the ultimate outcome of caries and periodontal disease, were 
strongly correlated with OHIP summary measures.  It is worth noting that bleeding on 
probing was more closely correlated to OHIP outcomes than the presence of severe 
periodontitis as defined by 1 site with ≥6mm CAL.  It is possible that patients would be 
more aware of multiple bleeding sites during brushing than the asymptomatic presence of 
one site that has ≥6mm CAL.  The presence of the signs of the disease may not be noted by 
the patient, but rather it is the symptoms appearing later that ultimately impact on 
OHRQOL.  
A longitudinal study of T1DM patients with a cohort of control subjects whose OHIP-14 
score was measured over a period of time would be required to demonstrate whether the 
OHIP score would change as the sequelae of caries and periodontal disease manifest 
themselves as the disease progresses with early tooth loss and subsequent loss of function.   
Studies that have shown a relationship between OHRQOL and periodontal disease have 
been in patients who have severe periodontitis and have been seen in a specialist centre for 
their periodontal treatment.  It is possible that there is a difference between such patients 
and those who were recruited into the current study.  Patients who had more severe disease 
including mobility and tooth loss would be more likely to report an impact on their 
OHRQOL while those with less severe disease would be less likely to do so.  In addition, 
the impact of diagnosed disease, the implications and long term sequelae of which have 
been explained to the patient, would likely be different from those with undiagnosed 
disease.  If an individual is aware of bleeding on brushing, but does not know that they 
may lose their teeth as a result of this, then the impact of this symptom on the individual 
will be different from on a recently well informed patient.  The patients in the study by 
Needleman had been referred by their general dental practitioners to a specialist in 
periodontology with a view to receiving periodontal care.  The private referral process is 
necessarily biased toward the recruitment of subjects who are more affluent and this will, 
in turn, affect dental awareness and motivation.  The patient’s knowledge of the disease 
process, the severity of disease and the socioeconomic status of these patients mean that 
the subjects in these studies may not be comparable with the general population 
(Needleman et al., 2004).   
6.4.3 Altered perception of oral health impacts 
The third explanation is that patients with diabetes genuinely do not suffer from additional 
impacts on their OHRQOL for other reasons.  It may be that diabetic patients do not 
perceive that their oral health is worse, even though it can be shown to be so.  One 
possibility is that T1DM patients are less concerned about their oral health due to the fact 
Douglas P Robertson, 2011   Chapter 6-299 
that they have a long term chronic condition that threatens their eyesight, their kidneys and 
their heart and it may be that this affects their outlook on oral health.  It is interesting that 
this study is the second to show that the OHIP is not increased in patients with diabetes.  
The study in Ireland was on only a small number of T1DM patients and there were no 
detailed chartings carried out, although they were obviously a dentally neglected group. 
34% of the patients had not seen a dentist in 5 years and just over 40% of them had seen a 
dentist in the previous years.  It is probably safe to assume that they would have had some 
dental disease and yet their OHIP-20 scores were lower than those reported by a population 
attending the local dental school.  It could however, also be argued that patients attending a 
dental school may not be dentally fit either and so we cannot draw any firm conclusions 
from this study based on the information available (Allen et al., 2008).   
When the diabetic patients were asked about their general QOL only 4 out of the whole 
diabetic group (182) stated that their quality of life was bad or very bad.  It seems that 
despite having a significant chronic disease the large majority of diabetic patients do not 
perceive this as having a negative impact on their quality of life.  It is one of the aims of 
diabetes management that patients are not made to feel that they are limited in their 
ambitions and lifestyle by their diabetic condition.  It is possible that in the same group 
poorer oral health may have a similarly insignificant effect.   
The ADDQOL showed that diabetes impacts on an individual’s quality of life in different 
ways for different life domains.  The areas of life that were least affected by diabetes were 
living conditions, finances and society reaction.  Patients did not feel that diabetes had a 
significant impact on their finances or their living condition, which indicates that patients 
do not feel materially disadvantaged by their condition.  The fact that T1DM patients do 
not feel stigmatised by their condition is a good thing for them and for society.  The areas 
of life where diabetes has the greatest negative impact are in “worries about life” and 
“freedom to eat as they pleased.”  These data are only exploratory and no firm conclusions 
can be drawn from this study due to the number of comparisons and the relatively low 
sample size which lacked statistical power.  The individual domains and the AWI are all 
negative indicating that diabetes has a significant negative impact on the life of most 
T1DM.   
The question was whether it could be shown that there was any relationship between the 
summary measures for the ADDQOL and OHIP scores and dental disease.  The aim was to 
identify whether poor OHRQOL and poor oral health could impact on diabetes specific or 
general quality of life measures.  The average weighted impact of diabetes on an 
individual’s quality of life was correlated with the OHIP sum and count measures.  This 
was highly significant (p < 0.001) although the correlation coefficient was only 0.307 and 
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0.298.  This could indicate that patients who have worse over all perception of their 
OHRQOL also have a lower perception of their diabetes specific quality of life.  In 
addition the AWI was also significantly correlated with functional limitation, physical 
pain, psychological discomfort, psychological disability, handicap and physical disability.  
These correlations were only 0.218-0.308.  In order to assess whether this relationship was 
caused by dental disease, bivariate correlations were calculated between the AWI and 
dental signs and symptoms.  There was no strong relationship between caries or 
periodontal disease although there was a correlation between pain and altered taste and 
AWI.  It is therefore possible that OHIP and AWI scores are not related directly through 
the presence of dental disease but may be influenced by the underlying psychological 
characteristics of the patients.  There are no other studies to date that have investigated the 
possibility of a relationship between global, diabetes specific and oral health related quality 
of life measures.   
6.5 Conclusions 
The oral health related quality of life of patients with T1DM does not seem to be worse 
than NDS.  This could be seen as a positive finding on its own however the lack of 
correlation between either oral disease or diabetes and OHIP-14 scores may give some 
cause for concern.  The mechanism by which T1DM patients who have slightly more 
dental disease have lower OHIP scores is unknown.  Further studies using qualitative 
methods for example focussed groups or structured interviews could be helpful in 
exploring this relationship.  OHIP measures were higher with increased ADDQOL AWI.  
This is unlikely to reflect a causal relationship but may represent a shared psychological 
characteristic.  This study has generated a lot of data surrounding the OHRQOL of T1DM 
as well as their Diabetes specific QOL.  The relationships that have been discovered in this 
exploratory analysis could form the basis of a further study to confirm these initial 
findings.   
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7.1 Conclusions 
This was the first study of its kind to examine the oral and dental health of non-smoking 
T1DM adults.  The conclusions from the clinical data support the view that patients with 
T1DM should be targeted with preventative oral and dental health advice.  Patients with 
T1DM had a greater extent and severity of periodontitis.  There was also evidence that the 
prevalence was increased as well although due to limitations in sample size this effect was 
not statistically significant.  There was little difference in the dental hard tissues of patients 
with T1DM and NDS.  Candidal density, reduced salivary flow rates and symptoms of 
xerostomia were higher in T1DM.  T1DM subjects did  not have any greater frequency or 
severity of oral health impacts on their quality of life as measured using the OHIP-14.  The 
study examining the bone biochemistry in periodontitis and T1DM showed that the ratio of 
RANKL:OPG was reduced.  This would tend to suggest that excessive bone loss is less of 
an issue in diabetes.  Reduced osteocalcin in T1DM suggests that T1DM patients may have 
a reduced capacity for bone healing and regeneration and this uncoupling may lead to net 
bone loss in response to bacterial stimulation.   
Encouragingly, the prevalence of periodontitis was lower in well controlled diabetic 
subjects suggesting that the effect of T1DM on the oral cavity can be ameliorated by good 
glycaemic control even though logistic regression analysis did not show a linear 
relationship.  It is important that health professionals work together in order to prevent and 
manage the oral complications of T1DM in the same way that there are preventive and 
screening programmes for other diabetic complications.  These findings highlight the need 
for incorporation of oral health education into T1DM care pathways, particularly since the 
majority of T1DM patients both in this study and in the United Kingdom generally have 
poor glycaemic control and knowledge of the link between diabetes and oral diseases is 
low.  Early screening and intervention for peridontal disease at diagnosis of diabetes, is of 
particular importance.  In addition, dentists and dental care professionals should be 
informed that patients with poor control of their diabetes have worse periodontitis.  The 
importance of contacting medical colleagues when caring for T1DM patients should be 
stressed because of the bi-directional relationship between general and oral health in 
T1DM.   
7 General conclusions 
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7.2 Further work 
Future studies are required to confirm the effect of periodontal disease including gingivitis 
and periodontitis on glycaemic control in patients suffering from T1DM.  The bi-
directional relationship between T1DM and oral health should be investigated to 
understand whether the oral cavity is a possible source of systemic inflammatory burden 
leading to poor glycaemic control.  Studies are also required to understand the mechanism 
of the increased risk of oral complications in diabetic patients.   
7.2.1 Pathogenesis and treatment of diabetes associated 
periodontitis 
The impact of T1DM on poor wound and bone healing could also be an avenue of 
interesting research in the light of the findings presented in chapter 4. Other areas which 
require further work include the hyper-inflammatory theory; the possibility exists that 
T1DM patients are more prone to inflammation and develop an inappropriate immuno-
inflammatory response to dental plaque (Salvi et al., 2010).  The mechanisms behind the 
altered innate and adaptive immune response including toll-like receptor activation and 
host defence peptides as well as defects in the adaptive immune response are all possible 
contributing factors to T1DM susceptibility.  The role of TLRs in diabetes and periodontal 
disease could be further investigated with a view to exploring whether this is one of the 
underlying explanatory mechanisms.   
7.2.2 Pathogenesis of diabetes associated oral candidosis 
In addition micro-biological investigation is warranted into the virulence factors possessed 
by species of C albicans found in T1DM and the mechanism by which their increased 
density of colonisation is achieved.  We have shown in a small study that C. albicans 
species taken from the T1DM population have different virulence factors.  Biofilm 
formation was significantly increased in the PCD group compared to NDS and BCD 
(better controlled diabetic) groups (P < 0.05).  Both haemolysin and proteinase levels were 
significantly greater in the diabetes groups than in the healthy control group (P < 0.05)       
( Rajendran et al., 2010).  Further investigation of these virulence factors in a larger study 
could confirm or refute these findings. 
7.2.3 Oral health education and improvement 
Further research to investigate the most appropriate delivery of oral heath messages and to 
audit and evaluate the introduction of services should be carried out to ensure that this is 
done with maximum efficiency.  Education and training of individuals involved in 
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providing care for patients with T1DM should be instigated.  The implication of these 
public health and targeting measures should be monitored through prospective studies to 
demonstrate the health benefits achieved in providing this preventive and therapeutic 
approach to the oral complications of T1DM.  
7.2.4 Measuring oral health impact  
The lack of impact of the oral complications of T1DM on oral health related quality of life 
measures is interesting.  It is increasingly important for researchers, clinicians and public 
policy makers to be able to measure quality of life and patient centred outcomes as valid 
forms of outcome.  What matters to the patient must feed into the way in which they are 
treated and the shared goals of treatment.  This study is the second in diabetic subjects to 
show that the OHIP questionnaire outcomes are not higher in diabetic subjects despite the 
evidence that they have more oral disease.  Further investigation of this phenomenon could 
include qualitative research methods including focus groups and structured interviews.  
Differences in psychosocial behaviour and perception of disease due to prolonged 
exposure to a serious chronic condition may account for the differences or targeting 
questionnaires in a qualitative fashion may be able to explain the reasons why T1DM 
patients do not suffer poorer levels of oral health related quality of life as a result of their 
increased prevalence of disease. 
One possible explanation for the fact that individuals suffering from periodontal disease 
and T1DM did not report poorer oral health related quality of life maybe due to the fact 
that current indexes do not record the impact of periodontal disease particularly well. The 
development of measures specifically designed to record the impact of periodontal disease 
on oral health related quality of life may be required.  Future work should involve focus 
groups, input from professionals and from subjects suffering from periodontitis in order to 
develop a valid tool that reliably measures differences in OHRQOL between groups and 
changes with treatment.   
There is a need for on-going research into the oral complications of T1DM.  As the number 
of people suffering from this disease increases in the coming years the oral health impact 
both economically and on individuals will continue to increase.  Methods to ameliorate this 
effect and research to inform our understanding of the pathogenesis are required in order to 
understand, plan for, prevent and treat the oral complications of T1DM in the future. 
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Appendix 4 Oral Health Questionnaire 
 
1. Are you registered with a general dental practitioner?   Yes  No 
 
 
2. If the answer to question 1 is “Yes” how often do you attend your general 
dental practitioner?     
 
At least once a year       Occasionally           Only when having trouble with your 
teeth 
        
 
 
3. What do you do if you have a dental emergency?  
 
_________________________________________________________________
__ 
 
 
4. Are you anxious about visiting the dentist?   Yes  No 
 
 
5. Would you have difficulty paying for dental services?   Yes   No 
 
 
6. What is the highest level of education you have received?  
  
No formal education       Primary school Secondary school University or college 
 
 
 
7. Many people own cars nowadays.  Is there a car or van normally available for 
use by you or your family?     
 Yes  No 
 
 
8. How often do you clean your teeth? 
 
Never    Less than once/day      Once a day      Twice a day    More than twice a day 
 
 
 
9. If you do clean your teeth, do you use a toothpaste containing fluoride? 
 
 Yes  No 
 
 
10. Nowadays, there are more things available in chemist shops to help with dental 
hygiene.  Do you use anything other than an ordinary toothbrush and 
toothpaste for dental hygiene purposes?  
    
 Yes  No 
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11. If the answer to question 10 is “Yes” do you use? 
 
Electric toothbrush         Floss       Interdental brushes       Toothpicks/sticks      
Other 
 
 
 
 
12. Do you use a mouthwash? Yes  No 
  
If the answer is “Yes” which one?  
 
_________________________________________________________________
__ 
 
 
13. In the last 12 months have you had any painful aching or discomfort in your  
     mouth? 
  
 Never  Hardly ever Occasionally Fairly often Very often 
 
 
 
If you have experienced any pain or discomfort in the last 12 months please 
answer questions 14 to 21.  Otherwise please move to question 22. 
 
14. What type of pain or discomfort do/did you have?  
  
Sharp      Throbbing       Dull ache        Burning hot or scalded        Tingling 
sensation 
 
 
 
15. Whereabouts in the mouth do/did you feel the pain or discomfort? 
 
_________________________________________________________________
__ 
 
 
16. How long has the pain or discomfort been present for (days)? 
 
_________________________________________________________________
__ 
 
 
17. Is it present all the time? Yes No 
 
 
18. If the answer to question 17 is “No” describe the pattern of pain or discomfort? 
 
_________________________________________________________________
__ 
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19. Does anything relieve the pain, if so what?  
 
_________________________________________________________________
__ 
 
20. Does anything make the pain worse, if so what?  
 
_________________________________________________________________
__. 
 
21. How severe is the pain on a scale of zero to 10? (please circle)  
 
no pain      intolerable pain 
 
 
 
 
22. Does your mouth feel dry when eating a meal?  Yes No 
 
 
23. Do you find it difficult to swallow dry foods? Yes No 
 
 
24. Do you sip liquids to help swallow dry foods? Yes No 
 
 
25. Do you wake during the night because your mouth is dry?  Yes        No 
 
 
26. Do you feel as if you have too little or too much saliva or, you are not aware of 
it? 
 
 Too little  Too much Unaware of saliva 
 
 
 
27. How many units of alcohol do you consume per week? 
____________________ 
 
 
28.  What type of alcohol do you drink (i.e. beer, wine, spirits and mixers)? 
 
_________________________________________________________________
__ 
 
29. In the last 12 months have you felt that your sense of taste has altered 
because of problems with your teeth, mouth or dentures?  
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
If you have noticed an alteration in your sense of taste: 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 8
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30. Did/do you have an unpleasant taste? Yes  No 
 
31. Did/do you have a metallic taste? Yes  No 
 
 
32. In the last 12 months have you found it difficult to talk because of problems 
with  
      your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
33. In the last 12 months have you found it uncomfortable to eat any foods 
because of problems with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
34. In the last 12 months have you felt self-conscious because of problems with 
your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
35. In the last 12 months have you felt tense because of problems with your teeth 
mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
36. In the last 12 months has your diet been unsatisfactory because of problems 
with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
37. In the last 12 months have you had to interrupt meals because of problems 
with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
 
 
38. How many meals do you eat per day? 
_________________________________ 
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39. How many between meal snacks do you eat per day?  
____________________ 
 
40. In the last 12 months have you found it difficult to relax because of problems 
with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
41. In the last 12 months have you been a bit embarrassed because of problems 
with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
42. In the last 12 months have you been a bit irritable with other people because of 
problems with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
43. In the last 12 months have you had difficulty doing your usual jobs because of 
problems with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
44. In the last 12 months have you felt that life in general was less satisfying 
because of problems with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
45. In the last 12 months have you been totally unable to function because of 
problems with your teeth mouth or dentures? 
 
 Never Hardly ever Occasionally Fairly often  Very often 
 
 
 
 
Thank you for taking the time to complete this questionnaire. 
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Appendix 5 ADDQOL© questionnaire (copyright professor 
Claire Bradley)  do not use without permission  
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